Page last updated: 2024-10-31

metoclopramide and Emesis

metoclopramide has been researched along with Emesis in 743 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Research Excerpts

ExcerptRelevanceReference
"To examine the clinical efficacy of prophylactic metoclopramide in reducing the incidence of nausea and vomiting in emergency department (ED) patients with acute pain who were treated with intravenous tramadol."9.69The efficacy of prophylactic metoclopramide in preventing nausea and vomiting in patients with acute pain treated with intravenous tramadol: a randomized double-blinded, placebo-controlled trial. ( Lokeskrawee, T; Patumanond, J; Phinyo, P; Sriwiset, H; Wongyikul, P, 2023)
"To assess and confirm the effect of ondansetron on behavior suggestive of nausea in dogs with vestibular syndrome."9.51Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study. ( Charalambous, M; Elliott, J; Foth, S; Henze, L; Kenward, H; Meller, S; Pelligand, L; Twele, F; Volk, HA, 2022)
" The EMPOWER (EMesis in Pregnancy – Ondansetron With mEtoClopRamide) trial aimed to compare the clinical effectiveness and cost-effectiveness of two anti-sickness drugs [metoclopramide (metoclopramide hydrochloride, Actavis UK Ltd, Barnstable, UK; IV Ratiopharm GmbH, Ulm, Germany) and ondansetron (ondansetron hydrochloride dehydrate, Wockhardt UK Ltd, Wrexham, UK; IV Hameln Pharma plus GmbH, Hameln)] for the treatment of nausea and vomiting in pregnancy."9.41Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT. ( Campbell, I; Fernandez-Garcia, C; Goudie, N; Graham, R; Howel, D; Lie, M; McColl, E; McParlin, C; Mossop, H; Nadeem, A; Nelson-Piercy, C; O'Hara, ME; Phillipson, J; Robson, S; Shehmar, M; Simpson, N; Steel, A; Ternent, L; Tuffnell, D; Williams, R, 2021)
" Maropitant (MRP) and metoclopramide (MCP) prevent emesis attributable to the opioid agent apomorphine in dogs."9.24A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs. ( Himelfarb, MA; Invaldi, SH; Litterio, NJ; Lorenzutti, AM; Martín-Flores, M; Zarazaga, MP, 2017)
"The aim of the study was to evaluate the efficiencies of selected anti-emetic drugs (metoclopramide, ondansetron and maropitant) in preventing vomiting in the treatment of canine parvoviral enteritis."9.24Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs. ( Keser, GO; Yalcin, E, 2017)
"Eligible patients were those who were mechanically ventilated and over 20 years old, with delayed gastric emptying (DGE), defined as a gastric residual volume ≥250 ml or vomiting, and who failed to respond to first-line prokinetic treatment of 3 doses of 10 mg IV metoclopramide over 24 h."9.22A randomised controlled feasibility and proof-of-concept trial in delayed gastric emptying when metoclopramide fails: We should revisit nasointestinal feeding versus dual prokinetic treatment: Achieving goal nutrition in critical illness and delayed gastr ( Allan, K; Brown, J; Greenwood, R; Manara, A; McWilliam, H; Taylor, SJ; Toher, D, 2016)
" The aim of this study was to verify if A + D is superior to metoclopramide plus dexamethasone (M + D) in preventing delayed emesis in cancer patients receiving the same prophylaxis for acute emesis."9.20Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study. ( Angelelli, L; Ballatori, E; Caserta, C; Cavanna, L; Ciuffreda, L; Colantonio, I; Fasola, G; Fatigoni, S; Fava, S; Ionta, MT; Licitra, L; Massidda, B; Mirabile, A; Palladino, MA; Roila, F; Ruggeri, B; Tocci, A; Zerilli, F, 2015)
"We compare efficacy of ondansetron and metoclopramide with placebo for adults with undifferentiated emergency department (ED) nausea and vomiting."9.19Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo. ( Braitberg, G; Egerton-Warburton, D; Mee, MJ; Meek, R, 2014)
" The granisetron group indicated a higher complete response rate in acute emesis (adjusted OR: 0."9.17Can granisetron injection used as primary prophylaxis improve the control of nausea and vomiting with low- emetogenic chemotherapy? ( Abdul Kassim, MS; Keat, CH; Phua, G; Poh, WK; Sriraman, M, 2013)
"During the 72-h observation period, 39 out of 56 (70%) patients receiving olanzapine had no emesis compared to 16 out of 52 (31%) patients with no emesis for patients receiving metoclopramide (p < 0."9.17The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. ( Gray, SE; Nagy, CK; Navari, RM, 2013)
" Parents or caregivers should be given more detailed discharge instructions about vomiting and diet considering the relatively long time to resuming a normal diet after ketamine sedation and the fact that KAV often occurred after ED discharge."9.16Adjunctive atropine versus metoclopramide: can we reduce ketamine-associated vomiting in young children? a prospective, randomized, open, controlled study. ( Choi, SC; Jeon, WC; Jung, YS; Kim, GW; Lee, JS; Min, YG; Park, EJ, 2012)
"To compare the efficacy of acupressure wrist bands, ondansetron, metoclopramide and placebo in the prevention of vomiting and nausea after strabismus surgery."9.15Comparing the efficacy of prophylactic p6 acupressure, ondansetron, metoclopramide and placebo in the prevention of vomiting and nausea after strabismus surgery. ( Arbabi, S; Ebrahim Soltani, AR; Goudarzi, M; Mohammadinasab, A; Mohammadinasab, F; Mohammadinasab, H; Samimi, M, 2011)
"To compare the efficacy and safety of ondansetron versus less expensive metoclopramide in the treatment of children with persistent vomiting with acute gastroenteritis."9.15Metoclopramide versus ondansetron for the treatment of vomiting in children with acute gastroenteritis. ( Abdulateef, H; Al-Ansari, K; Alomary, S; Alshawagfa, M; Kamal, K, 2011)
"We aimed to compare the relative efficacy of tropisetron and metoclopramide in treating nausea/vomiting in undifferentiated ED patients."9.15Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: A randomized, double-blinded, clinical trial. ( Chae, J; Frauman, AG; Taylor, DM, 2011)
"This study assesses the effects of ginger on nausea and vomiting caused by pregnancy and compares it with metoclopramide medicine."9.15Comparing the effects of ginger and metoclopramide on the treatment of pregnancy nausea. ( Farhadifar, F; Mohammadbeigi, R; Rezaiie, M; Shahgeibi, S; Soufizadeh, N, 2011)
"Of the 380 patients evaluated, significantly fewer ondansetron 4 mg treated patients (89/189; 47%) experienced postoperative nausea and/or vomiting compared with metoclopramide treated patients (115/ 191; 60%) during the study period (p = 0."9.13Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery. ( Diregpoke, S; Krobbuaban, B; Pitakpol, S, 2008)
"The aim of this study was to compare the incidence of nausea and vomiting in patients with acute pain treated with morphine along with prophylactic metoclopramide or placebo."9.12Use of a prophylactic antiemetic with morphine in acute pain: randomised controlled trial. ( Bradshaw, M; Sen, A, 2006)
"This study demonstrates that betamethasone does not prevent nausea, vomiting and increase of vasopressin induced by apomorphine, whereas metoclopramide prevents apomorphine-induced emesis."9.12Betamethasone does not prevent nausea and vomiting induced by the dopamine-agonist apomorphine. ( Axelsson, P; Lövqvist, A; Thörn, SE; Wattwil, L; Wattwil, M, 2006)
"A prospective randomized study was performed to assess the value of some individual risk factors for postoperative nausea and vomiting (PONV), and to compare the efficacy of ondansetron, metoclopramide, dexamethason, and combinations of these antiemetics in preventing PONV in patients after laparoscopic cholecystectomy."9.12Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study. ( Leksowski, K; Peryga, P; Szyca, R, 2006)
"To determine whether intermediate dose metoclopramide is more effective than standard dose metoclopramide for patients who present to the ED with nausea and vomiting."9.11Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. ( Basire, M; Cham, S; Kelly, AM, 2004)
"In low dose cisplatin regimen, complete suppression of delayed emesis occurred in 55 per cent patients receiving ondansetron and in 30 per cent patients receiving metoclopramide."9.11Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis. ( Bhatia, A; Sharma, M; Tripathi, KD, 2004)
"Aim of this study was to demonstrate that intravenous metoclopramide can reduce pain, nausea and discomfort during nasogastric tube (NGT) insertion in ED."9.11Effectiveness of pre-emptive metoclopramide infusion in alleviating pain, discomfort and nausea associated with nasogastric tube insertion: a randomised, double-blind, placebo-controlled trial. ( Karaca, MA; Ozucelik, DN; Sivri, B, 2005)
"In daily practice, a combination of oral dexamethasone and oral granisetron achieves an extremely high control of acute emesis (86% protection)."9.10A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis. ( Aapro, MS; Bernhard, J; De Pree, C; Maibach, R; Sessa, C; Thuerlimann, B, 2003)
" The number of patients who were emesis free (no nausea, retching, or vomiting) was significantly higher in patients who received granisetron (88% [2225]) than in those who received droperidol (64% [1625]; P = 0."9.10A comparison of granisetron, droperidol, and metoclopramide in the treatment of established nausea and vomiting after breast surgery: a double-blind, randomized, controlled trial. ( Fujii, Y; Kawasaki, T; Tanaka, H, 2003)
" The present study aimed to study the efficacy and tolerability of ondansetron versus (vs) metoclopramide in different dose related grades of cisplatin induced acute emesis."9.10Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy. ( Bhatia, A; Sharma, M; Tripathi, KD, 2003)
"The results obtained showed that ondansetron was more effective in controlling nausea and vomiting than metoclopramide, either objectively (2."9.10Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting. ( Bagatin, J; Hozo, I; Ljutić, D; Perković, D; Pivac, N; Rumboldt, Z, 2002)
"Although combination antiemetics prevent vomiting during the initial 24 h after high-dose (> or =100 mg/m2) cisplatin, many patients experience delayed emesis 24-120 h afterwards despite receiving prophylactic dexamethasone and metoclopramide during this time."9.09Oral cisapride for the control of delayed vomiting following high-dose cisplatin. ( Baltzer, L; Grant, SC; Hinckley, L; Kris, MG; Miller, VA; Pisters, KM; Pizzo, BA, 1999)
"Several studies have confirmed the efficacy of high-dose metoclopramide and, more recently, serotonin antagonists, with and without dexamethasone, in the prophylaxis of cisplatin-induced nausea and vomiting."9.09Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. ( Hussain, M; Khan, Z; Malik, I; Moid, I, 1999)
") doses of ondansetron 8 mg, ondansetron 16 mg and metoclopramide 10 mg in the treatment of opioid-induced emesis."9.09Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study Group. ( Alahuta, S; Chung, F; Curtis, P; Duvaldestin, P; Jacka, M; Lane, R; Luttropp, HH; McQuade, B; Rocherieux, S; Roy, M; Spraggs, C, 1999)
"Complete control of established postoperative nausea and vomiting, defined as no emesis and no need for another rescue antiemetic medication, was more frequent among the patients who had received granisetron (88%) than among those who had received droperidol (55%) or metoclopramide (50%) (P <."9.09Granisetron, droperidol, and metoclopramide for the treatment of established postoperative nausea and vomiting in women undergoing gynecologic surgery. ( Fujii, Y; Somekawa, Y; Tanaka, H, 2000)
"The aim of our single-center, prospective, randomized, open study was to evaluate the antiemetic efficacy and tolerability of a regimen based on a single oral dose of ondansetron 8 mg in comparison with a metoclopramide-based regimen, for prevention of acute FAC (fluorouracil, doxorubicin and cyclophosphamide) chemotherapy-induced emesis."9.09High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer. ( Bosnjak, SM; Mitrovi, LB; Nesković-Konstantinović, ZB; Radulović, SS; Susnjar, S, 2000)
"The serotonin (5HT3) antagonist ondansetron was compared in a randomised study with metoclopramide and dexamethasone for the prevention of chemotherapy induced emesis."9.08Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. ( Dick, GS; Meller, ST; Pinkerton, CR, 1995)
"A single 5-minute infusion of 3 mg granisetron was more effective and produced a less adverse effect than multiple doses of metoclopramide in controlling chemotherapy-induced emesis, both in the first 24 hours and over a 6-day period."9.08Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis. ( Chen, PM; Chiou, TJ; Fan, FS; Hsieh, RK; Liu, JH; Wei, CH, 1995)
" Patients were randomised into one of two groups, receiving either granisetron, a specific 5-HT3 antagonist or a combination of metoclopramide, dexamethasone phosphate and lorazepam to assess the comparative efficacy of the two regimens in the control of irradiation-induced nausea and vomiting."9.08Granisetron in the prevention of irradiation-induced emesis. ( Collis, C; Cunningham, J; Cunningham, S; Gandhi, L; Hamon, MD; Prentice, HG, 1995)
"Metoclopramide was significantly more effective at preventing both nausea and vomiting (20/44 (45%) compared with 32/47 (68%), p < 0."9.08Prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. A prospective randomized study of metoclopramide and transdermal hyoscine. ( Appelgren, L; Haglind, E; Thune, A, 1995)
"Successful control of vomiting was achieved in the first 24 hours, in 74% of the cycles containing cisplatin and 82% of the cycles without cisplatin, if ondansetron was used."9.08Ondansetron in chemotherapy-induced emesis. Our experience. ( Bandiera, AF; Fiorelli, C; Framarino dei Malatesta, M; Marzetti, L; Toccaceli Blasi, MR; Veneziano, M; Yacoub, M, 1995)
"To compare the efficacy of oral droperidol versus oral metoclopramide, or both oral droperidol and metoclopramide, on postoperative vomiting when used as a premedicant for strabismus surgery."9.08The effects of oral droperidol versus oral metoclopramide versus both oral droperidol and metoclopramide on postoperative vomiting when used as a premedicant for strabismus surgery. ( Brown, RE; Jones, E; Kymer, PJ; Lawhorn, CD; Pearce, L, 1995)
"This randomized, double-blind, multicentre, parallel-group study compared the efficacy and safety of an intravenous dose of ondansetron 4 mg for the prevention of postoperative nausea and vomiting (PONV) with metoclopramide 10 mg and placebo in patients undergoing major gynaecological surgery."9.08[Intravenous administration of ondansetron vs. metoclopramide for the prophylaxis of postoperative nausea and vomiting]. ( Rust, M, 1995)
"We have compared the efficacy of ondansetron, metoclopramide, droperidol and placebo in the prevention of postoperative nausea and vomiting in 118 day stay patients undergoing laparoscopic gynaecological procedures."9.08Prevention of nausea and vomiting after day case gynaecological laparoscopy. A comparison of ondansetron, droperidol, metoclopramide and placebo. ( McKay, AC; Mirakhur, RK; Paxton, LD, 1995)
" We compared the efficacy, toxicity, and patients' preference for tropisetron, a new 5-hydroxytryptamine3 (HT3) receptor antagonist, with those of a combination of high-dose metoclopramide, dexamethasone, diphenhydramine, and lorazepam (metoclopramide cocktail) in a randomized crossover study for the control of nausea and vomiting during cisplatin-containing chemotherapy."9.08Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis. ( Chang, TC; Cheng, HH; Hsieh, F; Lai, CH; Li, CL; Michael, BJ; Soong, YK; Tseng, CJ, 1996)
"Of the patients treated with metoclopramide plus methylprednisolone (n = 92), 53% had complete protection from delayed emesis, 16% a major response, 15% a minor response, and 15% no response."9.08Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial. ( Cannata, G; Gebbia, N; Gebbia, V; Testa, A; Tirrito, ML; Valenza, R, 1995)
"The aim of the present study was to compare the antiemetic efficacy of ondansetron (OND) with metoclopramide (MCP), both combined with corticosteroid (CS) in patients with malignant lymphoma."9.08Antiemetic efficacy of ondansetron and metoclopramide, both combined with corticosteroid, in malignant lymphoma patients receiving non-cisplatin chemotherapy. ( Jørgensen, M; Victor, MA, 1996)
"We conducted a prospective randomized study to compare granisetron, a 5-hydroxytryptamine-3 receptor antagonist with standard anti-emetics (control group) consisting mainly of metoclopramide, in the prophylaxis of emesis induced by conditioning prior to stem cell transplantation."9.08Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study. ( Asano, S; Ikeda, Y; Kimura, Y; Miyawaki, S; Oh, H; Okamoto, S; Onozawa, Y; Sakamaki, H; Takahashi, S; Tanosaki, R; Toyama, K, 1996)
" The recurrence of retching or vomiting was higher with propofol (58%) than with droperidol (4%) or metoclopramide (24%) (P < 0."9.08Treatment of postoperative nausea and vomiting: comparison of propofol, droperidol and metoclopramide. ( Lacroix, G; Lessard, MR; Trépanier, CA, 1996)
"The purpose of this retrospective study is to assess the frequency and intensity of chronic nausea in patients admitted to the Palliative Care Unit and the results of a metoclopramide-based treatment regimen."9.08Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. ( Babul, N; Bruera, E; Darke, A; Harsanyi, Z; Seifert, L; Suarez-Almazor, M; Watanabe, S, 1996)
"The efficacy of ondansetron 4 mg was compared with metoclopramide 10 mg for the prevention of post-operative nausea and vomiting in patients after major gynaecological abdominal surgery."9.08Comparison of ondansetron and metoclopramide for the prevention of post-operative nausea and vomiting after major gynaecological surgery. ( Chen, PP; Chui, PT; Gin, T, 1996)
"To compare the antimetic efficacy of prophylactic ondansetron, metoclopramide, and placebo for prevention of postoperative vomiting in pediatric tonsillectomy or adenotonsillectomy patients."9.08Prospective, randomized, double-blind, placebo-controlled comparison of metoclopramide and ondansetron for prevention of posttonsillectomy or adenotonsillectomy emesis. ( Bohnsack, LE; Bostrom, BC; Seay, RE; Stene, FN; Young, LA, 1996)
"The potent serotonin receptor (5-HT3) antagonists are new highly selective agents for the prevention and control of chemotherapy-induced nausea and vomiting that have been shown to be comparable to or more effective than traditional metoclopramide regimens."9.08A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy. ( Bastit, P; Cals, L; Cappelaere, P; Catimel, G; Chevallier, B; Claverie, N; Fabbro, M; Giovannini, M; Khayat, D; Splinter, T; Wendling, JL, 1997)
"048) with placebo (mean = 5) than ondansetron (mean = 2) and the proportion of patients experiencing no emesis was significantly greater (P = 0."9.08Antiemetic activity of ondansetron in acute gastroenteritis. ( Cubeddu, LX; Gonzalez, V; Guariguata, J; Miller, IA; Paska, W; Seijas, J; Talmaciu, I; Trujillo, LM, 1997)
"To evaluate the combined effect of granisetron and methylprednisolone against acute emesis induced by cytotoxic agents, we investigated the clinical response and the urinary excretion of 5-HIAA in 85 patients with ovarian cancer who received the same anticancer chemotherapeutic regimen in a prospective randomized trial."9.08Combination effect of granisetron and methylprednisolone for preventing emesis induced by cytotoxic agents. ( Cheng, X; Itamochi, H; Kigawa, J; Minagawa, Y; Okada, M; Terakawa, N, 1997)
"A double-blind, randomised, placebo-controlled trial was conducted to compare the efficacy of metoclopramide with the 5-HT3 antagonist, ondansetron, for the prevention of postoperative emesis in children undergoing elective strabismus surgery."9.08Efficacy of ondansetron and metoclopramide for preventing postoperative emesis following strabismus surgery in children. ( Mandal, NG; Shende, D, 1997)
"To compare the efficacy of oral ondansetron with oral metoclopramide for the prevention of postoperative vomiting and nausea in children undergoing strabismus surgery."9.08[Does oral ondansetron reduce the incidence of nausea and vomiting after surgery for strabismus in children?]. ( Amraoui, A; Benaguida, M; el Harrar, N; Idali, B; Laouissi, F; Mjahed, K, 1996)
"In a randomised, double-blind study, we have compared the incidence of postoperative nausea and vomitting in 124 patients undergoing major lower limb orthopaedic surgery following oral premedication with temazapam and ondansetron 8 mg, metoclopramide 10 mg or placebo."9.08Comparison of ondansetron, metoclopramide and placebo as premedicants to reduce nausea and vomiting after major surgery. ( Alexander, R; Fennelly, M, 1997)
" This difference was still significant when controlling for age, body weight, history of motion sickness, previous PONV episodes, duration of anesthesia, and intraoperative fentanyl consumption using a logistic model."9.08Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting. ( Finco, G; Gottin, L; Grosso, S; Ischia, S; Mosaner, W; Pinaroli, AM; Polati, E; Verlato, G, 1997)
"Granisetron is a better prophylactic antiemetic than droperidol or metoclopramide in female patients with a history of motion sickness undergoing major gynaecological surgery."9.08Prevention of PONV with granisetron, droperidol and metoclopramide in female patients with history of motion sickness. ( Fujii, Y; Tanaka, H; Toyooka, H, 1997)
"To compare the efficacy of ondansetron, droperidol, or metoclopramide with placebo in preventing postoperative vomiting following strabismus surgery."9.08A randomized, double-blind, placebo controlled comparison of droperidol, ondansetron, and metoclopramide for the prevention of vomiting following outpatient strabismus surgery in children. ( Elliott, WG; James, RL; Mims, G; Scuderi, PE; Weaver, RG; Weeks, DB, 1997)
" After experiencing at least one nausea and/or one emetic episode in the 6 h after recovery from anaesthesia, patients received either ondansetron 4 mg i."9.08Ondansetron compared with metoclopramide in the treatment of established postoperative nausea and vomiting. The French Ondansetron Study Group. ( Clyti, N; Conseiller, C; Diemunsch, P; Mamet, JP, 1997)
"Seminoma stage I patients on tropisetron experienced less nausea and vomiting during abdominal radiotherapy than patients receiving metoclopramide."9.08Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients. ( Aass, N; Fosså, SD; Håtun, DE; Thoresen, M, 1997)
"Granisetron is more effective than droperidol or metoclopramide in preventing PONV in female patients with a history of postoperative emesis."9.08Prevention of PONV with granisetron, droperidol or metoclopramide in patients with postoperative emesis. ( Fujii, Y; Saitoh, Y; Tanaka, H; Toyooka, H, 1998)
"Ondansetron 4 mg was compared with metoclopramide 10 mg for prevention of post-operative nausea and emesis in in-patients undergoing major gynaecological surgery in this double-blind, randomized, placebo-controlled, multicentre study."9.08International, multicentre, placebo-controlled study to evaluate the effectiveness of ondansetron vs. metoclopramide in the prevention of post-operative nausea and vomiting. ( Aune, H; Cohen, LA; Feiss, P; Hanson, A; Hasselstrøm, L; Maltby, JR; Morris, RW; Rocke, DA; Rozenberg, B; Rust, M, 1998)
"The antiemetic efficacy of droperidol, metoclopramide and granisetron was compared with placebo in the reduction of vomiting after paediatric surgery (the extremities; inguinal hernia; and phimosis) during general inhalational anaesthesia."9.08Prophylactic therapy with granisetron in the prevention of vomiting after paediatric surgery. A randomized, double-blind comparison with droperidol and metoclopramide. ( Fujii, Y; Tanaka, H, 1998)
"This study evaluates the prophylactic anti-emetic efficacy of granisetron, droperidol and metoclopramide, for the prevention of post-operative nausea and vomiting in female patients undergoing elective laparoscopic cholecystectomy."9.08Anti-emetic efficacy of prophylactic granisetron, droperidol and metoclopramide in the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled trial. ( Fujii, Y; Saitoh, Y; Tanaka, H; Toyooka, H, 1998)
"The incidence of postoperative emesis in the metoclopramide group was 60% versus 71% in a placebo group (p < 0."9.08Prophylactic metoclopramide administered immediately after the induction of anesthesia has no effect on the incidence of postoperative emesis after strabismus surgery. ( Haldar, M; Shende, D, 1998)
"A single institution, prospective, randomized trial was performed in terminal cancer patients to compare tropisetron (TRO), metoclopramide (MET), and chlorpromazine (CHL) in the management of nausea and emesis."9.08Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer. ( Befon, S; Liossi, C; Mystakidou, K; Vlachos, L, 1998)
"Ondansetron appeared to be superior to metoclopramide-diphenhydramine in the control of emesis induced by chemotherapy regimens containing cisplatin."9.08Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. ( Atay, AA; Köseoglu, V; Kürekçi, AE; Ozcan, O; Sarici, U; Sorici, U, 1998)
"To determine the contribution of metoclopramide to the efficacy of ondansetron in control of cisplatin-induced emesis, ondansetron was compared with ondansetron plus metoclopramide for antiemetic efficacy in a randomized double-blind trial."9.07Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis. ( Cho, GY; Kim, SH; Kim, SW; Lee, CW; Lee, JS; Lee, KH; Suh, CW, 1994)
"Lignocaine has been shown to reduce the incidence of pain on injection of propofol."9.07Propofol injection pain: comparing the addition of lignocaine or metoclopramide. ( Mecklem, DW, 1994)
"Oral metoclopramide may be given as a premedicant to reduce post-operative nausea and vomiting, but there is little evidence that it is effective."9.07Sustained release metoclopramide for prophylaxis of post-operative nausea and vomiting. ( Curran, JP; Elliott, RH; Graham, SG, 1994)
"The clinical efficacy and tolerability of a new nasal spray formulation of metoclopramide (MTC) was evaluated in terms of its ability to prevent the nausea and vomiting induced by a moderately emetic chemotherapy (cisplatin 20 mg/m2 weekly as radioenhancer+radiotherapy for a fractionated total of 60 Gy) in 12 patients with non-small-cell lung cancer, stage IIIB."9.07Efficacy and tolerability of nasally administered compared to parenterally administered metoclopramide in the symptomatic treatment of chemotherapy-induced emesis in cancer outpatients. A controlled clinical study. ( Confalonieri, M; Dimaiuta, M; Scanni, A; Tomirotti, M, 1994)
"In a prospective, double-blind study, we have examined the effect of preoperative nabilone on postoperative nausea and vomiting (PONV)."9.07Effect of nabilone on nausea and vomiting after total abdominal hysterectomy. ( Barrowcliffe, MP; Campbell, DN; Lewis, IH, 1994)
" Oral granisetron alone was as effective as met/dex in control of acute emesis in all parameters examined."9.07Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group. ( Cedar, E; Cunningham, J; Goedhals, L; Heron, JF; Jordaan, JP, 1994)
" A sample of 43 patients with breast cancer was accrued from September to November 1992 in a phase II study to assess the efficacy of granisetron in patients receiving FEC (5-FU, epirubicin, cyclophosphamide)."9.07Control of emesis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide. ( Ang, PT; Khoo, KS; Tan, EH, 1994)
"We studied the preventive effect on postoperative nausea and vomiting (PONV) of ondansetron, metoclopramide and placebo associated with epidural anaesthesia."9.07[Effects of ondansetron and metoclopramide on postoperative nausea and vomiting after epidural anesthesia in children]. ( Andreuccetti, T; Busoni, P; Calamandrei, M; Crescioli, M; Messeri, A; Sarti, A; Sestini, G, 1994)
"Metoclopramide is an active antiemetic against cisplatin-induced acute emesis."9.07Continuous infusion versus intermittent short infusion of metoclopramide for cisplatin-induced acute emesis. ( Kajita, M; Niimi, T; Saito, H; Shimokata, K; Yamori, S, 1994)
"We have compared the incidence of postoperative nausea and vomiting up to 48 h after day-case gynaecological laparoscopy after oral premedication with ondansetron 4 mg, metoclopramide 10 mg or a placebo allocated randomly and assessed blindly."9.07Nausea and vomiting after gynaecological laparoscopy: comparison of premedication with oral ondansetron, metoclopramide and placebo. ( Cooper, GM; Field, JM; Malins, AF; Nesling, PM, 1994)
"To determine the severity of emesis caused by ultra-high-dose cisplatin-carboplatin chemotherapy and to compare the antiemetic efficacy of an ondansetron regimen and a metoclopramide regimen."9.07Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy. ( Fanning, J; Hilgers, RD, 1994)
"We have compared the efficacy of ondansetron with droperidol and saline in the prevention of postoperative nausea and vomiting (PONV) in 120 ASA I and II patients undergoing hip and knee replacements and femoral resections."9.07Double-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting. ( Collis, R; Gan, TJ; Hetreed, M, 1994)
"We investigated the usefulness of concurrent therapy of granisetron with methylprednisolone sodium for on nausea, vomiting and anorexia induced by chemotherapy, including cisplatin, in patients with oral cancer."9.07[Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin]. ( Kawashima, T; Miyata, K; Morita, N; Ohmata, T; Sakamoto, T; Wada, T, 1993)
" The purpose of this study was to compare the incidence of emesis after propofol anaesthesia with and without nitrous oxide, compared with thiopentone and halothane anaesthesia, in hospital and up to 24 hr postoperatively, in outpatient paediatric patients after strabismus surgery."9.07Propofol anaesthesia reduces early postoperative emesis after paediatric strabismus surgery. ( Bevan, JC; Blackstock, D; Merrick, PM; Montgomery, CJ; Popovic, V; Reimer, EJ, 1993)
") was compared with a metoclopramide cocktail for the prevention of nausea and emesis."9.07An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. ( Frankendal, B; Hallén, C; Sorbe, B, 1994)
", Basel, Switzerland), a new 5-HT3 receptor antagonist, was compared in a randomized multicenter trial with a high-dose metoclopramide-dexamethasone cocktail for the prevention of nausea and emesis during cisplatin-containing chemotherapy."9.07A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. ( de Bruijn, KM; Glimelius, B; Hansen, O; Högberg, T; Räisänen, I; Schmidt, M; Sorbe, BG; Sörensen, BT; van Oosterom, AT; Wernstedt, L, 1994)
"Vomiting was prevented in two thirds of patients treated with MDL plus ondansetron, a result similar to that observed in earlier trials of MDL alone."9.07The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin. ( Baltzer, L; Kris, MG; Pisters, KM; Rigas, JR; Tyson, LB, 1994)
"The usefulness of alprazolam (minor tranquilizer) used in combination with metoclopramide plus methylprednisolone for the prevention and control of emesis induced by chemotherapies, including 5-day continuous intravenous infusion of cisplatin (25 mg/m2/day) for advanced lung cancer, was evaluated using a double-blind randomized crossover design."9.07Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis. ( Mori, K; Saito, Y; Tominaga, K, 1993)
"The cost effectiveness of ondansetron was compared with that of metoclopramide in the prevention of acute emesis due to highly emetogenic chemotherapy in an open, randomised, parallel group pilot study."9.07The real costs of emesis--an economic analysis of ondansetron vs. metoclopramide in controlling emesis in patients receiving chemotherapy for cancer. ( Cunningham, D; Davidson, N; Gore, M; Manchanda, M; Miocevich, M; Wells, N, 1993)
" To address its use with a widely used but less emetogenic regimen, we performed a double-blind, randomized clinical trial comparing ondansetron with dexamethasone and metoclopramide in patients with breast cancer receiving chemotherapy with cyclophosphamide, methotrexate, and fluorouracil."9.07Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil. ( Latreille, J; Levitt, M; Lofters, WS; Perrault, DJ; Potvin, M; Rayner, HL; Warner, E; Warr, D; Wilson, KS; Yelle, L, 1993)
"This report of a double-blind, randomized study performed to evaluate the comparative antiemetic efficacy of tropisetron (Navoban; Sandoz Pharma Ltd, Basel, Switzerland), a new 5-hydroxytryptamine receptor antagonist, focuses on treatment during stages of chemotherapy when nausea and vomiting are particularly severe."9.07A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis. ( Krzakowski, M; Lasota, W; Madej, G; Pawinski, A; Rogowski, W; Skoneczna, I, 1994)
"The efficacy and tolerability of tropisetron in preventing cisplatin-induced nausea and vomiting was studied in 2 open trials and compared with the efficacy and tolerability of metoclopramide plus lorazepam in a randomised crossover trial."9.07Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. ( Antonacci, RA; Berruti, A; Dogliotti, L; Faggiuolo, R; Ortega, C; Pazè, E, 1992)
"The efficacy of intravenous metoclopramide in controlling vomiting in children after tonsillectomy was determined in a prospective randomized, double-blind investigation."9.07Metoclopramide reduces the incidence of vomiting after tonsillectomy in children. ( Donlon, JV; Ferrari, LR, 1992)
" One hundred ten pediatric patients, ages 8 months to 14 yr, admitted for outpatient strabismus surgery were enrolled in a randomized, double-blinded study to compare droperidol and metoclopramide to placebo for the prevention of postoperative emesis."9.07A double-blinded comparison of metoclopramide and droperidol for prevention of emesis following strabismus surgery. ( Furst, SR; Lin, DM; Rodarte, A, 1992)
"Sixty patients were studied in a randomized, double-blind manner to determine whether metoclopramide added to droperidol decreased further the incidence of emetic symptoms (nausea, retching, vomiting) in outpatients receiving alfentanil anaesthesia for nasal surgery."9.07Metoclopramide does not decrease the incidence of nausea and vomiting after alfentanil for outpatient anaesthesia. ( AlHaddad, S; Furgerson, C; Khalil, I; Maurer, W; Whalley, DG, 1991)
" In this randomized, single-blind, multicenter, parallel group study, we compared the efficacy and safety of intravenous (IV) ondansetron with IV metoclopramide in the prevention of nausea and vomiting associated with high-dose (greater than or equal to 100 mg/m2) cisplatin chemotherapy."9.07A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. ( Gandara, D; Hainsworth, J; Harker, G; Harvey, W; Hesketh, P; Kasimis, B; Khojasteh, A; Monaghan, G; Oblon, D; Pendergrass, K, 1991)
"Ondansetron was compared with metoclopramide for antiemetic efficacy in a randomised double-blind trial in 122 patients with advanced breast cancer."9.07Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. ( Adler, M; Christmann, D; Fenzl, E; Marschner, NW; Nagel, GA; Upadhyaya, B, 1991)
"This double-blind randomized cross-over study was conducted to compare the safety and efficacy of high-dose prochlorperazine infusion and dexamethasone (HDPD) with an effective and safe combination of high-dose metoclopramide and dexamethasone (HDMD) in controlling cisplatin-induced emesis."9.07A double-blind randomized cross-over comparison of high-dose prochlorperazine with high-dose metoclopramide for cisplatin-induced emesis. ( Akhtar, SS; Bano, ZA; Bhat, GM; Bhat, MA, 1991)
"To prevent delayed emesis induced by cisplatin (mean dose 90 mg/m2), 120 consecutive patients were randomized to receive, in a 7-day crossover design, oral metoclopramide (20 mg q."9.07Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study. ( Ballatori, E; Basurto, C; Boschetti, E; Bracarda, S; Patoia, L; Penza, O; Picciafuoco, M; Roila, F; Santi, E; Tonato, M, 1991)
"Ondansetron is a 5-hydroxytryptamine 3-receptor antagonist which has shown activity in the prevention of cytotoxic-induced emesis."9.06Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation. ( Adams, M; Collis, CH; Lucraft, H; Priestman, S; Priestman, TJ; Roberts, JT; Upadhyaya, BK, 1990)
"To compare ondansetron (GR 38032F), a 5-hydroxytryptamine3-receptor antagonist, with metoclopramide in the prophylaxis of acute cisplatin-induced emesis, we conducted a double-blind crossover study in 97 patients scheduled to receive cisplatin (80 to 100 mg per square meter of body-surface area) for treatment of cancer."9.06Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. ( Azab, M; Bons, J; Brion, N; Droz, JP; Marty, M; Paes, D; Paule, B; Pouillart, P; Pujade-Lauraine, E; Scholl, S, 1990)
"Seventy-five breast cancer patients scheduled to receive a first course (in a new cycle) of cyclophosphamide, fluorouracil, and doxorubicin (FAC) or epirubicin (FEC) participated in a double-blind crossover study to compare the antiemetic efficacy and safety of ondansetron (GR38032), a 5-hydroxytryptamine3 (5-HT3) receptor antagonist, and metoclopramide."9.06A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. ( Bonneterre, J; Bons, J; Chevallier, B; Fargeot, P; Metz, R; Paes, D; Pujade-Lauraine, E; Spielmann, M; Tubiana-Hulin, M, 1990)
"The efficacy of ondansetron was compared with metoclopramide in the prophylaxis of nausea and vomiting induced by cyclophosphamide greater than or equal to 500 mg/m2 in combination with doxorubicin greater than or equal to 40 mg/m2 or epirubicin greater than or equal to 40 mg/m2."9.06A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group. ( Carruthers, L; Dicato, MA; Huys, JV; Kaasa, S; Kvaløy, S; Ries, F; Royer, E, 1990)
"To compare the efficacy and side effects of ondansetron with those of high-dose metoclopramide in treating acute and delayed cisplatin-induced nausea and vomiting."9.06Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study. ( Allman, EL; Beranek, P; De Mulder, PH; Mols-Jevdevic, S; Seynaeve, C; van Liessum, PA; Vermorken, JB; Verweij, J, 1990)
"This randomized, double-blind study evaluated the efficacy of metoclopramide administered at the completion of surgery as an antiemetic agent in pediatric patients undergoing ambulatory strabismus surgery; 126 unpremedicated ASA Physical Status 1 and 2 children ranging in age from 2 to 18 yr served as subjects."9.06Metoclopramide reduces the incidence of vomiting following strabismus surgery in children. ( Broadman, LM; Ceruzzi, W; Friendly, D; Hannallah, RS; Patane, PS; Ruttimann, U, 1990)
" cyclophosphamide, methotrexate, and 5-fluorouracil (CMF), 25 women with stage II breast cancer were entered into this study."9.06Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo. ( Giannarelli, D; Marolla, P; Nardi, M; Pinnaró, P; Pollera, CF; Terzoli, E, 1989)
" All patients received intravenous (IV) metoclopramide, dexamethasone, and lorazepam for the control of acute emesis during the period from 0 to 24 hours after cisplatin."9.06Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. ( Cirrincione, C; Clark, RA; Gralla, RJ; Groshen, S; Kris, MG; Tyson, LB, 1989)
"In a randomized, double-blind study, we compared the efficacy of metoclopramide hydrochloride with that of low-dose droperidol for prevention of nausea and vomiting during and after elective cesarean section with epidural anesthesia."9.06Metoclopramide versus droperidol for prevention of nausea and vomiting during epidural anesthesia for cesarean section. ( Bates, JN; Chestnut, DH; Choi, WW; Geiger, M; Ostman, PL; Owen, CL, 1989)
" Lorazepam and dexamethasone are increasingly being used to alleviate chemotherapy induced emesis."9.06The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial. ( Blackledge, GR; Burman, C; Cullen, MH; Kelly, K; O'Brien, ME; Palmer, K; Sharpe, J; Stuart, NS; Woodroffe, C, 1989)
"Sixty-four patients treated with cisplatin-containing regimens were entered into a randomized, double-blinded study examining the antiemetic efficacy of metoclopramide with and without lorazepam for control of cisplatin-induced emesis."9.06Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis. ( Al-Sarraf, M; Cummings, G; Gordon, CJ; Pazdur, R; Ziccarelli, A, 1989)
"Forty-two patients with advanced lung cancer undergoing chemotherapy containing cisplatin (80 mg/m2) were submitted to a randomized controlled trial to evaluate the effect of the combination of metoclopramide and dexamethasone for the treatment of delayed cisplatin-induced emesis occurring more than 24 hours after cisplatin administration."9.06Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial. ( Eguchi, K; Fujiwara, Y; Fukuda, M; Mae, M; Ohe, Y; Saijo, N; Sasaki, S; Sasaki, Y; Shinkai, T; Tamura, T, 1989)
" CMF were included in a double-blind comparative study aimed at evaluating the efficacy of 3 different drugs (methylprednisolone (MP), metoclopramide (MTC), and domperidone (DMP) in preventing chemotherapy-induced nausea and vomiting."9.06Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMF. ( Ballatori, E; Basurto, C; del Favero, A; Minotti, V; Roila, F; Tonato, M, 1987)
"Forty patients with advanced lung cancer who had received chemotherapy containing cisplatin (80 mg/m2) were accrued for a randomized controlled trial to evaluate the additional effect of prochlorperazine on the combination of high-dose metoclopramide and dexamethasone for the treatment of acute cisplatin-induced emesis."9.06[A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine]. ( Eguchi, K; Inoue, I; Nino, S; Saijo, N; Sakurai, M; Sasaki, Y; Shinkai, T; Suemasu, K; Tamura, T; Umehara, H, 1987)
"The antiemetic efficacy and toxicity of methylprednisolone (MP) and metoclopramide (MTC) in prevention of nausea and vomiting in breast cancer patients receiving intravenous cyclophosphamide methotrexate 5-fluorouracil (CMF) chemotherapy has been evaluated in a double-blind trial."9.06Methylprednisolone versus metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide methotrexate 5-fluorouracil: a double-blind randomized study. ( Ballatori, E; Basurto, C; Del Favero, A; Minotti, V; Roila, F; Tonato, M, 1988)
"Methylprednisolone sodium succinate and metoclopramide were compared for their efficacy, tolerance, and safety in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy in patients with cancer."9.06Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy. ( Erlichman, C; Levitt, M; Osoba, D; Pater, JL; Willan, AR, 1986)
"A randomized cross-over study on the effects of methylprednisolone (MP), metoclopramide (MT) and droperidol (DP) on the control of nausea and vomiting associated with cis-platinum chemotherapy was performed."9.06[Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy]. ( Akaza, H; Aso, Y; Fujita, K; Isurugi, K; Kawabe, K; Kinoshita, K; Koiso, K; Kondo, Y; Niijima, T; Yokoyama, M, 1986)
"Thirty three untreated patients being given cisplatin received metoclopramide (7 mg/kg) for antiemesis by either continuous or intermittent infusion in a random order."9.06Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin. ( Allan, SG; Cornbleet, MA; Leonard, RC; MacPherson, JS; Smyth, JF; Warrington, PS, 1986)
"One hundred and two patients with advanced solid tumors receiving chemotherapy were treated with metoclopramide (MCP; 100 mg) to prevent emesis."9.05Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide. ( Bruera, ED; Cedaro, L; Chacón, R; Estévez, R; Roca, E, 1983)
" Compared to metoclopramide, alizapride caused a faster regression of inappetence and of the frequency of daily vomiting."9.05[Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy]. ( Budach, V; Krüger, K, 1983)
"In a double-blind comparison of domperidone 10 mg, domperidone 4 mg, metoclopramide 10 mg and a placebo, 176 adult patients were given an intravenous injection of one of these substances after postoperative vomiting had occurred."9.05Postoperative vomiting treated with domperidone. A double-blind comparison with metoclopramide and a placebo. ( Boghaert, A; Carron, D; Gallant, J; Stockman, A, 1980)
"The effect of high-dose metoclopramide (2 mg/kg, 4 times every 2 hours) on the emesis of patients treated with CDDP (80 mg/m2) was examined by randomized control trial."9.05[Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis]. ( Eguchi, K; Fujita, J; Funaki, Y; Futami, H; Sakurai, M; Sasaki, Y; Sawamura, N; Takahashi, S; Yokoyama, S; Yoshioka, S, 1985)
"In a double-blind trial in 60 children suffering from gastroenteritis complicated by vomiting, it was found that suppositories of domperidone (30 mg) were more effective than either metoclopramide (10 mg) or placebo in reducing the severity of vomiting, nausea and other symptomatic parameters."9.04A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children. ( Ameryckx, L; Dhondt, F; Heck, E; Van Eygen, M; Van Ravensteyn, H, 1979)
"Forty-seven infants and children suffering from chronic vomiting or regurgitation, participated in a two-week double-blind trial comparing 1% drops of domperidone, 1% metoclopramide drops or placebo."9.04Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. ( Ameryckx, L; De Loore, I; Van Ravensteyn, H, 1979)
"One hundred and ninety-five female patients of child-bearing age were assessed for postoperative vomiting in a double-blind trial using domperidone, metoclopramide and placebo."9.04Prevention of postoperative nausea and vomiting by domperidone: A double-blind randomized study using domperidone, metoclopramide and a placebo. ( Ball, RW; Comyn, DJ; Cooke, RD, 1979)
"To assess the efficacy and safety of olanzapine when used as an antiemetic in the prevention and treatment of nausea and vomiting related to cancer in adults."8.98Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults. ( Burton, MJ; Head, K; Naessens, K; Plugge, E; Sutherland, A; Ware, L; Wee, B, 2018)
"To examine the medical evidence regarding the clinical efficacy and cost-effectiveness of the application of continuous subcutaneous metoclopramide and ondansetron to treat nausea and vomiting during pregnancy."8.88Reviewing the evidence for using continuous subcutaneous metoclopramide and ondansetron to treat nausea & vomiting during pregnancy. ( Kirkbride, MS; Reichmann, JP, 2012)
"8 mg/kg was superior to metoclopramide in preventing emesis induced by high dose cisplatin or by moderately emetogenic chemotherapy in high risk subgroups."8.79Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery. ( Balfour, JA; Goa, KL, 1997)
" Metoclopramide is generally acknowledged to be the single most effective conventional drug for the prevention of acute cisplatin-induced emesis and, therefore, was considered an appropriate agent for inclusion in comparative trials with ondansetron."8.78Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesis. ( Hesketh, PJ, 1992)
"Ondansetron is commonly used to treat nausea and vomiting in pregnancy despite inconclusive evidence of its safety."8.02Ondansetron use in early pregnancy and the risk of miscarriage. ( Boggess, K; Engel, SM; Jonsson Funk, M; Lund, JL; Stürmer, T; Suarez, EA, 2021)
"The objective of the study was to evaluate the rate of major congenital anomalies after first trimester exposure to ondansetron for nausea and vomiting of pregnancy (NVP)."8.02Pregnancy outcome following in-utero exposure to ondansetron: A prospective comparative observational study. ( Arnon, J; Diav-Citrin, O; Sakran, R; Shechtman, S, 2021)
" Delayed emesis following Cycle 1 of carboplatin was observed in 30% of patients."7.83Delayed nausea and vomiting from carboplatin doublet chemotherapy. ( Baggstrom, MQ; Chitneni, P; Gao, F; Govindan, R; Mann, J; Morgensztern, D; Waqar, MA; Waqar, SN; Williams, K, 2016)
"Metoclopramide is commonly used to treat vomiting caused by seasickness and acute gastroenteritis on cruise ships and serious adverse effects have not been reported from use at sea."7.80Long-lasting adverse effects after short-term low-dose treatment with metoclopramide for vomiting. ( Dahl, E; Diskin, AL, 2014)
"Patients with cancer frequently report gastrointestinal symptoms such as anorexia, early satiety, nausea, vomiting, and bloating."7.80Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: a multicentre evaluation. ( Chow, W; Darke, A; Harsanyi, Z; Marshall, D; Pearen, S; Plourde, JY; Wilson, J; Yoshida, S, 2002)
"Ondansetron was superior to placebo in Study 1; complete control of emesis (0 emetic episodes) over 15 days was achieved in 62% of ondansetron-treated patients compared to 34% of placebo-treated patients (P = 0."7.77Anti-emetic control with ondansetron in the chemotherapy of breast cancer: a review. ( Marschner, N, 1991)
"The aim of study was, comparison of effects of Metoclopramide and Dropridol associated with Dexamethasone on prevalence of nausea and vomiting after operation was considered."7.76Comparison the effects of metoclopramide and dropridol associated with dexamethasone on post operative nausea and vomiting. ( Ebrahim, A; Ebrahim, N; Hosssain, B; Yousef, M, 2010)
"The aim of the study was to evaluate the role of ramosetron for the prevention of chemoradiotherapy-induced nausea and vomiting (CRINV) in patients receiving upper abdominal irradiation with concurrent 5-fluorouracil chemotherapy."7.75Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer. ( Bang, YJ; Chie, EK; Ha, SW; Im, SA; Jang, JY; Kim, K; Kim, SW; Kim, TY; Oh, DY, 2009)
"In various countries, metoclopramide is the antiemetic drug of choice in pregnant women, but insufficient information exists regarding its safety in pregnancy."7.75The safety of metoclopramide use in the first trimester of pregnancy. ( Gorodischer, R; Koren, G; Levy, A; Matok, I; Sheiner, E; Wiznitzer, A, 2009)
"A patient who was given metoclopramide for vomiting and diarrhoea developed circulatory collapse with his blood pressure dropping to 50/20 mm Hg."7.75Circulatory collapse in a patient with gastrinoma after metoclopramide administration. ( Chan, AY; Chan, KW; Ching, CK; Lam, AW; Lau, KK; Lee, HH; Li, SM; Lo, J; Lok, CM; Luk, WF; Mak, CM, 2009)
" In the present studies, therefore, we used Suncus murinus, a species of insectivore capable of emesis, to investigate if the vanilloid receptor agonist resiniferatoxin is capable of modeling the emesis associated with migraine."7.73Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew). ( Andrews, PL; Cheng, FH; Moreaux, B; Ngan, MP; Rudd, JA; Sam, TS; Wai, MK; Wan, C, 2005)
"To assess the effectiveness of ondansetron in relieving symptoms of nausea and vomiting which were refractory to metoclopramide and cyclizine, in a patient receiving iloprost infusions."7.71Pre-emptive metoclopramide and ondansetron for nausea and vomiting associated with iloprost infusions. ( Roome, C; Thompson, J, 2001)
"A prospective trial was performed to better assess the risk of nausea and vomiting and the rescue value of tropisetron (TRO), a 5-HT3 receptor antagonist, in 88 patients undergoing fractionated radiotherapy to the abdomen or to large supradiaphragmatic fields and failing a first anti-emetic trial with metoclopramide (MET)."7.69Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide. ( Behrouz, F; Blazek, N; Coucke, P; Gebhard, S; Melliger, M; Miralbell, R; Philipp, S; Rosset, A; Schwabb, T; Wickenhauser, R, 1995)
"Although buprenorphine sometimes causes severe emesis, its relation to the menstrual cycle has not been reported."7.69Menstrual stage influences postoperative nausea and vomiting following epidural buprenorphine. ( Kamiyama, M; Kitamura, A; Kon, T; Ogawa, R, 1996)
"Fifty-one patients who received their first course of chemotherapy were studied to compare the respective efficacy and safety of granisetron and metoclopramide plus dexamethasone in the prevention of nausea and vomiting induced by emetogenic cytotoxic drugs."7.69Comparison of intravenous granisetron with metoclopramide plus dexamethasone in the prevention of nausea and vomiting associated with emetogenic cytotoxic chemotherapy. ( Chang, CS; Chen, LT; Chen, TP; Huang, SM; Lin, SF; Liu, TC; Wei, TC, 1997)
" Erythromycin administration is associated with gastrointestinal problems, disturbed gastrointestinal motility and emesis."7.68Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis. ( Pilot, MA; Qin, XY; Scott, M; Thompson, H, 1993)
" 5 min prior to morphine while each ferret was maintained under isoflurane-O2 anesthesia."7.68The effects of different antiemetic agents on morphine-induced emesis in ferrets. ( Essien, E; Thut, PD; Wynn, RL, 1993)
"A 4-year-old female blue and gold macaw (Ara ararauna) with a history of chronic vomiting was treated with metoclopramide hydrochloride."7.68Adverse drug reaction to metoclopramide hydrochloride in a macaw with proventricular dilatation syndrome. ( Massey, JG, 1993)
"Pancopride ((+-)N-(1-azabicyclo-[2,2,2]-oct-3-yl)-2-cyclopropylmethoxy-4-ami no-5-chlorobenzamide) is a new potent and selective 5-HT3 receptor antagonist, orally and parenterally effective against cytotoxic drug-induced emesis."7.68Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis. ( Beleta, J; Berga, P; Bou, J; Doménech, T; Fernández, AG; Gristwood, RW; Puig, J; Roberts, DJ, 1992)
" The syndrome was associated with metoclopramide antiemetic therapy given for post-operative nausea and vomiting."7.68Neuroleptic malignant syndrome associated with metoclopramide antiemetic therapy. ( Bakri, YN; Kawi, Z; Khan, R; Subhi, J, 1992)
"To evaluate the efficacy of a combined therapy of prednisolone and alprazolam for controlling cisplatin-induced delayed emesis, a study involving 14 non-small cell lung cancer patients receiving cisplatin (80 mg/m2) was conducted."7.68[A combined anti-emesis therapy of oral prednisolone and alprazolam for cisplatin-induced delayed emesis]. ( Horio, Y; Iwahara, T; Minami, H; Sakai, S; Shibagaki, T; Shimokata, K; Watanabe, A, 1990)
"In prospective alternative crossover test, we confirmed significant superiority of a three-drug combination of clonazepam (C) lorazepam (L) and dexamethasone (D) to (L) and (D) to control vomiting induced by 50 mg/m CDDP containing chemotherapy for gynecological malignancies (p less than 0."7.68[Evaluation of antiemetic effect of clonazepam, metoclopramide, dexamethasone and diphenhydramine for prevention of cisplatin-induced vomiting]. ( Asano, H; Hatae, M; Hokanishi, H; Mitsuo, M; Nakamura, Y; Onishi, Y; Sakurai, K, 1990)
"Nabilone is a cannabinoid anti-emetic which has been extensively evaluated in control of chemotherapy-induced vomiting."7.67An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting. ( Priestman, SG; Priestman, TJ, 1984)
"Using an original high-pressure liquid chromatographic assay, we measured serum levels of metoclopramide and defined a concentration-response relationship for metoclopramide control of cisplatin-induced emesis."7.67Optimizing metoclopramide control of cisplatin-induced emesis. ( Drayer, DE; Lewin, M; Lonski, L; Meyer, BR; Pasmantier, M; Reidenberg, MM, 1984)
"Repeated oral doses of metoclopramide (50 mg) and prednisone (25 mg) completely prevented nausea and vomiting (N + V) in approximately 50% and substantially reduced N + V in an additional 27%-36% of 56 chemotherapy courses in 30 consecutive cancer patients who were receiving primarily cisplatin."7.67Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide. ( Bachmann-Mettler, I; Glaus, A; Senn, HJ, 1984)
"To investigate the effectiveness of high oral doses of the antiemetic agent 4-amino-5-chloro-N-(2-diethyl-aminoethyl)-2-methoxybenzamide (metoclopramide, MCP, Gastrosil) against nausea and vomiting induced by certain cyostatic drugs, blood was withdrawn repeatedly from 9 patients; MCP plasma levels were then determined."7.67[Metoclopramide plasma levels following oral administration of high doses for prophylaxis of emesis in cytostatic therapy]. ( Köhler, M; Senn, HJ; Vergin, H, 1984)
"The authors tested the safety and efficacy of intravenous metoclopramide in the prevention of chemotherapy-induced nausea and vomiting."7.67Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation. ( McDermed, JE; Pileggi, J; Riech, LP; Strum, SB; Whitaker, H, 1984)
"Forty-six outpatients with breast cancer who had experienced severe emesis as a result of chemotherapy were evaluated for the antiemetic efficacy of high-dose metoclopramide (HD-MCP) and dexamethasone (DXM)."7.67High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study. ( Ben-Baruch, N; Ben-Yosef, R; Biran, S; Brufman, G; Gez, E; Uziely, B; Warner-Efraty, E; Yitzhaki, N, 1987)
"The antiemetic activity, gastric motor activity, and dopamine receptor effects of metoclopramide, dazopride, and sulpiride were assessed to establish if enhancement of gastric motility or antagonism of central dopamine receptors is the predominant action for drug-induced suppression of cisplatin-induced emesis."7.67Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility. ( Alphin, RS; Dannenburg, WN; Johnson, DN; Kinnier, WJ; Leonard, CA; Proakis, AG; Sancilio, LF; Smith, WL; Ward, JW, 1986)
" To prevent emesis, two high-dose metoclopramide regimens were started 2 hr before cytostatic therapy."7.67Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis. ( Achtert, G; Briemann, L; Brockmann, P; Hausleiter, HJ; Hellenbrecht, D; Hellstern, A; Hess, H; Hodgson, M; Mitrou, P; Saller, R, 1985)
"Intravenous metoclopramide and IM prochlorperazine and diazepam were compared in the management of vomiting occurring during treatment with cis-dichlorodiammineplatinum (cis-platinum)."7.67High-dose intravenous metoclopramide and intermittent intramuscular prochlorperazine and diazepam in the management of emesis induced by cis-dichlorodiammineplatinum. ( Chan, KK; Luesley, DM; Terry, PB, 1985)
"Having noticed psychotic traits in some patients showing incoercible vomiting due to antineoplastic drugs we have thought of establishing a therapy with lithium in the days preceding the therapeutic cycle in order to reduce the emetic events."7.67Sequential therapy with lithium in chemotherapy-induced vomiting. ( Alfano, G; Candido, A; Mango, G; Menichella, G; Rossi, P; Tartaglione, R, 1985)
"Nausea and emesis are common side effects of opioid drugs administered for pain relief in cancer patients."6.70A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. ( Albertsson, M; Chimontsi-Kypriou, V; Curtis, P; Daly, S; Hardy, J; McQuade, B; Stathopoulos, P, 2002)
"198 chemonaive patients with breast cancer, treated with a moderately emetogenic chemotherapy, were randomly assigned to receive either oral granisetron 1 mg twice a day on day 1, followed by metoclopramide, 60 mg on day 2 and 3, or ondansetron, 8 mg IV on day 1, followed by ondansetron 8 mg tablet twice a day on day 2 and 3."6.69[Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron]. ( Granisétron, PK; Mabro, M, 1999)
"Metoclopramide was ineffective."6.68The efficacy of prophylactic ondansetron, droperidol, perphenazine, and metoclopramide in the prevention of nausea and vomiting after major gynecologic surgery. ( Clark, K; Cronin, MK; Darvish, AH; Desilva, PH; McDonald, SM, 1995)
"Nausea and vomiting are extremely common and most distressing side effects of high-dose cisplatin therapy."6.68Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. ( Ata, E; Butt, A; Khan, MA; Khan, WA; Malik, IA; Qazilbash, M, 1995)
" We compared ondansetron and metoclopramide, both combined with dexamethasone, in cisplatin-treated patients."6.68Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research. ( , 1997)
"Tropisetron+dexamethasone was significantly superior to tropisetron alone both for acute (P = 0."6.68Comparison of three tropisetron-containing antiemetic regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nausea. ( Bangerter, M; Bruntsch, U; Drechsler, S; Eggert, J; Faerber, L; Gallmeier, WM; Gosse, H; Grote-Kiehn, J; Imhoff, W; Mezger, J; Oehm, C; Ukena, D; Untch, M, 1997)
"The metoclopramide dosage was 20 mg i."6.68Comparative evaluation of the clinical efficacy and safety of ondansetron and metoclopramide in the prophylaxis of emesis induced by cancer chemotherapy regimens including cisplatin. ( Advani, SH; Cooverji, ND; Dhar, AK; Gopal, R; Lal, HM, 1996)
"Delayed emesis has not been seen during the antiemetic therapies."6.67[Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron]. ( Baki, M; Czeglédi, F, 1994)
"Tropisetron is an effective and well-tolerated agent in the prevention of chemotherapy-induced vomiting."6.67Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting. ( Anderson, H; de Bruijn, KM; Howell, A; Logan, K; Sage, T; Thatcher, N, 1994)
"Droperidol was given just after induction and metoclopramide at the end of surgery, just before recovery."6.67Open placebo controlled comparison of the antiemetic effect of droperidol, metoclopramide or a combination of both in pediatric strabismus surgery. ( Pendeville, PE; Steinier, JR; Van Boven, MJ; Veyckemans, F, 1993)
" Tropisetron in combination with dexamethasone produced the best control of both acute and delayed emesis."6.67Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents. ( Bruntsch, U; Drechsler, S; Eggert, J; Faerber, L; Gosse, H; Imhoff, W; Ukena, D, 1994)
"Emesis is one of the most frequent and distressing adverse effects of cytotoxic chemotherapy."6.67Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies. ( Balduck, N; Hachimi-Idrissi, S; Maurus, R; Otten, J, 1994)
"Acute nausea was prevented completely in 40% of patients in the tropisetron group and in 61% of the metoclopramide cocktail group during course 1 (P < ."6.67Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience. ( Sorbe, BG, 1994)
"289 consecutive cancer patients receiving cisplatin chemotherapy (much greater than 50 mg/m2) were randomised to receive one of the following intravenous antiemetic regimens: ondansetron 0."6.67Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research. ( , 1992)
"Ondansetron was well tolerated in the dose and schedule used."6.67The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo. ( Bryson, JC; Finn, AL; Gandara, DR; Harvey, WH; Hesketh, PJ; Monaghan, GG; Perez, EA; Stokes, C, 1992)
"Droperidol was more effective in reducing severe vomiting."6.67[Droperidol versus metoclopramide. Prevention of emesis following strabismus surgery in children]. ( Braun, U; Feldmann, M; Klockgether-Radke, A; Mühlendyck, H, 1992)
"Metoclopramide was administered by continuous infusion to two groups each of 14 patients on chemotherapy, randomized to receive either doses adjusted to individual pharmacokinetic parameters or doses adjusted as usual to body weight."6.67Continuous infusion of high-dose metoclopramide: comparison of pharmacokinetically adjusted and standard doses for the control of cisplatin-induced acute emesis. ( Brechot, JM; Chastang, C; Delattre, C; Dupeyron, JP; Laaban, JP; Rochemaure, J, 1991)
"At the end of the treatment period, nausea, vomiting and reflux symptoms, adverse events and a global assessment of patients' symptom control were recorded by the investigator."6.67A comparison of controlled release metoclopramide and domperidone in the treatment of nausea and vomiting. ( Miller, AJ; Patel, NH; Roy, P, 1991)
" Overall, the evidence suggests that this dosing schedule for batanopride may be too toxic for clinical use."6.67Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis. ( Fleming, GF; Francher, D; Janisch, L; McEvilly, JM; Smaldone, L; Vokes, EE, 1991)
"Severe nausea was significantly less frequent with cinnarizine and 59% of the chemotherapy days were without nausea, compared to 46% of the days without cinnarizine (p less than 0."6.67Cinnarizine for prevention of nausea and vomiting during platin chemotherapy. ( Osterwalder, B; Schimke, J; Senn, HJ; Wilder-Smith, CH, 1991)
"Vomiting was not satisfactorily prevented by either treatment."6.67Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients. ( Hallén, C; Sorbe, B, 1991)
" We have, therefore, carried out a multicenter, double-blind randomized trial comparing a combination of high-dose metoclopramide (MTC) (1 mg/kg x 4) and methylprednisolone (P) (treatment A) with a shorter but higher single-dose schedule of metoclopramide (3 mg/kg x 2) combined with dexamethasone (DEX) and diphenhydramine (DIP) to prevent extrapyramidal reactions (treatment B)."6.66Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research ( Basurto, C; Bracarda, S; Di Costanzo, F; Donati, D; Malacarne, P; Monici, L; Patoia, L; Picciafuoco, M; Roila, F; Tonato, M, 1989)
"Clebopride was reasonably well tolerated at the used dosages, inducing sedation in 20% of cases (versus 24% with metoclopramide) and diarrhea in 37% (versus 20% with metoclopramide)."6.66[Comparative study on the tolerance and efficacy of high doses of metoclopramide and clebopride in vomiting induced by cisplatin]. ( Díaz-Rubio, E; Martín, M, 1989)
"19 mg/l with doses which varied considerably owing to marked scattering of pharmacokinetic parameters."6.66[Dosage adjustment of metoclopramide for controlling vomiting induced by cisplatin: pharmacokinetic approach]. ( Brechot, JM; Delattre, C; Delfour, C; Dupeyron, JP; Guyon, F; Lebeau, B; Rochemaure, J, 1988)
"Droperidol was significantly more effective than domperidone, metoclopramide or placebo in reducing emetic sequelae."6.66Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery. ( Madej, TH; Simpson, KH, 1986)
"The metoclopramide regimen was either 2 mg/kg i."6.66A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis. ( Abdulhay, G; Dana, BW; Everts, E; McDermott, M, 1987)
" With the dosage and schedule used, AZP provided only limited antiemetic protection, with less than 10% of the patients free of emesis."6.66A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin. ( Carlini, P; Marolla, P; Nardi, M; Pollera, CF, 1987)
" It is concluded that there is a dose-response relationship for the antiemetic effect of metoclopramide."6.66High-dose versus low-dose metoclopramide in the prevention of cisplatin-induced emesis. A randomized crossover study in patients with ovarian carcinoma. ( Grande, T; Moxnes, A; Onsrud, M; Solesvik, O; Sollien, A, 1988)
"Continuous infusion of metoclopramide was compared with bolus dosing in a randomized, double-blind study in 27 patients receiving cisplatin therapy."6.66Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis. ( Agostinucci, WA; Dinonno, EB; Gannon, RH; Golub, GR; Martin, RS; Schauer, PK, 1988)
"In a randomized trial of 58 cancer patients receiving strongly emetogenic cytostatic drugs (cisplatin or comparable cytostatic agents, alone or in combination), the anti-emetic action of oral metoclopramide was tested, alone or combined with prednisone."6.66[Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone]. ( Bachmann-Mettler, I; Glaus, A; Köhler, M; Senn, HJ; Weigand, W, 1986)
"To better define the dose-response relationship of moderate-dose (MD) metoclopramide (MCP), 42 patients receiving their first course of cisplatin (50 mg/m2) were randomly allocated to receive a short-course regimen of MCP, either at 1 mg/kg X 1 dose, 30 min before cisplatin (regimen A) or 1 mg/kg X 2 doses, 30 min before and 1 h after cisplatin (regimen B)."6.66Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesis. ( Calabresi, F; Conti, EM; De Nigris, A; Pollera, CF, 1987)
"The metoclopramide-treated group demonstrated a statistically significant decrease in the incidence of nausea and vomiting."6.66Metoclopramide as prophylaxis for nausea and vomiting induced by fluorescein. ( Brown, RE; Drew, SJ; Sabates, R, 1987)
"Metoclopramide was compared to a metoclopramide plus dexamethasone combination in patients receiving high-dose cisplatinum."6.66Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis. ( Akerley, WL; Baker, CR; Cariffe, PA; Grunberg, SM; Johnson, KB; Krailo, MD, 1986)
"Metoclopramide was given at a dosage of 2 mg/kg (H) or 1 mg/kg (M), intravenously, 30 minutes before and 2."6.66[Randomized controlled study of high-dose metoclopramide (2 mg/kg x 4:H) vs moderate-dose metoclopramide (1 mg/kg x 4:M) in the prevention of CDDP-induced emesis]. ( Dozono, H; Ohmi, K, 1986)
"Metoclopramide (MCP) was given i."6.65Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting. ( Carlini, P; Cognetti, F; Conti, EM; Cortese, M; Pinnarò, P; Pollera, CF, 1984)
"In a population of 51 ambulant cancer patients treated with doxorubicin-containing chemotherapy we conducted a double-blind cross-over randomized trial, comparing the anti-emetic efficacy of a combination of amitriptyline (25 mg p."6.65Amitriptyline plus fluphenazine to prevent chemotherapy-induced emesis in cancer patients: a double-blind randomized cross-over study. ( Blijham, GH; Mellink, WA; van Deyk, WA, 1984)
"Metoclopramide was superior to placebo and to prochlorperazine in reducing the volume of emesis (P = 0."6.65Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. ( Bordin, LA; Braun, DW; Braun, TJ; Gralla, RJ; Itri, LM; Kelsen, DP; Pisko, SE; Squillante, AE; Young, CW, 1981)
" The importance of adequate dosage of metoclopramide and the role of IV metoclopramide are emphasized."6.65Metoclopramide in the reduction of nausea and vomiting associated with combined chemotherapy. ( Cox, R; Leyland, MJ; Newman, CE, 1982)
"Metoclopramide is a prokinetic agent reported to be safe in parturients."6.48Metoclopramide for nausea and vomiting prophylaxis during and after Caesarean delivery: a systematic review and meta-analysis. ( Habib, AS; Mishriky, BM, 2012)
" High-dose metoclopramide has demonstrated efficacy in small series of patients in the treatment of cisplatin-induced vomiting."6.15Advances in anti-emetic therapy. ( Bakowski, MT, 1984)
"Metoclopramide, 4-amino-5-chloro-2-methoxy-N-(2-diethyl-aminoethyl) benzamide, is advocated for use in gastro-intestinal diagnostics, and in treating various types of vomiting and a variety of functional and organic gastro-intestinal disorders."6.14Metoclopramide: a review of its pharmacological properties and clinical use. ( Avery, GS; Brogden, RN; Pinder, RM; Sawyer, PR; Speight, TM, 1976)
"We considered akathisia and cancer-related anxiety/agitation as possible causes of restlessness and insomnia, and prescribed clonazepam."5.72Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case report. ( Deguchi, Y; Inoue, K; Itoh, Y; Sakamoto, S; Uchida, S, 2022)
"To examine the clinical efficacy of prophylactic metoclopramide in reducing the incidence of nausea and vomiting in emergency department (ED) patients with acute pain who were treated with intravenous tramadol."5.69The efficacy of prophylactic metoclopramide in preventing nausea and vomiting in patients with acute pain treated with intravenous tramadol: a randomized double-blinded, placebo-controlled trial. ( Lokeskrawee, T; Patumanond, J; Phinyo, P; Sriwiset, H; Wongyikul, P, 2023)
"To assess and confirm the effect of ondansetron on behavior suggestive of nausea in dogs with vestibular syndrome."5.51Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study. ( Charalambous, M; Elliott, J; Foth, S; Henze, L; Kenward, H; Meller, S; Pelligand, L; Twele, F; Volk, HA, 2022)
" The EMPOWER (EMesis in Pregnancy – Ondansetron With mEtoClopRamide) trial aimed to compare the clinical effectiveness and cost-effectiveness of two anti-sickness drugs [metoclopramide (metoclopramide hydrochloride, Actavis UK Ltd, Barnstable, UK; IV Ratiopharm GmbH, Ulm, Germany) and ondansetron (ondansetron hydrochloride dehydrate, Wockhardt UK Ltd, Wrexham, UK; IV Hameln Pharma plus GmbH, Hameln)] for the treatment of nausea and vomiting in pregnancy."5.41Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT. ( Campbell, I; Fernandez-Garcia, C; Goudie, N; Graham, R; Howel, D; Lie, M; McColl, E; McParlin, C; Mossop, H; Nadeem, A; Nelson-Piercy, C; O'Hara, ME; Phillipson, J; Robson, S; Shehmar, M; Simpson, N; Steel, A; Ternent, L; Tuffnell, D; Williams, R, 2021)
" Prior treatment with each dosage of metoclopramide significantly reduced the frequency of emetic episodes (P<0."5.36Effects of metoclopramide on emesis in cats sedated with xylazine hydrochloride. ( Jarolmasjed, S; Kolahian, S, 2010)
"Metoclopramide is a dopamine receptor blocking drug that is commonly used to treat nausea and vomiting."5.31Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. ( Addis, A; Arnon, J; Berkovitch, M; Elbirt, D; Greenberg, R; Magee, L; Mazzota, P; Merlob, P; Moretti, M; Ornoy, A; Schuler-Faccini, L; Stahl, B, 2002)
"and metoclopramide 0."5.29Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study. ( Cannata, G; Gebbia, N; Gebbia, V; Testa, A, 1996)
"Despite treatment, emesis remains a major problem with cisplatin chemotherapy."5.28[Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam]. ( Hsu, KP; Li, YT; Mau, YK; Tsui, MS; Tu, FC, 1991)
"Both zacopride and BMY25801 were effective against emesis and related signs."5.28Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret. ( King, GL; Landauer, MR, 1990)
"Metoclopramide is a very effective drug in preventing the acute emetic and nauseating effects of cisplatin."5.28Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomiting. ( Schimke, J; Senn, HJ; Vergin, H; Wilder-Smith, C, 1989)
" In these six patients plasma metoclopramide half-life was 5."5.27Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting. ( Bateman, DN; Proctor, SJ; Taylor, WB, 1984)
"Metoclopramide was orally administered (10 or 20 mg) to 22 subjects, 75 min before parabolic flight."5.27Hormonal responses of metoclopramide-treated subjects experiencing nausea or emesis during parabolic flight. ( Kohl, RL, 1987)
"Diphenhydramine was administered intramuscularly 30 minutes before and 5 hours after chemotherapy."5.27[The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine]. ( Arihiro, T; Dozono, H; Morimoto, O; Ochiai, K; Sasaki, H; Takahashi, S; Terashima, Y; Tsuruoka, M; Yasuda, M; Yokoyama, S, 1987)
" The quantitative dose-response curves of the four doses of the emetic agonist cisplatin were shifted to the right by increasing doses of MCL."5.27Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis. ( Hellenbrecht, D; Saller, R, 1986)
"Metoclopramide was administered four times intravenously at a dose of 1."5.27[Antiemetic combination of metoclopramide and methylprednisolone for cisplatin-induced vomiting]. ( Amano, H; Fujimoto, K; Saito, H; Shimokata, K; Tsunekawa, H; Yasuda, Y; Yoshii, S, 1985)
"Metoclopramide (Paspertin) was infused intravenously in the high doses of 1."5.27Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis. ( Hellenbrecht, D; Hellstern, A; Hess, H; Saller, R, 1985)
"Metoclopramide was used as an antiemetic."5.26[Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)]. ( Antz, H; Doepfmer, K; FEAUX DE Lacroix, W; Groth, W; Runne, U, 1980)
" Maropitant (MRP) and metoclopramide (MCP) prevent emesis attributable to the opioid agent apomorphine in dogs."5.24A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs. ( Himelfarb, MA; Invaldi, SH; Litterio, NJ; Lorenzutti, AM; Martín-Flores, M; Zarazaga, MP, 2017)
"The aim of the study was to evaluate the efficiencies of selected anti-emetic drugs (metoclopramide, ondansetron and maropitant) in preventing vomiting in the treatment of canine parvoviral enteritis."5.24Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs. ( Keser, GO; Yalcin, E, 2017)
"There was no evidence that prophylactic metoclopramide affected the risk of vomiting, nausea, or the need for rescue medication when provided prior to intravenous opioids in the acute care setting."5.22Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting. ( Carlson, JN; Gottlieb, M; Peksa, GD, 2022)
"Eligible patients were those who were mechanically ventilated and over 20 years old, with delayed gastric emptying (DGE), defined as a gastric residual volume ≥250 ml or vomiting, and who failed to respond to first-line prokinetic treatment of 3 doses of 10 mg IV metoclopramide over 24 h."5.22A randomised controlled feasibility and proof-of-concept trial in delayed gastric emptying when metoclopramide fails: We should revisit nasointestinal feeding versus dual prokinetic treatment: Achieving goal nutrition in critical illness and delayed gastr ( Allan, K; Brown, J; Greenwood, R; Manara, A; McWilliam, H; Taylor, SJ; Toher, D, 2016)
" The aim of this study was to verify if A + D is superior to metoclopramide plus dexamethasone (M + D) in preventing delayed emesis in cancer patients receiving the same prophylaxis for acute emesis."5.20Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study. ( Angelelli, L; Ballatori, E; Caserta, C; Cavanna, L; Ciuffreda, L; Colantonio, I; Fasola, G; Fatigoni, S; Fava, S; Ionta, MT; Licitra, L; Massidda, B; Mirabile, A; Palladino, MA; Roila, F; Ruggeri, B; Tocci, A; Zerilli, F, 2015)
"We compare efficacy of ondansetron and metoclopramide with placebo for adults with undifferentiated emergency department (ED) nausea and vomiting."5.19Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo. ( Braitberg, G; Egerton-Warburton, D; Mee, MJ; Meek, R, 2014)
" The granisetron group indicated a higher complete response rate in acute emesis (adjusted OR: 0."5.17Can granisetron injection used as primary prophylaxis improve the control of nausea and vomiting with low- emetogenic chemotherapy? ( Abdul Kassim, MS; Keat, CH; Phua, G; Poh, WK; Sriraman, M, 2013)
"To estimate whether the addition of metoclopramide or its combination with ondansetron to a prophylactic phenylephrine infusion provides improved intraoperative nausea and vomiting prophylaxis compared with phenylephrine infusion alone."5.17Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial. ( Allen, TK; George, RB; Habib, AS; Ituk, US; McKeen, DM; Megalla, SA; White, WD, 2013)
"During the 72-h observation period, 39 out of 56 (70%) patients receiving olanzapine had no emesis compared to 16 out of 52 (31%) patients with no emesis for patients receiving metoclopramide (p < 0."5.17The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. ( Gray, SE; Nagy, CK; Navari, RM, 2013)
" Parents or caregivers should be given more detailed discharge instructions about vomiting and diet considering the relatively long time to resuming a normal diet after ketamine sedation and the fact that KAV often occurred after ED discharge."5.16Adjunctive atropine versus metoclopramide: can we reduce ketamine-associated vomiting in young children? a prospective, randomized, open, controlled study. ( Choi, SC; Jeon, WC; Jung, YS; Kim, GW; Lee, JS; Min, YG; Park, EJ, 2012)
"Several trials had independently noted that patients receiving megestrol acetate had less nausea and vomiting, but this antiemetic activity of megestrol acetate has not been reported separately in the literature."5.15Antiemetic activity of megestrol acetate in patients receiving chemotherapy. ( Bi, F; Cao, D; Gou, HF; Hou, M; Jiang, M; Luo, de Y; Qiu, M; Shen, Y; Wang, J; Xu, F; Yang, Y; Yi, C; Zang, J; Zhou, XJ, 2011)
"To compare the efficacy of acupressure wrist bands, ondansetron, metoclopramide and placebo in the prevention of vomiting and nausea after strabismus surgery."5.15Comparing the efficacy of prophylactic p6 acupressure, ondansetron, metoclopramide and placebo in the prevention of vomiting and nausea after strabismus surgery. ( Arbabi, S; Ebrahim Soltani, AR; Goudarzi, M; Mohammadinasab, A; Mohammadinasab, F; Mohammadinasab, H; Samimi, M, 2011)
"To compare the efficacy and safety of ondansetron versus less expensive metoclopramide in the treatment of children with persistent vomiting with acute gastroenteritis."5.15Metoclopramide versus ondansetron for the treatment of vomiting in children with acute gastroenteritis. ( Abdulateef, H; Al-Ansari, K; Alomary, S; Alshawagfa, M; Kamal, K, 2011)
"We aimed to compare the relative efficacy of tropisetron and metoclopramide in treating nausea/vomiting in undifferentiated ED patients."5.15Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: A randomized, double-blinded, clinical trial. ( Chae, J; Frauman, AG; Taylor, DM, 2011)
"This study assesses the effects of ginger on nausea and vomiting caused by pregnancy and compares it with metoclopramide medicine."5.15Comparing the effects of ginger and metoclopramide on the treatment of pregnancy nausea. ( Farhadifar, F; Mohammadbeigi, R; Rezaiie, M; Shahgeibi, S; Soufizadeh, N, 2011)
"Of the 380 patients evaluated, significantly fewer ondansetron 4 mg treated patients (89/189; 47%) experienced postoperative nausea and/or vomiting compared with metoclopramide treated patients (115/ 191; 60%) during the study period (p = 0."5.13Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery. ( Diregpoke, S; Krobbuaban, B; Pitakpol, S, 2008)
"Metoclopramide use during first trimester of pregnancy was not associated with the risk of major congenital malformations."5.12Use of metoclopramide in the first trimester and risk of major congenital malformations: A systematic review and meta-analysis. ( Sun, L; Wen, X; Xi, Y; Zou, W, 2021)
"First-line antiemetics for nausea and vomiting in advanced cancer are metoclopramide and haloperidol, and second-line medications are methotrimeprazine and olanzapine."5.12MASCC antiemetics in advanced cancer updated guideline. ( Bruera, E; Capela, A; Davies, A; Davis, M; DeFeo, G; Del Fabbro, E; Hui, D; Ripamonti, C, 2021)
"The aim of this study was to compare the incidence of nausea and vomiting in patients with acute pain treated with morphine along with prophylactic metoclopramide or placebo."5.12Use of a prophylactic antiemetic with morphine in acute pain: randomised controlled trial. ( Bradshaw, M; Sen, A, 2006)
"This study demonstrates that betamethasone does not prevent nausea, vomiting and increase of vasopressin induced by apomorphine, whereas metoclopramide prevents apomorphine-induced emesis."5.12Betamethasone does not prevent nausea and vomiting induced by the dopamine-agonist apomorphine. ( Axelsson, P; Lövqvist, A; Thörn, SE; Wattwil, L; Wattwil, M, 2006)
"A prospective randomized study was performed to assess the value of some individual risk factors for postoperative nausea and vomiting (PONV), and to compare the efficacy of ondansetron, metoclopramide, dexamethason, and combinations of these antiemetics in preventing PONV in patients after laparoscopic cholecystectomy."5.12Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study. ( Leksowski, K; Peryga, P; Szyca, R, 2006)
"In children and adolescents with osteosarcoma, granisetron was safe and more efficient than metoclopramide plus dimenhydrinate for controlling chemotherapy-induced emesis and nausea."5.12Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma. ( Caran, EM; Luisi, FA; Petrilli, AS; Tanaka, C, 2006)
"To determine whether intermediate dose metoclopramide is more effective than standard dose metoclopramide for patients who present to the ED with nausea and vomiting."5.11Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study. ( Basire, M; Cham, S; Kelly, AM, 2004)
"In low dose cisplatin regimen, complete suppression of delayed emesis occurred in 55 per cent patients receiving ondansetron and in 30 per cent patients receiving metoclopramide."5.11Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis. ( Bhatia, A; Sharma, M; Tripathi, KD, 2004)
"Aim of this study was to demonstrate that intravenous metoclopramide can reduce pain, nausea and discomfort during nasogastric tube (NGT) insertion in ED."5.11Effectiveness of pre-emptive metoclopramide infusion in alleviating pain, discomfort and nausea associated with nasogastric tube insertion: a randomised, double-blind, placebo-controlled trial. ( Karaca, MA; Ozucelik, DN; Sivri, B, 2005)
"In daily practice, a combination of oral dexamethasone and oral granisetron achieves an extremely high control of acute emesis (86% protection)."5.10A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis. ( Aapro, MS; Bernhard, J; De Pree, C; Maibach, R; Sessa, C; Thuerlimann, B, 2003)
" The number of patients who were emesis free (no nausea, retching, or vomiting) was significantly higher in patients who received granisetron (88% [2225]) than in those who received droperidol (64% [1625]; P = 0."5.10A comparison of granisetron, droperidol, and metoclopramide in the treatment of established nausea and vomiting after breast surgery: a double-blind, randomized, controlled trial. ( Fujii, Y; Kawasaki, T; Tanaka, H, 2003)
"This study compares pyridoxine-metoclopramide combination therapy to prochlorperazine and promethazine monotherapies in the outpatient treatment of nausea and vomiting in pregnancy."5.10Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy. ( Bsat, FA; Hoffman, DE; Seubert, DE, 2003)
" The present study aimed to study the efficacy and tolerability of ondansetron versus (vs) metoclopramide in different dose related grades of cisplatin induced acute emesis."5.10Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy. ( Bhatia, A; Sharma, M; Tripathi, KD, 2003)
"The results obtained showed that ondansetron was more effective in controlling nausea and vomiting than metoclopramide, either objectively (2."5.10Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting. ( Bagatin, J; Hozo, I; Ljutić, D; Perković, D; Pivac, N; Rumboldt, Z, 2002)
"Although combination antiemetics prevent vomiting during the initial 24 h after high-dose (> or =100 mg/m2) cisplatin, many patients experience delayed emesis 24-120 h afterwards despite receiving prophylactic dexamethasone and metoclopramide during this time."5.09Oral cisapride for the control of delayed vomiting following high-dose cisplatin. ( Baltzer, L; Grant, SC; Hinckley, L; Kris, MG; Miller, VA; Pisters, KM; Pizzo, BA, 1999)
"Several studies have confirmed the efficacy of high-dose metoclopramide and, more recently, serotonin antagonists, with and without dexamethasone, in the prophylaxis of cisplatin-induced nausea and vomiting."5.09Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. ( Hussain, M; Khan, Z; Malik, I; Moid, I, 1999)
"The purpose of the present study was to examine whether its is possible to successfully replace ondansetron (OND) with metoclopramide (MCP) in patients exposed to moderately emetogenic chemotherapy who did not experience severe nausea and vomiting while undergoing OND treatment during their first chemotherapy cycle."5.09Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy. ( Athanasiou, E; Dimitrakopoulos, A; Katsikas, M; Koufos, C; Linardaki, G; Tsavaris, NB, 1999)
") doses of ondansetron 8 mg, ondansetron 16 mg and metoclopramide 10 mg in the treatment of opioid-induced emesis."5.09Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study Group. ( Alahuta, S; Chung, F; Curtis, P; Duvaldestin, P; Jacka, M; Lane, R; Luttropp, HH; McQuade, B; Rocherieux, S; Roy, M; Spraggs, C, 1999)
"Complete control of established postoperative nausea and vomiting, defined as no emesis and no need for another rescue antiemetic medication, was more frequent among the patients who had received granisetron (88%) than among those who had received droperidol (55%) or metoclopramide (50%) (P <."5.09Granisetron, droperidol, and metoclopramide for the treatment of established postoperative nausea and vomiting in women undergoing gynecologic surgery. ( Fujii, Y; Somekawa, Y; Tanaka, H, 2000)
"The aim of our single-center, prospective, randomized, open study was to evaluate the antiemetic efficacy and tolerability of a regimen based on a single oral dose of ondansetron 8 mg in comparison with a metoclopramide-based regimen, for prevention of acute FAC (fluorouracil, doxorubicin and cyclophosphamide) chemotherapy-induced emesis."5.09High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer. ( Bosnjak, SM; Mitrovi, LB; Nesković-Konstantinović, ZB; Radulović, SS; Susnjar, S, 2000)
"The serotonin (5HT3) antagonist ondansetron was compared in a randomised study with metoclopramide and dexamethasone for the prevention of chemotherapy induced emesis."5.08Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. ( Dick, GS; Meller, ST; Pinkerton, CR, 1995)
"A single 5-minute infusion of 3 mg granisetron was more effective and produced a less adverse effect than multiple doses of metoclopramide in controlling chemotherapy-induced emesis, both in the first 24 hours and over a 6-day period."5.08Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis. ( Chen, PM; Chiou, TJ; Fan, FS; Hsieh, RK; Liu, JH; Wei, CH, 1995)
" Patients were randomised into one of two groups, receiving either granisetron, a specific 5-HT3 antagonist or a combination of metoclopramide, dexamethasone phosphate and lorazepam to assess the comparative efficacy of the two regimens in the control of irradiation-induced nausea and vomiting."5.08Granisetron in the prevention of irradiation-induced emesis. ( Collis, C; Cunningham, J; Cunningham, S; Gandhi, L; Hamon, MD; Prentice, HG, 1995)
"Metoclopramide was significantly more effective at preventing both nausea and vomiting (20/44 (45%) compared with 32/47 (68%), p < 0."5.08Prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. A prospective randomized study of metoclopramide and transdermal hyoscine. ( Appelgren, L; Haglind, E; Thune, A, 1995)
"Successful control of vomiting was achieved in the first 24 hours, in 74% of the cycles containing cisplatin and 82% of the cycles without cisplatin, if ondansetron was used."5.08Ondansetron in chemotherapy-induced emesis. Our experience. ( Bandiera, AF; Fiorelli, C; Framarino dei Malatesta, M; Marzetti, L; Toccaceli Blasi, MR; Veneziano, M; Yacoub, M, 1995)
"To compare the efficacy of oral droperidol versus oral metoclopramide, or both oral droperidol and metoclopramide, on postoperative vomiting when used as a premedicant for strabismus surgery."5.08The effects of oral droperidol versus oral metoclopramide versus both oral droperidol and metoclopramide on postoperative vomiting when used as a premedicant for strabismus surgery. ( Brown, RE; Jones, E; Kymer, PJ; Lawhorn, CD; Pearce, L, 1995)
"This randomized, double-blind, multicentre, parallel-group study compared the efficacy and safety of an intravenous dose of ondansetron 4 mg for the prevention of postoperative nausea and vomiting (PONV) with metoclopramide 10 mg and placebo in patients undergoing major gynaecological surgery."5.08[Intravenous administration of ondansetron vs. metoclopramide for the prophylaxis of postoperative nausea and vomiting]. ( Rust, M, 1995)
"We have compared the efficacy of ondansetron, metoclopramide, droperidol and placebo in the prevention of postoperative nausea and vomiting in 118 day stay patients undergoing laparoscopic gynaecological procedures."5.08Prevention of nausea and vomiting after day case gynaecological laparoscopy. A comparison of ondansetron, droperidol, metoclopramide and placebo. ( McKay, AC; Mirakhur, RK; Paxton, LD, 1995)
" We compared the efficacy, toxicity, and patients' preference for tropisetron, a new 5-hydroxytryptamine3 (HT3) receptor antagonist, with those of a combination of high-dose metoclopramide, dexamethasone, diphenhydramine, and lorazepam (metoclopramide cocktail) in a randomized crossover study for the control of nausea and vomiting during cisplatin-containing chemotherapy."5.08Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis. ( Chang, TC; Cheng, HH; Hsieh, F; Lai, CH; Li, CL; Michael, BJ; Soong, YK; Tseng, CJ, 1996)
"Of the patients treated with metoclopramide plus methylprednisolone (n = 92), 53% had complete protection from delayed emesis, 16% a major response, 15% a minor response, and 15% no response."5.08Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial. ( Cannata, G; Gebbia, N; Gebbia, V; Testa, A; Tirrito, ML; Valenza, R, 1995)
"Intravenous antiemetic combinations containing a 5-HT3 receptor antagonist (like metoclopramide, ondansetron, or granisetron) with dexamethasone have become the standard therapy for the treatment of acute chemotherapy-induced vomiting."5.08Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin. ( Clark, RA; Cleri, LB; Gralla, RJ; Kris, MG; Pisters, KM; Tyson, LB, 1995)
"Both metoclopramide and prochlorperazine in combination with lorazepam and diphenhydramine offer good control of nausea and vomiting although the sedation and low risk for cardiac toxicity limit the regimen to an inpatient setting with close monitoring."5.08Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation. ( Gilbert, CJ; Ohly, KV; Peters, WP; Rosner, G, 1995)
"The aim of the present study was to compare the antiemetic efficacy of ondansetron (OND) with metoclopramide (MCP), both combined with corticosteroid (CS) in patients with malignant lymphoma."5.08Antiemetic efficacy of ondansetron and metoclopramide, both combined with corticosteroid, in malignant lymphoma patients receiving non-cisplatin chemotherapy. ( Jørgensen, M; Victor, MA, 1996)
"We conducted a prospective randomized study to compare granisetron, a 5-hydroxytryptamine-3 receptor antagonist with standard anti-emetics (control group) consisting mainly of metoclopramide, in the prophylaxis of emesis induced by conditioning prior to stem cell transplantation."5.08Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study. ( Asano, S; Ikeda, Y; Kimura, Y; Miyawaki, S; Oh, H; Okamoto, S; Onozawa, Y; Sakamaki, H; Takahashi, S; Tanosaki, R; Toyama, K, 1996)
" We report a single-blind randomized crossover trial comparing the efficacy of tropisetron plus dexamethasone (TROPDEX) vs conventional combination of metoclopramide, dexamethasone and diphenhydramine (METDEX) in prevention of acute and delayed vomiting in Chinese patients receiving high dose cisplatin."5.08The antiemetic efficacy of tropisetron plus dexamethasone as compared with conventional metoclopramide-dexamethasone combination in Orientals receiving cisplatin chemotherapy: a randomized crossover trial. ( Au, GK; Cheng, AC; Choy, D; Chua, DT; Kwong, DL; Sham, JS; Yau, CC, 1996)
" The recurrence of retching or vomiting was higher with propofol (58%) than with droperidol (4%) or metoclopramide (24%) (P < 0."5.08Treatment of postoperative nausea and vomiting: comparison of propofol, droperidol and metoclopramide. ( Lacroix, G; Lessard, MR; Trépanier, CA, 1996)
"The purpose of this retrospective study is to assess the frequency and intensity of chronic nausea in patients admitted to the Palliative Care Unit and the results of a metoclopramide-based treatment regimen."5.08Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. ( Babul, N; Bruera, E; Darke, A; Harsanyi, Z; Seifert, L; Suarez-Almazor, M; Watanabe, S, 1996)
"The efficacy of ondansetron 4 mg was compared with metoclopramide 10 mg for the prevention of post-operative nausea and vomiting in patients after major gynaecological abdominal surgery."5.08Comparison of ondansetron and metoclopramide for the prevention of post-operative nausea and vomiting after major gynaecological surgery. ( Chen, PP; Chui, PT; Gin, T, 1996)
"This study determined the overall incidence of postoperative nausea and vomiting (PONV) in 38 patients undergoing laparoscopic gynaecological procedures who received a standardized propofol/isoflurane anaesthetic but no preoperative antiemetic."5.08A randomized double-blinded comparison of metoclopramide, ondansetron and cyclizine in day-case laparoscopy. ( Watts, SA, 1996)
"To compare the antimetic efficacy of prophylactic ondansetron, metoclopramide, and placebo for prevention of postoperative vomiting in pediatric tonsillectomy or adenotonsillectomy patients."5.08Prospective, randomized, double-blind, placebo-controlled comparison of metoclopramide and ondansetron for prevention of posttonsillectomy or adenotonsillectomy emesis. ( Bohnsack, LE; Bostrom, BC; Seay, RE; Stene, FN; Young, LA, 1996)
"The purpose of this study was to compare the effectiveness of granisetron, metoclopramide and placebo in reducting the frequencies of retching and vomiting in children who had undergone strabismus repair and tonsillectomy with or without adenoidectomy."5.08Antiemetic efficacy of granisetron and metoclopramide in children undergoing ophthalmic or ENT surgery. ( Fujii, Y; Tanaka, H; Toyooka, H, 1996)
"The potent serotonin receptor (5-HT3) antagonists are new highly selective agents for the prevention and control of chemotherapy-induced nausea and vomiting that have been shown to be comparable to or more effective than traditional metoclopramide regimens."5.08A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy. ( Bastit, P; Cals, L; Cappelaere, P; Catimel, G; Chevallier, B; Claverie, N; Fabbro, M; Giovannini, M; Khayat, D; Splinter, T; Wendling, JL, 1997)
"In a prospective, randomised, double-blind trial, we assessed the relative efficacy of prophylactic ondansetron and metoclopramide administration in the reduction of postoperative nausea and vomiting in 60 patients undergoing routine major neurosurgical procedures."5.08A comparison of prophylactic ondansetron and metoclopramide administration in patients undergoing major neurosurgical procedures. ( Barsoum, LZ; Jones, NC; Pugh, SC, 1996)
"048) with placebo (mean = 5) than ondansetron (mean = 2) and the proportion of patients experiencing no emesis was significantly greater (P = 0."5.08Antiemetic activity of ondansetron in acute gastroenteritis. ( Cubeddu, LX; Gonzalez, V; Guariguata, J; Miller, IA; Paska, W; Seijas, J; Talmaciu, I; Trujillo, LM, 1997)
"To evaluate the combined effect of granisetron and methylprednisolone against acute emesis induced by cytotoxic agents, we investigated the clinical response and the urinary excretion of 5-HIAA in 85 patients with ovarian cancer who received the same anticancer chemotherapeutic regimen in a prospective randomized trial."5.08Combination effect of granisetron and methylprednisolone for preventing emesis induced by cytotoxic agents. ( Cheng, X; Itamochi, H; Kigawa, J; Minagawa, Y; Okada, M; Terakawa, N, 1997)
"A double-blind, randomised, placebo-controlled trial was conducted to compare the efficacy of metoclopramide with the 5-HT3 antagonist, ondansetron, for the prevention of postoperative emesis in children undergoing elective strabismus surgery."5.08Efficacy of ondansetron and metoclopramide for preventing postoperative emesis following strabismus surgery in children. ( Mandal, NG; Shende, D, 1997)
"To compare the efficacy of oral ondansetron with oral metoclopramide for the prevention of postoperative vomiting and nausea in children undergoing strabismus surgery."5.08[Does oral ondansetron reduce the incidence of nausea and vomiting after surgery for strabismus in children?]. ( Amraoui, A; Benaguida, M; el Harrar, N; Idali, B; Laouissi, F; Mjahed, K, 1996)
"In a randomised, double-blind study, we have compared the incidence of postoperative nausea and vomitting in 124 patients undergoing major lower limb orthopaedic surgery following oral premedication with temazapam and ondansetron 8 mg, metoclopramide 10 mg or placebo."5.08Comparison of ondansetron, metoclopramide and placebo as premedicants to reduce nausea and vomiting after major surgery. ( Alexander, R; Fennelly, M, 1997)
" This difference was still significant when controlling for age, body weight, history of motion sickness, previous PONV episodes, duration of anesthesia, and intraoperative fentanyl consumption using a logistic model."5.08Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting. ( Finco, G; Gottin, L; Grosso, S; Ischia, S; Mosaner, W; Pinaroli, AM; Polati, E; Verlato, G, 1997)
"Granisetron is a better prophylactic antiemetic than droperidol or metoclopramide in female patients with a history of motion sickness undergoing major gynaecological surgery."5.08Prevention of PONV with granisetron, droperidol and metoclopramide in female patients with history of motion sickness. ( Fujii, Y; Tanaka, H; Toyooka, H, 1997)
" The purpose of this study was to compare the efficacy of ondansetron, a highly selective 5-hydroxytryptamine subtype-3 receptor antagonist, with that of metoclopramide for the prevention of postoperative emesis in patients undergoing cataract surgery."5.08Prophylactic intravenous ondansetron in patients undergoing cataract extraction under general anesthesia. ( Ascaso, FJ; Ayala, I; Carbonell, P; Castro, FJ; Palomar, A, 1997)
"To compare the efficacy of ondansetron, droperidol, or metoclopramide with placebo in preventing postoperative vomiting following strabismus surgery."5.08A randomized, double-blind, placebo controlled comparison of droperidol, ondansetron, and metoclopramide for the prevention of vomiting following outpatient strabismus surgery in children. ( Elliott, WG; James, RL; Mims, G; Scuderi, PE; Weaver, RG; Weeks, DB, 1997)
" After experiencing at least one nausea and/or one emetic episode in the 6 h after recovery from anaesthesia, patients received either ondansetron 4 mg i."5.08Ondansetron compared with metoclopramide in the treatment of established postoperative nausea and vomiting. The French Ondansetron Study Group. ( Clyti, N; Conseiller, C; Diemunsch, P; Mamet, JP, 1997)
"Seminoma stage I patients on tropisetron experienced less nausea and vomiting during abdominal radiotherapy than patients receiving metoclopramide."5.08Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients. ( Aass, N; Fosså, SD; Håtun, DE; Thoresen, M, 1997)
"To establish a dose-response relationship for ondansetron, and to evaluate any effects of oral premedication with metoclopramide in pediatric patients undergoing tonsillectomy and adenoidectomy and strabismus surgery."5.08Ondansetron dose response curve in high-risk pediatric patients. ( Kymer, PJ; Lawhorn, CD; Shirey, R; Stewart, FC; Stoner, JM; Volpe, P, 1997)
"Granisetron is more effective than droperidol or metoclopramide in preventing PONV in female patients with a history of postoperative emesis."5.08Prevention of PONV with granisetron, droperidol or metoclopramide in patients with postoperative emesis. ( Fujii, Y; Saitoh, Y; Tanaka, H; Toyooka, H, 1998)
"Ondansetron 4 mg was compared with metoclopramide 10 mg for prevention of post-operative nausea and emesis in in-patients undergoing major gynaecological surgery in this double-blind, randomized, placebo-controlled, multicentre study."5.08International, multicentre, placebo-controlled study to evaluate the effectiveness of ondansetron vs. metoclopramide in the prevention of post-operative nausea and vomiting. ( Aune, H; Cohen, LA; Feiss, P; Hanson, A; Hasselstrøm, L; Maltby, JR; Morris, RW; Rocke, DA; Rozenberg, B; Rust, M, 1998)
"The antiemetic efficacy of droperidol, metoclopramide and granisetron was compared with placebo in the reduction of vomiting after paediatric surgery (the extremities; inguinal hernia; and phimosis) during general inhalational anaesthesia."5.08Prophylactic therapy with granisetron in the prevention of vomiting after paediatric surgery. A randomized, double-blind comparison with droperidol and metoclopramide. ( Fujii, Y; Tanaka, H, 1998)
"This study evaluates the prophylactic anti-emetic efficacy of granisetron, droperidol and metoclopramide, for the prevention of post-operative nausea and vomiting in female patients undergoing elective laparoscopic cholecystectomy."5.08Anti-emetic efficacy of prophylactic granisetron, droperidol and metoclopramide in the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled trial. ( Fujii, Y; Saitoh, Y; Tanaka, H; Toyooka, H, 1998)
"The incidence of postoperative emesis in the metoclopramide group was 60% versus 71% in a placebo group (p < 0."5.08Prophylactic metoclopramide administered immediately after the induction of anesthesia has no effect on the incidence of postoperative emesis after strabismus surgery. ( Haldar, M; Shende, D, 1998)
"A single institution, prospective, randomized trial was performed in terminal cancer patients to compare tropisetron (TRO), metoclopramide (MET), and chlorpromazine (CHL) in the management of nausea and emesis."5.08Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer. ( Befon, S; Liossi, C; Mystakidou, K; Vlachos, L, 1998)
"To compare the prophylactic administration of ondansetron plus droperidol, droperidol plus metoclopramide, and perphenazine to determine effects on postoperative nausea, vomiting, and sedation after laparoscopic cholecystectomy."5.08Prophylactic antiemetics for laparoscopic cholecystectomy: a comparison of perphenazine, droperidol plus ondansetron, and droperidol plus metoclopramide. ( Freiberger, D; Gosnell, JL; Steinbrook, RA, 1998)
"Ondansetron appeared to be superior to metoclopramide-diphenhydramine in the control of emesis induced by chemotherapy regimens containing cisplatin."5.08Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. ( Atay, AA; Köseoglu, V; Kürekçi, AE; Ozcan, O; Sarici, U; Sorici, U, 1998)
"The aim of this study was to determine the mechanism of action of radiation-induced emesis by determining the incidence of radiation-induced emesis following hemibody irradiation; the effects of specific antiemetics especially ondansetron, a 5-hydroxytryptamine receptor antagonist, and to determine the relationship between radiation-induced emesis and serotonin (5-hydroxytryptamine) through its active metabolite, 5-hydroxyindoleacetic acid (5-HIAA)."5.07On the mechanism of radiation-induced emesis: the role of serotonin. ( Anderson, RF; Hoffman, LG; Ornitz, RD; Scarantino, CW, 1994)
"To determine the contribution of metoclopramide to the efficacy of ondansetron in control of cisplatin-induced emesis, ondansetron was compared with ondansetron plus metoclopramide for antiemetic efficacy in a randomized double-blind trial."5.07Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis. ( Cho, GY; Kim, SH; Kim, SW; Lee, CW; Lee, JS; Lee, KH; Suh, CW, 1994)
"Lignocaine has been shown to reduce the incidence of pain on injection of propofol."5.07Propofol injection pain: comparing the addition of lignocaine or metoclopramide. ( Mecklem, DW, 1994)
"We carried out a randomized, single-blind, cross-over trial to compare the antiemetic effect, for both acute and delayed emesis, of granisetron plus dexamethasone (GRN+Dx) with that of high-dose metoclopramide plus dexamethasone (HDMP+Dx)."5.07A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin. ( Arioka, H; Eguchi, K; Karato, A; Kunikane, H; Nakashima, H; Nisio, M; Ohe, Y; Ohmatsu, H; Shinkai, T; Tamura, T, 1994)
"Oral metoclopramide may be given as a premedicant to reduce post-operative nausea and vomiting, but there is little evidence that it is effective."5.07Sustained release metoclopramide for prophylaxis of post-operative nausea and vomiting. ( Curran, JP; Elliott, RH; Graham, SG, 1994)
"The clinical efficacy and tolerability of a new nasal spray formulation of metoclopramide (MTC) was evaluated in terms of its ability to prevent the nausea and vomiting induced by a moderately emetic chemotherapy (cisplatin 20 mg/m2 weekly as radioenhancer+radiotherapy for a fractionated total of 60 Gy) in 12 patients with non-small-cell lung cancer, stage IIIB."5.07Efficacy and tolerability of nasally administered compared to parenterally administered metoclopramide in the symptomatic treatment of chemotherapy-induced emesis in cancer outpatients. A controlled clinical study. ( Confalonieri, M; Dimaiuta, M; Scanni, A; Tomirotti, M, 1994)
"In a prospective, double-blind study, we have examined the effect of preoperative nabilone on postoperative nausea and vomiting (PONV)."5.07Effect of nabilone on nausea and vomiting after total abdominal hysterectomy. ( Barrowcliffe, MP; Campbell, DN; Lewis, IH, 1994)
" Acetaminophen and meperidine were given for postoperative pain."5.07Prophylactic antiemetic treatment with ondansetron in children undergoing tonsillectomy. ( Furst, SR; Rodarte, A, 1994)
" dexamethasone and oral metoclopramide) for delayed emesis, while they had received either i."5.07Cisplatin-induced delayed emesis: pattern and prognostic factors during three subsequent cycles. Italian Group for Antiemetic Research. ( , 1994)
" Oral granisetron alone was as effective as met/dex in control of acute emesis in all parameters examined."5.07Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group. ( Cedar, E; Cunningham, J; Goedhals, L; Heron, JF; Jordaan, JP, 1994)
" A sample of 43 patients with breast cancer was accrued from September to November 1992 in a phase II study to assess the efficacy of granisetron in patients receiving FEC (5-FU, epirubicin, cyclophosphamide)."5.07Control of emesis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide. ( Ang, PT; Khoo, KS; Tan, EH, 1994)
"We studied the preventive effect on postoperative nausea and vomiting (PONV) of ondansetron, metoclopramide and placebo associated with epidural anaesthesia."5.07[Effects of ondansetron and metoclopramide on postoperative nausea and vomiting after epidural anesthesia in children]. ( Andreuccetti, T; Busoni, P; Calamandrei, M; Crescioli, M; Messeri, A; Sarti, A; Sestini, G, 1994)
"Metoclopramide is an active antiemetic against cisplatin-induced acute emesis."5.07Continuous infusion versus intermittent short infusion of metoclopramide for cisplatin-induced acute emesis. ( Kajita, M; Niimi, T; Saito, H; Shimokata, K; Yamori, S, 1994)
"To improve the treatment of cisplatin-induced acute emesis and vomiting, the adjuvant effect of two different doses of metoclopramide and metoclopramide plus droperidol was compared to a defined standard antiemetic regiment."5.07Comparison of four antiemetic regimens for the treatment of cisplatin-induced vomiting. ( Hernádi, Z; Juhász, B; Lampé, L; Póka, R, 1993)
"We have compared the incidence of postoperative nausea and vomiting up to 48 h after day-case gynaecological laparoscopy after oral premedication with ondansetron 4 mg, metoclopramide 10 mg or a placebo allocated randomly and assessed blindly."5.07Nausea and vomiting after gynaecological laparoscopy: comparison of premedication with oral ondansetron, metoclopramide and placebo. ( Cooper, GM; Field, JM; Malins, AF; Nesling, PM, 1994)
"To determine the severity of emesis caused by ultra-high-dose cisplatin-carboplatin chemotherapy and to compare the antiemetic efficacy of an ondansetron regimen and a metoclopramide regimen."5.07Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy. ( Fanning, J; Hilgers, RD, 1994)
"This placebo-controlled, randomized, double-blind trial was designed to evaluate the efficacy of three prophylactic antiemetic regimens on postoperative nausea and vomiting (PONV) during patient-controlled analgesia (PCA) with morphine."5.07Prophylactic antiemetic therapy with patient-controlled analgesia: a double-blind, placebo-controlled comparison of droperidol, metoclopramide, and tropisetron. ( Kaufmann, MA; Rosow, C; Schneider, M; Schnieper, P, 1994)
"We have compared the efficacy of ondansetron with droperidol and saline in the prevention of postoperative nausea and vomiting (PONV) in 120 ASA I and II patients undergoing hip and knee replacements and femoral resections."5.07Double-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting. ( Collis, R; Gan, TJ; Hetreed, M, 1994)
"We investigated the usefulness of concurrent therapy of granisetron with methylprednisolone sodium for on nausea, vomiting and anorexia induced by chemotherapy, including cisplatin, in patients with oral cancer."5.07[Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin]. ( Kawashima, T; Miyata, K; Morita, N; Ohmata, T; Sakamoto, T; Wada, T, 1993)
" The purpose of this study was to compare the incidence of emesis after propofol anaesthesia with and without nitrous oxide, compared with thiopentone and halothane anaesthesia, in hospital and up to 24 hr postoperatively, in outpatient paediatric patients after strabismus surgery."5.07Propofol anaesthesia reduces early postoperative emesis after paediatric strabismus surgery. ( Bevan, JC; Blackstock, D; Merrick, PM; Montgomery, CJ; Popovic, V; Reimer, EJ, 1993)
"Ondansetron plus dexamethasone was significantly more efficacious and better tolerated than metoclopramide plus dexamethasone and diphenhydramine during three cycles of chemotherapy and, in contrast to the metoclopramide regimen, the efficacy of ondansetron plus dexamethasone, at least for vomiting, is maintained in subsequent cycles."5.07Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research. ( , 1993)
") was compared with a metoclopramide cocktail for the prevention of nausea and emesis."5.07An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. ( Frankendal, B; Hallén, C; Sorbe, B, 1994)
", Basel, Switzerland), a new 5-HT3 receptor antagonist, was compared in a randomized multicenter trial with a high-dose metoclopramide-dexamethasone cocktail for the prevention of nausea and emesis during cisplatin-containing chemotherapy."5.07A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. ( de Bruijn, KM; Glimelius, B; Hansen, O; Högberg, T; Räisänen, I; Schmidt, M; Sorbe, BG; Sörensen, BT; van Oosterom, AT; Wernstedt, L, 1994)
"Vomiting was prevented in two thirds of patients treated with MDL plus ondansetron, a result similar to that observed in earlier trials of MDL alone."5.07The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin. ( Baltzer, L; Kris, MG; Pisters, KM; Rigas, JR; Tyson, LB, 1994)
"The usefulness of alprazolam (minor tranquilizer) used in combination with metoclopramide plus methylprednisolone for the prevention and control of emesis induced by chemotherapies, including 5-day continuous intravenous infusion of cisplatin (25 mg/m2/day) for advanced lung cancer, was evaluated using a double-blind randomized crossover design."5.07Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis. ( Mori, K; Saito, Y; Tominaga, K, 1993)
"The cost effectiveness of ondansetron was compared with that of metoclopramide in the prevention of acute emesis due to highly emetogenic chemotherapy in an open, randomised, parallel group pilot study."5.07The real costs of emesis--an economic analysis of ondansetron vs. metoclopramide in controlling emesis in patients receiving chemotherapy for cancer. ( Cunningham, D; Davidson, N; Gore, M; Manchanda, M; Miocevich, M; Wells, N, 1993)
"This pilot randomized study compared MDL 72,222, a highly selective 5-HT3 receptor antagonist, with a high-dose metoclopramide regimen (HDM) for chemotherapy-induced nausea and vomiting."5.07Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen. ( Barrett, RJ; Hahne, WF; Heck, K; Homesley, HD; Lentz, SS; Lovelace, JV; McLees, B; Woodlief, L, 1993)
" To address its use with a widely used but less emetogenic regimen, we performed a double-blind, randomized clinical trial comparing ondansetron with dexamethasone and metoclopramide in patients with breast cancer receiving chemotherapy with cyclophosphamide, methotrexate, and fluorouracil."5.07Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil. ( Latreille, J; Levitt, M; Lofters, WS; Perrault, DJ; Potvin, M; Rayner, HL; Warner, E; Warr, D; Wilson, KS; Yelle, L, 1993)
"Tiapride (Tiapridal, Delagrange), a dopaminergic D2 receptor blocking agent having anxiolytic, sedative, antiemetic and analgesic properties was compared with metoclopramide and placebo in a randomized double-blind trial to determine its effects on post-operative nausea, vomiting, and sedation."5.07Tiapride versus metoclopramide: comparison after minor gynaecological surgery. ( Joshi, R; Sivaganesanathan, A, 1993)
"This report of a double-blind, randomized study performed to evaluate the comparative antiemetic efficacy of tropisetron (Navoban; Sandoz Pharma Ltd, Basel, Switzerland), a new 5-hydroxytryptamine receptor antagonist, focuses on treatment during stages of chemotherapy when nausea and vomiting are particularly severe."5.07A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis. ( Krzakowski, M; Lasota, W; Madej, G; Pawinski, A; Rogowski, W; Skoneczna, I, 1994)
"The efficacy and tolerability of tropisetron in preventing cisplatin-induced nausea and vomiting was studied in 2 open trials and compared with the efficacy and tolerability of metoclopramide plus lorazepam in a randomised crossover trial."5.07Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. ( Antonacci, RA; Berruti, A; Dogliotti, L; Faggiuolo, R; Ortega, C; Pazè, E, 1992)
" Costs, effects and cost-effectiveness of ondansetron in the prophylaxis of acute nausea and vomiting induced by chemotherapy are assessed relative to antiemetic therapy with metoclopramide."5.07Economic evaluation of ondansetron: preliminary analysis using clinical trial data prior to price setting. ( Buxton, MJ; O'Brien, BJ, 1992)
"The efficacy of intravenous metoclopramide in controlling vomiting in children after tonsillectomy was determined in a prospective randomized, double-blind investigation."5.07Metoclopramide reduces the incidence of vomiting after tonsillectomy in children. ( Donlon, JV; Ferrari, LR, 1992)
" One hundred ten pediatric patients, ages 8 months to 14 yr, admitted for outpatient strabismus surgery were enrolled in a randomized, double-blinded study to compare droperidol and metoclopramide to placebo for the prevention of postoperative emesis."5.07A double-blinded comparison of metoclopramide and droperidol for prevention of emesis following strabismus surgery. ( Furst, SR; Lin, DM; Rodarte, A, 1992)
"Prevention and treatment of postoperative nausea and vomiting with ephedrine, droperidol and metoclopramide have been reported to be effective."5.07Comparison of antiemetic effect among ephedrine, droperidol and metoclopramide in pediatric inguinal hernioplasty. ( Kang, HM; Liou, CM; Liu, YC; Tso, HS, 1992)
"In order to decide the administration method of metoclopramide for prevention or control of chemotherapy-induced nausea and vomiting in multidrug chemotherapy, with cisplatin 5-day continuous intravenous infusion (25 mg/m2/day) for patients with advanced lung cancer, a randomised crossover study of intermittent bolus infusion (1 mg/kg, 30 min, every 8 h, day 1-5) and continuous infusion (3 mg/kg/24 h, 120 h) of metoclopramide was performed."5.07Comparison of continuous and intermittent bolus infusions of metoclopramide during 5-day continuous intravenous infusion with cisplatin. ( Miyazawa, N; Mori, K; Saitou, Y; Tominaga, K, 1991)
" One of these agents, batanopride, produced no severe toxicity at doses that prevented emesis due to chemotherapy in early Phase I trials."5.07A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy. ( Findlay, B; Kaizer, L; Laberge, F; Latreille, J; Lofters, WS; Osoba, D; Pater, J; Rusthoven, J; Warr, D; Wilson, K, 1991)
"Sixty patients were studied in a randomized, double-blind manner to determine whether metoclopramide added to droperidol decreased further the incidence of emetic symptoms (nausea, retching, vomiting) in outpatients receiving alfentanil anaesthesia for nasal surgery."5.07Metoclopramide does not decrease the incidence of nausea and vomiting after alfentanil for outpatient anaesthesia. ( AlHaddad, S; Furgerson, C; Khalil, I; Maurer, W; Whalley, DG, 1991)
" In this randomized, single-blind, multicenter, parallel group study, we compared the efficacy and safety of intravenous (IV) ondansetron with IV metoclopramide in the prevention of nausea and vomiting associated with high-dose (greater than or equal to 100 mg/m2) cisplatin chemotherapy."5.07A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. ( Gandara, D; Hainsworth, J; Harker, G; Harvey, W; Hesketh, P; Kasimis, B; Khojasteh, A; Monaghan, G; Oblon, D; Pendergrass, K, 1991)
"Ondansetron, a new 5-HT3 receptor antagonist, has been compared with high-dose metoclopramide in the control of acute emesis (24 h) induced by cisplatin (greater than or equal to 100 mg/m2)."5.07Progress in the control of acute and delayed emesis induced by cisplatin. ( Gandara, DR, 1991)
"Ondansetron was compared with metoclopramide for antiemetic efficacy in a randomised double-blind trial in 122 patients with advanced breast cancer."5.07Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. ( Adler, M; Christmann, D; Fenzl, E; Marschner, NW; Nagel, GA; Upadhyaya, B, 1991)
"This double-blind randomized cross-over study was conducted to compare the safety and efficacy of high-dose prochlorperazine infusion and dexamethasone (HDPD) with an effective and safe combination of high-dose metoclopramide and dexamethasone (HDMD) in controlling cisplatin-induced emesis."5.07A double-blind randomized cross-over comparison of high-dose prochlorperazine with high-dose metoclopramide for cisplatin-induced emesis. ( Akhtar, SS; Bano, ZA; Bhat, GM; Bhat, MA, 1991)
"To prevent delayed emesis induced by cisplatin (mean dose 90 mg/m2), 120 consecutive patients were randomized to receive, in a 7-day crossover design, oral metoclopramide (20 mg q."5.07Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study. ( Ballatori, E; Basurto, C; Boschetti, E; Bracarda, S; Patoia, L; Penza, O; Picciafuoco, M; Roila, F; Santi, E; Tonato, M, 1991)
"Ondansetron is a 5-hydroxytryptamine 3-receptor antagonist which has shown activity in the prevention of cytotoxic-induced emesis."5.06Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation. ( Adams, M; Collis, CH; Lucraft, H; Priestman, S; Priestman, TJ; Roberts, JT; Upadhyaya, BK, 1990)
"To compare ondansetron (GR 38032F), a 5-hydroxytryptamine3-receptor antagonist, with metoclopramide in the prophylaxis of acute cisplatin-induced emesis, we conducted a double-blind crossover study in 97 patients scheduled to receive cisplatin (80 to 100 mg per square meter of body-surface area) for treatment of cancer."5.06Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. ( Azab, M; Bons, J; Brion, N; Droz, JP; Marty, M; Paes, D; Paule, B; Pouillart, P; Pujade-Lauraine, E; Scholl, S, 1990)
"Seventy-five breast cancer patients scheduled to receive a first course (in a new cycle) of cyclophosphamide, fluorouracil, and doxorubicin (FAC) or epirubicin (FEC) participated in a double-blind crossover study to compare the antiemetic efficacy and safety of ondansetron (GR38032), a 5-hydroxytryptamine3 (5-HT3) receptor antagonist, and metoclopramide."5.06A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. ( Bonneterre, J; Bons, J; Chevallier, B; Fargeot, P; Metz, R; Paes, D; Pujade-Lauraine, E; Spielmann, M; Tubiana-Hulin, M, 1990)
"40 patients with metastatic breast cancer, under treatment with epirubicin (greater than 50 mg/m2) and cyclophosphamide (greater than 500 mg/m2), had an antiemetic therapy with Ondansetron 3 x 8 mg day, for a maximum of 10 cycles."5.06[Long-term results of the anti-emetic effectiveness of the 5-HT3 antagonist ondansetron]. ( Adler, M; Albrecht, U; Jaenicke, F; Marschner, NW; Nagel, GA, 1990)
"To compare the efficacy and side effects of ondansetron with those of high-dose metoclopramide in treating acute and delayed cisplatin-induced nausea and vomiting."5.06Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study. ( Allman, EL; Beranek, P; De Mulder, PH; Mols-Jevdevic, S; Seynaeve, C; van Liessum, PA; Vermorken, JB; Verweij, J, 1990)
"This randomized, double-blind study evaluated the efficacy of metoclopramide administered at the completion of surgery as an antiemetic agent in pediatric patients undergoing ambulatory strabismus surgery; 126 unpremedicated ASA Physical Status 1 and 2 children ranging in age from 2 to 18 yr served as subjects."5.06Metoclopramide reduces the incidence of vomiting following strabismus surgery in children. ( Broadman, LM; Ceruzzi, W; Friendly, D; Hannallah, RS; Patane, PS; Ruttimann, U, 1990)
" cyclophosphamide, methotrexate, and 5-fluorouracil (CMF), 25 women with stage II breast cancer were entered into this study."5.06Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo. ( Giannarelli, D; Marolla, P; Nardi, M; Pinnaró, P; Pollera, CF; Terzoli, E, 1989)
" All patients received intravenous (IV) metoclopramide, dexamethasone, and lorazepam for the control of acute emesis during the period from 0 to 24 hours after cisplatin."5.06Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. ( Cirrincione, C; Clark, RA; Gralla, RJ; Groshen, S; Kris, MG; Tyson, LB, 1989)
"In a randomized, double-blind study, we compared the efficacy of metoclopramide hydrochloride with that of low-dose droperidol for prevention of nausea and vomiting during and after elective cesarean section with epidural anesthesia."5.06Metoclopramide versus droperidol for prevention of nausea and vomiting during epidural anesthesia for cesarean section. ( Bates, JN; Chestnut, DH; Choi, WW; Geiger, M; Ostman, PL; Owen, CL, 1989)
" Lorazepam and dexamethasone are increasingly being used to alleviate chemotherapy induced emesis."5.06The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial. ( Blackledge, GR; Burman, C; Cullen, MH; Kelly, K; O'Brien, ME; Palmer, K; Sharpe, J; Stuart, NS; Woodroffe, C, 1989)
"Nineteen women receiving their first cycle of adjuvant chemotherapy for early breast cancer were randomized between two antiemetic drugs: methylprednisolone (MPN) 125mg and metoclopramide (MCP) 20mg, both given by intravenous push as a single dose."5.06Methylprednisolone versus metoclopramide as antiemetic treatment in patients receiving adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) chemotherapy: a randomized crossover blind study. ( Biran, S; Cass, Y; Gera, C; Gez, E; Nathan, S; Ochayon, L; Rubello, E; Sulkes, A, 1989)
"Sixty-four patients treated with cisplatin-containing regimens were entered into a randomized, double-blinded study examining the antiemetic efficacy of metoclopramide with and without lorazepam for control of cisplatin-induced emesis."5.06Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis. ( Al-Sarraf, M; Cummings, G; Gordon, CJ; Pazdur, R; Ziccarelli, A, 1989)
"Forty-two patients with advanced lung cancer undergoing chemotherapy containing cisplatin (80 mg/m2) were submitted to a randomized controlled trial to evaluate the effect of the combination of metoclopramide and dexamethasone for the treatment of delayed cisplatin-induced emesis occurring more than 24 hours after cisplatin administration."5.06Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial. ( Eguchi, K; Fujiwara, Y; Fukuda, M; Mae, M; Ohe, Y; Saijo, N; Sasaki, S; Sasaki, Y; Shinkai, T; Tamura, T, 1989)
"A double-blind, randomized, crossover study was conducted to compare the efficacy and safety of high-dose dexamethasone (Protocol D) with a combination of dexamethasone, metoclopramide and diphenhydramine (Protocol DMD) in the management of chemotherapy-induced nausea and vomiting in cancer patients."5.06Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide and diphenhydramine. ( Ababtain, WA; Abdullah, KA; al-Idrissi, HY; Boukhary, HA; Ibrahim, EM; Macaulay, HM, 1988)
" CMF were included in a double-blind comparative study aimed at evaluating the efficacy of 3 different drugs (methylprednisolone (MP), metoclopramide (MTC), and domperidone (DMP) in preventing chemotherapy-induced nausea and vomiting."5.06Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMF. ( Ballatori, E; Basurto, C; del Favero, A; Minotti, V; Roila, F; Tonato, M, 1987)
"Forty patients with advanced lung cancer who had received chemotherapy containing cisplatin (80 mg/m2) were accrued for a randomized controlled trial to evaluate the additional effect of prochlorperazine on the combination of high-dose metoclopramide and dexamethasone for the treatment of acute cisplatin-induced emesis."5.06[A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine]. ( Eguchi, K; Inoue, I; Nino, S; Saijo, N; Sakurai, M; Sasaki, Y; Shinkai, T; Suemasu, K; Tamura, T; Umehara, H, 1987)
"Combinations of metoclopramide and dexamethasone given intravenously control vomiting caused by high doses of cisplatin."5.06Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial. ( Clark, RA; Gralla, RJ; Groshen, S; Kris, MG; Tyson, LB, 1987)
"A randomized prospective clinical trial was conducted to evaluate the potential utility of adding transdermal scopolamine to a standard regimen of metoclopramide and dexamethasone for the prevention of cisplatin-induced emesis."5.06A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen. ( Meyer, BR; O'Mara, V; Reidenberg, MM, 1987)
"The antiemetic efficacy and toxicity of methylprednisolone (MP) and metoclopramide (MTC) in prevention of nausea and vomiting in breast cancer patients receiving intravenous cyclophosphamide methotrexate 5-fluorouracil (CMF) chemotherapy has been evaluated in a double-blind trial."5.06Methylprednisolone versus metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide methotrexate 5-fluorouracil: a double-blind randomized study. ( Ballatori, E; Basurto, C; Del Favero, A; Minotti, V; Roila, F; Tonato, M, 1988)
"A double-blind, randomized, crossover study was conducted to compare the efficacy and safety of high-dose dexamethasone and high-dose metoclopramide in the treatment of chemotherapy-induced nausea and vomiting."5.06Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy. ( Absood, G; Al-Dossary, E; Al-Ethan, S; Al-Idrissi, HY; Al-Jammaa, A; Eliopoulos, A; Ibrahim, A; Ibrahim, EM, 1986)
"The efficacy of secobarbital sodium plus chlorpromazine (SC) in the prevention of cisplatin induced emesis was compared to the combination of metoclopramide, diphenhydramine, and dexamethasone (MDD)."5.06The antiemetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial. ( Bateman, M; Flaum, MA; Kardinal, CG; Richards, PD, 1986)
"Methylprednisolone sodium succinate and metoclopramide were compared for their efficacy, tolerance, and safety in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy in patients with cancer."5.06Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy. ( Erlichman, C; Levitt, M; Osoba, D; Pater, JL; Willan, AR, 1986)
"The existence of a threshold serum metoclopramide level above which total protection from cisplatin-induced vomiting is more likely to occur has been proposed."5.06Examination of the correlation of serum metoclopramide levels with antiemetic efficacy in patients receiving cisplatin. ( Bernstein, L; Cohen, JL; Grunberg, SM; McDermed, JE, 1987)
"A randomized cross-over study on the effects of methylprednisolone (MP), metoclopramide (MT) and droperidol (DP) on the control of nausea and vomiting associated with cis-platinum chemotherapy was performed."5.06[Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy]. ( Akaza, H; Aso, Y; Fujita, K; Isurugi, K; Kawabe, K; Kinoshita, K; Koiso, K; Kondo, Y; Niijima, T; Yokoyama, M, 1986)
"25 mg droperidol, 20 mg metoclopramide or a saline placebo intravenously 5-10 min before the end of anaesthesia in a double-blind random fashion to prevent post-operative nausea and vomiting."5.06Droperidol, alizapride and metoclopramide in the prevention and treatment of post-operative emetic sequelae. ( Gordin, A; Heikkinen, H; Kauste, A; Korttila, K; Tuominen, M, 1986)
"Thirty three untreated patients being given cisplatin received metoclopramide (7 mg/kg) for antiemesis by either continuous or intermittent infusion in a random order."5.06Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin. ( Allan, SG; Cornbleet, MA; Leonard, RC; MacPherson, JS; Smyth, JF; Warrington, PS, 1986)
"The present trial was designed to compare the effect of metoclopramide(MCP) + dexamethasone(DM) (Method A) with that of MCP + DM + lorazepam(Lor) (Method B) in the treatment of CDDP (cis-diamminedichloroplatinum)-induced nausea and vomiting in a randomized fashion."5.06[Anti-emetic treatment with metoclopramide and other drugs during CDDP therapy]. ( Arai, R; Furuse, K; Hayashi, S; Kawahara, M; Kiyota, T; Kodama, N; Tsuruta, S, 1987)
" Ondansetron revealed the largest effect in comparison to placebo for cessation of vomiting (odds ratio = 0."5.05Antiemetics in Children With Acute Gastroenteritis: A Meta-analysis. ( Acosta-Reyes, J; Florez, ID; Niño-Serna, LF; Veroniki, AA, 2020)
" A combination of Nabilone and metoclopramide was used in an unrandomized pilot study (prior to the withdrawal of Nabilone from clinical use); these patients recorded better scores for nausea and vomiting and patient acceptability than those in the randomized study."5.05Antiemetics for patients treated with antitumor chemotherapy. ( Bolton, A; de Pemberton, R; Whitehouse, JM; Williams, CJ, 1980)
"One hundred and two patients with advanced solid tumors receiving chemotherapy were treated with metoclopramide (MCP; 100 mg) to prevent emesis."5.05Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide. ( Bruera, ED; Cedaro, L; Chacón, R; Estévez, R; Roca, E, 1983)
"Metoclopramide is an effective antiemetic for cisplatin-induced vomiting when given in parenteral high-dose regimens but not oral low-dose regimens."5.05Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study. ( Cariffe, P; Gala, KV; Grunberg, SM; Jamin, D; Johnson, K; Krailo, M; Lampenfeld, M; Strych, D, 1984)
" Compared to metoclopramide, alizapride caused a faster regression of inappetence and of the frequency of daily vomiting."5.05[Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy]. ( Budach, V; Krüger, K, 1983)
"In a double-blind comparison of domperidone 10 mg, domperidone 4 mg, metoclopramide 10 mg and a placebo, 176 adult patients were given an intravenous injection of one of these substances after postoperative vomiting had occurred."5.05Postoperative vomiting treated with domperidone. A double-blind comparison with metoclopramide and a placebo. ( Boghaert, A; Carron, D; Gallant, J; Stockman, A, 1980)
"An open-label clinical trial was conducted to test the safety and efficacy of intravenous metoclopramide monohydrochloride in preventing chemotherapy-induced nausea and vomiting."5.05Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy. ( McDermed, JE; Opfell, RW; Riech, LP; Strum, SB, 1982)
"Fifty-five patients with delayed gastric emptying and the symptoms of nausea, vomiting, postprandial bloating and early satiety were treated with metoclopramide."5.05Metoclopramide therapy in fifty-five patients with delayed gastric emptying. ( Davidson, ED; Hersh, T; Moore, C; Perkel, MS, 1980)
"The effect of high-dose metoclopramide (2 mg/kg, 4 times every 2 hours) on the emesis of patients treated with CDDP (80 mg/m2) was examined by randomized control trial."5.05[Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis]. ( Eguchi, K; Fujita, J; Funaki, Y; Futami, H; Sakurai, M; Sasaki, Y; Sawamura, N; Takahashi, S; Yokoyama, S; Yoshioka, S, 1985)
"Using a sensitive and specific high-pressure liquid chromatographic (HPLC) assay, we measured serum levels of metoclopramide in 18 cancer patients receiving high-dose intravenous (IV) therapy to prevent cisplatin-induced emesis."5.05Clinical pharmacokinetics of high-dose metoclopramide in cancer patients receiving cisplatin therapy. ( Cohen, JL; Joseph, C; McDermed, JE; Strum, SB, 1985)
"The antinausea and antivomiting effects of delta-9-tetrahydrocannabinol (THC) in children receiving cancer chemotherapy were compared with those of metoclopramide syrup and prochlorperazine tablets in two double-blind studies."5.04Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. ( Ekert, H; Jurk, IH; Loughnan, P; Mobilia, J; Waters, KD, 1979)
"In a double-blind trial in 60 children suffering from gastroenteritis complicated by vomiting, it was found that suppositories of domperidone (30 mg) were more effective than either metoclopramide (10 mg) or placebo in reducing the severity of vomiting, nausea and other symptomatic parameters."5.04A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children. ( Ameryckx, L; Dhondt, F; Heck, E; Van Eygen, M; Van Ravensteyn, H, 1979)
"Forty-seven infants and children suffering from chronic vomiting or regurgitation, participated in a two-week double-blind trial comparing 1% drops of domperidone, 1% metoclopramide drops or placebo."5.04Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. ( Ameryckx, L; De Loore, I; Van Ravensteyn, H, 1979)
"One hundred and ninety-five female patients of child-bearing age were assessed for postoperative vomiting in a double-blind trial using domperidone, metoclopramide and placebo."5.04Prevention of postoperative nausea and vomiting by domperidone: A double-blind randomized study using domperidone, metoclopramide and a placebo. ( Ball, RW; Comyn, DJ; Cooke, RD, 1979)
"A technique of premiedication using oral diazepam and metoclopramide with a drink is described and shown to provide better sedation and less vomiting than pethidine and atropine given intramuscularly without a drink to a group of similar patients."5.04Oral premedication: diazepam, metoclopramide and a drink. ( Deshpande, S; Fry, EN, 1977)
"Twelve patients with complete, or nearly complete, pyloric obstruction due to duodenal ulcer, were treated conservatively with metoclopramide."5.04The use of metoclopramide in acute pyloric obstruction. A clinical trial. ( Dintsman, M; Zer, M, 1975)
"To assess the efficacy and safety of olanzapine when used as an antiemetic in the prevention and treatment of nausea and vomiting related to cancer in adults."4.98Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults. ( Burton, MJ; Head, K; Naessens, K; Plugge, E; Sutherland, A; Ware, L; Wee, B, 2018)
" Addition of metoclopramide 10 mg improves relief of nausea and vomiting."4.89Aspirin with or without an antiemetic for acute migraine headaches in adults. ( Derry, S; Kirthi, V; Moore, RA, 2013)
"To examine the medical evidence regarding the clinical efficacy and cost-effectiveness of the application of continuous subcutaneous metoclopramide and ondansetron to treat nausea and vomiting during pregnancy."4.88Reviewing the evidence for using continuous subcutaneous metoclopramide and ondansetron to treat nausea & vomiting during pregnancy. ( Kirkbride, MS; Reichmann, JP, 2012)
"In patients with advanced cancer not being treated with chemotherapy or radiation therapy, metoclopramide can be used to reduce nausea and vomiting."4.88[Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review]. ( Alt-Epping, B; Benze, G; Geyer, A; Nauck, F, 2012)
"The objective of the present study was to conduct a systematic review and meta-analysis of randomized controlled trials, comparing metoclopramide with placebo, for preventing vomiting in patients who have received i."4.87Review article: Prophylactic metoclopramide for patients receiving intravenous morphine in the emergency setting: a systematic review and meta-analysis of randomized controlled trials. ( Bendall, JC; Middleton, PM; Simpson, PM, 2011)
"Oral ondansetron increased the proportion of patients who had ceased vomiting and reduced the number needing intravenous rehydration and immediate hospital admission."4.87Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. ( Carter, B; Fedorowicz, Z; Jagannath, VA, 2011)
"Based on the safety and efficacy of ondansetron, it may be used as a first-line agent for relief of nausea or vomiting for most patient populations in the ED."4.86Antiemetic therapy for nausea and vomiting in the emergency department. ( Amini, R; Hays, DP; Patanwala, AE; Rosen, P, 2010)
" Addition of metoclopramide 10 mg improves relief of nausea and vomiting."4.86Aspirin with or without an antiemetic for acute migraine headaches in adults. ( Derry, S; Kirthi, V; McQuay, HJ; Moore, RA, 2010)
"The small number of included trials provided some limited evidence favouring the use of ondansetron and metoclopramide over placebo to reduce the number of episodes of vomiting due to gastroenteritis in children."4.85Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. ( Al-Hashimi, H; Alhashimi, D; Fedorowicz, Z, 2009)
"The small number of included trials provided some, albeit weak and unreliable, evidence which appeared to favor the use of ondansetron and metoclopramide over placebo to reduce the number of episodes of vomiting due to gastroenteritis in children."4.83Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. ( Alhashimi, D; Alhashimi, H; Fedorowicz, Z, 2006)
"The small number of included trials provided some, albeit weak and unreliable, evidence which appeared to favor the use of ondansetron and metoclopramide over placebo to reduce the number of episodes of vomiting due to gastroenteritis in children."4.83Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. ( Alhashimi, D; Alhashimi, H; Fedorowicz, Z, 2006)
"A short cut review was carried out to establish whether metoclopramide reduced nausea and vomiting after the administration of morphine."4.82Best evidence topic reports. Metoclopramide versus placebo with opioid. ( Alsalim, W; Butler, J; Leung, WC, 2004)
" In the last decade the use of high-dose metoclopramide and, especially, the introduction of the 5-HT3 receptor antagonists, have been major leaps forward in the control of chemotherapy-induced emesis."4.79Optimal control of acute cisplatin-induced emesis. ( de Mulder, PH; de Wit, R; Verweij, J, 1996)
"In the past few years important progress in the prevention of chemotherapy-induced nausea and vomiting has been made mainly thanks to the introduction of the 5-HT3 receptor antagonists in clinical practice (ondansetron, granisetron, tropisetron)."4.79[Recent improvements in antiemetic therapy]. ( Basurto, C; Ciccarese, G; Palladino, MA; Roila, F, 1997)
"8 mg/kg was superior to metoclopramide in preventing emesis induced by high dose cisplatin or by moderately emetogenic chemotherapy in high risk subgroups."4.79Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery. ( Balfour, JA; Goa, KL, 1997)
"This paper described an outline of clinically applications of 5-HT3 receptor antagonists, mainly on ondansetron, which control nausea and vomiting associated with cancer chemotherapy."4.78[An outline of 5-HT3 receptor antagonists (2)--In clinical applications]. ( Ohta, J; Taguchi, T; Tsukagoshi, S, 1993)
"Ondansetron is more effective than high-dose metoclopramide in the prevention of acute nausea and vomiting due to highly emetogenic chemotherapy, and, unlike metoclopramide, is rarely associated with extrapyramidal effects."4.78Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy. ( Milne, RJ; Plosker, GL, 1992)
" Metoclopramide is generally acknowledged to be the single most effective conventional drug for the prevention of acute cisplatin-induced emesis and, therefore, was considered an appropriate agent for inclusion in comparative trials with ondansetron."4.78Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesis. ( Hesketh, PJ, 1992)
" 2), metoclopramide has been confirmed as an effective drug in treating and preventing various types of vomiting and as a useful agent in oesophageal reflux disease, gastroparesis, dyspepsia, and in a variety of functional gastrointestinal disorders."4.76Metoclopramide. An updated review of its pharmacological properties and clinical use. ( Brogden, RN; Hamilton, CW; Harrington, RA; Heel, RC; Linkewich, JA; Romankiewicz, JA, 1983)
" A third drug, lactulose (useful in treating hepatic encephalopathy), will soon be available."4.75Some aspects of medical management of gastrointestinal disease. I. ( Badley, BW, 1975)
"Following the administration of metoclopramide for vomiting associated with pertussis cough, the patient exhibited distressing symptoms, including torticollis, facial grimacing, and tongue protrusion."4.31Metoclopramide-induced acute dystonic reaction: A pediatric case report. ( Adebambo, S; Adenikinju, J; Egbunu, E; Elendu, C; Ogala, F; Ologunde, T, 2023)
"Ondansetron is commonly used to treat nausea and vomiting in pregnancy despite inconclusive evidence of its safety."4.02Ondansetron use in early pregnancy and the risk of miscarriage. ( Boggess, K; Engel, SM; Jonsson Funk, M; Lund, JL; Stürmer, T; Suarez, EA, 2021)
"The objective of the study was to evaluate the rate of major congenital anomalies after first trimester exposure to ondansetron for nausea and vomiting of pregnancy (NVP)."4.02Pregnancy outcome following in-utero exposure to ondansetron: A prospective comparative observational study. ( Arnon, J; Diav-Citrin, O; Sakran, R; Shechtman, S, 2021)
" Common etiologies included constipation, opioid use, and "other," and treatments associated with a statistically significant decrease in nausea/vomiting were olanzapine, laxatives, corticosteroids, domperidone, and metoclopramide."3.91The nature of nausea: prevalence, etiology, and treatment in patients with advanced cancer not receiving antineoplastic treatment. ( Frandsen, K; Groenvold, M; Harder, S; Herrstedt, J; Isaksen, J; Jespersen, BA; Mondrup, L; Neergaard, MA; Sigaard, J, 2019)
"Using the Quebec Pregnancy Cohort (1998-2015), first-trimester doxylamine-pyridoxine, metoclopramide, and ondansetron exposures were assessed for their association with MCM."3.91New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy. ( Bérard, A; Bernatsky, S; Gorgui, J; Sheehy, O; Soares de Moura, C; Zhao, JP, 2019)
" Delayed emesis following Cycle 1 of carboplatin was observed in 30% of patients."3.83Delayed nausea and vomiting from carboplatin doublet chemotherapy. ( Baggstrom, MQ; Chitneni, P; Gao, F; Govindan, R; Mann, J; Morgensztern, D; Waqar, MA; Waqar, SN; Williams, K, 2016)
"Metoclopramide is commonly used to treat vomiting caused by seasickness and acute gastroenteritis on cruise ships and serious adverse effects have not been reported from use at sea."3.80Long-lasting adverse effects after short-term low-dose treatment with metoclopramide for vomiting. ( Dahl, E; Diskin, AL, 2014)
"Patients with cancer frequently report gastrointestinal symptoms such as anorexia, early satiety, nausea, vomiting, and bloating."3.80Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: a multicentre evaluation. ( Chow, W; Darke, A; Harsanyi, Z; Marshall, D; Pearen, S; Plourde, JY; Wilson, J; Yoshida, S, 2002)
"The purpose of this study was to formulate and characterize metoclopramide solid lipid nanoparticles (MCP-SLNs) and incorporating it into suppository bases for treatment of nausea and vomiting, produced with chemotherapeutic agents, using one dose per day."3.79Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository. ( Abass, HA; Attia, MA; Heikal, OA; Mohamed, RA, 2013)
"While providing a better efficacy in acute emesis control, the low incidence of acute emesis and high ICER makes use of granisetron as primary prophylaxis in LEC controversial."3.79Cost-effectiveness analysis of granisetron-based versus standard antiemetic regimens in low-emetogenic chemotherapy: a hospital-based perspective from Malaysia. ( Ghani, NA; Keat, CH, 2013)
"We examined treatment outcomes in women with severe nausea and vomiting of pregnancy (NVP) receiving outpatient nursing support and either subcutaneous metoclopramide or subcutaneous ondansetron via a microinfusion pump."3.77Treatment of severe nausea and vomiting of pregnancy with subcutaneous medications. ( Desch, C; Fox, NS; Istwan, N; Klauser, CK; Palmer, B; Rebarber, A; Rhea, D; Saltzman, D, 2011)
" Ondansetron 8 mg and dexamethasone 8 mg intravenously were the standard antiemetic therapy for prevention of acute chemotherapy-induced nausea and vomiting."3.77Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy. ( Baak-Pablo, RF; Gelderblom, H; Guchelaar, HJ; Hakimi, M; Mustofa, M; Nortier, JW; Perwitasari, DA; van der Straaten, RJ; Wessels, JA, 2011)
"Ondansetron was superior to placebo in Study 1; complete control of emesis (0 emetic episodes) over 15 days was achieved in 62% of ondansetron-treated patients compared to 34% of placebo-treated patients (P = 0."3.77Anti-emetic control with ondansetron in the chemotherapy of breast cancer: a review. ( Marschner, N, 1991)
"In total knee and hip arthroplasty, methylprednisolone is effective in preventing postoperative nausea; however, higher doses of methylprednisolone may be needed to prevent vomiting."3.76Methylprednisolone reduces postoperative nausea in total knee and hip arthroplasty. ( Ejiri, M; Ishiguro, N; Kuzuya, T; Miyagawa, Y; Osada, T; Yamada, K, 2010)
"The aim of study was, comparison of effects of Metoclopramide and Dropridol associated with Dexamethasone on prevalence of nausea and vomiting after operation was considered."3.76Comparison the effects of metoclopramide and dropridol associated with dexamethasone on post operative nausea and vomiting. ( Ebrahim, A; Ebrahim, N; Hosssain, B; Yousef, M, 2010)
"The aim of the study was to evaluate the role of ramosetron for the prevention of chemoradiotherapy-induced nausea and vomiting (CRINV) in patients receiving upper abdominal irradiation with concurrent 5-fluorouracil chemotherapy."3.75Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer. ( Bang, YJ; Chie, EK; Ha, SW; Im, SA; Jang, JY; Kim, K; Kim, SW; Kim, TY; Oh, DY, 2009)
"In various countries, metoclopramide is the antiemetic drug of choice in pregnant women, but insufficient information exists regarding its safety in pregnancy."3.75The safety of metoclopramide use in the first trimester of pregnancy. ( Gorodischer, R; Koren, G; Levy, A; Matok, I; Sheiner, E; Wiznitzer, A, 2009)
"A patient who was given metoclopramide for vomiting and diarrhoea developed circulatory collapse with his blood pressure dropping to 50/20 mm Hg."3.75Circulatory collapse in a patient with gastrinoma after metoclopramide administration. ( Chan, AY; Chan, KW; Ching, CK; Lam, AW; Lau, KK; Lee, HH; Li, SM; Lo, J; Lok, CM; Luk, WF; Mak, CM, 2009)
" In the present studies, therefore, we used Suncus murinus, a species of insectivore capable of emesis, to investigate if the vanilloid receptor agonist resiniferatoxin is capable of modeling the emesis associated with migraine."3.73Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew). ( Andrews, PL; Cheng, FH; Moreaux, B; Ngan, MP; Rudd, JA; Sam, TS; Wai, MK; Wan, C, 2005)
" However, retching and vomiting were significantly inhibited by pretreatment with ondansetron and metoclopramide in cisplatin and copper sulfate groups (P=0."3.73Value of mink vomit model in study of anti-emetic drugs. ( Liu, ZT; Wang, L; Yang, ZH; Yue, W; Zhang, F, 2006)
" Cisplatin, apomorphine, copper sulfate and X-radiation were used to establish vomiting model."3.72[A new vomiting animal model--mink]. ( Fang, X; Liu, YX; Minami, M; Wang, L; Yue, W; Zhang, F, 2003)
"Two double-blind, placebo-controlled, prospective randomized trials in the emergency department (ED) setting have examined the use of metoclopramide for the prevention of opiate-induced nausea and vomiting."3.71Low incidence of nausea and vomiting with intravenous opiate analgesia in the ED. ( Paoloni, R; Talbot-Stern, J, 2002)
"To assess the effectiveness of ondansetron in relieving symptoms of nausea and vomiting which were refractory to metoclopramide and cyclizine, in a patient receiving iloprost infusions."3.71Pre-emptive metoclopramide and ondansetron for nausea and vomiting associated with iloprost infusions. ( Roome, C; Thompson, J, 2001)
" Two doses of oral metoclopramide 10 mg in solution were administered for nausea and vomiting."3.70Respiratory failure following oral administration of metoclopramide. ( MacLaren, R; Shields, CA, 1998)
"A two-stage retrospective audit of the efficacy of antiemetics used with intravenous cyclophosphamide 600 mg/m2, methotrexate 40 mg/m2 and 5-fluorouracil 600 mg/m2 (CMF) chemotherapy for breast cancer has been performed in a single centre."3.70An audit of antiemetic use with CMF chemotherapy. ( Brown, RS; Brown, TK; Gaze, MN; Hoare, D, 1998)
" Intravenous ondansetron 8 mg and dexamethasone 20 mg served as an alternative regimen in patients <30 years old with a history of extrapyramidal manifestations or emesis in previous cycles."3.70Anthropometric and pharmacotherapeutic variables on acute emesis induced by cisplatin-containing chemotherapy. ( Catalán Arlandis, JL; Jiménez Torres, NV, 2000)
"A prospective trial was performed to better assess the risk of nausea and vomiting and the rescue value of tropisetron (TRO), a 5-HT3 receptor antagonist, in 88 patients undergoing fractionated radiotherapy to the abdomen or to large supradiaphragmatic fields and failing a first anti-emetic trial with metoclopramide (MET)."3.69Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide. ( Behrouz, F; Blazek, N; Coucke, P; Gebhard, S; Melliger, M; Miralbell, R; Philipp, S; Rosset, A; Schwabb, T; Wickenhauser, R, 1995)
"We evaluated the antiemetic efficacy of tropisetron, a 5-HT3 receptor antagonist, during its compassionate use in children with malignant disease who during previous chemotherapy cycles experienced emesis refractory to metoclopramide-based treatments."3.69Tropisetron (ICS 205-930) in pediatric oncology: first results in patients refractory to antiemetic metoclopramide-based treatments. ( Armiraglio, A; Cefalo, G; Pagan, MG; Rottoli, L, 1994)
"Although buprenorphine sometimes causes severe emesis, its relation to the menstrual cycle has not been reported."3.69Menstrual stage influences postoperative nausea and vomiting following epidural buprenorphine. ( Kamiyama, M; Kitamura, A; Kon, T; Ogawa, R, 1996)
"Fifty-one patients who received their first course of chemotherapy were studied to compare the respective efficacy and safety of granisetron and metoclopramide plus dexamethasone in the prevention of nausea and vomiting induced by emetogenic cytotoxic drugs."3.69Comparison of intravenous granisetron with metoclopramide plus dexamethasone in the prevention of nausea and vomiting associated with emetogenic cytotoxic chemotherapy. ( Chang, CS; Chen, LT; Chen, TP; Huang, SM; Lin, SF; Liu, TC; Wei, TC, 1997)
" Erythromycin administration is associated with gastrointestinal problems, disturbed gastrointestinal motility and emesis."3.68Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis. ( Pilot, MA; Qin, XY; Scott, M; Thompson, H, 1993)
" 5 min prior to morphine while each ferret was maintained under isoflurane-O2 anesthesia."3.68The effects of different antiemetic agents on morphine-induced emesis in ferrets. ( Essien, E; Thut, PD; Wynn, RL, 1993)
"A 4-year-old female blue and gold macaw (Ara ararauna) with a history of chronic vomiting was treated with metoclopramide hydrochloride."3.68Adverse drug reaction to metoclopramide hydrochloride in a macaw with proventricular dilatation syndrome. ( Massey, JG, 1993)
"Pancopride ((+-)N-(1-azabicyclo-[2,2,2]-oct-3-yl)-2-cyclopropylmethoxy-4-ami no-5-chlorobenzamide) is a new potent and selective 5-HT3 receptor antagonist, orally and parenterally effective against cytotoxic drug-induced emesis."3.68Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis. ( Beleta, J; Berga, P; Bou, J; Doménech, T; Fernández, AG; Gristwood, RW; Puig, J; Roberts, DJ, 1992)
" The syndrome was associated with metoclopramide antiemetic therapy given for post-operative nausea and vomiting."3.68Neuroleptic malignant syndrome associated with metoclopramide antiemetic therapy. ( Bakri, YN; Kawi, Z; Khan, R; Subhi, J, 1992)
"Lorazepam, dexamethasone and high-dose metoclopramide were given to 54 patients to prevent emesis induced by cisplatin (50-120 mg/m2) on day 1, while prochlorperazine and dexamethasone were administered on days 2 and 3 for control of delayed emesis."3.68Acute and delayed emesis after cisplatin-based regimen: description and prevention. ( Beaulieu, R; Courchesne, Y; Latreille, J; Letendre, F; Lorange, A; Louvet, C; Monte, M; Neemeh, JA; Pretty, HM, 1991)
"The antiemetic activity of DAU 6215, a novel antagonist of 5-HT3 receptors, was investigated in animal models of cytotoxic treatment-evoked emesis and compared with the antiemetic activity of ondansetron and metoclopramide."3.68Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation. ( Algate, DR; Bonali, P; Donetti, A; Micheletti, R; Montagna, E; Nicola, M; Rimoldi, EM; Sagrada, A; Schiantarelli, P; Turconi, M, 1991)
"To evaluate the efficacy of a combined therapy of prednisolone and alprazolam for controlling cisplatin-induced delayed emesis, a study involving 14 non-small cell lung cancer patients receiving cisplatin (80 mg/m2) was conducted."3.68[A combined anti-emesis therapy of oral prednisolone and alprazolam for cisplatin-induced delayed emesis]. ( Horio, Y; Iwahara, T; Minami, H; Sakai, S; Shibagaki, T; Shimokata, K; Watanabe, A, 1990)
"In prospective alternative crossover test, we confirmed significant superiority of a three-drug combination of clonazepam (C) lorazepam (L) and dexamethasone (D) to (L) and (D) to control vomiting induced by 50 mg/m CDDP containing chemotherapy for gynecological malignancies (p less than 0."3.68[Evaluation of antiemetic effect of clonazepam, metoclopramide, dexamethasone and diphenhydramine for prevention of cisplatin-induced vomiting]. ( Asano, H; Hatae, M; Hokanishi, H; Mitsuo, M; Nakamura, Y; Onishi, Y; Sakurai, K, 1990)
"Nabilone is a cannabinoid anti-emetic which has been extensively evaluated in control of chemotherapy-induced vomiting."3.67An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting. ( Priestman, SG; Priestman, TJ, 1984)
"Using an original high-pressure liquid chromatographic assay, we measured serum levels of metoclopramide and defined a concentration-response relationship for metoclopramide control of cisplatin-induced emesis."3.67Optimizing metoclopramide control of cisplatin-induced emesis. ( Drayer, DE; Lewin, M; Lonski, L; Meyer, BR; Pasmantier, M; Reidenberg, MM, 1984)
"Repeated oral doses of metoclopramide (50 mg) and prednisone (25 mg) completely prevented nausea and vomiting (N + V) in approximately 50% and substantially reduced N + V in an additional 27%-36% of 56 chemotherapy courses in 30 consecutive cancer patients who were receiving primarily cisplatin."3.67Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide. ( Bachmann-Mettler, I; Glaus, A; Senn, HJ, 1984)
"To investigate the effectiveness of high oral doses of the antiemetic agent 4-amino-5-chloro-N-(2-diethyl-aminoethyl)-2-methoxybenzamide (metoclopramide, MCP, Gastrosil) against nausea and vomiting induced by certain cyostatic drugs, blood was withdrawn repeatedly from 9 patients; MCP plasma levels were then determined."3.67[Metoclopramide plasma levels following oral administration of high doses for prophylaxis of emesis in cytostatic therapy]. ( Köhler, M; Senn, HJ; Vergin, H, 1984)
"The authors tested the safety and efficacy of intravenous metoclopramide in the prevention of chemotherapy-induced nausea and vomiting."3.67Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation. ( McDermed, JE; Pileggi, J; Riech, LP; Strum, SB; Whitaker, H, 1984)
"We evaluated whether chronic nausea and vomiting in diabetic patients correlate with abnormal gastric emptying of liquid or solid, or both liquid and solid, radiolabeled meals and recorded the acute effects of metoclopramide."3.67Gastric emptying in patients with diabetes mellitus. ( Kalbfleisch, JH; Loo, FD; Palmer, DW; Soergel, KH; Wood, CM, 1984)
"Because of vomiting, a 15 years old girl inserted one metoclopramide suppository."3.67[Effect of metoclopramide in a subject at risk for Huntington's chorea]. ( Escousse, A; Fabre, JL; Giroud, M; Nivelon-Chevallier, A; Putelat, R, 1985)
"The effect of metoclopramide premedication on the incidence of gastric regurgitation and postoperative nausea and vomiting was studied in 101 women during gynaecological procedures performed under mask anaesthesia."3.67Silent regurgitation in day case gynaecological patients. ( Anderson, WG; Miller, CD, 1988)
" Vomiting was a frequent side effect (about 20 per cent of cases) and was treated successfully with metoclopramide at a dosage of 0."3.67Treatment of pseudopregnancy with bromocriptin, an ergot alkaloid. ( Janssens, LA, 1986)
"Forty-six outpatients with breast cancer who had experienced severe emesis as a result of chemotherapy were evaluated for the antiemetic efficacy of high-dose metoclopramide (HD-MCP) and dexamethasone (DXM)."3.67High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study. ( Ben-Baruch, N; Ben-Yosef, R; Biran, S; Brufman, G; Gez, E; Uziely, B; Warner-Efraty, E; Yitzhaki, N, 1987)
"The antiemetic activity, gastric motor activity, and dopamine receptor effects of metoclopramide, dazopride, and sulpiride were assessed to establish if enhancement of gastric motility or antagonism of central dopamine receptors is the predominant action for drug-induced suppression of cisplatin-induced emesis."3.67Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility. ( Alphin, RS; Dannenburg, WN; Johnson, DN; Kinnier, WJ; Leonard, CA; Proakis, AG; Sancilio, LF; Smith, WL; Ward, JW, 1986)
"In two previous consecutive studies on antiemetic combination of metoclopramide and dexamethasone was found to be very active against nausea and vomiting induced by cisplatin (DDP; 50 mg/m2) alone or in combination with other cytotoxic emetogenic drugs."3.67Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses. ( Caporali, C; Carlini, P; Cognetti, F; Pinnarò, P; Ruggeri, EM, 1986)
" To prevent emesis, two high-dose metoclopramide regimens were started 2 hr before cytostatic therapy."3.67Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis. ( Achtert, G; Briemann, L; Brockmann, P; Hausleiter, HJ; Hellenbrecht, D; Hellstern, A; Hess, H; Hodgson, M; Mitrou, P; Saller, R, 1985)
"Intravenous metoclopramide and IM prochlorperazine and diazepam were compared in the management of vomiting occurring during treatment with cis-dichlorodiammineplatinum (cis-platinum)."3.67High-dose intravenous metoclopramide and intermittent intramuscular prochlorperazine and diazepam in the management of emesis induced by cis-dichlorodiammineplatinum. ( Chan, KK; Luesley, DM; Terry, PB, 1985)
"Sixteen of 26 patients given 51 courses of treatment of the doxorubicin and cisplatin combination with no antiemetic therapy suffered the same number of vomiting episodes and had the same duration of vomiting as did the remaining ten patients given 20 cycles of this chemotherapy plus the standard high-dose metoclopramide regimen."3.67Lack of antiemetic effect of high-dose metoclopramide. ( Christiansen, NP; Hrushesky, WJ; Roemeling, RV, 1985)
"Having noticed psychotic traits in some patients showing incoercible vomiting due to antineoplastic drugs we have thought of establishing a therapy with lithium in the days preceding the therapeutic cycle in order to reduce the emetic events."3.67Sequential therapy with lithium in chemotherapy-induced vomiting. ( Alfano, G; Candido, A; Mango, G; Menichella, G; Rossi, P; Tartaglione, R, 1985)
"Metoclopramide hydrochloride was administered to nine children for the treatment of gastric stasis (N=6) and unexplained vomiting (N=3)."3.66Enhanced gastroduodenal motility in children. ( Hitch, DC; Torres-Pinedo, RB; Vanhoutte, JJ, 1982)
" Antagonism with metoclopramide provided complete protection from cisplatin-induced emesis."3.66Cisplatin-induced emesis in the Ferret: a new animal model. ( Bradner, WT; Florczyk, AP; Schurig, JE, 1982)
"When given with pethidine 100 mg or morphine 10 mg as preanaesthetic medication, 10 and 20 mg of metoclopramide cause a reduction in postoperative nausea and vomiting in women undergoing a standard operation with a standard anaesthetic technique."3.65Studies of drugs given before anaesthesia. XXIV: Metocloramide with morphine and pethidine. ( Assaf, RA; Clarke, RS; Dundee, JW; Samuel, IO, 1974)
"Metoclopramide is a dopamine antagonist, which may enhance efficacy of ondansetron and dexamethasone."2.77Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice. ( Akewanlop, C; Ithimakin, S; Keerativitayanan, N; Laocharoenkeat, A; Nimmannit, A; Runglodvatana, K; Soparattanapaisarn, N; Srimuninnimit, V, 2012)
"Pretreatment with ondansetron or metoclopramide does not reduce oral contrast solution ingestion time."2.74Pretreatment of patients requiring oral contrast abdominal computed tomography with antiemetics: a randomized controlled trial of efficacy. ( Bamber, D; Chohan, J; Garra, G; Singer, AJ; Thode, HC; Troxell, R, 2009)
"Heptaplatin is a newly developed platinum derivative which has been reported to be less toxic than cisplatin."2.70Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer. ( Ahn, JH; Bahng, H; Chang, HM; Kang, WC; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, JS, 2002)
"Nausea and emesis are common side effects of opioid drugs administered for pain relief in cancer patients."2.70A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. ( Albertsson, M; Chimontsi-Kypriou, V; Curtis, P; Daly, S; Hardy, J; McQuade, B; Stathopoulos, P, 2002)
"198 chemonaive patients with breast cancer, treated with a moderately emetogenic chemotherapy, were randomly assigned to receive either oral granisetron 1 mg twice a day on day 1, followed by metoclopramide, 60 mg on day 2 and 3, or ondansetron, 8 mg IV on day 1, followed by ondansetron 8 mg tablet twice a day on day 2 and 3."2.69[Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron]. ( Granisétron, PK; Mabro, M, 1999)
"None of these differences reached statistical significance."2.69Prophylactic metoclopramide is unnecessary with intravenous analgesia in the ED. ( Paoloni, R; Talbot-Stern, J, 2000)
"Metoclopramide was ineffective."2.68The efficacy of prophylactic ondansetron, droperidol, perphenazine, and metoclopramide in the prevention of nausea and vomiting after major gynecologic surgery. ( Clark, K; Cronin, MK; Darvish, AH; Desilva, PH; McDonald, SM, 1995)
"An intermittent intake of low-dose droperidol with morphine given via a PCA delivery system in two treatment groups gave evidence for a dose-response relation between the amount of droperidol added and the proportion of patients needing a rescue antiemetic."2.68Antiemetic efficacy of a droperidol-morphine combination in patient-controlled analgesia. ( Bach, T; Jackson, D; McKenzie, R; Riley, T; Tantisira, B, 1995)
"Nausea and vomiting are extremely common and most distressing side effects of high-dose cisplatin therapy."2.68Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. ( Ata, E; Butt, A; Khan, MA; Khan, WA; Malik, IA; Qazilbash, M, 1995)
"Metoclopramide was ineffective."2.68Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo. ( Attia, M; Channa, AB; el Bakry, AK; el Gammal, K; el Gammal, M; Elhattab, YS; Jaroudi, R; Khoshim, MH; Naguib, M; Saddique, A, 1996)
" We compared ondansetron and metoclopramide, both combined with dexamethasone, in cisplatin-treated patients."2.68Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research. ( , 1997)
"Tropisetron+dexamethasone was significantly superior to tropisetron alone both for acute (P = 0."2.68Comparison of three tropisetron-containing antiemetic regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nausea. ( Bangerter, M; Bruntsch, U; Drechsler, S; Eggert, J; Faerber, L; Gallmeier, WM; Gosse, H; Grote-Kiehn, J; Imhoff, W; Mezger, J; Oehm, C; Ukena, D; Untch, M, 1997)
"The metoclopramide dosage was 20 mg i."2.68Comparative evaluation of the clinical efficacy and safety of ondansetron and metoclopramide in the prophylaxis of emesis induced by cancer chemotherapy regimens including cisplatin. ( Advani, SH; Cooverji, ND; Dhar, AK; Gopal, R; Lal, HM, 1996)
"Delayed emesis has not been seen during the antiemetic therapies."2.67[Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron]. ( Baki, M; Czeglédi, F, 1994)
"Female patients with ovarian cancer are at high risk for emesis."2.67Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research. ( , 1994)
"Tropisetron is an effective and well-tolerated agent in the prevention of chemotherapy-induced vomiting."2.67Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting. ( Anderson, H; de Bruijn, KM; Howell, A; Logan, K; Sage, T; Thatcher, N, 1994)
"ondansetron was superior to metoclopramide in preventing nausea and vomiting after general anaesthesia for day-case gynaecological laparoscopic surgery."2.67Antiemetic efficacy of prophylactic ondansetron in laparoscopic surgery: randomized, double-blind comparison with metoclopramide. ( Norton, AC; Raphael, JH, 1993)
"Droperidol was given just after induction and metoclopramide at the end of surgery, just before recovery."2.67Open placebo controlled comparison of the antiemetic effect of droperidol, metoclopramide or a combination of both in pediatric strabismus surgery. ( Pendeville, PE; Steinier, JR; Van Boven, MJ; Veyckemans, F, 1993)
" The overall incidence of adverse experiences was significantly lower in the granisetron group (60."2.67The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in patients receiving fractionated chemotherapy over 5 days. The Granisetron Study Group. ( , 1993)
" Tropisetron in combination with dexamethasone produced the best control of both acute and delayed emesis."2.67Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents. ( Bruntsch, U; Drechsler, S; Eggert, J; Faerber, L; Gosse, H; Imhoff, W; Ukena, D, 1994)
"Emesis is one of the most frequent and distressing adverse effects of cytotoxic chemotherapy."2.67Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies. ( Balduck, N; Hachimi-Idrissi, S; Maurus, R; Otten, J, 1994)
"Acute nausea was prevented completely in 40% of patients in the tropisetron group and in 61% of the metoclopramide cocktail group during course 1 (P < ."2.67Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience. ( Sorbe, BG, 1994)
"289 consecutive cancer patients receiving cisplatin chemotherapy (much greater than 50 mg/m2) were randomised to receive one of the following intravenous antiemetic regimens: ondansetron 0."2.67Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research. ( , 1992)
"Ondansetron was well tolerated in the dose and schedule used."2.67The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo. ( Bryson, JC; Finn, AL; Gandara, DR; Harvey, WH; Hesketh, PJ; Monaghan, GG; Perez, EA; Stokes, C, 1992)
"The metoclopramide regimen was five times as expensive as prochlorperazine."2.67A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy. ( Bishop, JF; Buchanan, L; Cooper, IA; Laidlaw, C; Matthews, J; Olver, IN; Smith, R; Wolf, M, 1992)
"Ondansetron hydrochloride is a selective serotonin subtype 3 (5HT3) receptor antagonist that has been shown to be an effective antiemetic in patients receiving cisplatin chemotherapy."2.67Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy. ( Einhorn, L; House, K; Nagy, C; Sledge, GW, 1992)
"Vomiting was decreased in the DXM groups compared to groups A and C (p < 0."2.67Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial. ( Bacoyannis, C; Droufakou, S; Kosmidis, P; Kozatsani-Halividi, D; Mylonakis, N; Tsaroucha-Noutsou, E; Tsavaris, N; Tsoutsos, H; Valilis, P, 1992)
" Regimen B, employing a lower dosage of metoclopramide and steroids and using a more simple schedule of administration should be the preferred treatment."2.67Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients. ( Basurto, C; Boschetti, E; Bracarda, S; Del Favero, A; Lupattelli, M; Picciafuoco, M; Roila, F; Sassi, M; Tonato, M, 1992)
"Droperidol was more effective in reducing severe vomiting."2.67[Droperidol versus metoclopramide. Prevention of emesis following strabismus surgery in children]. ( Braun, U; Feldmann, M; Klockgether-Radke, A; Mühlendyck, H, 1992)
"Metoclopramide was administered by continuous infusion to two groups each of 14 patients on chemotherapy, randomized to receive either doses adjusted to individual pharmacokinetic parameters or doses adjusted as usual to body weight."2.67Continuous infusion of high-dose metoclopramide: comparison of pharmacokinetically adjusted and standard doses for the control of cisplatin-induced acute emesis. ( Brechot, JM; Chastang, C; Delattre, C; Dupeyron, JP; Laaban, JP; Rochemaure, J, 1991)
"Metoclopramide-treated patients did not demonstrate a lower incidence of nausea or emesis but did tolerate oral liquids earlier after surgery than the placebo group (P less than 0."2.67Outpatient cholecystectomy simulated in an inpatient population. ( Downes, TW; Hayes, DH; McKinnon, WM; Treen, DC, 1991)
"At the end of the treatment period, nausea, vomiting and reflux symptoms, adverse events and a global assessment of patients' symptom control were recorded by the investigator."2.67A comparison of controlled release metoclopramide and domperidone in the treatment of nausea and vomiting. ( Miller, AJ; Patel, NH; Roy, P, 1991)
" Overall, the evidence suggests that this dosing schedule for batanopride may be too toxic for clinical use."2.67Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis. ( Fleming, GF; Francher, D; Janisch, L; McEvilly, JM; Smaldone, L; Vokes, EE, 1991)
" It is concluded that oral lorazepam is an effective and safe adjuvant to MCP for the control of vomiting during cancer chemotherapy."2.67Low dose, oral lorazepam: a safe and effective adjuvant to antiemetic therapy. ( Advani, SH; Banavali, SD; Charak, BS; Gopal, R; Iyer, RS; Saikia, TK, 1991)
"Severe nausea was significantly less frequent with cinnarizine and 59% of the chemotherapy days were without nausea, compared to 46% of the days without cinnarizine (p less than 0."2.67Cinnarizine for prevention of nausea and vomiting during platin chemotherapy. ( Osterwalder, B; Schimke, J; Senn, HJ; Wilder-Smith, CH, 1991)
"Vomiting was not satisfactorily prevented by either treatment."2.67Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients. ( Hallén, C; Sorbe, B, 1991)
"56 female patients with breast carcinoma and treated with polychemotherapy: adriamycin, vindesine, ciclophosphamide and 5-fluorouracil were studied, divided in three groups with different antiemetic schedule: group A 40 mg/iv of metoclopramide; group B 40 mg iv of metoclopramide and 125 mg/iv of methylprednisolone before beginning chemotherapy; and group C 2 mg/oral of lorazepam, 125 mg/iv methyl-prednisolone and 1 mg/kg/oral of metoclopramide previously to begin chemotherapy; at two and four hours of the first dose, metoclopramide was repeated the same doses (really) three doses each two hours."2.67[Antiemetic treatments associated with antineoplastic chemotherapy]. ( Guillén Lloveria, G; Mayordomo Cámara, JJ; Sáenz Cusi, A; Sáez Martínez, MJ; Tres Sánchez, A, 1990)
" Only one adverse event, headache, occurred in more than five patients in the granisetron group."2.67Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group. ( Chevallier, B, 1990)
"Sixty-nine patients with malignant tumors receiving cancer chemotherapy, 90% including cis-platinum, were evaluated in a randomized crossover study for the antiemetic efficacy and the side effects of two antiemetic regimens: chlorpromazine (CPM) 2."2.66Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study. ( Ben-Yosef, R; Biran, S; Brufman, G; Catane, R; Gez, E, 1989)
"The metoclopramide dosage was escalated in six steps from 0."2.66Dose-ranging antiemetic trial of high-dose oral metoclopramide. ( Clark, RA; Gralla, RJ; Kris, MG; Tyson, LB; Young, CW, 1989)
" We have, therefore, carried out a multicenter, double-blind randomized trial comparing a combination of high-dose metoclopramide (MTC) (1 mg/kg x 4) and methylprednisolone (P) (treatment A) with a shorter but higher single-dose schedule of metoclopramide (3 mg/kg x 2) combined with dexamethasone (DEX) and diphenhydramine (DIP) to prevent extrapyramidal reactions (treatment B)."2.66Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research ( Basurto, C; Bracarda, S; Di Costanzo, F; Donati, D; Malacarne, P; Monici, L; Patoia, L; Picciafuoco, M; Roila, F; Tonato, M, 1989)
"Clebopride was reasonably well tolerated at the used dosages, inducing sedation in 20% of cases (versus 24% with metoclopramide) and diarrhea in 37% (versus 20% with metoclopramide)."2.66[Comparative study on the tolerance and efficacy of high doses of metoclopramide and clebopride in vomiting induced by cisplatin]. ( Díaz-Rubio, E; Martín, M, 1989)
"19 mg/l with doses which varied considerably owing to marked scattering of pharmacokinetic parameters."2.66[Dosage adjustment of metoclopramide for controlling vomiting induced by cisplatin: pharmacokinetic approach]. ( Brechot, JM; Delattre, C; Delfour, C; Dupeyron, JP; Guyon, F; Lebeau, B; Rochemaure, J, 1988)
"Droperidol was significantly more effective than domperidone, metoclopramide or placebo in reducing emetic sequelae."2.66Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery. ( Madej, TH; Simpson, KH, 1986)
"The metoclopramide regimen was either 2 mg/kg i."2.66A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis. ( Abdulhay, G; Dana, BW; Everts, E; McDermott, M, 1987)
" With the dosage and schedule used, AZP provided only limited antiemetic protection, with less than 10% of the patients free of emesis."2.66A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin. ( Carlini, P; Marolla, P; Nardi, M; Pollera, CF, 1987)
"Thirty-two patients with primary lung cancer receiving combination chemotherapy including cisplatin at a dosage of 80-120 mg/m2 were entered into an antiemetic randomized crossover trial."2.66[Antiemetic effects of combinations of metoclopramide, droperidol and dexamethasone for the prevention of cisplatin-induced gastro-intestinal toxicity: a randomized crossover trial]. ( Fujii, M; Kamei, H; Kiura, K; Okabe, K; Toki, H, 1987)
" It is concluded that there is a dose-response relationship for the antiemetic effect of metoclopramide."2.66High-dose versus low-dose metoclopramide in the prevention of cisplatin-induced emesis. A randomized crossover study in patients with ovarian carcinoma. ( Grande, T; Moxnes, A; Onsrud, M; Solesvik, O; Sollien, A, 1988)
"Continuous infusion of metoclopramide was compared with bolus dosing in a randomized, double-blind study in 27 patients receiving cisplatin therapy."2.66Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis. ( Agostinucci, WA; Dinonno, EB; Gannon, RH; Golub, GR; Martin, RS; Schauer, PK, 1988)
"Metoclopramide serum levels were measured by high-performance liquid chromatography."2.66Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial. ( Anthony, LB; Brenner, DE; Burish, TG; Greco, FA; Hainsworth, JD; Hande, KR; Krozely, MG; Woodward, NJ, 1986)
"In a randomized trial of 58 cancer patients receiving strongly emetogenic cytostatic drugs (cisplatin or comparable cytostatic agents, alone or in combination), the anti-emetic action of oral metoclopramide was tested, alone or combined with prednisone."2.66[Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone]. ( Bachmann-Mettler, I; Glaus, A; Köhler, M; Senn, HJ; Weigand, W, 1986)
"Metoclopramide was more effective in decreasing the volume of emesis than was alizapride (median of 100 ml vs."2.66The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial. ( Bischoff, AK; Brunner, KW; Galeazzi, RL; Joss, RA; Pirovino, M; Ryssel, HJ, 1986)
" A further trial is necessary to determine the optimal dosage and scheduling of the available agents."2.66[Randomized crossover trial of the antiemetic effects obtained with metoclopramide and droperidol versus those obtained with metoclopramide, droperidol and methylprednisolone in patients receiving cis-platinum chemotherapy]. ( Fujii, M; Kiura, K; Okabe, K; Tamai, M; Toki, H, 1986)
"We designed a multicenter, double-blind randomized study to determine the safety and antiemetic effectiveness of intravenous (IV) methylprednisolone (P) combined with high-dose IV metoclopramide (MTC) v MTC alone in 200 untreated cancer patients receiving cisplatin chemotherapy."2.66Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research. ( Ballatori, E; Basurto, C; Bella, M; DiCostanzo, F; Donati, D; Morsia, D; Passalacqua, R; Roila, F; Tognoni, G; Tonato, M, 1987)
"To better define the dose-response relationship of moderate-dose (MD) metoclopramide (MCP), 42 patients receiving their first course of cisplatin (50 mg/m2) were randomly allocated to receive a short-course regimen of MCP, either at 1 mg/kg X 1 dose, 30 min before cisplatin (regimen A) or 1 mg/kg X 2 doses, 30 min before and 1 h after cisplatin (regimen B)."2.66Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesis. ( Calabresi, F; Conti, EM; De Nigris, A; Pollera, CF, 1987)
"The metoclopramide-treated group demonstrated a statistically significant decrease in the incidence of nausea and vomiting."2.66Metoclopramide as prophylaxis for nausea and vomiting induced by fluorescein. ( Brown, RE; Drew, SJ; Sabates, R, 1987)
" The biological half-life of metoclopramide was 9."2.66Antiemetic effect and pharmacokinetics of high dose metoclopramide in cancer patients treated with cisplatin-containing chemotherapy regimens. ( Havsteen, H; Kjaer, M; Nielsen, H, 1986)
"The oral bioavailability of high-dose metoclopramide was studied in 12 patients, who received oral or intravenous (i."2.66Oral bioavailability of high-dose metoclopramide. ( Bateman, DN; Taylor, WB, 1986)
"Metoclopramide was compared to a metoclopramide plus dexamethasone combination in patients receiving high-dose cisplatinum."2.66Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis. ( Akerley, WL; Baker, CR; Cariffe, PA; Grunberg, SM; Johnson, KB; Krailo, MD, 1986)
" Its optimal dosage schedule, however, has not yet been completely defined."2.66Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research. ( Ballatori, E; Basurto, C; Canaletti, R; Colombo, N; DiCostanzo, F; Donati, D; Morsia, D; Passalacqua, R; Roila, F; Tonato, M, 1985)
"Four consecutive trials were undertaken to study lorazepam at each of three dosage levels and diphenhydramine when used in combination with iv metoclopramide and dexamethasone in patients receiving cisplatin at 120 mg/m2."2.66Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone. ( Clark, RA; Fiore, JJ; Gralla, RJ; Groshen, S; Kelsen, DP; Kris, MG; Tyson, LB, 1985)
" The results demonstrate that the dosage regimen originally suggested by Gralla for cytostatic drugs, with forced diuresis for high-dose metoclopramide therapy, may also be applied, with no dosage reduction, with to other cytostatic drugs which do not require forced diuresis."2.66Pharmacokinetic studies of high-dose metoclopramide with and without forced diuresis. ( Braun, J; Domschke, S; Domschke, W; Ell, C; König, HJ, 1985)
"Metoclopramide was given at a dosage of 2 mg/kg (H) or 1 mg/kg (M), intravenously, 30 minutes before and 2."2.66[Randomized controlled study of high-dose metoclopramide (2 mg/kg x 4:H) vs moderate-dose metoclopramide (1 mg/kg x 4:M) in the prevention of CDDP-induced emesis]. ( Dozono, H; Ohmi, K, 1986)
"Metoclopramide (MCP) was given i."2.65Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting. ( Carlini, P; Cognetti, F; Conti, EM; Cortese, M; Pinnarò, P; Pollera, CF, 1984)
"In a population of 51 ambulant cancer patients treated with doxorubicin-containing chemotherapy we conducted a double-blind cross-over randomized trial, comparing the anti-emetic efficacy of a combination of amitriptyline (25 mg p."2.65Amitriptyline plus fluphenazine to prevent chemotherapy-induced emesis in cancer patients: a double-blind randomized cross-over study. ( Blijham, GH; Mellink, WA; van Deyk, WA, 1984)
"Metoclopramide was superior to placebo and to prochlorperazine in reducing the volume of emesis (P = 0."2.65Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. ( Bordin, LA; Braun, DW; Braun, TJ; Gralla, RJ; Itri, LM; Kelsen, DP; Pisko, SE; Squillante, AE; Young, CW, 1981)
" The importance of adequate dosage of metoclopramide and the role of IV metoclopramide are emphasized."2.65Metoclopramide in the reduction of nausea and vomiting associated with combined chemotherapy. ( Cox, R; Leyland, MJ; Newman, CE, 1982)
"5."2.64Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism. ( Debono, A; Marsden, CD; Parkes, JD; Price, P; Rosenthaler, J, 1978)
"Nausea is a common symptom in advanced cancer, with a prevalence of up to 70%."2.55Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery). ( Good, P; Hardy, JR; Haywood, A; Khan, S; Rickett, K; Vayne-Bossert, P, 2017)
"Nausea and vomiting is a common and distressing presenting complaint in emergency departments (ED)."2.52Drugs for the treatment of nausea and vomiting in adults in the emergency department setting. ( Egerton-Warburton, D; Furyk, JS; Meek, RA, 2015)
"Metoclopramide is a prokinetic agent reported to be safe in parturients."2.48Metoclopramide for nausea and vomiting prophylaxis during and after Caesarean delivery: a systematic review and meta-analysis. ( Habib, AS; Mishriky, BM, 2012)
"Nausea and vomiting are common symptoms of migraine, which can be controlled with a variety of anti-emetics including phenothiazines and antihistamines."2.41Anti-emetics. ( MacGregor, EA, 2001)
"Nausea and vomiting are debilitating side effects that often accompany the administration of chemotherapy and may lead to adverse physiological and psychological effects."2.39Antiemetics in children receiving cancer chemotherapy. ( Billett, AL; Sallan, SE, 1994)
"Ondansetron (GR 38032F) is a highly selective 5-HT3 receptor antagonist, one of a new class of compounds which may have several therapeutic applications."2.38Ondansetron. Therapeutic use as an antiemetic. ( Heel, RC; Milne, RJ, 1991)
"Nausea and vomiting are a serious side effect of chemotherapy, frequently leading to failure of treatment compliance."2.38[Nausea and vomiting induced by chemotherapy: bases to a rational treatment]. ( Fodor, M; Gallardo, J, 1989)
"Nausea and vomiting are the most feared toxicities of chemotherapy."2.38Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens. ( Grunberg, SM, 1989)
" Pyridoxine is considered safe for use during pregnancy, but its efficacy in treating nausea and vomiting has not been determined."2.37Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy. ( Leathem, AM, 1986)
"Metoclopramide also has an important place in the investigation of the role of dopamine in physiological and pathological processes."2.37Metoclopramide--a review. ( Desmond, PV; Watson, KJ, 1986)
"Metoclopramide appears to be an effective drug in stimulating the mobility of the upper gastrointestinal tract without increasing gastric secretions."2.36Review of a new gastrointestinal drug--metoclopramide. ( Nappi, JM; Ponte, CD, 1981)
"We considered akathisia and cancer-related anxiety/agitation as possible causes of restlessness and insomnia, and prescribed clonazepam."1.72Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case report. ( Deguchi, Y; Inoue, K; Itoh, Y; Sakamoto, S; Uchida, S, 2022)
"Nausea is a common symptom in patients taken care of by the ambulance service."1.43Preventing and alleviating patients' symptoms of nausea and vomiting while in the care of the ambulance service - a qualitative study. ( Hjelte Judell, O; Lindström, V; Vicente, V; Westerlund, A, 2016)
"Nausea and vomiting are common, but prevalence of antiemetic use in ED patients is unknown."1.43Oligoantiemesis or Inadequate Prescription of Antiemetics in the Emergency Department: A Local and National Perspective. ( Garra, G; Singer, AJ; Thode, HC, 2016)
"All patients scheduled for breast cancer surgery at Danderyd Hospital, Stockholm, Sweden during 1 year (March 2003-March 2004) were asked to participate in this prospective, observational study."1.39Is there an association between PONV and chemotherapy-induced nausea and vomiting? ( Eksborg, S; Lönnqvist, PA; Öbrink, E; Oddby-Muhrbeck, E; Rotstein, S, 2013)
"Metoclopramide has the greatest evidence for efficacy followed by phenothiazines and tropisetron."1.36Nausea and vomiting in advanced cancer. ( Ang, SK; Davis, MP; Shoemaker, LK, 2010)
" Prior treatment with each dosage of metoclopramide significantly reduced the frequency of emetic episodes (P<0."1.36Effects of metoclopramide on emesis in cats sedated with xylazine hydrochloride. ( Jarolmasjed, S; Kolahian, S, 2010)
"For moderate dehydration, eight CPGs advocated nasogastric (NG) rehydration in preference to intravenous (IV) rehydration."1.35Emergency department management of gastro-enteritis in Australia and New Zealand. ( Babl, FE; Borland, M; Schutz, J; Sheriff, N, 2008)
"Metoclopramide probably has a mechanism of action to prevent U46619-induced emesis via 5-HT(4) receptor activation and NK(1) tachykinin receptor antagonists could be useful to prevent emesis induced by TP receptor activation in man."1.35Mechanism of the prostanoid TP receptor agonist U46619 for inducing emesis in the ferret. ( Kan, KK; Ngan, MP; Rudd, JA; Wai, MK, 2008)
" Clinicians should attempt to treat patients with the lowest effective dosage of medication for the briefest therapeutic period to minimize the risks of adverse reactions."1.31Metoclopramide-induced supersensitivity psychosis. ( Lu, ML; Pan, JJ; Shen, WW; Su, KP; Teng, HW, 2002)
"Metoclopramide is a dopamine receptor blocking drug that is commonly used to treat nausea and vomiting."1.31Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. ( Addis, A; Arnon, J; Berkovitch, M; Elbirt, D; Greenberg, R; Magee, L; Mazzota, P; Merlob, P; Moretti, M; Ornoy, A; Schuler-Faccini, L; Stahl, B, 2002)
"Emesis was characterized by expulsion of solid or liquid material."1.29Emesis induced in domestic pigs: a new experimental tool for detection of antiemetic drugs and for evaluation of emetogenic potential of new anticancer agents. ( Göthert, M; Herold, H; Szelenyi, I, 1994)
"Domperidone did not inhibit these cytotoxic agents-induced emeses."1.29The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis. ( Fukuda, T; Haga, K; Inaba, K; Morimoto, Y; Setoguchi, M; Shoji, H, 1993)
"Vomiting was the first cause of admission in diabetics."1.29Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin. ( Gallar, P; Guijo, G; Oliet, A; Ortega, O; Vigil, A, 1993)
" Thus, controlling the adverse side effects associated with radiation therapy is critical to optimal patient care."1.29Controlling the toxicity of palliative radiotherapy: the role of 5-HT3 antagonists. ( Priestman, TJ, 1996)
"and metoclopramide 0."1.29Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study. ( Cannata, G; Gebbia, N; Gebbia, V; Testa, A, 1996)
"Severe vomiting was present in 34 (89%) and proved to be a serious obstacle to the administration of enteral charcoal."1.28Management of theophylline overdose patients in the intensive care unit. ( Henderson, A; Pond, SM; Wright, DM, 1992)
"Despite treatment, emesis remains a major problem with cisplatin chemotherapy."1.28[Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam]. ( Hsu, KP; Li, YT; Mau, YK; Tsui, MS; Tu, FC, 1991)
"Cisapride was a potent stimulant of gastric emptying in rats, 7 times more potent than metoclopramide."1.28General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride. ( Awouters, FH; Megens, AA; Niemegeers, CJ, 1991)
"Despite this preventative treatment, nausea and/or vomiting occurred in over one-third of all the courses."1.28[Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin]. ( Aoki, Y; Horiuchi, Y; Kamikawa, R; Kyokane, K; Miwa, Y; Nagai, H; Ninomiya, E; Noro, T; Suga, S; Yasue, K, 1990)
"The neuroleptic malignant syndrome is a serious and potentially fatal complication of neuroleptic and other dopamine antagonist drugs that are commonly used in symptom control in advanced cancer."1.28The neuroleptic malignant syndrome. ( O'Neill, WM, 1990)
"Nausea and emesis during cancer chemotherapy are very common, but can often be controlled with repetitive boli of antiemetic drugs."1.28Patient-controlled antiemesis for cancer chemotherapy-induced nausea and vomiting. ( Naji, P; Osterwalder, B; Schuler, L; Senn, HJ; Wilder-Smith, CH, 1990)
"Both zacopride and BMY25801 were effective against emesis and related signs."1.28Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret. ( King, GL; Landauer, MR, 1990)
"Metoclopramide is a very effective drug in preventing the acute emetic and nauseating effects of cisplatin."1.28Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomiting. ( Schimke, J; Senn, HJ; Vergin, H; Wilder-Smith, C, 1989)
"Metoclopramide was given in 4 doses of 1mg/kg on the same schedule."1.28[Antiemetic efficacy of betamethasone versus betamethasone combined with metoclopramide in cisplatin-treated cancer patients]. ( Kagami, Y; Narimatsu, N; Nishio, M; Sakurai, T; Tomita, M, 1989)
"Sixty patients with Hodgkin's disease were treated with a polychemotherapy regimen including very emetic dacarbazine and adriamycin in addition to bleomycin and vincristine on 622 treatment days during the last 10 years."1.28[Management of vomiting induced by polychemotherapy in Hodgkin's disease]. ( Berényi, E; Kiss, E, 1989)
"In a randomized crossover study 57 cancer patients receiving chemotherapy with high emetic potential were treated with low-dose levonantradol or standard-dose metoclopramide and crossed over to the other antiemetic drug in the next identical chemotherapy cycle."1.27Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy. ( Altenburg, HP; Heim, ME; Queisser, W, 1984)
"Metoclopramide was given intravenously (IV) at a dose of 0."1.27Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy. ( McDermed, JE; McDermott, NM; Streng, BR; Strum, SB, 1984)
"With increasingly effective cancer chemotherapy, the control of chemotherapy-induced nausea and vomiting has become more important."1.27Control of cancer chemotherapy-induced nausea and vomiting. ( Eyre, HJ; Ward, JH, 1984)
" In these six patients plasma metoclopramide half-life was 5."1.27Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting. ( Bateman, DN; Proctor, SJ; Taylor, WB, 1984)
"Nausea and vomiting are often severe and prolonged, rendering a patient unfit for further treatment."1.27[New aspects in the antiemetic therapy of cytostatic drug-induced vomiting]. ( Gerhartz, H; Hiller, E, 1984)
"Metoclopramide was orally administered (10 or 20 mg) to 22 subjects, 75 min before parabolic flight."1.27Hormonal responses of metoclopramide-treated subjects experiencing nausea or emesis during parabolic flight. ( Kohl, RL, 1987)
"Metoclopramide was nonselectively active against emesis induced by cytostatic agents, radiation and D2-dopamine receptor agonists, whereas domperidone was selectively effective against emesis induced by apomorphine and hydergine only."1.27BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties. ( Buyniski, JP; Crenshaw, RR; Gylys, JA; Nicolosi, WD; Wright, RN, 1988)
"Diphenhydramine was administered intramuscularly 30 minutes before and 5 hours after chemotherapy."1.27[The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine]. ( Arihiro, T; Dozono, H; Morimoto, O; Ochiai, K; Sasaki, H; Takahashi, S; Terashima, Y; Tsuruoka, M; Yasuda, M; Yokoyama, S, 1987)
" The quantitative dose-response curves of the four doses of the emetic agonist cisplatin were shifted to the right by increasing doses of MCL."1.27Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis. ( Hellenbrecht, D; Saller, R, 1986)
"Vomiting was observed more frequently after non intra-ocular surgery than after intra-ocular surgery (37% cf."1.27Vomiting after ophthalmic surgery. Effects of intra-operative antiemetics and postoperative oral fluid restriction. ( Laghari, NA; Lambourne, A; Van den Berg, AA; Yazji, NS, 1987)
"Nausea and vomiting are common complications of cisplatin chemotherapy."1.27Evaluation of ethanol as an antiemetic in patients receiving cisplatin. ( Adelstein, DJ; Hines, JD; Spiess, JL, 1987)
"Metoclopramide hydrochloride is an antiemetic and gastric motility stimulant with a wide variety of extrapyramidal side effects, including parkinsonism."1.27Metoclopramide-induced parkinsonism in hemodialysis patients. Report of two cases. ( Diamond, BF; Kimmel, PL; Sirota, RA; Stein, HD; Trichtinger, MD; Yudis, M, 1986)
"Emesis was observed from 0."1.27[Experimental study on the control of cisplatin-induced emesis in dogs]. ( Abo, T; Ito, J; Okada, M; Okamoto, Y; Takahashi, K; Yamashita, T, 1987)
"Metoclopramide (MCP) was used as an antiemetic agent in 11 pediatric oncology patients during 22 courses of cancer therapy including cisplatin, doxorubicin, and other agents."1.27Metoclopramide as an antiemetic agent in pediatric oncology patients. ( Blatt, J; Felix, C; Howrie, DL; Juhl, RP; Wollman, M, 1986)
"Metoclopramide was administered four times intravenously at a dose of 1."1.27[Antiemetic combination of metoclopramide and methylprednisolone for cisplatin-induced vomiting]. ( Amano, H; Fujimoto, K; Saito, H; Shimokata, K; Tsunekawa, H; Yasuda, Y; Yoshii, S, 1985)
"Metoclopramide (Paspertin) was infused intravenously in the high doses of 1."1.27Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis. ( Hellenbrecht, D; Hellstern, A; Hess, H; Saller, R, 1985)
"Magnesium deficiency was present in seven patients and its correction resulted in amelioration of the symptom complex."1.26Chronic intestinal pseudo-obstruction. ( Brandenburg, D; Brooks, WS; Hersh, T; Hirsh, EH, 1981)
"Metoclopramide was used as an antiemetic."1.26[Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)]. ( Antz, H; Doepfmer, K; FEAUX DE Lacroix, W; Groth, W; Runne, U, 1980)
" The toxicity of high dose metoclopramide was of concern mainly in patients younger than 30, and/or when dosage escalation have been attempted."1.26[High dose metoclopramide during cancer chemotherapy. Phase II study in 80 consecutive patients]. ( Albin, H; Bui, NB; Durand, M; Hoerni, B; Marit, G; Mauriac, L, 1982)
"Although vomiting was not inhibited by chlorpromazine or atropine, a strong inhibition was evident when metoclopramide was administered subcutaneously at such doses as inhibit vomiting induced by oral administration of CuSO4."1.25Pharmacological studies of caerulein. II. The possibility of mediation through the central nervous system. ( Kojima, T; Koyama, Y; Marumo, H; Nakamura, N; Shiozaki, S, 1975)

Research

Studies (743)

TimeframeStudies, this research(%)All Research%
pre-1990294 (39.57)18.7374
1990's301 (40.51)18.2507
2000's58 (7.81)29.6817
2010's69 (9.29)24.3611
2020's21 (2.83)2.80

Authors

AuthorsStudies
Youssefyeh, RD2
Campbell, HF2
Klein, S2
Airey, JE2
Darkes, P1
Powers, M2
Schnapper, M2
Neuenschwander, K1
Fitzpatrick, LR1
Pendley, CE1
Woodward, R1
Rodriguez, W1
Golec, S1
Studt, W1
Piana, F1
Minghella, E1
Sun, L1
Xi, Y1
Wen, X1
Zou, W1
Robson, S1
McParlin, C1
Mossop, H1
Lie, M1
Fernandez-Garcia, C1
Howel, D1
Graham, R1
Ternent, L1
Steel, A1
Goudie, N1
Nadeem, A1
Phillipson, J1
Shehmar, M1
Simpson, N1
Tuffnell, D1
Campbell, I1
Williams, R1
O'Hara, ME1
McColl, E1
Nelson-Piercy, C1
Gottlieb, M1
Carlson, JN1
Peksa, GD1
Sher, AA1
Iqbal, A1
Adil, M1
Ullah, S1
Bawazeer, S1
Binmahri, MK1
Zamil, LZ1
Irfan, M1
Sakamoto, S1
Deguchi, Y1
Uchida, S1
Itoh, Y1
Inoue, K1
Henze, L1
Foth, S1
Meller, S1
Twele, F1
Charalambous, M1
Kenward, H1
Elliott, J1
Pelligand, L1
Volk, HA1
Na, S1
Jung, DE1
Hwang, E1
Kim, T1
Sriwiset, H1
Lokeskrawee, T1
Patumanond, J1
Wongyikul, P1
Phinyo, P1
Elendu, C1
Adenikinju, J1
Ogala, F1
Ologunde, T1
Adebambo, S1
Egbunu, E1
Barney, EZ1
Fuller, ME1
Habib, AS4
Harder, S2
Groenvold, M2
Herrstedt, J3
Niño-Serna, LF1
Acosta-Reyes, J1
Veroniki, AA1
Florez, ID1
Rowland, KD1
Fuehrer, J1
Motov, SM1
Vilke, G1
Rosenbaum, SB1
Quenzer, F1
Radhakrishnan, V1
Pai, V1
Rajaraman, S1
Mehra, N1
Ganesan, T1
Dhanushkodi, M1
Perumal Kalaiyarasi, J1
Rajan, AK1
Selvarajan, G1
Ranganathan, R1
Karunakaran, P1
Sagar, TG1
Kaneishi, K1
Imai, K1
Nishimura, K1
Sakurai, N1
Kohara, H1
Ishiki, H1
Kanai, Y1
Oyamada, S1
Yamaguchi, T1
Morita, T1
Iwase, S1
van der Vorst, MJDL1
Toffoli, EC1
Beusink, M1
van Linde, ME1
van Voorthuizen, T1
Brouwer, S1
van Zweeden, AA1
Vrijaldenhoven, S1
Berends, JC1
Berkhof, J1
Verheul, HMW1
Suarez, EA1
Boggess, K1
Engel, SM1
Stürmer, T1
Lund, JL1
Jonsson Funk, M1
Sakran, R1
Shechtman, S1
Arnon, J2
Diav-Citrin, O1
Lacy, BE1
Cangemi, DJ1
Davis, M1
Hui, D1
Davies, A1
Ripamonti, C1
Capela, A1
DeFeo, G1
Del Fabbro, E1
Bruera, E3
Taylor, SJ1
Allan, K1
McWilliam, H1
Manara, A1
Brown, J1
Greenwood, R1
Toher, D1
Vayne-Bossert, P1
Haywood, A1
Good, P1
Khan, S1
Rickett, K1
Hardy, JR1
Kim, GH1
Jung, KW1
Brioschi, FA1
Gioeni, D1
Jacchetti, A1
Carotenuto, AM1
Sutherland, A1
Naessens, K1
Plugge, E1
Ware, L1
Head, K1
Burton, MJ1
Wee, B1
Isaksen, J1
Neergaard, MA1
Frandsen, K1
Sigaard, J1
Mondrup, L1
Jespersen, BA1
Giusti, R1
Mazzotta, M1
Filetti, M1
Daniele, G1
Tsukuura, H2
Ficorella, C1
Porzio, G1
Marchetti, P1
Verna, L1
Lee, CS1
Chen, KC1
Yu, CH1
Bérard, A1
Sheehy, O1
Gorgui, J1
Zhao, JP1
Soares de Moura, C1
Bernatsky, S1
Keat, CH2
Phua, G1
Abdul Kassim, MS1
Poh, WK1
Sriraman, M1
Kirthi, V2
Derry, S2
Moore, RA2
George, RB1
McKeen, DM1
White, WD1
Ituk, US1
Megalla, SA1
Allen, TK1
Silvestris, N1
Brunetti, AE1
Russano, M1
Nardulli, P1
Mohamed, RA1
Abass, HA1
Attia, MA1
Heikal, OA1
Ghani, NA1
Dahl, E1
Diskin, AL1
Li, HQ1
Chan, IS1
Tang, ML1
Tian, GL1
Tang, NS1
Egerton-Warburton, D3
Meek, R3
Mee, MJ2
Braitberg, G1
Heiberger, A1
Zhang, XF1
Yin, GZ1
Liu, QG1
Liu, XM1
Wang, B1
Yu, L1
Liu, SN1
Cui, HY1
Lv, Y1
Furyk, JS2
McKenzie, S1
Pitts, SR1
Roila, F19
Ruggeri, B1
Ballatori, E14
Fatigoni, S1
Caserta, C1
Licitra, L1
Mirabile, A1
Ionta, MT1
Massidda, B1
Cavanna, L1
Palladino, MA2
Tocci, A1
Fava, S1
Colantonio, I1
Angelelli, L1
Ciuffreda, L1
Fasola, G1
Zerilli, F1
Meek, RA1
Ando, Y1
Gyawali, B1
Matsumoto, M1
Sugishita, M1
Honda, K1
Urakawa, H1
Maeda, O1
Hasegawa, Y1
Smith, LA1
Azariah, F1
Lavender, VT1
Stoner, NS1
Bettiol, S1
Bajgoric, S1
Samra, K1
Chandrapalan, S1
Gautam, N1
Beer, AM1
Westerlund, A1
Vicente, V1
Hjelte Judell, O1
Lindström, V1
Waqar, SN1
Mann, J1
Baggstrom, MQ1
Waqar, MA1
Chitneni, P1
Williams, K1
Gao, F1
Morgensztern, D1
Govindan, R1
Singer, AJ2
Garra, G2
Thode, HC2
Lewis, K1
Alqahtani, Z1
Mcintyre, L1
Almenawer, S1
Alshamsi, F1
Rhodes, A1
Evans, L1
Angus, DC1
Alhazzani, W1
Lorenzutti, AM1
Martín-Flores, M1
Litterio, NJ1
Himelfarb, MA1
Invaldi, SH1
Zarazaga, MP1
Malekolkottab, M1
Khalili, H1
Mohammadi, M1
Ramezani, M1
Nourian, A1
Yalcin, E1
Keser, GO1
Schutz, J1
Babl, FE1
Sheriff, N1
Borland, M1
Kan, KK1
Ngan, MP2
Wai, MK2
Rudd, JA3
Bamber, D1
Chohan, J1
Troxell, R1
Krobbuaban, B1
Pitakpol, S1
Diregpoke, S1
Kim, K1
Chie, EK1
Jang, JY1
Kim, SW2
Oh, DY1
Im, SA1
Kim, TY1
Bang, YJ1
Ha, SW1
Hawkins, R1
Grunberg, S1
Pikó, B1
Bassam, A1
Alhashimi, D3
Al-Hashimi, H1
Fedorowicz, Z4
Du Bois, A2
Matok, I1
Gorodischer, R1
Koren, G1
Sheiner, E1
Wiznitzer, A1
Levy, A1
Lau, KK1
Chan, KW1
Lok, CM1
Lam, AW1
Lee, HH1
Luk, WF1
Mak, CM1
Ching, CK1
Lo, J1
Li, SM1
Chan, AY1
Patanwala, AE1
Amini, R1
Hays, DP1
Rosen, P1
Trepanier, L1
Ang, SK1
Shoemaker, LK1
Davis, MP1
McQuay, HJ1
Zang, J1
Hou, M1
Gou, HF1
Qiu, M1
Wang, J1
Zhou, XJ1
Luo, de Y1
Yang, Y1
Jiang, M1
Cao, D1
Bi, F1
Xu, F1
Shen, Y1
Yi, C1
Molassiotis, A3
Brearley, SG1
Stamataki, Z1
Kolahian, S1
Jarolmasjed, S1
Miyagawa, Y1
Ejiri, M1
Kuzuya, T1
Osada, T1
Ishiguro, N1
Yamada, K1
Salvo, N1
Doble, B1
Khan, L1
Amirthevasar, G1
Dennis, K1
Pasetka, M1
Deangelis, C1
Tsao, M1
Chow, E1
Yousef, M1
Ebrahim, N1
Ebrahim, A1
Hosssain, B1
Ithimakin, S1
Runglodvatana, K1
Nimmannit, A1
Akewanlop, C1
Srimuninnimit, V1
Keerativitayanan, N1
Soparattanapaisarn, N1
Laocharoenkeat, A1
Bonilla-Palomas, JL1
López-López, JM1
Moreno-Conde, M1
Gallego de la Sacristana, A1
Gámez-López, AL1
Villar-Ráez, A1
Klauser, CK1
Fox, NS1
Istwan, N1
Rhea, D1
Rebarber, A1
Desch, C1
Palmer, B1
Saltzman, D1
Ebrahim Soltani, AR1
Mohammadinasab, H1
Goudarzi, M1
Arbabi, S1
Mohammadinasab, A1
Mohammadinasab, F1
Samimi, M1
Festin, M1
Al-Ansari, K1
Alomary, S1
Abdulateef, H1
Alshawagfa, M1
Kamal, K1
Simpson, PM1
Bendall, JC1
Middleton, PM1
Perwitasari, DA1
Wessels, JA1
van der Straaten, RJ1
Baak-Pablo, RF1
Mustofa, M1
Hakimi, M1
Nortier, JW1
Gelderblom, H1
Guchelaar, HJ1
Jagannath, VA1
Carter, B1
Chae, J1
Taylor, DM1
Frauman, AG1
Mishriky, BM2
Wickham, R1
Mohammadbeigi, R1
Shahgeibi, S1
Soufizadeh, N1
Rezaiie, M1
Farhadifar, F1
Pinto, TF1
Rocha, R1
Paula, CA1
de Jesus, RP1
Stich, O1
Nagy, S1
Reinhard, M1
Hetzel, A1
Winkler, C1
Taschner, C1
Leschka, SC1
Weiller, C1
Rijntjes, M1
Reichmann, JP1
Kirkbride, MS1
Lalla, R1
Malhotra, HS1
Garg, RK1
Verma, R1
Cayley, WE1
Gelfand, AA1
Goadsby, PJ1
Benze, G1
Alt-Epping, B1
Geyer, A1
Nauck, F1
Lee, JS3
Jeon, WC1
Park, EJ1
Min, YG1
Jung, YS1
Kim, GW1
Choi, SC1
Oddby-Muhrbeck, E1
Öbrink, E1
Eksborg, S1
Rotstein, S1
Lönnqvist, PA1
Navari, RM3
Nagy, CK1
Gray, SE1
Wilson, J1
Plourde, JY1
Marshall, D1
Yoshida, S1
Chow, W1
Harsanyi, Z2
Pearen, S1
Darke, A2
Ahn, JH1
Kang, YK1
Kim, TW1
Bahng, H1
Chang, HM1
Kang, WC1
Kim, WK1
Park, JS1
Lu, ML1
Pan, JJ1
Teng, HW1
Su, KP1
Shen, WW1
Berkovitch, M1
Mazzota, P1
Greenberg, R1
Elbirt, D1
Addis, A1
Schuler-Faccini, L1
Merlob, P1
Stahl, B1
Magee, L1
Moretti, M1
Ornoy, A1
Paoloni, R2
Talbot-Stern, J2
MacGregor, EA1
Numbenjapon, T1
Sriswasdi, C1
Mongkonsritragoon, W1
Leelasiri, A1
Prayoonwiwat, W1
Aapro, MS3
Thuerlimann, B1
Sessa, C1
De Pree, C1
Bernhard, J1
Maibach, R1
Yue, W2
Zhang, F2
Wang, L2
Fang, X1
Liu, YX1
Minami, M1
Fujii, Y10
Tanaka, H10
Kawasaki, T1
Bsat, FA1
Hoffman, DE1
Seubert, DE1
Bhatia, A2
Tripathi, KD2
Sharma, M2
Kubota, Y2
Mihara, K1
Ishii, F1
Ohno, K1
Ogata, H1
Makimura, M1
Kikuchi, N1
Kitano, T1
Alsalim, W1
Leung, WC1
Butler, J1
Cham, S1
Basire, M1
Kelly, AM1
Cheng, FH1
Andrews, PL3
Moreaux, B1
Sam, TS1
Wan, C1
Basurto, C14
Bracarda, S7
Del Favero, A13
Tonato, M16
Weschules, DJ1
Ozucelik, DN1
Karaca, MA1
Sivri, B1
Bradshaw, M1
Sen, A1
Yang, ZH1
Liu, ZT1
Axelsson, P1
Thörn, SE1
Lövqvist, A1
Wattwil, L1
Wattwil, M1
Leksowski, K1
Peryga, P1
Szyca, R1
Alhashimi, H2
Luisi, FA1
Petrilli, AS1
Tanaka, C1
Caran, EM1
Kerstan, A1
Seitz, CS1
Bröcker, EB1
Trautmann, A1
Lajolo, PP1
del Giglio, A1
Lou, E1
Abou-Zeid, N1
Moutzouris, DA1
Manetas, S1
Mountantonakis, SE1
Falagas, ME1
Fiore, JJ2
Gralla, RJ12
Bakowski, MT1
Giroud, M2
Fabre, JL2
Putelat, R2
Caillot, X1
Escousse, A2
Nivelon-Chevalier, A1
Dumas, R1
Maule, WF1
Perry, MC1
Palazzo, MG1
Strunin, L1
Kotlarek-Haus, S1
Orzechowska-Juzwenko, K1
Gabryś, K1
Williams, CJ1
Bolton, A1
de Pemberton, R1
Whitehouse, JM1
Baggerman, C1
Laszlo, J1
Bachmann-Mettler, I3
Priestman, TJ3
Priestman, SG1
Jensen, NH1
Termansen, K1
Bruera, ED2
Roca, E2
Cedaro, L1
Chacón, R1
Estévez, R1
Harrington, RA1
Hamilton, CW1
Brogden, RN2
Linkewich, JA1
Romankiewicz, JA1
Heel, RC2
Guldager, H1
Jensen, FM1
Andersen, KH1
Arnfred, I1
Ell, C4
König, HJ4
Gutmann, W1
Domschke, S3
Domschke, W3
Clarke, RS4
Spelina, KR1
Gerber, HR1
Pagels, IL1
Cognetti, F2
Pinnarò, P3
Carlini, P3
Conti, EM2
Cortese, M1
Pollera, CF6
Gagen, M1
Gochnour, D1
Young, D1
Gaginella, T1
Neidhart, J1
Domenici, R1
Saponati, G1
Castelli, S1
Manchikanti, L1
Marrero, TC1
Roush, JR1
Valenzuela, JE1
Dooley, CP1
Mellink, WA1
Blijham, GH1
van Deyk, WA1
Allan, SG5
Cornbleet, MA4
Lockhart, SP1
Warrington, PS5
Leonard, RC4
Smyth, JF2
Chiara, S1
Scarsi, P1
Campora, E1
Bruzzi, P1
Tatarek, R1
Rosso, R1
Barlow, AM1
Jalihal, SS1
Feldman, M1
Schiller, LR1
Fielding, JW1
Priestman, T1
Kris, MG10
Tyson, LB9
Clark, RA8
Bowcock, SJ1
Stockdale, AD1
Bolton, JA1
Kang, AA1
Retsas, S1
Golland, IM1
Smyth, JN1
Heim, ME1
Queisser, W1
Altenburg, HP1
Strum, SB4
McDermed, JE6
Streng, BR1
McDermott, NM1
Perego, P1
Brivio, F1
Pulinetti, B1
Bugatti, A1
Baldoni, A1
Eyre, HJ1
Ward, JH1
Taylor, WB3
Proctor, SJ1
Bateman, DN3
Meyer, BR2
Lewin, M1
Drayer, DE1
Pasmantier, M1
Lonski, L1
Reidenberg, MM2
Senn, HJ6
Glaus, A2
Grunberg, SM6
Gala, KV1
Lampenfeld, M1
Jamin, D1
Johnson, K1
Cariffe, P1
Strych, D1
Krailo, M1
Donovitz, GS1
O'Quinn, AG1
Smith, ML1
Plezia, PM2
Alberts, DS2
Kessler, J1
Graham, V1
Surwit, EA1
Vergin, H2
Köhler, M2
Reich, SD1
Paice, JA1
Gever, LN1
Niddam, R1
Perrot-Marsault, M1
Budach, V1
Krüger, K1
Burrows, CF1
Chacón, RD1
Chan, SC1
Lo, JR1
Wong, KC1
Grau, JJ1
Millá, A1
Cirera, L1
Estapé, J1
Terrin, BN1
McWilliams, NB1
Maurer, HM1
Pileggi, J1
Riech, LP2
Whitaker, H1
Loo, FD1
Palmer, DW1
Soergel, KH1
Kalbfleisch, JH1
Wood, CM1
Hiller, E1
Gerhartz, H1
Ise, T1
Ohira, M1
Omiya, A1
Hirose, M1
Shibata, T1
Hirsh, EH1
Brandenburg, D1
Hersh, T2
Brooks, WS1
Daniels, M1
Belt, RJ1
Runne, U1
Doepfmer, K1
Antz, H1
Groth, W1
FEAUX DE Lacroix, W1
Boghaert, A1
Carron, D1
Gallant, J1
Stockman, A1
Schulze-Delrieu, K2
Ponte, CD1
Nappi, JM1
Caruso, U1
D'Iddio, S1
Cravotto, E1
Pesce, S1
Betti, I1
Ruscitto, G1
Ecari, U1
Sabrie, AM1
Itri, LM1
Pisko, SE1
Squillante, AE1
Kelsen, DP2
Braun, DW1
Bordin, LA1
Braun, TJ1
Young, CW2
Mosca, S1
D'Amato, L1
Gargiulo, PL1
Cautela, G1
Cristau, P1
Laverdant, C1
Coquelin, JP1
Narbonne, G1
Padrón, F1
Sanz, J1
Flórez, J1
Opfell, RW1
Cox, R1
Newman, CE1
Leyland, MJ1
Hitch, DC1
Vanhoutte, JJ1
Torres-Pinedo, RB1
Cowan, AN1
Bui, NB2
Marit, G2
Hoerni, B2
Albin, H1
Durand, M1
Mauriac, L1
Florczyk, AP1
Schurig, JE1
Bradner, WT1
Bolis, PF1
Guaschino, S1
Paganelli, AM1
Sampaolo, P1
Giordano, L1
Visone, C1
Rosatti, R1
Di Mezza, G1
Montanino, C1
Turtur, A1
Losanna Cannavacciuolo, G1
Green, L1
Brown, MD1
Diamond, MJ2
Keeri-Szanto, M1
Reuss, D1
Perkel, MS1
Moore, C1
Davidson, ED1
Rose, JB3
McCloskey, JJ1
Dick, GS1
Meller, ST1
Pinkerton, CR1
Scarantino, CW1
Ornitz, RD1
Hoffman, LG1
Anderson, RF1
Chiou, TJ1
Wei, CH1
Hsieh, RK1
Fan, FS1
Liu, JH1
Chen, PM1
Heron, JF2
Parasuraman, TV1
Osterhaus, JT1
Miralbell, R1
Coucke, P1
Behrouz, F1
Blazek, N1
Melliger, M1
Philipp, S1
Wickenhauser, R1
Gebhard, S1
Schwabb, T1
Rosset, A1
Desilva, PH1
Darvish, AH1
McDonald, SM1
Cronin, MK1
Clark, K1
McKenzie, R1
Tantisira, B1
Jackson, D1
Bach, T1
Riley, T1
Prentice, HG1
Cunningham, S1
Gandhi, L1
Cunningham, J2
Collis, C1
Hamon, MD1
Thune, A1
Appelgren, L1
Haglind, E1
Framarino dei Malatesta, M1
Veneziano, M1
Fiorelli, C1
Bandiera, AF1
Yacoub, M1
Toccaceli Blasi, MR1
Marzetti, L1
Cubeddu, LX3
Hoffmann, IS1
Lee, CW1
Suh, CW1
Lee, KH1
Cho, GY1
Kim, SH1
Martin, TM2
Kymer, PJ2
Brown, RE2
Lawhorn, CD2
Jones, E1
Pearce, L1
Rust, M2
Paxton, LD1
McKay, AC1
Mirakhur, RK1
Mecklem, DW1
Seng, KT1
Tiong, CE1
Hiang, TC1
Ohmatsu, H3
Eguchi, K4
Shinkai, T4
Tamura, T3
Ohe, Y2
Nisio, M1
Kunikane, H1
Arioka, H1
Karato, A1
Nakashima, H1
Elliott, RH1
Graham, SG1
Curran, JP1
Tomirotti, M1
Dimaiuta, M1
Confalonieri, M1
Scanni, A1
Szelenyi, I1
Herold, H1
Göthert, M1
Rubenstein, EB2
Elting, LS2
Malik, IA1
Khan, WA1
Qazilbash, M1
Ata, E1
Butt, A1
Khan, MA1
Lewis, IH2
Campbell, DN1
Barrowcliffe, MP1
Furst, SR2
Rodarte, A2
Czeglédi, F1
Baki, M1
Walder, AD1
Aitkenhead, AR1
Goedhals, L1
Jordaan, JP1
Cedar, E1
Yaddanapudi, LN1
Olver, IN2
Matthews, JP2
Bishop, JF3
Smith, RA1
Billett, AL1
Sallan, SE1
Hesketh, PJ5
Bleiberg, H2
Autier, P1
Michaux, D1
Pater, J3
Slamet, L1
Zee, B1
Osoba, D4
Warr, D4
Rusthoven, J2
Tan, EH1
Ang, PT1
Khoo, KS1
Cefalo, G1
Rottoli, L1
Armiraglio, A1
Pagan, MG1
Goldspiel, BR1
Kohler, DR1
Misra, R1
Agarwal, N1
Calamandrei, M1
Andreuccetti, T1
Crescioli, M1
Messeri, A1
Sarti, A1
Sestini, G1
Busoni, P1
Anderson, H1
Thatcher, N1
Howell, A1
Logan, K1
Sage, T1
de Bruijn, KM2
Sims, C1
Johnson, CM1
Bergesio, R1
Delfos, SJ1
Avraamides, EA1
Saito, H3
Shimokata, K3
Yamori, S1
Kajita, M1
Niimi, T1
Zbrozek, AS2
Cantor, SB1
Cardenas, MP1
Hill, DP1
Qin, XY1
Pilot, MA1
Thompson, H2
Scott, M1
Póka, R1
Hernádi, Z1
Juhász, B1
Lampé, L1
Haga, K1
Inaba, K1
Shoji, H1
Morimoto, Y1
Fukuda, T1
Setoguchi, M1
Malins, AF1
Field, JM1
Nesling, PM1
Cooper, GM1
Fanning, J1
Hilgers, RD1
Kaufmann, MA1
Rosow, C1
Schnieper, P1
Schneider, M1
Fleishman, SB1
Lavin, MR1
Sattler, M1
Szarka, H1
Gan, TJ1
Collis, R1
Hetreed, M1
Phillips, S1
Ruggier, R1
Hutchinson, SE1
Kawashima, T1
Wada, T1
Morita, N1
Ohmata, T1
Miyata, K1
Sakamoto, T1
Reimer, EJ1
Montgomery, CJ1
Bevan, JC1
Merrick, PM1
Blackstock, D1
Popovic, V1
Carella, G1
Marra, L1
Wynn, RL2
Essien, E1
Thut, PD1
Hindle, A1
Tsukagoshi, S1
Ohta, J1
Taguchi, T1
Raphael, JH1
Norton, AC1
Sorbe, B4
Hallén, C4
Frankendal, B1
Sorbe, BG2
Högberg, T1
Glimelius, B1
Schmidt, M1
Wernstedt, L1
Hansen, O2
Sörensen, BT1
Räisänen, I1
van Oosterom, AT1
Baltzer, L2
Rigas, JR1
Pisters, KM3
Pendeville, PE1
Veyckemans, F1
Van Boven, MJ1
Steinier, JR1
Clerico, M1
Bertetto, O1
Morandini, MP1
Cardinali, C1
Giaccone, G1
Cullen, MH2
Mori, K2
Saito, Y1
Tominaga, K2
Cunningham, D4
Gore, M1
Davidson, N1
Miocevich, M1
Manchanda, M1
Wells, N1
Gallar, P1
Oliet, A1
Vigil, A1
Ortega, O1
Guijo, G1
Massey, JG1
Bhandari, P1
Homesley, HD2
Hahne, WF1
McLees, B1
Heck, K1
Barrett, RJ1
Lentz, SS1
Woodlief, L1
Lovelace, JV1
Levitt, M2
Yelle, L1
Rayner, HL1
Lofters, WS2
Perrault, DJ1
Wilson, KS1
Latreille, J4
Potvin, M1
Warner, E1
Michaloudis, D1
O'Keeffe, N1
O'Sullivan, K1
Healy, TE1
Joshi, R1
Sivaganesanathan, A1
Chang, TC1
Hsieh, F1
Lai, CH1
Tseng, CJ1
Cheng, HH1
Li, CL1
Michael, BJ1
Soong, YK1
Naylor, RJ4
Pfeiffer, P1
Madsen, B1
Andersen, I1
Hansen, B1
Mathiesen, B1
Gebbia, V2
Testa, A2
Valenza, R1
Cannata, G2
Tirrito, ML1
Gebbia, N2
Cleri, LB1
Gilbert, CJ1
Ohly, KV1
Rosner, G1
Peters, WP1
Jørgensen, M1
Victor, MA1
Sekine, I2
Nishiwaki, Y2
Kakinuma, R2
Kubota, K2
Hojo, F2
Matsumoto, T2
Yokozaki, M2
Kodama, T2
Soukop, M3
Verweij, J2
de Wit, R2
de Mulder, PH2
Rittenberg, C1
Peralta, M1
Lettow, L1
Cronin, M1
Hall, JE2
Harmer, M2
Torrance, C1
Jordan, S1
Masters, JC1
O'Grady, M1
Ali-Melkkilä, T1
Kanto, J1
Katevuo, R1
Kitamura, A1
Kon, T1
Kamiyama, M1
Ogawa, R1
Okamoto, S1
Takahashi, S5
Tanosaki, R1
Sakamaki, H1
Onozawa, Y1
Oh, H1
Miyawaki, S1
Kimura, Y1
Toyama, K1
Ikeda, Y1
Asano, S1
Chua, DT1
Sham, JS1
Au, GK1
Choy, D1
Kwong, DL1
Yau, CC1
Cheng, AC1
Güller, R1
Reichlin, B1
Jost, G1
Barrenetxea, G1
Schneider, J1
Centeno, MM1
Romero, H1
de la Rica, M1
Rodríguez-Escudero, FJ1
Page, B1
Dallara, J1
Basade, M1
Kulkarni, SS1
Dhar, AK2
Sastry, PS1
Saikia, B1
Advani, SH4
Lacroix, G1
Lessard, MR1
Trépanier, CA1
Naguib, M1
el Bakry, AK1
Khoshim, MH1
Channa, AB1
el Gammal, M1
el Gammal, K1
Elhattab, YS1
Attia, M1
Jaroudi, R1
Saddique, A1
Iwanaga, Y1
Miyashita, N1
Saito, T1
Morikawa, K1
Itoh, Z1
Baines, D1
Seifert, L1
Watanabe, S1
Babul, N1
Suarez-Almazor, M1
Chen, PP1
Chui, PT1
Gin, T1
Steinbrook, RA2
Freiberger, D2
Gosnell, JL2
Brooks, DC1
Watts, SA1
Stene, FN1
Seay, RE1
Young, LA1
Bohnsack, LE1
Bostrom, BC1
Cupissol, D1
Venkatraman, E1
Toyooka, H7
Harrington, ML1
Moore, MP1
Talcott, PA1
Bagley, RS1
Sandmeier, P1
Chevallier, B3
Cappelaere, P1
Splinter, T1
Fabbro, M1
Wendling, JL1
Cals, L1
Catimel, G1
Giovannini, M1
Khayat, D1
Bastit, P1
Claverie, N1
Stein, DJ1
Birnbach, DJ1
Danzer, BI1
Kuroda, MM1
Grunebaum, A1
Thys, DM1
Suga, S2
Iwase, H1
Shimada, M1
Nishio, Y1
Ichihara, T1
Ichihara, S1
Kusugami, K1
Pugh, SC1
Jones, NC1
Barsoum, LZ1
Trujillo, LM1
Talmaciu, I1
Gonzalez, V1
Guariguata, J1
Seijas, J1
Miller, IA1
Paska, W1
Fry, RA1
Walker, MA1
Bliss, A1
Pitkänen, MT1
Numminen, MK1
Tuominen, MK1
Rosenberg, PH1
Chang, CS1
Chen, LT1
Huang, SM1
Liu, TC1
Lin, SF1
Chen, TP1
Wei, TC1
Madej, G1
Krzakowski, M2
Pawinski, A1
Lasota, W1
Rogowski, W1
Skoneczna, I1
Bruntsch, U2
Drechsler, S2
Eggert, J2
Gosse, H2
Ukena, D2
Imhoff, W2
Faerber, L2
Otten, J1
Hachimi-Idrissi, S1
Balduck, N1
Maurus, R1
Tavorath, R1
Kigawa, J1
Minagawa, Y1
Itamochi, H1
Cheng, X1
Okada, M2
Terakawa, N1
Shende, D2
Mandal, NG1
Mjahed, K1
el Harrar, N1
Idali, B1
Laouissi, F1
Benaguida, M1
Amraoui, A1
Goto, K1
Miyamoto, T1
Takafuji, J1
Ciccarese, G1
Alexander, R1
Fennelly, M1
Polati, E1
Verlato, G1
Finco, G1
Mosaner, W1
Grosso, S1
Gottin, L1
Pinaroli, AM1
Ischia, S1
Balfour, JA1
Goa, KL1
Wong, RH1
Lao, L1
Berman, BM1
Carter, AK1
Ascaso, FJ1
Ayala, I1
Carbonell, P1
Castro, FJ1
Palomar, A1
Khoo, VS1
Rainford, K1
Horwich, A1
Dearnaley, DP1
Grote-Kiehn, J1
Bangerter, M1
Oehm, C1
Mezger, J1
Untch, M1
Gallmeier, WM1
Scuderi, PE1
Weaver, RG1
James, RL1
Mims, G1
Elliott, WG1
Weeks, DB1
Diemunsch, P1
Conseiller, C1
Clyti, N1
Mamet, JP1
Moyle, JT1
Aass, N1
Håtun, DE1
Thoresen, M1
Fosså, SD1
Saunders, MI1
Hoskin, PJ1
Pigott, K1
Powell, ME1
Goodchild, K1
Dische, S1
Denekamp, J1
Stratford, MR1
Dennis, MF1
Rojas, AM1
Bach-Styles, T1
Martin-Sheridan, D1
Hughes, C1
Kaufman, S1
Stewart, FC1
Stoner, JM1
Shirey, R1
Volpe, P1
Monagle, J1
Barnes, R1
Goodchild, C1
Hewitt, M1
Brüggenjürgen, B1
Saitoh, Y2
Morris, RW1
Aune, H1
Feiss, P1
Hanson, A1
Hasselstrøm, L1
Maltby, JR1
Rocke, DA1
Rozenberg, B1
Cohen, LA1
Harper, CM1
Barker, JP1
Haldar, M1
Mystakidou, K1
Befon, S1
Liossi, C1
Vlachos, L1
MacLaren, R1
Shields, CA1
Köseoglu, V1
Kürekçi, AE1
Sarici, U1
Atay, AA1
Ozcan, O1
Sorici, U1
Brown, RS1
Brown, TK1
Hoare, D1
Gaze, MN1
Pizzo, BA1
Miller, VA1
Grant, SC1
Hinckley, L1
Berto, P1
De Angelis, V1
Neri, C1
Olivieri, A1
Plosker, GL1
Milne, RJ2
Malik, I1
Moid, I1
Khan, Z1
Hussain, M1
Kobayashi, N1
Mabro, M1
Granisétron, PK1
Gorchein, A1
Mukhopadhyay, K1
Narang, A1
Kumar, P1
Chakraborty, S1
Mittal, BR1
Cohen, N1
Alon, I1
Almoznino-Sarfian, D1
Gorelik, O1
Chachasvili, S1
Litvinjuk, V1
Modai, D1
Weissgarten, J1
Bouaggad, A1
Bouderka, MA1
Semkaoui, A1
Haida, F1
Abassi, O1
Tsavaris, NB3
Koufos, C1
Katsikas, M1
Dimitrakopoulos, A1
Athanasiou, E1
Linardaki, G1
Chung, F1
Lane, R1
Spraggs, C1
McQuade, B2
Jacka, M1
Luttropp, HH1
Alahuta, S1
Rocherieux, S1
Roy, M1
Duvaldestin, P1
Curtis, P2
Lachaine, J1
Laurier, C1
Langleben, A1
Vaillant, L1
Somekawa, Y1
Catalán Arlandis, JL1
Jiménez Torres, NV1
Gopal, R3
Lal, HM1
Cooverji, ND1
Bosnjak, SM1
Nesković-Konstantinović, ZB1
Radulović, SS1
Susnjar, S1
Mitrovi, LB1
Suga, A1
Tanaka, M1
Roome, C1
Thompson, J1
Yoshida, K1
Tatsukawa, H1
Ashida, K1
Matsubara, K1
Uwatoko, H1
Ogasawara, H1
Katsuma, Y1
Kitamura, K1
Zatman, TF1
Manusirivithaya, S1
Chareoniam, V1
Isariyodom, P1
Sungsab, D1
Ljutić, D1
Perković, D1
Rumboldt, Z1
Bagatin, J1
Hozo, I1
Pivac, N1
Hardy, J1
Daly, S1
Albertsson, M1
Chimontsi-Kypriou, V1
Stathopoulos, P1
Mok, TS1
Yam, BM1
Yung, H1
Gibbs, D1
Tarsy, D1
Parkes, JD2
Marsden, CD2
Caralps, A1
Rosser, R1
Herxheimer, A1
Ekert, H1
Waters, KD1
Jurk, IH1
Mobilia, J1
Loughnan, P1
Badley, BW1
Price, P1
Debono, A1
Rosenthaler, J1
Edelstyn, GA1
MacRae, KD1
MacDonald, FM1
Van Eygen, M1
Dhondt, F1
Heck, E1
Ameryckx, L2
Van Ravensteyn, H2
De Loore, I1
Cooke, RD1
Comyn, DJ1
Ball, RW1
Gylys, JA2
Doran, KM1
Buyniski, JP2
Swann, IL1
Thompson, EN1
Qureshi, K1
Kahn, T1
Elias, EG1
Mason, GR1
Reynolds, GJ1
Pinder, RM1
Sawyer, PR1
Speight, TM1
Avery, GS1
Fry, EN1
Deshpande, S1
Borgne, D1
Grillet, Y1
Lucas, F1
Zer, M1
Dintsman, M1
Kocián, J1
Kociánová, J1
Nakamura, N1
Shiozaki, S1
Koyama, Y1
Kojima, T1
Marumo, H1
Nuss, D1
Winship, WS1
Angrist, B1
Shopsin, B1
Gershon, S1
Holmsen, R1
Corsini, GU1
Zompo, MD1
Cianchetti, C1
Mangoni, A1
Diehl, V1
Wilan, A1
Venner, P1
Kaizer, L2
Laberge, F2
Stewart, D1
O'Connell, G1
Houghton, LA1
Fowler, P1
Keene, ON1
Read, NW1
Fürst, CJ2
Johansson, S2
Fredrikson, M2
Hursti, T2
Steineck, G2
Peterson, C2
Dogliotti, L1
Antonacci, RA1
Pazè, E1
Ortega, C1
Berruti, A1
Faggiuolo, R1
Gandara, DR3
Harvey, WH1
Monaghan, GG1
Perez, EA1
Stokes, C1
Bryson, JC1
Finn, AL1
Alon, E1
Himmelseher, S1
Wolf, M2
Laidlaw, C1
Cooper, IA2
Matthews, J1
Smith, R1
Buchanan, L1
Sledge, GW1
Einhorn, L1
Nagy, C1
House, K1
Fukui, H1
Yamamoto, M1
Sato, S1
Roberts, RH1
Tan, ST1
Sinclair, SW1
Putnam, PE1
Orenstein, SR1
Wessel, HB1
Stowe, RM1
Fernández, AG1
Puig, J1
Beleta, J1
Doménech, T1
Bou, J1
Berga, P1
Gristwood, RW1
Roberts, DJ1
Tsavaris, N3
Tsaroucha-Noutsou, E2
Bacoyannis, C3
Mylonakis, N4
Valilis, P2
Kozatsani-Halividi, D2
Tsoutsos, H2
Droufakou, S1
Kosmidis, P3
Buxton, MJ1
O'Brien, BJ1
Wetchler, BV1
Russell, D1
Kenny, GN1
Ferrari, LR1
Donlon, JV1
Moreno, I4
Rosell, R5
Abad, A2
Barnadas, A2
Carles, J2
Ribelles, N2
Solano, V1
Font, A1
Sands, R1
Roberts, JT2
Marsh, M1
Gill, A1
Lin, DM1
Bakri, YN1
Khan, R1
Subhi, J1
Kawi, Z1
Sassi, M2
Lupattelli, M2
Picciafuoco, M6
Boschetti, E3
Liu, YC1
Kang, HM1
Liou, CM1
Tso, HS1
Henderson, A1
Wright, DM1
Pond, SM1
Klockgether-Radke, A1
Feldmann, M1
Braun, U1
Mühlendyck, H1
Brechot, JM2
Dupeyron, JP2
Delattre, C2
Chastang, C1
Laaban, JP1
Rochemaure, J2
Saitou, Y1
Miyazawa, N1
Li, YT2
Mau, YK2
Hsu, KP2
Treen, DC1
Downes, TW1
Hayes, DH1
McKinnon, WM1
Lucraft, H1
Collis, CH1
Adams, M1
Upadhyaya, BK1
Priestman, S1
Wilson, K1
Findlay, B1
Louvet, C1
Lorange, A1
Letendre, F1
Beaulieu, R1
Pretty, HM1
Courchesne, Y1
Neemeh, JA1
Monte, M1
Abad-Esteve, A3
Whalley, DG1
AlHaddad, S1
Khalil, I1
Maurer, W1
Furgerson, C1
Lim, KS1
Lim, BL1
Tee, CS1
Vengadasalam, D1
Karvounis, N2
Klinaki, A1
Marr, HE1
Davey, PT1
Bartlett, AJ1
Roy, P1
Patel, NH1
Miller, AJ1
Hainsworth, J1
Harvey, W1
Pendergrass, K1
Kasimis, B1
Oblon, D1
Monaghan, G1
Gandara, D1
Hesketh, P1
Khojasteh, A1
Harker, G1
Marschner, N1
Sagrada, A1
Turconi, M1
Bonali, P1
Schiantarelli, P1
Micheletti, R1
Montagna, E1
Nicola, M1
Algate, DR1
Rimoldi, EM1
Donetti, A1
Marschner, NW2
Adler, M2
Nagel, GA2
Christmann, D1
Fenzl, E1
Upadhyaya, B1
Campbell, NN1
Thomas, AD1
Tsui, MS1
Tu, FC1
Fleming, GF1
Vokes, EE1
McEvilly, JM1
Janisch, L1
Francher, D1
Smaldone, L2
González Barón, M1
Chacón, JI1
García Girón, C1
Ordóñez Gallego, A1
García de Paredes, ML1
Feliu, J1
Zamora, P1
Herranz, C1
Garrido, P1
Artal, A1
Megens, AA1
Awouters, FH1
Niemegeers, CJ1
Charak, BS2
Banavali, SD2
Iyer, RS1
Saikia, TK2
Francom, M1
Zamanis, N1
Zinelis, A1
Tsoutsos, E1
Sarafidou, M1
Wilder-Smith, CH2
Schimke, J2
Osterwalder, B2
Costall, B3
Tattersall, FD2
Dieras, V1
Extra, JM1
Le Bonniec, M1
Madelaine, I1
Espie, M1
Marty, M2
Molino, A1
Guglielmo, L1
Azzolini, ME1
Biondani, P1
Capelli, MC1
Grandinetti, A1
Griso, C1
Martinelli, G1
Martini, N1
Zanotti, R1
Froidevaux, P1
Roth, A1
Alberto, P1
Akhtar, SS1
Bano, ZA1
Bhat, GM1
Bhat, MA1
Patoia, L2
Santi, E1
Penza, O1
Salles, G1
Archimbaud, E1
Thomas, X1
Fiere, D1
Kaasa, S2
Mella, O1
Kvikstad, A1
Hannibal, J1
Hallas, J1
Andersen, E1
Laursen, LC1
Hansen, M1
Tongia, SK1
Bhagwat, AW1
Tres Sánchez, A1
Sáez Martínez, MJ1
Mayordomo Cámara, JJ1
Guillén Lloveria, G1
Sáenz Cusi, A1
Nagai, H1
Horiuchi, Y1
Kyokane, K1
Miwa, Y1
Aoki, Y1
Yasue, K1
Noro, T1
Kamikawa, R1
Ninomiya, E1
Pouillart, P1
Scholl, S1
Droz, JP2
Azab, M2
Brion, N1
Pujade-Lauraine, E2
Paule, B1
Paes, D2
Bons, J2
Bonneterre, J1
Metz, R1
Fargeot, P1
Spielmann, M1
Tubiana-Hulin, M1
Kvaløy, S1
Dicato, MA1
Ries, F1
Huys, JV1
Royer, E1
Carruthers, L1
Jaenicke, F1
Albrecht, U1
Seynaeve, C1
Vermorken, JB1
van Liessum, PA1
Mols-Jevdevic, S1
Allman, EL1
Beranek, P1
King, GL2
Watanabe, A1
Horio, Y1
Minami, H1
Shibagaki, T1
Iwahara, T1
Sakai, S1
Kessler, JF1
Berens, PL1
Chase, JL1
Roe, DJ1
Tortorice, PV1
O'Connell, MB1
Stephens, SH1
Silvey, VL1
Wheeler, RH1
Bone, ME1
Wilkinson, DJ1
Young, JR1
McNeil, J1
Charlton, S1
Gwynne, A1
Malone, JM1
Christensen, CW1
Yashinsky, D1
Malviya, VK1
Deppe, G1
Díaz-Rubio, E4
González-Larriba, JL1
Martín, M2
Valerdi, JJ1
Barriga, JJ1
O'Neill, WM1
Schuler, L1
Naji, P1
Midgaard, T1
Plezia, P1
Alberts, D1
Aapro, M1
Sartiano, G1
Dorn, M1
Brady, M1
Comerski, C1
Schwartz, SE1
Fairchild, C1
Papaioannou, D1
Beldecos, D1
Kakoliris, S1
Komitsopoulou, P1
Karagiaouris, P1
Sarmas, J1
Tzannou, I1
Przepiorka, D1
Katlubeck, A1
Taylor, D1
Aglietti, L1
Landauer, MR1
Federico, M1
Sabbatini, R1
Piccinini, P1
Zironi, S1
Piccinini, L1
Silingardi, V1
Hatae, M1
Nakamura, Y1
Mitsuo, M1
Sakurai, K1
Asano, H1
Onishi, Y1
Hokanishi, H1
Kikuchi, K1
Tsuyuki, A1
Fujishiro, Y1
Utsumi, T1
Fujisaki, M1
Kurihara, E1
Uematsu, M1
Broadman, LM1
Ceruzzi, W1
Patane, PS1
Hannallah, RS1
Ruttimann, U1
Friendly, D1
Gallardo, J1
Fodor, M1
Nardi, M2
Marolla, P2
Terzoli, E1
Giannarelli, D2
Dundee, JW4
Ghaly, RG1
Bill, KM1
Chestnutt, WN1
Fitzpatrick, KT1
Lynas, AG1
Wilder-Smith, C1
Cirrincione, C1
Groshen, S3
Gez, E4
Ben-Yosef, R2
Catane, R2
Brufman, G2
Biran, S4
Marshall, G1
Kerr, S1
Vowels, M1
O'Gorman-Hughes, D1
White, L1
Culine, S1
Pietri, F1
Ghosn, M1
Ben Amor, B1
Lupera, H1
Theodore, C1
Renaux, J1
Chestnut, DH2
Owen, CL2
Geiger, M1
Bates, JN2
Choi, WW2
Ostman, PL1
O'Brien, ME1
Woodroffe, C1
Kelly, K1
Burman, C1
Palmer, K1
Stuart, NS1
Blackledge, GR1
Sharpe, J1
Donati, D3
Malacarne, P1
Monici, L1
Di Costanzo, F1
Sulkes, A1
Ochayon, L1
Gera, C1
Nathan, S1
Cass, Y1
Rubello, E1
Kagami, Y1
Nishio, M1
Narimatsu, N1
Tomita, M1
Sakurai, T1
Buzzi, F1
Calabresi, F3
Ballmer, PE1
Reinhart, WH1
Berényi, E1
Kiss, E1
Skåre, NG1
Underskog, I1
Hatae, Y1
Takeda, T1
Nakadate, H1
Hatayama, Y1
Kishino, T1
Ogawa, Y1
Kohl, RL1
Sato, T1
Igarashi, N1
Minami, S1
Okabe, T1
Hashimoto, H1
Hasui, M1
Kato, E1
Bradley, CJ1
Forrest, GJ2
Hutcheon, AW2
Adams, L1
Sneddon, M1
Harding, M1
Kerr, DJ2
Kaye, SB3
Guyon, F1
Delfour, C1
Lebeau, B1
Dodds, LJ1
Leathem, AM1
Howden, CW1
Gordon, CJ1
Pazdur, R1
Ziccarelli, A1
Cummings, G1
Al-Sarraf, M1
Saijo, N4
Sasaki, Y4
Fujiwara, Y1
Mae, M1
Fukuda, M1
Sasaki, S1
Madej, TH2
Simpson, KH2
Huo, ML1
Wang, YS1
Wang, P1
Xiang, YS1
Wang, JG1
Wright, RN1
Nicolosi, WD1
Crenshaw, RR1
Murakami, M1
Ota, K1
Umehara, H2
Sawamura, N3
Kusano, H1
Yokoyama, S4
Suemasu, K3
Parikh, PM1
Koppikar, SB1
Giri, N1
Nadkarni, P1
Minotti, V3
Vollmer-Larsen, B1
Sonne, N1
Richtsmeier, WJ1
Mazur, EM1
Domeney, AM2
Gunning, SJ1
Kelly, ME1
Nohria, V1
Owera-Atepo, JB1
Simpson, KM1
Tan, CC1
Tattersall, D1
Parashos, PJ2
Dugan, WM2
Fry, MW2
Nivelon-Chevallier, A1
Chen, JT1
Hirai, Y1
Yagi, H1
Katase, K1
Shimizu, Y1
Nakayama, K1
Teshima, H1
Hamada, T1
Fujimoto, I1
Yamuchi, K1
Blumenberg, D1
Sridhar, KS1
Donnelly, E1
al-Idrissi, HY2
Ibrahim, EM2
Abdullah, KA1
Ababtain, WA1
Boukhary, HA1
Macaulay, HM1
Dana, BW1
McDermott, M1
Everts, E1
Abdulhay, G1
Edge, SB1
Funkhouser, WK1
Berman, A1
Seipp, C1
Tanner, A1
Wesley, R1
Rosenberg, SA1
Chang, AE1
Palmer, MC1
Colls, BM1
Fujii, M2
Kiura, K2
Kamei, H1
Okabe, K2
Toki, H2
Aasebø, U2
Slørdal, L1
Prytz, PS1
Aarbakke, J1
Nino, S1
Inoue, I1
Sakurai, M2
Miner, WD1
Sanger, GJ1
Turner, DH1
Scott, K1
Ackland, S1
Yuen, K1
Morton, C1
Hillcoat, BL1
Shiu, W1
Tsang, V1
Lam, YM1
Zacharia, A1
Martin, WM1
O'Mara, V1
Simpson, JM1
Hawthorn, J1
Ostler, KJ1
Michaud, M1
Partington, J1
Brenneis, C1
Paterson, AH1
MacDonald, RN1
Kobayashi, H1
Onsrud, M1
Moxnes, A1
Sollien, A1
Grande, T1
Solesvik, O1
Miller, CD1
Anderson, WG1
Cheyne, AJ1
Rosenblatt, E1
Lev, LM1
Robinson, E1
Ehler, E1
Akerley, WL2
Bindi, M1
Pepi, F1
Sebaste, L1
Tucci, E1
Pirtoli, L1
Agostinucci, WA2
Gannon, RH2
Golub, GR1
Martin, RS2
Schauer, PK3
Dinonno, EB1
Hayashi, Y1
Iwasaka, T1
Hachisuga, T1
Fukuda, K1
Tanaka, T1
Matsuo, N1
Sugimori, H1
Mathia, WJ1
Bell, SK1
Leak, WD1
Dozono, H2
Yasuda, M1
Ochiai, K1
Tsuruoka, M1
Morimoto, O1
Sasaki, H1
Arihiro, T1
Terashima, Y1
Joss, R1
Rohrbach, D1
Pirovino, M2
Bischoff, A1
Kiser, J1
Brunner, K1
Goldsmith, TL1
Norton, JA1
Young, AB1
Tibbs, PA1
Dempsey, RJ1
Rapp, RP1
Anthony, LB1
Krozely, MG1
Woodward, NJ1
Hainsworth, JD1
Hande, KR1
Brenner, DE1
Greco, FA1
Burish, TG1
Weigand, W1
Saller, R6
Hellenbrecht, D6
Bühring, M1
Hess, H3
Desmond, PV1
Watson, KJ1
Joss, RA1
Galeazzi, RL1
Bischoff, AK1
Ryssel, HJ1
Brunner, KW1
Ibrahim, A1
Absood, G1
Al-Dossary, E1
Al-Jammaa, A1
Al-Ethan, S1
Eliopoulos, A1
Richards, PD1
Flaum, MA1
Bateman, M1
Kardinal, CG1
Rhinehart, SN1
Triplett, WC1
Minnick, DJ1
Tamai, M1
Veenhof, CH1
Janssens, LA1
Erlichman, C1
Willan, AR1
Pater, JL1
Bella, M1
Passalacqua, R2
Morsia, D2
DiCostanzo, F2
Tognoni, G1
De Nigris, A1
Craig, JB1
Powell, BL1
White, DR1
Capizzi, RL1
Gumbart, CH1
Sorensen, SH1
Bickers, JN1
Vandewalker, GE1
Ribas-Mundó, M1
Fernández-Marcial, C1
Van den Berg, AA2
Lambourne, A2
Yazji, NS1
Laghari, NA1
Bécouarn, Y1
Nguyen, BB1
David, M1
Lakdja, F1
Brunet, R1
Chauvergne, J1
Spiess, JL1
Adelstein, DJ1
Hines, JD1
Warner-Efraty, E1
Ben-Baruch, N1
Yitzhaki, N1
Uziely, B1
Sabates, R1
Drew, SJ1
Friedman, LS1
Weinrauch, LA1
D'Elia, JA1
Saab, GA1
Ibrahim, N1
Azouri, N1
Presant, CA1
Wiseman, C1
Gala, K1
Kennedy, P1
Bouzaglou, A1
Blayney, D1
Schindler, J1
Rigas, M1
Melville, J1
Dolan, J1
Alba, E1
Bastus, R1
Castro, I1
Ojeda, B1
de Andrés, L1
Bernstein, L1
Cohen, JL2
Alphin, RS2
Proakis, AG1
Leonard, CA1
Smith, WL2
Dannenburg, WN1
Kinnier, WJ1
Johnson, DN1
Sancilio, LF2
Ward, JW1
Jackson, CB1
Niijima, T1
Isurugi, K1
Akaza, H1
Kondo, Y1
Kawabe, K1
Fujita, K1
Koiso, K1
Yokoyama, M1
Kinoshita, K1
Aso, Y1
Martín Jiménez, M2
González Larriba, JL1
Sangro, B1
Ruggeri, EM1
Caporali, C1
Sirota, RA1
Kimmel, PL1
Trichtinger, MD1
Diamond, BF1
Stein, HD1
Yudis, M1
Kauste, A1
Tuominen, M1
Heikkinen, H1
Gordin, A1
Korttila, K1
Havsteen, H1
Nielsen, H1
Kjaer, M1
MacPherson, JS1
Bernstein, G1
Rifkin, H1
Kodama, N1
Furuse, K1
Kawahara, M1
Arai, R1
Tsuruta, S1
Hayashi, S1
Kiyota, T1
Krailo, MD1
Johnson, KB1
Baker, CR1
Cariffe, PA1
Monrás, P1
Fernández, C1
Serichol, M1
Clotet, M1
Ribas Mundó, M1
Ito, J1
Abo, T1
Okamoto, Y1
Yamashita, T1
Takahashi, K1
Jordan, NS1
Schauer, A1
Nightingale, C1
Golub, G1
Williams, HM1
Funaki, Y1
Fujita, J3
Futami, H2
Yoshioka, S1
Waldmann, CS1
Verghese, C1
Short, SM1
Goldhill, DR1
Evans, SJ1
Krebs, HB1
Myers, MB1
Wheelock, JB1
Goplerud, DR1
Funaki, U1
Shimizu, E1
Pruitt, BT1
Justice, RL1
Periman, P1
Joseph, C1
Kearsley, JH1
Tattersall, MH1
Swierz, J1
Szutkowski, Z1
Nowakowski, W1
Canaletti, R1
Colombo, N1
Gilchrist, NL1
Hepplestone, A1
Calder, IT1
McArdle, CS1
Vella, L1
Francis, D1
Houlton, P1
Reynolds, F1
Bayliss, EJ1
Braun, J1
Howrie, DL1
Felix, C1
Wollman, M1
Juhl, RP1
Blatt, J1
Ohmi, K1
Walters, JK1
Frontenas, P1
Saad Zoi, R1
Daste, J1
Briemann, L1
Hellstern, A2
Mitrou, P1
Hodgson, M1
Achtert, G1
Brockmann, P2
Hausleiter, HJ1
Myhr, K1
Markman, M1
Newman, DR1
Hawkins, RS1
Pfau, L1
Luesley, DM1
Terry, PB1
Chan, KK1
Benrubi, GI1
Norvell, M1
Nuss, RC1
Robinson, H1
Roemeling, RV1
Christiansen, NP1
Hrushesky, WJ1
Amano, H1
Yasuda, Y1
Tsunekawa, H1
Fujimoto, K1
Yoshii, S1
McCallum, RW1
Graham, J1
Blackie, RG1
McGovern, E1
Kelman, AW1
Candido, A1
Rossi, P1
Tartaglione, R1
Alfano, G1
Menichella, G1
Mango, G1
Zambetti, M1
Bajetta, E1
Bidoli, P1
Verusio, C1
Paul, AK1
Masterton, G1
Schofield, CB1
Tait, IB1
Palmer, HM1
Beardwell, CG1
Howard, PJ1
Assaf, RA1
Samuel, IO1
Johnson, AG1
McMurray, GN1
Howard, FA1
Sharp, DS1
McGarry, J1
Robinson, OP1
Middleton, RS1
Bloch, A1

Clinical Trials (27)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
MEtoclopramide, DExamethasone or Axoli (Palonoseton) for the Prevention of Delayed Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy: the MEDEA-trial[NCT02135510]Phase 3249 participants (Actual)Interventional2013-06-30Completed
Prevalence and Burden of Nausea and Vomiting in Pregnant Women in Switzerland: Survey Purity 2022[NCT06055192]200 participants (Anticipated)Observational2023-09-30Not yet recruiting
Enhanced Recovery at Cesarean Birth to Improve Postoperative Outcomes and Reduce Postoperative Length of Stay[NCT02956616]Phase 2118 participants (Actual)Interventional2017-09-01Completed
The Effect of Adding Metoclopramide and Ondansetron to a Prophylactic Phenylephrine Infusion for the Management of Nausea and Vomiting Associated With Spinal Anesthesia for Cesarean Section[NCT01216410]306 participants (Actual)Interventional2008-12-31Completed
Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Acute Migraine Attack in the Emergency Department: a Randomized Double-blind Controlled Trial[NCT04252521]150 participants (Actual)Interventional2019-07-03Completed
Nasally Inhaled Isopropyl Alcohol Versus Oral Ondansetron for the Treatment of Nausea in the Emergency Department: A Double-Blind Randomized Controlled Trial[NCT02760069]Phase 4122 participants (Actual)Interventional2016-01-31Completed
Phase II Trial Testing the Antiemetic Efficacy of a Single-day Low Dose Aprepitant (or Fosaprepitant) Added to a 5-HT3 Receptor Antagonist Plus Dexamethasone in Patients Receiving Carboplatin[NCT03237611]Phase 215 participants (Actual)Interventional2018-10-30Terminated (stopped due to Expired IRB approval on 2/11/21)
Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis: a Double-blind Randomized Trial[NCT00869310]Phase 3303 participants (Actual)Interventional2009-09-30Terminated (stopped due to we terminated the study before enrolling 303/560 due to a slow accrual)
Isopropyl Alcohol Inhalation as Anti-emetic Therapy in the Emergency Department[NCT04464915]0 participants (Actual)Interventional2020-07-31Withdrawn (stopped due to Given the COVID-19 pandemic, there has been a temporary suspension of study activities, therefore the study has not yet been initiated.)
Effect of Ketamine Versus Sevoflurane On The Right Ventricular Pressure During Congenital Pulmonary Stenosis Balloon Dilatation[NCT05582213]40 participants (Actual)Interventional2022-10-01Completed
Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)[NCT03125811]Early Phase 1121 participants (Actual)Interventional2017-07-17Completed
Phase III Prospective Randomized Trial Comparing Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting in the Treatment of Gastrointestinal Cancer[NCT00971399]Phase 3172 participants (Anticipated)Interventional2009-09-30Completed
Acute Mountain Sickness Treatment: A Double-blind Comparison of Metoclopramide vs. Ibuprofen[NCT01522326]300 participants (Anticipated)Interventional2012-03-01Completed
Do Peri-operative High Doses of Intravenous Glucocorticoids Improve Short-term Functional Outcome After Direct Anterior Total Hip Arthroplasty? A Randomized, Single Surgeon, Placebo Controlled, Double Blind Study[NCT04317872]70 participants (Anticipated)Interventional2020-07-01Recruiting
Ondansetron Vs Metoclopramide in the Treatment of Vomiting in Gastroenteritis Patients: A Randomized Controlled Trial[NCT01165866]Phase 4170 participants (Actual)Interventional2008-06-30Completed
Comparison of Gastric Volumes by Gastric Ultrasound in Term Parturients Undergoing Scheduled Elective Cesarean Delivery With and Without Metoclopramide[NCT05033041]Phase 472 participants (Anticipated)Interventional2021-10-20Recruiting
Randomized Single-Blind Study of Nometex as an Adjunct to Standard Anti-emetics in Ovarian and Advanced Endometrial and Cervical Cancer Patients Who Receive Moderately to Highly Emetogenic Chemotherapy[NCT01980160]0 participants (Actual)Interventional2013-11-30Withdrawn (stopped due to Did not receive IRB approval from our institution therefore the study was closed.)
Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.[NCT03606369]Phase 2/Phase 3560 participants (Anticipated)Interventional2015-11-05Recruiting
Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer[NCT04669132]Phase 250 participants (Actual)Interventional2020-12-17Completed
A Randomized, Double-Blind Trial to Compare the Clinical Efficacy and Safety of Granisetron vs. Metoclopramide Combined to Dexamethasone in the Prophylaxis of Chemotherapy-Induced Delayed Emesis[NCT00003213]Phase 3267 participants (Actual)Interventional1996-05-31Completed
The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis[NCT04169828]176 participants (Anticipated)Interventional2019-08-02Recruiting
Optimizing Anesthesia Antiemetic Measures Versus Combination With Dexamethasone or Ondansetron in the Prevention of Postoperative Nausea and Vomiting.[NCT00825071]Phase 4180 participants (Actual)Interventional2007-11-30Completed
A Randomized Controlled Trial of Cesamet(R) (Nabilone) for the Prevention of Postoperative Nausea and Vomiting in Elective Surgery[NCT02115529]Phase 2331 participants (Actual)Interventional2014-04-30Completed
Is Intra-operative Acupuncture Point P6 Stimulation as Effective as Traditional Pharmacotherapy in Reducing Nausea and Vomiting During Cesarean Section With Regional Anesthesia?[NCT02959840]Phase 4180 participants (Actual)Interventional2015-07-31Completed
A Phase III, Randomized, Open-label, Active-controlled, Two-arm, Parallel-design, Interventional Clinical Trial Evaluating the Efficacy and Safety of Ondansetron 8 mg IV/ IM Injection Compared to Metoclopramide 10 mg in the Management of Nausea and Vomiti[NCT05876585]Phase 3126 participants (Anticipated)Interventional2023-06-30Not yet recruiting
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence[NCT01549652]133 participants (Actual)Interventional2011-04-30Completed
Aromatherapy for Management of Chemotherapy-induced Symptoms[NCT02670941]Early Phase 131 participants (Actual)Interventional2016-01-31Terminated (stopped due to Slow accrual; Received grant funding for a similar but different study.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Discharge on Postoperative Day #2

Number of patients discharged on postoperative Day #2 (NCT02956616)
Timeframe: Until patient's day of hospital discharge or a maximum of one month from cesarean delivery

InterventionParticipants (Count of Participants)
Enhanced Recovery5
Routine Perioperative Care2

Postoperative Length of Hospital Stay

Postoperative Length of Hospital Stay in Hours from time of surgery (NCT02956616)
Timeframe: Until patient's day of hospital discharge or a maximum of one month from cesarean delivery

InterventionHours (Median)
Enhanced Recovery73.58
Routine Perioperative Care75.50

Postoperative Pain Medication Requirement

The amount of postoperative pain medication required for each patient in Morphine Milligram Equivalents (NCT02956616)
Timeframe: Until patient's day of hospital discharge or a maximum of one month from cesarean delivery

InterventionMorphine Milligram Equivalents (Mean)
Enhanced Recovery117.16
Routine Perioperative Care119.38

Breastfeeding Initiation

All patients will be queried regarding whether breastfeeding was initiated after cesarean birth and how soon after birth (NCT02956616)
Timeframe: Until patient's day of hospital discharge or a maximum of one month from cesarean delivery

,
InterventionParticipants (Count of Participants)
BreastfeedingBottlefeedingBoth Breastfeeding and Bottlefeeding
Enhanced Recovery39415
Routine Perioperative Care29229

Intraoperative Nausea and Vomiting

Comparison of intraoperative nausea and vomiting between the 3 groups. (NCT01216410)
Timeframe: Intraoperatively

Interventionparticipants (Number)
Combination Group23
Metoclopramide31
Phenylephrine Infusion49

Maternal Hemodynamics

The number of patients with systolic blood pressure decrease to less than 20 % of baseline intraoperatively (NCT01216410)
Timeframe: Intraoperatively

Interventionparticipants with SBP< 20 % baseline (Number)
Combination Group16
Metoclopramide19
Phenylephrine Infusion16

Pruritus

(NCT01216410)
Timeframe: 0-24 hrs

Interventionparticipants (Number)
Combination Group95
Metoclopramide93
Phenylephrine Infusion97

Satisfaction

1=very satisfied, 2=somewhat satisfied, 3= neither satisfied nor dissatisfied, 4=somewhat dissatisfied, 5= very dissatisfied. Number of very satisfied subjects posted. (NCT01216410)
Timeframe: 24 h

Interventionparticipants (Number)
Combination Group94
Metoclopramide85
Phenylephrine Infusion87

Postoperative Nausea and Vomiting (PONV)

(NCT01216410)
Timeframe: 0-2h, 2-6h, 6-24h

,,
Interventionparticipants (Number)
0-2 hrs PONV2-6 hrs PONV6-24 hrs PONV
Combination Group202822
Metoclopramide333526
Phenylephrine Infusion394122

Nausea 100 mm Visual Analogue Scale (VAS)

Full Scale Name: Nausea 100-mm visual analogue scale. Scale Construct: Measures nausea as reported by the patient Scale Range: Minimum is 0 (no nausea) to 100 (worst nausea imaginable). These values quantify, on an interval scale anchored at 0, the patient's subjective sensation of nausea. Higher values represent worse outcomes (e.g., more nausea). Patient makes a single vertical mark on a 100 mm horizontal line with 0 at the left and 100 on the right to depict their nausea. (NCT02760069)
Timeframe: 30 minutes post intervention

Interventionunits on a scale (Mean)
Inhaled ISO + Oral Ondansetron23
Inhaled ISO + Oral Placebo19
Inhaled Placebo + Oral Ondansetron42

Number of Participants Who Required Rescue Anti-emetics

Whether patient required rescue anti-emetics (binary variable). Measured using nurse drug administration record. (NCT02760069)
Timeframe: Study duration (up to 5 hours post intervention)

InterventionParticipants (Count of Participants)
Inhaled ISO + Oral Ondansetron11
Inhaled ISO + Oral Placebo10
Inhaled Placebo + Oral Ondansetron18

Complete Control Rate of Chemotherapy-induced Nausea and Vomiting (CINV) Following 1st Cycle of Chemotherapy

Complete control rate of nausea and vomiting is defined as the percentage of patients without episodes of nausea or emesis, or rescue medication administered, during the overall phase of the first carboplatin-based chemotherapy cycle. Data was collected by administration of the MASCC Antiemesis Tool. The MASCC Antiemesis Tool is an eight-item questionnaire administered to patients to assess the occurrence of vomiting and nausea both during the first 24 hours after chemotherapy as well as the occurrence of delayed nausea and vomiting from the day after to 120 hours after chemotherapy. (NCT03237611)
Timeframe: 24 hours following the first cycle of chemotherapy

InterventionParticipants (Count of Participants)
VomitingNausea
Low Dose Aprepitant or Fosaprepitant1110

Complete Control Rate of Chemotherapy-induced Nausea and Vomiting (CINV) Following 1st Cycle of Chemotherapy

Complete control rate of nausea and vomiting is defined as the percentage of patients without episodes of nausea or emesis, or rescue medication administered, during the overall phase of the first carboplatin-based chemotherapy cycle. Data was collected by administration of the MASCC Antiemesis Tool. The MASCC Antiemesis Tool is an eight-item questionnaire administered to patients to assess the occurrence of vomiting and nausea both during the first 24 hours after chemotherapy as well as the occurrence of delayed nausea and vomiting from the day after to 120 hours after chemotherapy. (NCT03237611)
Timeframe: From 24 to 120 hours following the first cycle of chemotherapy, approximately 5 days

InterventionParticipants (Count of Participants)
VomitingNausea
Low Dose Aprepitant or Fosaprepitant99

Complete Control Rate of Chemotherapy-induced Nausea and Vomiting (CINV) Following 2nd Cycle of Chemotherapy

Complete control rate of nausea and vomiting is defined as the percentage of patients without episodes of nausea or emesis, or rescue medication administered, during overall phase of the second chemotherapy cycle. Data was collected by administration of the MASCC Antiemesis Tool. The MASCC Antiemesis Tool is an eight-item questionnaire administered to patients to assess the occurrence of vomiting and nausea both during the first 24 hours after chemotherapy as well as the occurrence of delayed nausea and vomiting from the day after to 120 hours after chemotherapy. (NCT03237611)
Timeframe: 24 hours following the second cycle of chemotherapy

InterventionParticipants (Count of Participants)
VomitingNausea
Low Dose Aprepitant or Fosaprepitant33

Complete Control Rate of Chemotherapy-induced Nausea and Vomiting (CINV) Following 2nd Cycle of Chemotherapy

Complete control rate of nausea and vomiting is defined as the percentage of patients without episodes of nausea or emesis, or rescue medication administered, during overall phase of the second chemotherapy cycle. Data was collected by administration of the MASCC Antiemesis Tool. The MASCC Antiemesis Tool is an eight-item questionnaire administered to patients to assess the occurrence of vomiting and nausea both during the first 24 hours after chemotherapy as well as the occurrence of delayed nausea and vomiting from the day after to 120 hours after chemotherapy. (NCT03237611)
Timeframe: From 24 to 120 hours following the second cycle of chemotherapy, approximately 5 days

InterventionParticipants (Count of Participants)
VomitingNausea
Low Dose Aprepitant or Fosaprepitant33

Nausea

The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea at any point during the surgical procedure in each group. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control44
Metoclopramide, Ondansetron14
Acupressure Point P6 Stimulator22

Nausea During Stage I (After the Administration of CSE and Until Eversion of the Uterus)

Patients offer their subjective assessments of the level of nausea on a scale of 0-10 (0 = no nausea, 10 = worst nausea ever experienced) during stage I. The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea in each group at this point. Patients that report nausea (1 or more on our scale) will be recorded as that they have experienced nausea. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control33
Metoclopramide, Ondansetron7
Acupressure Point P6 Stimulator14

Nausea During Stage II (After Eversion of the Uterus and Until Replacement of the Uterus)

Patients offer their subjective assessments of the level of nausea on a scale of 0-10 (0 = no nausea, 10 = worst nausea ever experienced) during stage II. The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea in each group at this point. Patients that report nausea (1 or more on our scale) will be recorded as that they have experienced nausea. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control12
Metoclopramide, Ondansetron6
Acupressure Point P6 Stimulator5

Nausea During Stage III (After Replacement of the Uterus and to the Next 15 Minutes)

Patients offer their subjective assessments of the level of nausea on a scale of 0-10 (0 = no nausea, 10 = worst nausea ever experienced) during stage III. The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea in each group at this point. Patients that report nausea (1 or more on our scale) will be recorded as that they have experienced nausea. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control16
Metoclopramide, Ondansetron8
Acupressure Point P6 Stimulator14

Nausea During Stage IV (the Rest of the Time Until Arrival at PACU)

Patients offer their subjective assessments of the level of nausea on a scale of 0-10 (0 = no nausea, 10 = worst nausea ever experienced) during stage IV. The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea in each group at this point. Patients that report nausea (1 or more on our scale) will be recorded as that they have experienced nausea. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control3
Metoclopramide, Ondansetron4
Acupressure Point P6 Stimulator0

Overall Anesthetic Care Satisfaction

Patients are asked their overall anesthetic care satisfaction (0 = Not Satisfied, 10 = Extremely Satisfied). Data are expressed as number of parturients who gave a score of 8 or higher. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control53
Metoclopramide, Ondansetron58
Acupressure Point P6 Stimulator56

Satisfaction of Anti-emetic Treatment

Patients are asked their anti-emetic treatment satisfaction (0 = Not Satisfied, 10 = Extremely Satisfied). Data are expressed as number of parturients who gave a score of 8 or higher. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control49
Metoclopramide, Ondansetron58
Acupressure Point P6 Stimulator55

Vomiting

The investigators will perform objective assessments of whether or not the patients have vomited during the procedure. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control27
Metoclopramide, Ondansetron10
Acupressure Point P6 Stimulator8

Vomiting During Stage I (After the Administration of CSE and Until Eversion of the Uterus)

The investigators will perform objective assessments of whether or not the patients have vomited during stage I. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control20
Metoclopramide, Ondansetron5
Acupressure Point P6 Stimulator4

Vomiting During Stage II (After Eversion of the Uterus and Until Replacement of the Uterus)

The investigators will perform objective assessments of whether or not the patients have vomited during stage II. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control10
Metoclopramide, Ondansetron1
Acupressure Point P6 Stimulator3

Vomiting During Stage III (After Replacement of the Uterus and to the Next 15 Minutes)

The investigators will perform objective assessments of whether or not the patients have vomited during stage III. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control9
Metoclopramide, Ondansetron4
Acupressure Point P6 Stimulator6

Vomiting During Stage IV (the Rest of the Time Until Arrival at PACU)

The investigators will perform objective assessments of whether or not the patients have vomited during stage IV. The investigators will then analyze if there is a statistically significant difference between the number of patients that vomit in each group. (NCT02959840)
Timeframe: During the surgical procedure

InterventionParticipants (Count of Participants)
Control0
Metoclopramide, Ondansetron2
Acupressure Point P6 Stimulator0

Beck Depression Inventory Score (BDIS) Change From Baseline (Prevention of Opioid Withdrawal)

The Beck Depression Inventory (a 21-item self-report multiple-choice inventory) yields a single summed score between 0 and 63; higher scores indicate more severe depression. Change is from baseline score (taken at the beginning of the first study visit, prior to beginning of titration into morphine) to the score taken after taking morphine for 30 days (score taken prior to receiving ondansetron or placebo, at the beginning of second study visit). (NCT01549652)
Timeframe: 2 study days 1 month apart (at the start of each study visit)

Interventionunits on a scale (Mean)
Prevention of Opioid Withdrawal-0.44

Change in Pain Visual Analog Scale (VAS) From Baseline (Prevention of Opioid Withdrawal)

The VAS is a 0 to 100 millimeter scale where 0 corresponds to no pain and 100 to extreme pain, used by participants to indicated their level of pain over the last two weeks. Change is from baseline score for average level of pain (taken at the beginning of the first study visit, prior to beginning of titration into morphine) to the score taken after taking morphine for 30 days (score taken prior to receiving ondansetron or placebo, at the beginning of second study visit). (NCT01549652)
Timeframe: 2 study days 1 month apart (at the start of each study visit)

Interventionunits on a scale (Mean)
Prevention of Opioid Withdrawal-2.68

Change in Roland-Morris Disability Index (RMDI) From Baseline (Prevention of Opioid Withdrawal)

The Roland-Morris Disability Index is a 24-question instrument used to assess level of disability from lower back pain. Scores range from 0-24 with lower scores corresponding to fewer symptoms. Change is from baseline score (taken at the beginning of the first study visit, prior to beginning of titration into morphine) to the score taken after taking morphine for 30 days (score taken prior to receiving ondansetron or placebo, at the beginning of second study visit). (NCT01549652)
Timeframe: 2 study days 1 month apart (at the start of each study visit)

Interventionunits on a scale (Mean)
Prevention of Opioid Withdrawal-2.59

Beck Depression Inventory Score (BDIS) Change From Baseline (Prevention of Physical Dependence)

The Beck Depression Inventory (a 21-item self-report multiple-choice inventory) yields a single summed score between 0 and 63; higher scores indicate more severe depression. Change is from baseline score (taken at the beginning of the first study visit, prior to beginning of titration into morphine) to the score taken after taking morphine for 30 days (score taken at the beginning of second study visit). (NCT01549652)
Timeframe: 2 study days 1 month apart (at the start of each study visit)

Interventionunits on a scale (Mean)
Change in BDIS (Ondansetron)Change in BDIS (Placebo)
Prevention of Physical Dependence-0.60.2

Change in Objective Opioid Withdrawal Score (OOWS) From Baseline (Prevention of Opioid Withdrawal)

"Originally developed by Handelsman, the Objective Opioid Withdrawal Scale (OOWS) score is a well-characterized measure of opioid withdrawal in humans, calculated as the sum of a 13-item physician assessment documenting physically observable signs of withdrawal, which are rated as present (1) or absent (0) during the observation period. The minimum score of 0 means the patient is not showing any signs of opioid withdrawal. The maximum score of 13 signifies all signs of opioid withdrawal to the largest extent possible.~Immediately prior to ondansetron or placebo administration a baseline OOWS score was taken. 30 minutes later participants received naloxone, then 15 minutes later an OOWS score was taken. If deemed necessary by the clinician, participants may have received a second naloxone dose (25 minutes following 1st naloxone dose), then 15 minutes later an OOWS score was taken. Change from the baseline OOWS score to the score assessed following the last naloxone dose is reported." (NCT01549652)
Timeframe: Baseline; 15 minutes following last naloxone dose

Interventionunits on a scale (Mean)
Change in OOWS (Ondansetron)Change in OOWS (Placebo)
Prevention of Opioid Withdrawal3.63.6

Change in Objective Opioid Withdrawal Score From Baseline (Prevention of Physical Dependence)

"Originally developed by Handelsman, the OOWS score is a well-characterized measure of opioid withdrawal in humans, calculated as the sum of a 13-item physician assessment documenting physically observable signs of withdrawal, which are rated as present (1) or absent (0) during the observation period. The maximum score is 13 and suggests the patient is showing all signs of opioid withdrawal to the largest extent possible. The minimum score of 0 suggests the patient is not showing any signs of opioid withdrawal.~Immediately prior to ondansetron or placebo administration a baseline OOWS score was taken. 30 minutes later participants received naloxone, then 15 minutes later an OOWS score was taken. If necessary (as deemed by the clinician), participants may have received a second naloxone dose (25 minutes following 1st naloxone dose), then 15 minutes later an OOWS score was taken. Change from the baseline OOWS score to the score assessed following the last naloxone dose is reported." (NCT01549652)
Timeframe: Baseline; 15 minutes following last naloxone dose

Interventionunits on a scale (Mean)
Change in OOWS (Ondansetron)Change in OOWS (Placebo)
Prevention of Physical Dependence4.54.2

Change in Pain Visual Analog Scale (VAS) From Baseline (Prevention of Physical Dependence)

The VAS is a 0 to 100 millimeter scale where 0 corresponds to no pain and 100 to extreme pain, used by participants to indicated their level of pain over the last two weeks. Change is from baseline score for average level of pain (taken at the beginning of the first study visit, prior to beginning of titration into morphine) to the score taken after taking morphine for 30 days (score taken at the beginning of second study visit). (NCT01549652)
Timeframe: 2 study days 1 month apart (at the start of each study visit)

Interventionunits on a scale (Mean)
Change in VAS Score (Ondansetron)Change in VAS Score (Placebo)
Prevention of Physical Dependence-2.9-2.8

Change in Roland-Morris Disability (RMDI) Index From Baseline (Prevention of Physical Dependence)

The Roland-Morris Disability Index is a 24-question instrument used to assess level of disability from lower back pain. Scores range from 0-24 with lower scores corresponding to fewer symptoms. Change is from baseline score (taken at the beginning of the first study visit, prior to beginning of titration into morphine) to the score taken after taking morphine for 30 days (score taken at the beginning of second study visit). (NCT01549652)
Timeframe: 2 study days 1 month apart (at the start of each study visit)

Interventionunits on a scale (Mean)
Change in RMDI (Ondansetron)Change in RMDI (Placebo)
Prevention of Physical Dependence-4.6-2.0

Change in Subjective Opioid Withdrawal Score (SOWS) From Baseline (Prevention of Opioid Withdrawal)

The Subjective Opioid Withdrawal Score (SOWS) score is calculated as the sum of 16 subjective patient-reported symptom scores rated on a scale of 0 to 4 (0=not at all, 4=extremely) based on what subjects were experiencing at the time of testing. A maximum score of 64 would suggest the patient is experiencing the symptoms of withdrawal to the maximum extent possible while the lowest score of 0 would suggest the patient is not experiencing any of the symptoms of withdrawal. Immediately prior to ondansetron or placebo administration a baseline SOWS score was taken. 30 minutes later participants received naloxone, then 15 minutes later an SOWS score was taken. If necessary (as deemed by the clinician), participants may have received a second naloxone dose (25 minutes following 1st naloxone dose), then 15 minutes later an SOWS score was taken. Change from the baseline SOWS score to the score assessed following the last naloxone dose is reported (NCT01549652)
Timeframe: Baseline; 15 minutes following last naloxone dose

Interventionunits on a scale (Mean)
Change in SOWS (Ondansetron)Change in SOWS (Placebo)
Prevention of Opioid Withdrawal12.512.2

Change in Subjective Opioid Withdrawal Score From Baseline (Prevention of Physical Dependence)

The SOWS score is composed of 16 subjective symptoms rated on a scale of 0 to 4 (0=not at all, 4=extremely) based on what subjects were experiencing at the time of testing. A maximum score of 64 would suggest the patient is experiencing the symptoms of withdrawal to the maximum extent possible while the lowest score of 0 would suggest the patient is not experiencing any of the symptoms of withdrawal. Immediately prior to ondansetron or placebo administration a baseline SOWS score was taken. 30 minutes later participants received naloxone, then 15 minutes later an SOWS score was taken. If necessary (as deemed by the clinician), participants may have received a second naloxone dose (25 minutes following 1st naloxone dose), then 15 minutes later an SOWS score was taken. Change from the baseline SOWS score to the score assessed following the last naloxone dose is reported (NCT01549652)
Timeframe: Baseline; 15 minutes following last naloxone dose

Interventionunits on a scale (Mean)
Change in SOWS (Ondansetron)Change in SOWS (Placebo)
Prevention of Physical Dependence16.412.0

Profile of Mood States (POMS) Change in Score From Baseline (Prevention of Opioid Withdrawal)

Profile of Mood States (POMS) is a 65-question survey of how participants have been feeling over the past week, assessing tension, depression, anger, fatigue, confusion and vigor. Each question is on a 5-point scale: 0 (not at all) to 4 (extremely). Overall score range: 0 to 200 (lower scores corresponding to fewer symptoms), calculated by adding total scores for tension, depression, anger, fatigue and confusing, and subtracting that total score from the total score for vigor. Immediately prior to ondansetron or placebo administration a baseline POMS score was taken. 30 minutes later participants received naloxone, then 15 minutes later a POMS score was taken. If necessary (as deemed by the clinician), participants may have received a second naloxone dose (25 minutes following 1st naloxone dose), then 15 minutes later an POMS score was taken. Change from the baseline POMS score to the score assessed following the last naloxone dose is reported. (NCT01549652)
Timeframe: Baseline; 15 minutes following last naloxone dose

Interventionunits on a scale (Mean)
Change in POMS Score (Ondansetron)Change in POMS Score (Placebo)
Prevention of Opioid Withdrawal29.328.3

Profile of Mood States (POMS) Change in Score From Baseline (Prevention of Physical Dependence)

(Profile of Mood States) POMS is a 65-question survey of how participants have been feeling over the past week, assessing tension, depression, anger, fatigue, confusion and vigor. Each question is on a 5-point scale: 0 (not at all) to 4 (extremely). Overall score range: 0 to 200 (lower scores corresponding to fewer symptoms), calculated by adding total scores for tension, depression, anger, fatigue and confusing, and subtracting that total score from the total score for vigor. Immediately prior to ondansetron or placebo administration a baseline POMS score was taken. 30 minutes later participants received naloxone, then 15 minutes later a POMS score was taken. If necessary (as deemed by the clinician), participants may have received a second naloxone dose (25 minutes following 1st naloxone dose), then 15 minutes later an POMS score was taken. Change from the baseline POMS score to the score assessed following the last naloxone dose is reported. (NCT01549652)
Timeframe: Baseline; 15 minutes following last naloxone dose

Interventionunits on a scale (Mean)
Change in POMS (Ondansetron)Change in POMS (Placebo)
Prevention of Physical Dependence36.129.2

Reviews

91 reviews available for metoclopramide and Emesis

ArticleYear
Use of metoclopramide in the first trimester and risk of major congenital malformations: A systematic review and meta-analysis.
    PloS one, 2021, Volume: 16, Issue:9

    Topics: Antiemetics; Congenital Abnormalities; Female; Humans; Metoclopramide; Nausea; Odds Ratio; Pregnancy

2021
Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting.
    The Cochrane database of systematic reviews, 2022, 05-19, Volume: 5

    Topics: Adult; Analgesics, Opioid; Antiemetics; Female; Humans; Male; Metoclopramide; Nausea; Vomiting

2022
Antiemetics in Children With Acute Gastroenteritis: A Meta-analysis.
    Pediatrics, 2020, Volume: 145, Issue:4

    Topics: Acute Disease; Antiemetics; Child; Child, Preschool; Dexamethasone; Diarrhea; Dimenhydrinate; Domper

2020
Should Antiemetics be Given Prophylactically with Intravenous Opioids While Treating Acute Pain in the Emergency Department?: Clinical Practice Paper Approved by American Academy of Emergency Medicine Clinical Guidelines Committee.
    The Journal of emergency medicine, 2020, Volume: 58, Issue:4

    Topics: Acute Pain; Analgesics, Opioid; Antiemetics; Emergency Medicine; Emergency Service, Hospital; Humans

2020
MASCC antiemetics in advanced cancer updated guideline.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021, Volume: 29, Issue:12

    Topics: Antiemetics; Humans; Metoclopramide; Nausea; Neoplasms; Vomiting

2021
Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery).
    The Cochrane database of systematic reviews, 2017, 07-03, Volume: 7

    Topics: Adrenal Cortex Hormones; Adult; Chlorpromazine; Dexamethasone; Humans; Indoles; Metoclopramide; Naus

2017
[Vomiting].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2017, 12-25, Volume: 70, Issue:6

    Topics: Antineoplastic Agents; Feeding Behavior; Gastric Emptying; Gastritis; Gastroparesis; Humans; Metoclo

2017
Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults.
    The Cochrane database of systematic reviews, 2018, 09-21, Volume: 9

    Topics: Adult; Antiemetics; Antineoplastic Agents; Benzodiazepines; Chemoradiotherapy; Dexamethasone; Disord

2018
Aspirin with or without an antiemetic for acute migraine headaches in adults.
    The Cochrane database of systematic reviews, 2013, Apr-30, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Aspirin; Drug Therapy, Combination; Hum

2013
Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
    The Cochrane database of systematic reviews, 2015, Sep-28, Issue:9

    Topics: Adult; Antiemetics; Droperidol; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; N

2015
Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
    The Cochrane database of systematic reviews, 2015, Sep-28, Issue:9

    Topics: Adult; Antiemetics; Droperidol; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; N

2015
Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
    The Cochrane database of systematic reviews, 2015, Sep-28, Issue:9

    Topics: Adult; Antiemetics; Droperidol; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; N

2015
Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
    The Cochrane database of systematic reviews, 2015, Sep-28, Issue:9

    Topics: Adult; Antiemetics; Droperidol; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; N

2015
Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
    The Cochrane database of systematic reviews, 2015, Sep-28, Issue:9

    Topics: Adult; Antiemetics; Droperidol; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; N

2015
Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
    The Cochrane database of systematic reviews, 2015, Sep-28, Issue:9

    Topics: Adult; Antiemetics; Droperidol; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; N

2015
Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
    The Cochrane database of systematic reviews, 2015, Sep-28, Issue:9

    Topics: Adult; Antiemetics; Droperidol; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; N

2015
Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
    The Cochrane database of systematic reviews, 2015, Sep-28, Issue:9

    Topics: Adult; Antiemetics; Droperidol; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; N

2015
Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
    The Cochrane database of systematic reviews, 2015, Sep-28, Issue:9

    Topics: Adult; Antiemetics; Droperidol; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; N

2015
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
    The Cochrane database of systematic reviews, 2015, Nov-12, Issue:11

    Topics: Adult; Antiemetics; Antineoplastic Agents; Cannabinoids; Chlorpromazine; Dizziness; Domperidone; Eup

2015
Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
    BMJ case reports, 2015, Dec-23, Volume: 2015

    Topics: Adult; Antiemetics; Cannabinoids; Cannabis; Disease Management; Dronabinol; Humans; Male; Marijuana

2015
The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials.
    Critical care (London, England), 2016, Aug-15, Volume: 20, Issue:1

    Topics: Chi-Square Distribution; Critical Illness; Diarrhea; Domperidone; Dopamine Antagonists; Enteral Nutr

2016
Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes.
    Clinical journal of oncology nursing, 2009, Volume: 13, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Humans; Metoclopramide; Nausea; Neoplasms; Substance P; Treatmen

2009
[Treatment of tumor therapy-induced nausea and vomiting].
    Magyar onkologia, 2009, Volume: 53, Issue:1

    Topics: Anti-Anxiety Agents; Antiemetics; Antineoplastic Agents; Aprepitant; Drug Therapy, Combination; Huma

2009
Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents.
    The Cochrane database of systematic reviews, 2009, Apr-15, Issue:2

    Topics: Acute Disease; Adolescent; Antiemetics; Child; Child, Preschool; Gastroenteritis; Humans; Metoclopra

2009
[Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].
    Medizinische Klinik (Munich, Germany : 1983), 1998, Volume: 93 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benchmarking; Dexamethasone; Dose-Response Relations

1998
Antiemetic therapy for nausea and vomiting in the emergency department.
    The Journal of emergency medicine, 2010, Volume: 39, Issue:3

    Topics: Antiemetics; Droperidol; Emergency Service, Hospital; Humans; Metoclopramide; Nausea; Ondansetron; P

2010
Antiemetic therapy for nausea and vomiting in the emergency department.
    The Journal of emergency medicine, 2010, Volume: 39, Issue:3

    Topics: Antiemetics; Droperidol; Emergency Service, Hospital; Humans; Metoclopramide; Nausea; Ondansetron; P

2010
Antiemetic therapy for nausea and vomiting in the emergency department.
    The Journal of emergency medicine, 2010, Volume: 39, Issue:3

    Topics: Antiemetics; Droperidol; Emergency Service, Hospital; Humans; Metoclopramide; Nausea; Ondansetron; P

2010
Antiemetic therapy for nausea and vomiting in the emergency department.
    The Journal of emergency medicine, 2010, Volume: 39, Issue:3

    Topics: Antiemetics; Droperidol; Emergency Service, Hospital; Humans; Metoclopramide; Nausea; Ondansetron; P

2010
Acute vomiting in cats: rational treatment selection.
    Journal of feline medicine and surgery, 2010, Volume: 12, Issue:3

    Topics: Acute Disease; Animals; Antiemetics; Cat Diseases; Cats; Chlorpromazine; Diarrhea; Famotidine; Indol

2010
Aspirin with or without an antiemetic for acute migraine headaches in adults.
    The Cochrane database of systematic reviews, 2010, Apr-14, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Aspirin; Drug Therapy, Combination; Hum

2010
Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials.
    International journal of radiation oncology, biology, physics, 2012, Jan-01, Volume: 82, Issue:1

    Topics: Antiemetics; Humans; Metoclopramide; Nausea; Radiotherapy; Randomized Controlled Trials as Topic; Se

2012
Nausea and vomiting in early pregnancy.
    BMJ clinical evidence, 2009, Jun-03, Volume: 2009

    Topics: Acupressure; Administration, Oral; Domperidone; Female; Humans; Metoclopramide; Nausea; Phytotherapy

2009
Review article: Prophylactic metoclopramide for patients receiving intravenous morphine in the emergency setting: a systematic review and meta-analysis of randomized controlled trials.
    Emergency medicine Australasia : EMA, 2011, Volume: 23, Issue:4

    Topics: Acute Disease; Analgesics, Opioid; Antiemetics; Dopamine Agonists; Emergencies; Humans; Injections,

2011
Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents.
    The Cochrane database of systematic reviews, 2011, Sep-07, Issue:9

    Topics: Acute Disease; Adolescent; Antiemetics; Child; Child, Preschool; Fluid Therapy; Gastroenteritis; Hos

2011
Metoclopramide for nausea and vomiting prophylaxis during and after Caesarean delivery: a systematic review and meta-analysis.
    British journal of anaesthesia, 2012, Volume: 108, Issue:3

    Topics: Anesthesia, Conduction; Anesthesia, Obstetrical; Antiemetics; Cesarean Section; Female; Humans; Intr

2012
Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
    Cancer control : journal of the Moffitt Cancer Center, 2012, Volume: 19, Issue:2 Suppl

    Topics: Antiemetics; Antineoplastic Agents; Humans; Metoclopramide; Nausea; Prochlorperazine; Vomiting

2012
Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
    Cancer control : journal of the Moffitt Cancer Center, 2012, Volume: 19, Issue:2 Suppl

    Topics: Antiemetics; Antineoplastic Agents; Humans; Metoclopramide; Nausea; Prochlorperazine; Vomiting

2012
Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
    Cancer control : journal of the Moffitt Cancer Center, 2012, Volume: 19, Issue:2 Suppl

    Topics: Antiemetics; Antineoplastic Agents; Humans; Metoclopramide; Nausea; Prochlorperazine; Vomiting

2012
Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
    Cancer control : journal of the Moffitt Cancer Center, 2012, Volume: 19, Issue:2 Suppl

    Topics: Antiemetics; Antineoplastic Agents; Humans; Metoclopramide; Nausea; Prochlorperazine; Vomiting

2012
Reviewing the evidence for using continuous subcutaneous metoclopramide and ondansetron to treat nausea & vomiting during pregnancy.
    Managed care (Langhorne, Pa.), 2012, Volume: 21, Issue:5

    Topics: Antiemetics; Evidence-Based Medicine; Female; Humans; Infusions, Subcutaneous; Metoclopramide; Nause

2012
Treatment of pediatric migraine in the emergency room.
    Pediatric neurology, 2012, Volume: 47, Issue:4

    Topics: Adolescent; Age Distribution; Age of Onset; Analgesics; Antiemetics; Child; Child, Preschool; Dihydr

2012
[Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].
    Schmerz (Berlin, Germany), 2012, Volume: 26, Issue:5

    Topics: Antiemetics; Antipsychotic Agents; Chronic Disease; Domperidone; Dopamine Antagonists; Drug Therapy,

2012
Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: a multicentre evaluation.
    Journal of palliative care, 2002,Summer, Volume: 18, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anorexia; Antiemetics; Delayed-Action Preparat

2002
Anti-emetics.
    Current medical research and opinion, 2001, Volume: 17 Suppl 1

    Topics: Antiemetics; Domperidone; Dopamine Antagonists; Humans; Metoclopramide; Migraine Disorders; Nausea;

2001
[Effectiveness of anti-emetics for the prophylaxis of cisplatin-induced delayed emesis: a systematic review].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2004, Volume: 124, Issue:1

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; H

2004
Best evidence topic reports. Metoclopramide versus placebo with opioid.
    Emergency medicine journal : EMJ, 2004, Volume: 21, Issue:3

    Topics: Analgesics, Opioid; Antiemetics; Evidence-Based Medicine; Humans; Male; Metoclopramide; Middle Aged;

2004
Antiemetic therapy in patients treated with cisplatin chemotherapy.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Controlled Clinical Trials as Topic; Double-Blind Met

1989
Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents.
    The Cochrane database of systematic reviews, 2006, Jul-19, Issue:3

    Topics: Acute Disease; Adolescent; Antiemetics; Child; Gastroenteritis; Humans; Metoclopramide; Ondansetron;

2006
Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents.
    The Cochrane database of systematic reviews, 2006, Oct-18, Issue:4

    Topics: Acute Disease; Adolescent; Antiemetics; Child; Gastroenteritis; Humans; Metoclopramide; Ondansetron;

2006
Prevention of emesis from multiple-day and high-dose chemotherapy regimens.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2007, Volume: 5, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Benzodiazepines; Drug Therapy, Combination; Humans; Isoquinoline

2007
Pharmacologic treatment of chemotherapy-induced nausea and vomiting.
    Cancer investigation, 1984, Volume: 2, Issue:5

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Butyrophenones; Chemoreceptor Cells; Dr

1984
Advances in anti-emetic therapy.
    Cancer treatment reviews, 1984, Volume: 11, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Chemoreceptor Cells; Clinical Trials as Topic; Dexamethasone; Do

1984
Anaesthesia and emesis. II: Prevention and management.
    Canadian Anaesthetists' Society journal, 1984, Volume: 31, Issue:4

    Topics: Anesthesia; Antiemetics; Butyrophenones; Domperidone; Histamine H1 Antagonists; Humans; Metocloprami

1984
Treatment of nausea and vomiting caused by cancer chemotherapy.
    Cancer treatment reviews, 1982, Volume: 9 Suppl B

    Topics: Antiemetics; Antineoplastic Agents; Cannabinoids; Dronabinol; Humans; Metoclopramide; Nausea; Vomiti

1982
Metoclopramide. An updated review of its pharmacological properties and clinical use.
    Drugs, 1983, Volume: 25, Issue:5

    Topics: Animals; Drug Interactions; Gastrointestinal Diseases; Humans; Kinetics; Metoclopramide; Vomiting

1983
Nausea and vomiting.
    British journal of anaesthesia, 1984, Volume: 56, Issue:1

    Topics: Analgesics; Anesthetics; Domperidone; Humans; Metoclopramide; Nausea; Phenothiazines; Piperazines; S

1984
Dopamine antagonists in the upper gastrointestinal tract.
    Scandinavian journal of gastroenterology. Supplement, 1984, Volume: 96

    Topics: Diabetic Neuropathies; Digestive System; Domperidone; Dopamine Antagonists; Duodenum; Dyspepsia; Eso

1984
Disorders of gastrointestinal motility associated with diabetes mellitus.
    Annals of internal medicine, 1983, Volume: 98, Issue:3

    Topics: Autonomic Nervous System Diseases; Bethanechol Compounds; Constipation; Diabetes Complications; Diab

1983
Drug therapy. Metoclopramide.
    The New England journal of medicine, 1981, Jul-02, Volume: 305, Issue:1

    Topics: Dopamine Antagonists; Esophagitis; Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Motil

1981
Review of a new gastrointestinal drug--metoclopramide.
    American journal of hospital pharmacy, 1981, Volume: 38, Issue:6

    Topics: Diabetes Complications; Gastric Emptying; Humans; Metoclopramide; Stomach Diseases; Vomiting

1981
[Pharmacological and clinical characteristics of metoclopramide].
    La Clinica terapeutica, 1981, May-15, Volume: 97, Issue:3

    Topics: Endocrine Glands; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Metoclopramide; Musc

1981
Antiemetics in children receiving cancer chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:5

    Topics: Antiemetics; Antineoplastic Agents; Child; Dexamethasone; Humans; Metoclopramide; Nausea; Neoplasms;

1994
Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:5

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Humans; Metoclopramide; Nausea; Neopla

1994
Cost-effectiveness analysis of antiemetic treatment.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Antiemetics; Cost-Benefit Analysis; Costs and Cost Analysis; Dexamethasone; Europe; European Union;

1994
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Huma

1994
Pharmacoeconomic analysis of ondansetron versus metoclopramide for cisplatin-induced nausea and vomiting.
    American journal of hospital pharmacy, 1994, Jun-15, Volume: 51, Issue:12

    Topics: Cisplatin; Costs and Cost Analysis; Economics, Pharmaceutical; Humans; Metoclopramide; Nausea; Ondan

1994
Delayed emesis: a dilemma in antiemetic control.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1993, Volume: 1, Issue:4

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Dexamethasone; Drug Therapy, Combination; Forecasti

1993
Ondansetron: a specific serotonin antagonist for the prevention of chemotherapy-induced vomiting.
    Important advances in oncology, 1994

    Topics: Administration, Oral; Adult; Antineoplastic Agents; Child; Cisplatin; Clinical Trials, Phase I as To

1994
[An outline of 5-HT3 receptor antagonists (2)--In clinical applications].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:15

    Topics: Antineoplastic Agents; Granisetron; Humans; Metoclopramide; Nausea; Ondansetron; Serotonin Antagonis

1993
The 5-hydroxytryptamine receptor antagonists as antiemetics: preclinical evaluation and mechanism of action.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A Suppl 1

    Topics: Animals; Antiemetics; Dogs; Ferrets; Humans; Metoclopramide; Ondansetron; Receptors, Serotonin; Sero

1993
Emesis and anti-emesis.
    Cancer surveys, 1994, Volume: 21

    Topics: Animals; Antiemetics; Antineoplastic Agents; Humans; Metoclopramide; Rabbits; Receptors, Serotonin;

1994
Optimal control of acute cisplatin-induced emesis.
    Oncology, 1996, Volume: 53 Suppl 1

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dopamine Antagonists; Humans; Metoclopramide; Nausea;

1996
Postoperative nausea and vomiting in children.
    Paediatric anaesthesia, 1996, Volume: 6, Issue:1

    Topics: Anesthetics, Inhalation; Antiemetics; Child; Droperidol; Humans; Incidence; Metoclopramide; Nausea;

1996
Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin.
    Cancer, 1996, Nov-15, Volume: 78, Issue:10

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Double-Blind Method; Female; Granisetron

1996
Drug treatment of chemotherapy-induced delayed emesis.
    Drugs, 1996, Volume: 52, Issue:5

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Humans; Metoclopramide; Nausea; Neopla

1996
[Recent improvements in antiemetic therapy].
    Tumori, 1997, Volume: 83, Issue:2 Suppl

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Granisetron

1997
Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery.
    Drugs, 1997, Volume: 54, Issue:2

    Topics: Administration, Oral; Age Factors; Antiemetics; Dexamethasone; Humans; Indoles; Injections, Intraven

1997
[Effectiveness and cost of 5-HT3-antagonists in acute chemotherapy-induced emesis. Health-economic analysis based on current meta-analytic data].
    Medizinische Klinik (Munich, Germany : 1983), 1997, Dec-15, Volume: 92, Issue:12

    Topics: Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Germany; Humans; Metoclopramide; Selectiv

1997
Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:8

    Topics: Adult; Antiemetics; Antineoplastic Agents; Child; Dexamethasone; Humans; Metoclopramide; Neoplasms;

1998
Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.
    PharmacoEconomics, 1992, Volume: 2, Issue:4

    Topics: Costs and Cost Analysis; Drug Therapy; Drug Tolerance; Economics, Pharmaceutical; Forecasting; Formu

1992
Metoclopramide.
    Gastroenterology, 1979, Volume: 77, Issue:4 Pt 1

    Topics: Animals; Digestive System; Gastrointestinal Motility; Humans; Metoclopramide; Muscle, Smooth; Nausea

1979
Some aspects of medical management of gastrointestinal disease. I.
    Canadian Medical Association journal, 1975, Jan-25, Volume: 112, Issue:2

    Topics: Diarrhea; Disaccharides; Endoscopy; Esophagitis; Gastric Juice; Gastric Mucosa; Gastrointestinal Dis

1975
Metoclopramide: a review of its pharmacological properties and clinical use.
    Drugs, 1976, Volume: 12, Issue:2

    Topics: Animals; Basal Ganglia Diseases; Cardiovascular System; Central Nervous System; Clinical Trials as T

1976
Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesis.
    Seminars in oncology, 1992, Volume: 19, Issue:4 Suppl 10

    Topics: Antiemetics; Cisplatin; Clinical Trials as Topic; Female; Humans; Imidazoles; Male; Metoclopramide;

1992
Antiemetic agents.
    Current opinion in oncology, 1992, Volume: 4, Issue:4

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Humans; Imi

1992
5-HT3 antagonists in postoperative nausea and vomiting.
    British journal of anaesthesia, 1992, Volume: 69, Issue:7 Suppl 1

    Topics: Aged; Anesthesia, General; Humans; Male; Metoclopramide; Nausea; Ondansetron; Postoperative Complica

1992
Ondansetron. Therapeutic use as an antiemetic.
    Drugs, 1991, Volume: 41, Issue:4

    Topics: Antiemetics; Antineoplastic Agents; Humans; Imidazoles; Metoclopramide; Nausea; Ondansetron; Radiati

1991
Emerging differences between 5-HT3 receptor antagonists.
    Anti-cancer drugs, 1991, Volume: 2, Issue:6

    Topics: Animals; Antiemetics; Gastrointestinal Motility; Humans; Metoclopramide; Serotonin Antagonists; Vomi

1991
Anti-emetic control with ondansetron in the chemotherapy of breast cancer: a review.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27 Suppl 1

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Double-Blind Method;

1991
5HT3-antagonist receptors: their role in drug-induced emesis.
    Nouvelle revue francaise d'hematologie, 1990, Volume: 32, Issue:6

    Topics: Antiemetics; Antineoplastic Agents; Antipsychotic Agents; Dexamethasone; Dopamine Antagonists; Drug

1990
[Nausea and vomiting during treatment with cytostatics].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1991, Mar-20, Volume: 111, Issue:8

    Topics: Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Metoclop

1991
Management of chemotherapy-induced nausea and vomiting.
    Pharmacotherapy, 1990, Volume: 10, Issue:2

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Benzodiazepines; Butyrophenones; Cannab

1990
Batanopride (BMY-25801): a new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis.
    Cancer treatment reviews, 1990, Volume: 17, Issue:2-3

    Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dogs; Dopamine Antagonists; Female; Ferrets;

1990
[Nausea and vomiting induced by chemotherapy: bases to a rational treatment].
    Revista medica de Chile, 1989, Volume: 117, Issue:11

    Topics: Antiemetics; Antineoplastic Agents; Butyrophenones; Drug Therapy, Combination; Metoclopramide; Nause

1989
Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens.
    Blood reviews, 1989, Volume: 3, Issue:4

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepine

1989
The control of cancer chemotherapy-induced nausea and vomiting.
    Journal of clinical and hospital pharmacy, 1985, Volume: 10, Issue:2

    Topics: Adrenal Cortex Hormones; Anti-Anxiety Agents; Antiemetics; Antineoplastic Agents; Antipsychotic Agen

1985
Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy.
    Clinical pharmacy, 1986, Volume: 5, Issue:8

    Topics: Antiemetics; Antipsychotic Agents; Dicyclomine; Diphenhydramine; Doxylamine; Drug Combinations; Fema

1986
[Recent advances in the management of chemotherapy-induced emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:3 Pt 1

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Domperidone; Dronabinol; Drug Therapy,

1986
Combination antiemetics for cisplatin chemotherapy.
    Cancer, 1988, Apr-15, Volume: 61, Issue:8

    Topics: Antiemetics; Cisplatin; Dexamethasone; Diphenhydramine; Droperidol; Drug Evaluation; Drug Therapy, C

1988
Metoclopramide--a review.
    The Medical journal of Australia, 1986, Mar-31, Volume: 144, Issue:7

    Topics: Anxiety; Digestive System; Dopamine Antagonists; Drug Interactions; Female; Gastric Emptying; Gastro

1986
[The treatment of vomiting caused by the administration of cytostatic agents].
    Nederlands tijdschrift voor geneeskunde, 1986, Aug-16, Volume: 130, Issue:33

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Humans; Loraz

1986
[Progress in the management of vomiting associated with antineoplastic agents].
    Nihon rinsho. Japanese journal of clinical medicine, 1985, Volume: 43, Issue:2

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Evaluation; Drug Therapy, Combination; Human

1985
[The control of chemotherapy-induced nausea and vomiting].
    Gan no rinsho. Japan journal of cancer clinics, 1985, Volume: 31, Issue:7

    Topics: Antiemetics; Antineoplastic Agents; Chemoreceptor Cells; Chlorpromazine; Cisplatin; Domperidone; Hum

1985
Recent advances in the prevention or reduction of cytotoxic-induced emesis.
    The Medical journal of Australia, 1985, Oct-14, Volume: 143, Issue:8

    Topics: Antiemetics; Antineoplastic Agents; Benzodiazepines; Cannabinoids; Drug Evaluation; Glucocorticoids;

1985

Trials

382 trials available for metoclopramide and Emesis

ArticleYear
Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT.
    Health technology assessment (Winchester, England), 2021, Volume: 25, Issue:63

    Topics: Antiemetics; Cost-Benefit Analysis; Female; Humans; Metoclopramide; Nausea; Ondansetron; Pregnancy;

2021
Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.
    Journal of veterinary internal medicine, 2022, Volume: 36, Issue:5

    Topics: Animals; Antiemetics; Arginine Vasopressin; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Met

2022
The efficacy of prophylactic metoclopramide in preventing nausea and vomiting in patients with acute pain treated with intravenous tramadol: a randomized double-blinded, placebo-controlled trial.
    BMC research notes, 2023, Jul-27, Volume: 16, Issue:1

    Topics: Acute Pain; Analgesics, Opioid; Antiemetics; Double-Blind Method; Humans; Metoclopramide; Nausea; Tr

2023
Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced vomiting in children: An open-label, randomized phase 3 trial.
    Pediatric blood & cancer, 2020, Volume: 67, Issue:9

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Fe

2020
Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial.
    The oncologist, 2021, Volume: 26, Issue:1

    Topics: Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Double-Blind Method; Humans; Male; Metoclop

2021
A randomised controlled feasibility and proof-of-concept trial in delayed gastric emptying when metoclopramide fails: We should revisit nasointestinal feeding versus dual prokinetic treatment: Achieving goal nutrition in critical illness and delayed gastr
    Clinical nutrition ESPEN, 2016, Volume: 14

    Topics: Adult; Critical Illness; Enteral Nutrition; Erythromycin; Female; Gastric Emptying; Gastrointestinal

2016
Effect of metoclopramide on nausea and emesis in dogs premedicated with morphine and dexmedetomidine.
    Veterinary anaesthesia and analgesia, 2018, Volume: 45, Issue:2

    Topics: Analgesics, Opioid; Animals; Antiemetics; Dexmedetomidine; Dogs; Dopamine Antagonists; Female; Male;

2018
Can granisetron injection used as primary prophylaxis improve the control of nausea and vomiting with low- emetogenic chemotherapy?
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:1

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Female; G

2013
Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial.
    Obstetrics and gynecology, 2013, Volume: 121, Issue:3

    Topics: Adult; Anesthesia, Spinal; Antiemetics; Cardiotonic Agents; Cesarean Section; Drug Therapy, Combinat

2013
Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial.
    Obstetrics and gynecology, 2013, Volume: 121, Issue:3

    Topics: Adult; Anesthesia, Spinal; Antiemetics; Cardiotonic Agents; Cesarean Section; Drug Therapy, Combinat

2013
Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial.
    Obstetrics and gynecology, 2013, Volume: 121, Issue:3

    Topics: Adult; Anesthesia, Spinal; Antiemetics; Cardiotonic Agents; Cesarean Section; Drug Therapy, Combinat

2013
Antiemetics added to phenylephrine infusion during cesarean delivery: a randomized controlled trial.
    Obstetrics and gynecology, 2013, Volume: 121, Issue:3

    Topics: Adult; Anesthesia, Spinal; Antiemetics; Cardiotonic Agents; Cesarean Section; Drug Therapy, Combinat

2013
Optimal control of nausea and vomiting with a three-drug antiemetic regimen with aprepitant in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:11

    Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Benztropine; Camptoth

2013
Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Annals of emergency medicine, 2014, Volume: 64, Issue:5

    Topics: Adult; Aged; Antiemetics; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; Middle

2014
Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Annals of emergency medicine, 2014, Volume: 64, Issue:5

    Topics: Adult; Aged; Antiemetics; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; Middle

2014
Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Annals of emergency medicine, 2014, Volume: 64, Issue:5

    Topics: Adult; Aged; Antiemetics; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; Middle

2014
Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Annals of emergency medicine, 2014, Volume: 64, Issue:5

    Topics: Adult; Aged; Antiemetics; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; Middle

2014
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:6

    Topics: Activities of Daily Living; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Ag

2015
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:6

    Topics: Activities of Daily Living; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Ag

2015
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:6

    Topics: Activities of Daily Living; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Ag

2015
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:6

    Topics: Activities of Daily Living; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Ag

2015
A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2017, Volume: 58, Issue:1

    Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hysterectomy; Male; Metoclopra

2017
Metoclopramide as intermittent and continuous infusions in critically ill patients: a pilot randomized clinical trial.
    Journal of comparative effectiveness research, 2017, Volume: 6, Issue:2

    Topics: Adult; Aged; Antiemetics; Critical Illness; Drug Administration Schedule; Energy Intake; Enteral Nut

2017
Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
    Journal of veterinary pharmacology and therapeutics, 2017, Volume: 40, Issue:6

    Topics: Animals; Antiemetics; Dog Diseases; Dogs; Female; Male; Metoclopramide; Ondansetron; Parvoviridae In

2017
Pretreatment of patients requiring oral contrast abdominal computed tomography with antiemetics: a randomized controlled trial of efficacy.
    Annals of emergency medicine, 2009, Volume: 53, Issue:4

    Topics: Administration, Oral; Adult; Analysis of Variance; Antiemetics; Chi-Square Distribution; Contrast Me

2009
Ondansetron vs. metoclopramide for the prevention of nausea and vomiting after gynecologic surgery.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:5

    Topics: Adult; Aged; Antiemetics; Double-Blind Method; Female; Gynecologic Surgical Procedures; Humans; Meto

2008
Antiemetic activity of megestrol acetate in patients receiving chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Drug Therapy

2011
Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2012, Volume: 20, Issue:4

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Doub

2012
Comparing the efficacy of prophylactic p6 acupressure, ondansetron, metoclopramide and placebo in the prevention of vomiting and nausea after strabismus surgery.
    Acta medica Iranica, 2011, Volume: 49, Issue:4

    Topics: Acupressure; Adolescent; Adult; Antiemetics; Child; Combined Modality Therapy; Double-Blind Method;

2011
Metoclopramide versus ondansetron for the treatment of vomiting in children with acute gastroenteritis.
    Journal of pediatric gastroenterology and nutrition, 2011, Volume: 53, Issue:2

    Topics: Adolescent; Antiemetics; Child; Child, Preschool; Dopamine Antagonists; Double-Blind Method; Female;

2011
Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: A randomized, double-blinded, clinical trial.
    Emergency medicine Australasia : EMA, 2011, Volume: 23, Issue:5

    Topics: Adult; Aged; Antiemetics; Double-Blind Method; Emergency Medical Services; Emergency Service, Hospit

2011
Comparing the effects of ginger and metoclopramide on the treatment of pregnancy nausea.
    Pakistan journal of biological sciences : PJBS, 2011, Aug-15, Volume: 14, Issue:16

    Topics: Adult; Antiemetics; Double-Blind Method; Female; Humans; Metoclopramide; Nausea; Placebos; Pregnancy

2011
Adjunctive atropine versus metoclopramide: can we reduce ketamine-associated vomiting in young children? a prospective, randomized, open, controlled study.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2012, Volume: 19, Issue:10

    Topics: Anesthetics, Dissociative; Antiemetics; Atropine; Child, Preschool; Female; Humans; Infant; Ketamine

2012
The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Aprepitant; Benzodiazepines; Cis

2013
Long-term safety and clinical effectiveness of controlled-release metoclopramide in cancer-associated dyspepsia syndrome: a multicentre evaluation.
    Journal of palliative care, 2002,Summer, Volume: 18, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anorexia; Antiemetics; Delayed-Action Preparat

2002
Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2

    Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protoc

2002
Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2002, Volume: 85, Issue:11

    Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols

2002
A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemother

2003
A comparison of granisetron, droperidol, and metoclopramide in the treatment of established nausea and vomiting after breast surgery: a double-blind, randomized, controlled trial.
    Clinical therapeutics, 2003, Volume: 25, Issue:4

    Topics: Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron;

2003
Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy.
    Journal of perinatology : official journal of the California Perinatal Association, 2003, Volume: 23, Issue:7

    Topics: Adult; Antiemetics; Drug Therapy, Combination; Female; Humans; Hyperemesis Gravidarum; Metoclopramid

2003
Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    The Indian journal of medical research, 2003, Volume: 118

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Female; Humans; Male; Met

2003
Intermediate dose metoclopramide is not more effective than standard dose metoclopramide for patients who present to the emergency department with nausea and vomiting: a pilot study.
    Emergency medicine Australasia : EMA, 2004, Volume: 16, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Dose-Response Relationship, Drug; Emergency

2004
Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
    The Indian journal of medical research, 2004, Volume: 120, Issue:3

    Topics: Adult; Antiemetics; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combin

2004
Effectiveness of pre-emptive metoclopramide infusion in alleviating pain, discomfort and nausea associated with nasogastric tube insertion: a randomised, double-blind, placebo-controlled trial.
    International journal of clinical practice, 2005, Volume: 59, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Double-Blind Method; Female; Gagging; Human

2005
Use of a prophylactic antiemetic with morphine in acute pain: randomised controlled trial.
    Emergency medicine journal : EMJ, 2006, Volume: 23, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Female;

2006
Betamethasone does not prevent nausea and vomiting induced by the dopamine-agonist apomorphine.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2006, Volume: 53, Issue:4

    Topics: Adult; Apomorphine; Betamethasone; Dopamine Agonists; Dopamine Antagonists; Female; Glucocorticoids;

2006
Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study.
    Surgical endoscopy, 2006, Volume: 20, Issue:6

    Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Dexamethasone; Drug Therapy, Combination; F

2006
Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma.
    Sao Paulo medical journal = Revista paulista de medicina, 2006, Mar-02, Volume: 124, Issue:2

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Bone Neoplasms; Child; Dimenhydrinate; Female; Grani

2006
Skipping day 2 antiemetic medications may improve chemotherapy induced delayed nausea and vomiting control: results of two pilot phase II trials.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antiemetics; Antineoplastic Combined Chemotherapy Pro

2007
Advances in anti-emetic therapy.
    Cancer treatment reviews, 1984, Volume: 11, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Chemoreceptor Cells; Clinical Trials as Topic; Dexamethasone; Do

1984
Antiemetics for patients treated with antitumor chemotherapy.
    Cancer clinical trials, 1980, Volume: 3, Issue:4

    Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Cyclizine; Dronabinol; Drug Therapy, Combination; F

1980
Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug and therapeutics bulletin, 1984, Feb-10, Volume: 22, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Human

1984
[Metoclopramide in the prevention of postoperative nausea and vomiting].
    Ugeskrift for laeger, 1983, Jan-24, Volume: 145, Issue:4

    Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Metocloprami

1983
Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide.
    Cancer treatment reports, 1983, Volume: 67, Issue:4

    Topics: Adult; Antineoplastic Agents; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Drug Syn

1983
[Domperidone and metoclopramide in the prevention of postoperative nausea and vomiting].
    Ugeskrift for laeger, 1983, Jun-06, Volume: 145, Issue:23

    Topics: Abortion, Induced; Adolescent; Adult; Clinical Trials as Topic; Domperidone; Double-Blind Method; Fe

1983
[Prevention of cytostatic-induced vomiting. High-dosage metoclopramide versus an antiemetic combination in a controlled comparison].
    Die Medizinische Welt, 1983, Sep-02, Volume: 34, Issue:35

    Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug

1983
Nausea and vomiting during spinal anaesthesia. Effect of metoclopramide and domperidone: a double-blind trial.
    Anaesthesia, 1984, Volume: 39, Issue:2

    Topics: Aged; Anesthesia, Spinal; Blood Pressure; Clinical Trials as Topic; Domperidone; Double-Blind Method

1984
Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cl

1984
A randomized trial of metoclopramide and a combination of dexamethasone and lorazepam for prevention of chemotherapy-induced vomiting.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; D

1984
[Symptomatic therapy of vomiting in children. Clinical study of a new preparation with anti-emetic activity (Clebopride)].
    Minerva pediatrica, 1984, Feb-15, Volume: 36, Issue:3

    Topics: Benzamides; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Female;

1984
Preanesthetic cimetidine and metoclopramide for acid aspiration prophylaxis in elective surgery.
    Anesthesiology, 1984, Volume: 61, Issue:1

    Topics: Adult; Anesthesia; Cimetidine; Clinical Trials as Topic; Gastric Acid; Gastric Juice; Humans; Inhala

1984
Amitriptyline plus fluphenazine to prevent chemotherapy-induced emesis in cancer patients: a double-blind randomized cross-over study.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:9

    Topics: Adult; Amitriptyline; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doub

1984
Emesis due to cancer chemotherapy: results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:12

    Topics: Adolescent; Adult; Aged; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; M

1984
Low-dose metoclopramide versus methylprednisolone in controlling chemotherapy induced nausea and vomiting.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Male; Methylprednisolo

1984
Antiemetic prophylaxis with high dose metoclopramide or lorazepam in vomiting induced by chemotherapy.
    British medical journal (Clinical research ed.), 1984, Jun-23, Volume: 288, Issue:6434

    Topics: Cisplatin; Dacarbazine; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Vomiting

1984
Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.
    British medical journal (Clinical research ed.), 1984, Oct-06, Volume: 289, Issue:6449

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Humans; Metoc

1984
Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Double-Blind Method; Drug Evaluati

1984
Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide.
    Gynecologic oncology, 1984, Volume: 18, Issue:3

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Droperidol; Drug

1984
[Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy].
    Fortschritte der Medizin, 1983, Oct-20, Volume: 101, Issue:39

    Topics: Adolescent; Adult; Aged; Antiemetics; Appetite; Double-Blind Method; Female; Humans; Male; Metoclopr

1983
Vomiting after anaesthesia for termination of pregnancy in Chinese.
    Singapore medical journal, 1983, Volume: 24, Issue:6

    Topics: Abortion, Induced; Anesthesia, Obstetrical; China; Ethnicity; Female; Humans; Metoclopramide; Preane

1983
[Metoclopramide and cisplatin].
    Medicina clinica, 1983, Dec-17, Volume: 81, Issue:20

    Topics: Cisplatin; Drug Evaluation; Humans; Metoclopramide; Random Allocation; Vomiting

1983
[Clinical evaluation of antiemetics for vomiting due to cancer chemotherapy in children].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:6

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; D

1982
[Prevention of cytostatic-induced vomiting with high-dose metoclopramide].
    Deutsche medizinische Wochenschrift (1946), 1983, Jun-17, Volume: 108, Issue:24

    Topics: Antineoplastic Agents; Humans; Metoclopramide; Vomiting

1983
Postoperative vomiting treated with domperidone. A double-blind comparison with metoclopramide and a placebo.
    Acta anaesthesiologica Belgica, 1980, Volume: 31, Issue:2

    Topics: Adult; Aged; Antiemetics; Benzimidazoles; Clinical Trials as Topic; Domperidone; Double-Blind Method

1980
[Domperidone as an anti-emetic in antineoplastic chemotherapy].
    Minerva chirurgica, 1981, Jun-15, Volume: 36, Issue:11

    Topics: Aged; Antineoplastic Agents; Benzimidazoles; Clinical Trials as Topic; Domperidone; Female; Gastroin

1981
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
    The New England journal of medicine, 1981, Oct-15, Volume: 305, Issue:16

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Metoclo

1981
[Study of cipropride in the treatment of digestive disorders induced by anticancer chemotherapy. Double-blind study using metoclopramide].
    Medecine & chirurgie digestives, 1981, Volume: 10, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Female; Humans; M

1981
[Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
    Medicina clinica, 1981, Sep-10, Volume: 77, Issue:4

    Topics: Antiemetics; Benzamides; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Humans; Metoclopr

1981
Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy.
    JAMA, 1982, May-21, Volume: 247, Issue:19

    Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination;

1982
Metoclopramide in the reduction of nausea and vomiting associated with combined chemotherapy.
    Cancer chemotherapy and pharmacology, 1982, Volume: 8, Issue:1

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Hum

1982
Reduction of postoperative vomiting by preoperative administration of oral metoclopramide.
    Canadian Anaesthetists' Society journal, 1980, Volume: 27, Issue:1

    Topics: Adolescent; Adult; Double-Blind Method; Female; Gastrointestinal Motility; Humans; Intraoperative Ca

1980
Metoclopramide therapy in fifty-five patients with delayed gastric emptying.
    The American journal of gastroenterology, 1980, Volume: 74, Issue:3

    Topics: Adolescent; Adult; Aged; Diabetes Complications; Drainage; Female; Gastric Emptying; Humans; Male; M

1980
Rapid intravenous administration of ondansetron or metoclopramide is not associated with cardiovascular compromise in children.
    Paediatric anaesthesia, 1995, Volume: 5, Issue:2

    Topics: Adolescent; Age Factors; Antiemetics; Blood Pressure; Body Weight; Child; Child, Preschool; Double-B

1995
Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis.
    Archives of disease in childhood, 1995, Volume: 73, Issue:3

    Topics: Administration, Oral; Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child

1995
On the mechanism of radiation-induced emesis: the role of serotonin.
    International journal of radiation oncology, biology, physics, 1994, Nov-15, Volume: 30, Issue:4

    Topics: Dexamethasone; Drug Therapy, Combination; Female; Hemibody Irradiation; Humans; Hydroxyindoleacetic

1994
Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis.
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1995, Volume: 56, Issue:1

    Topics: Adult; Aged; Antiemetics; Cisplatin; Female; Granisetron; Humans; Injections, Intravenous; Male; Met

1995
Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone.
    Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 10

    Topics: Acute Disease; Administration, Oral; Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Dru

1995
The efficacy of prophylactic ondansetron, droperidol, perphenazine, and metoclopramide in the prevention of nausea and vomiting after major gynecologic surgery.
    Anesthesia and analgesia, 1995, Volume: 81, Issue:1

    Topics: Akathisia, Drug-Induced; Consciousness; Double-Blind Method; Droperidol; Female; Humans; Hypotension

1995
Antiemetic efficacy of a droperidol-morphine combination in patient-controlled analgesia.
    Journal of clinical anesthesia, 1995, Volume: 7, Issue:2

    Topics: Adolescent; Adult; Analgesia, Patient-Controlled; Dose-Response Relationship, Drug; Double-Blind Met

1995
Granisetron in the prevention of irradiation-induced emesis.
    Bone marrow transplantation, 1995, Volume: 15, Issue:3

    Topics: Adult; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gra

1995
Prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. A prospective randomized study of metoclopramide and transdermal hyoscine.
    The European journal of surgery = Acta chirurgica, 1995, Volume: 161, Issue:4

    Topics: Administration, Cutaneous; Adult; Aged; Cholecystectomy, Laparoscopic; Dizziness; Female; Humans; In

1995
Ondansetron in chemotherapy-induced emesis. Our experience.
    European journal of gynaecological oncology, 1995, Volume: 16, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Female; Genital Neoplas

1995
Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis.
    Journal of Korean medical science, 1994, Volume: 9, Issue:5

    Topics: Adult; Aged; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Eating; Female; Humans; Male

1994
The effects of oral droperidol versus oral metoclopramide versus both oral droperidol and metoclopramide on postoperative vomiting when used as a premedicant for strabismus surgery.
    Journal of clinical anesthesia, 1995, Volume: 7, Issue:1

    Topics: Administration, Oral; Adolescent; Ambulatory Surgical Procedures; Anesthesia Recovery Period; Child;

1995
[Intravenous administration of ondansetron vs. metoclopramide for the prophylaxis of postoperative nausea and vomiting].
    Der Anaesthesist, 1995, Volume: 44, Issue:4

    Topics: Adult; Double-Blind Method; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Metoc

1995
Prevention of nausea and vomiting after day case gynaecological laparoscopy. A comparison of ondansetron, droperidol, metoclopramide and placebo.
    Anaesthesia, 1995, Volume: 50, Issue:5

    Topics: Adult; Ambulatory Surgical Procedures; Anesthesia, General; Double-Blind Method; Droperidol; Female;

1995
Propofol injection pain: comparing the addition of lignocaine or metoclopramide.
    Anaesthesia and intensive care, 1994, Volume: 22, Issue:5

    Topics: Adult; Anesthesia Recovery Period; Anesthesia, Intravenous; Blood Pressure; Extrapyramidal Tracts; F

1994
Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study.
    British journal of clinical pharmacology, 1994, Volume: 38, Issue:3

    Topics: Adult; Aged; Antiemetics; Cisplatin; Cross-Over Studies; Female; Humans; Infusions, Intravenous; Mal

1994
A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin.
    Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:11

    Topics: Adult; Aged; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Female; Granis

1994
Sustained release metoclopramide for prophylaxis of post-operative nausea and vomiting.
    European journal of anaesthesiology, 1994, Volume: 11, Issue:6

    Topics: Administration, Oral; Adult; Delayed-Action Preparations; Double-Blind Method; Elective Surgical Pro

1994
Efficacy and tolerability of nasally administered compared to parenterally administered metoclopramide in the symptomatic treatment of chemotherapy-induced emesis in cancer outpatients. A controlled clinical study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:6

    Topics: Administration, Intranasal; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans;

1994
Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial.
    American journal of clinical oncology, 1995, Volume: 18, Issue:2

    Topics: Adult; Cisplatin; Clemastine; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lorazepam; M

1995
Effect of nabilone on nausea and vomiting after total abdominal hysterectomy.
    British journal of anaesthesia, 1994, Volume: 73, Issue:2

    Topics: Adult; Aged; Antiemetics; Double-Blind Method; Dronabinol; Drug Administration Schedule; Female; Hum

1994
Prophylactic antiemetic treatment with ondansetron in children undergoing tonsillectomy.
    Anesthesiology, 1994, Volume: 81, Issue:4

    Topics: Acetaminophen; Antiemetics; Child; Child, Preschool; Double-Blind Method; Droperidol; Female; Humans

1994
[Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron].
    Orvosi hetilap, 1994, Oct-30, Volume: 135, Issue:44

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Huma

1994
Antiemetic efficacy of metoclopramide when included in a patient-controlled analgesia infusion.
    Anaesthesia, 1994, Volume: 49, Issue:9

    Topics: Adult; Aged; Analgesia, Patient-Controlled; Double-Blind Method; Female; Gynecology; Humans; Metoclo

1994
Cisplatin-induced delayed emesis: pattern and prognostic factors during three subsequent cycles. Italian Group for Antiemetic Research.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7

    Topics: Acute Disease; Chi-Square Distribution; Cisplatin; Dexamethasone; Diphenhydramine; Drug Therapy, Com

1994
Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7

    Topics: Administration, Oral; Adult; Aged; Chi-Square Distribution; Cisplatin; Constipation; Dexamethasone;

1994
Evaluation of two antiemetic agents during outpatient gynaecological surgery.
    Singapore medical journal, 1994, Volume: 35, Issue:3

    Topics: Abortion, Induced; Adult; Ambulatory Surgical Procedures; Analysis of Variance; Anesthesia, General;

1994
The roles of patient and observer assessments in anti-emetic trials.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:9

    Topics: Cross-Over Studies; Double-Blind Method; Humans; Lorazepam; Metoclopramide; Nurses; Observer Variati

1994
Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Italian Group for Antiemetic Research.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Cisplatin; Dexamethasone; Diphenhydramine; Drug Combinations; Drug T

1994
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Huma

1994
Control of emesis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Constipation; Cyclophosphamide; Epirubicin; Fem

1994
[Effects of ondansetron and metoclopramide on postoperative nausea and vomiting after epidural anesthesia in children].
    Cahiers d'anesthesiologie, 1994, Volume: 42, Issue:1

    Topics: Anesthesia, Epidural; Child; Child, Preschool; Female; Humans; Male; Metoclopramide; Nausea; Ondanse

1994
Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Femal

1994
Rectal indomethacin for analgesia after appendicectomy in children.
    Anaesthesia and intensive care, 1994, Volume: 22, Issue:3

    Topics: Administration, Rectal; Analgesia; Analgesia, Patient-Controlled; Appendectomy; Child; Double-Blind

1994
Continuous infusion versus intermittent short infusion of metoclopramide for cisplatin-induced acute emesis.
    American journal of clinical oncology, 1994, Volume: 17, Issue:5

    Topics: Acute Disease; Adult; Aged; Chi-Square Distribution; Cisplatin; Female; Humans; Infusions, Intraveno

1994
Comparison of four antiemetic regimens for the treatment of cisplatin-induced vomiting.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1993, Volume: 42, Issue:1

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Droperidol; Female; Humans;

1993
Nausea and vomiting after gynaecological laparoscopy: comparison of premedication with oral ondansetron, metoclopramide and placebo.
    British journal of anaesthesia, 1994, Volume: 72, Issue:2

    Topics: Adolescent; Adult; Ambulatory Surgical Procedures; Anesthesia, General; Female; Gynecology; Humans;

1994
Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
    Obstetrics and gynecology, 1994, Volume: 83, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dexamethasone; Diphenh

1994
Prophylactic antiemetic therapy with patient-controlled analgesia: a double-blind, placebo-controlled comparison of droperidol, metoclopramide, and tropisetron.
    Anesthesia and analgesia, 1994, Volume: 78, Issue:5

    Topics: Analgesia, Patient-Controlled; Antiemetics; Double-Blind Method; Droperidol; Elective Surgical Proce

1994
Double-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting.
    British journal of anaesthesia, 1994, Volume: 72, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia, Epidural; Anesthesia, General; Double-Blind

1994
Zingiber officinale (ginger)--an antiemetic for day case surgery.
    Anaesthesia, 1993, Volume: 48, Issue:8

    Topics: Adult; Ambulatory Surgical Procedures; Antiemetics; Double-Blind Method; Female; Humans; Metoclopram

1993
[Clinical effects of granisetron and methylprednisolone against nausea, vomiting and anorexia induced by cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:13

    Topics: Adult; Aged; Anorexia; Cisplatin; Domperidone; Drug Therapy, Combination; Female; Granisetron; Human

1993
Propofol anaesthesia reduces early postoperative emesis after paediatric strabismus surgery.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1993, Volume: 40, Issue:10

    Topics: Ambulatory Surgical Procedures; Anesthesia Recovery Period; Anesthesia, Inhalation; Anesthesia, Intr

1993
Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:12

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Dexamethasone; Diphenhydramin

1993
Antiemetic efficacy of prophylactic ondansetron in laparoscopic surgery: randomized, double-blind comparison with metoclopramide.
    British journal of anaesthesia, 1993, Volume: 71, Issue:6

    Topics: Adolescent; Adult; Ambulatory Surgical Procedures; Anesthesia, General; Double-Blind Method; Female;

1993
An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Cancer chemotherapy and pharmacology, 1994, Volume: 33, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Drug Administration Schedule; Female; Genita

1994
A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Cancer, 1994, Jan-15, Volume: 73, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Female; Humans; Indoles; Male; Metoclopramid

1994
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.
    Cancer, 1994, Feb-01, Volume: 73, Issue:3

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Fema

1994
Open placebo controlled comparison of the antiemetic effect of droperidol, metoclopramide or a combination of both in pediatric strabismus surgery.
    Acta anaesthesiologica Belgica, 1993, Volume: 44, Issue:1

    Topics: Antiemetics; Child; Child, Preschool; Double-Blind Method; Droperidol; Drug Administration Schedule;

1993
Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin. A double-blind, placebo-controlled study with crossover design.
    Tumori, 1993, Apr-30, Volume: 79, Issue:2

    Topics: Adult; Aged; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; M

1993
Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
    Oncology, 1993, Volume: 50 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell

1993
The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in patients receiving fractionated chemotherapy over 5 days. The Granisetron Study Group.
    Journal of cancer research and clinical oncology, 1993, Volume: 119, Issue:9

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug The

1993
Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Double-blind randomized crossover study in patients with cisplatin-induced emesis.
    American journal of clinical oncology, 1993, Volume: 16, Issue:4

    Topics: Adult; Aged; Alprazolam; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non

1993
The real costs of emesis--an economic analysis of ondansetron vs. metoclopramide in controlling emesis in patients receiving chemotherapy for cancer.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:3

    Topics: Antineoplastic Agents; Cost-Benefit Analysis; Drug Costs; Drug Utilization Review; Female; Hospitals

1993
Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen.
    American journal of clinical oncology, 1993, Volume: 16, Issue:2

    Topics: Adult; Aged; Antiemetics; Cisplatin; Diphenhydramine; Drug Therapy, Combination; Female; Genital Neo

1993
Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.
    The New England journal of medicine, 1993, Apr-15, Volume: 328, Issue:15

    Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophospha

1993
Postoperative nausea and vomiting: a comparison of anti-emetic drugs used alone or in combination.
    Journal of the Royal Society of Medicine, 1993, Volume: 86, Issue:3

    Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Drug Combinations; Humans; Metoclopramide; Naus

1993
Tiapride versus metoclopramide: comparison after minor gynaecological surgery.
    European journal of anaesthesiology, 1993, Volume: 10, Issue:2

    Topics: Abortion, Incomplete; Abortion, Missed; Adolescent; Adult; Dilatation and Curettage; Double-Blind Me

1993
Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:3

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Drug Therapy, Combin

1996
Sustained-release metoclopramide plus methylprednisolone versus placebo plus methylprednisolone as antiemetic prophylaxis during non-cisplatin chemotherapy. A randomized double-blind cross-over trial.
    Acta oncologica (Stockholm, Sweden), 1996, Volume: 35, Issue:1

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplas

1996
Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
    Cancer, 1995, Nov-15, Volume: 76, Issue:10

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Cisplatin; Drug Therapy, Combination; Female; Granis

1995
Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.
    Cancer, 1995, Sep-01, Volume: 76, Issue:5

    Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm

1995
Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
    Cancer, 1995, Dec-01, Volume: 76, Issue:11

    Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combine

1995
Antiemetic efficacy of ondansetron and metoclopramide, both combined with corticosteroid, in malignant lymphoma patients receiving non-cisplatin chemotherapy.
    Acta oncologica (Stockholm, Sweden), 1996, Volume: 35, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemot

1996
A randomized cross-over trial of granisetron and dexamethasone versus granisetron alone: the role of dexamethasone on day 1 in the control of cisplatin-induced delayed emesis.
    Japanese journal of clinical oncology, 1996, Volume: 26, Issue:3

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cross-Over Studies; Dexamethasone; Drug

1996
Management of cyclophosphamide-induced emesis over repeat courses.
    Oncology, 1996, Volume: 53 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cyclophosphamide; Dexamethasone;

1996
Cisplatin and emesis: aspects of treatment and a new trial for delayed emesis using oral dexamethasone plus ondansetron beginning at 16 hours after cisplatin.
    Oncology, 1996, Volume: 53 Suppl 1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin;

1996
Erythromycin as a prokinetic agent in children.
    Anaesthesia, 1996, Volume: 51, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Double-Blind Method; Erythromycin; Gastr

1996
Tropisetron and metoclopramide in the prevention of postoperative nausea and vomiting. A comparative, placebo controlled study in patients undergoing ophthalmic surgery.
    Anaesthesia, 1996, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Aged; Anesthesia, General; Antiemetics; Double-Blind Method; Female; Humans; Indo

1996
Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study.
    Bone marrow transplantation, 1996, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Antiemetics; Antineoplastic Agents; Female; Granisetron; Hematopoietic Stem Cell

1996
The antiemetic efficacy of tropisetron plus dexamethasone as compared with conventional metoclopramide-dexamethasone combination in Orientals receiving cisplatin chemotherapy: a randomized crossover trial.
    British journal of clinical pharmacology, 1996, Volume: 41, Issue:5

    Topics: Antiemetics; Antineoplastic Agents; Asian People; Cisplatin; Cross-Over Studies; Dexamethasone; Diph

1996
[Colonic preparation with sodium phosphate. Prospective, randomized, placebo-controlled double blind study with various antiemetics].
    Schweizerische medizinische Wochenschrift, 1996, Aug-06, Volume: 126, Issue:31-32

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Cathartics; Cisapride

1996
Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:5

    Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms;

1996
Comparison of dexamethasone and metoclopramide as antiemetics in children receiving cancer chemotherapy.
    Indian pediatrics, 1996, Volume: 33, Issue:4

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cr

1996
Treatment of postoperative nausea and vomiting: comparison of propofol, droperidol and metoclopramide.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1996, Volume: 43, Issue:2

    Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Female; Humans; Male; Metoclopramide; Middle Ag

1996
Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1996, Volume: 43, Issue:3

    Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Granisetron; H

1996
Posttonsillectomy vomiting. Ondansetron or metoclopramide during paediatric tonsillectomy: are two doses better than one?
    Paediatric anaesthesia, 1996, Volume: 6, Issue:1

    Topics: Analysis of Variance; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics, Inhalation; Anes

1996
Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen.
    Journal of pain and symptom management, 1996, Volume: 11, Issue:3

    Topics: Aged; Antiemetics; Antineoplastic Agents; Female; Humans; Male; Metoclopramide; Nausea; Neoplasms; R

1996
Comparison of ondansetron and metoclopramide for the prevention of post-operative nausea and vomiting after major gynaecological surgery.
    European journal of anaesthesiology, 1996, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Analgesics, Opioid; Antiemetics; Double-Blind Method; Female; Humans; Hysterectom

1996
Prophylactic antiemetics for laparoscopic cholecystectomy: ondansetron versus droperidol plus metoclopramide.
    Anesthesia and analgesia, 1996, Volume: 83, Issue:5

    Topics: Adrenergic Agonists; Adult; Antiemetics; Atropine; Chemoprevention; Cholecystectomy, Laparoscopic; C

1996
A randomized double-blinded comparison of metoclopramide, ondansetron and cyclizine in day-case laparoscopy.
    Anaesthesia and intensive care, 1996, Volume: 24, Issue:5

    Topics: Adult; Ambulatory Surgical Procedures; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics,

1996
Prospective, randomized, double-blind, placebo-controlled comparison of metoclopramide and ondansetron for prevention of posttonsillectomy or adenotonsillectomy emesis.
    Journal of clinical anesthesia, 1996, Volume: 8, Issue:7

    Topics: Adenoidectomy; Analgesics; Anesthesia, Inhalation; Anesthetics, Inhalation; Antiemetics; Child; Chil

1996
Antiemetic efficacy of granisetron and metoclopramide in children undergoing ophthalmic or ENT surgery.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1996, Volume: 43, Issue:11

    Topics: Adenoidectomy; Antiemetics; Child; Child, Preschool; Double-Blind Method; Granisetron; Humans; Metoc

1996
Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Com

1997
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1997, Volume: 5, Issue:1

    Topics: Acute Disease; Alcoholism; Antiemetics; Antineoplastic Agents; Basal Ganglia Diseases; Cisplatin; Do

1997
Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section.
    Anesthesia and analgesia, 1997, Volume: 84, Issue:2

    Topics: Acupressure; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Doub

1997
Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin.
    Internal medicine (Tokyo, Japan), 1996, Volume: 35, Issue:12

    Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy

1996
A comparison of prophylactic ondansetron and metoclopramide administration in patients undergoing major neurosurgical procedures.
    Anaesthesia, 1996, Volume: 51, Issue:12

    Topics: Antiemetics; Double-Blind Method; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Neurosu

1996
Antiemetic activity of ondansetron in acute gastroenteritis.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:1

    Topics: Acute Disease; Antiemetics; Child; Child, Preschool; Diarrhea; Female; Fluid Therapy; Gastroenteriti

1997
Comparison of metoclopramide and ondansetron for the prevention of nausea and vomiting after intrathecal morphine.
    European journal of anaesthesiology, 1997, Volume: 14, Issue:2

    Topics: Aged; Analgesics, Opioid; Antiemetics; Blood Pressure; Double-Blind Method; Female; Hip; Humans; Inj

1997
A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Seminars in oncology, 1994, Volume: 21, Issue:5 Suppl 9

    Topics: Adult; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Dopamine Antagonists; Double-Bl

1994
Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Seminars in oncology, 1994, Volume: 21, Issue:5 Suppl 9

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Dopamine Antagonists; Drug Therapy,

1994
Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
    Seminars in oncology, 1994, Volume: 21, Issue:5 Suppl 9

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Dopamine Antagonists; Femal

1994
Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Seminars in oncology, 1994, Volume: 21, Issue:5 Suppl 9

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Dopamine Antagonists; Drug Therapy,

1994
Combination effect of granisetron and methylprednisolone for preventing emesis induced by cytotoxic agents.
    Gynecologic and obstetric investigation, 1997, Volume: 43, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Granisetron; Humans; Hydroxyi

1997
Efficacy of ondansetron and metoclopramide for preventing postoperative emesis following strabismus surgery in children.
    Anaesthesia, 1997, Volume: 52, Issue:5

    Topics: Age Distribution; Antiemetics; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infant;

1997
[Does oral ondansetron reduce the incidence of nausea and vomiting after surgery for strabismus in children?].
    Annales francaises d'anesthesie et de reanimation, 1996, Volume: 15, Issue:7

    Topics: Administration, Oral; Adolescent; Antiemetics; Child; Female; Humans; Male; Metoclopramide; Nausea;

1996
Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis--JCOG study 9413.
    British journal of cancer, 1997, Volume: 76, Issue:1

    Topics: Antiemetics; Cisplatin; Dexamethasone; Female; Granisetron; Humans; Lung Neoplasms; Male; Metoclopra

1997
Comparison of ondansetron, metoclopramide and placebo as premedicants to reduce nausea and vomiting after major surgery.
    Anaesthesia, 1997, Volume: 52, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Double-Blind Method; Female; Humans; Male;

1997
Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting.
    Anesthesia and analgesia, 1997, Volume: 85, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Anesthesia Recovery Period; Anesthetics, Intravenous; Antiemet

1997
Prevention of PONV with granisetron, droperidol and metoclopramide in female patients with history of motion sickness.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1997, Volume: 44, Issue:8

    Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Mi

1997
Prophylactic intravenous ondansetron in patients undergoing cataract extraction under general anesthesia.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1997, Volume: 211, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia, General; Antiemetics; Cataract Extraction; C

1997
The effect of antiemetics and reduced radiation fields on acute gastrointestinal morbidity of adjuvant radiotherapy in stage I seminoma of the testis: a randomized pilot study.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1997, Volume: 9, Issue:4

    Topics: Acute Disease; Adult; Antiemetics; Diarrhea; Gastrointestinal Diseases; Humans; Lymphatic Metastasis

1997
Comparison of three tropisetron-containing antiemetic regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nausea.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1997, Volume: 5, Issue:5

    Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Administration S

1997
A randomized, double-blind, placebo controlled comparison of droperidol, ondansetron, and metoclopramide for the prevention of vomiting following outpatient strabismus surgery in children.
    Journal of clinical anesthesia, 1997, Volume: 9, Issue:7

    Topics: Ambulatory Surgical Procedures; Antiemetics; Child; Child, Preschool; Double-Blind Method; Droperido

1997
Ondansetron compared with metoclopramide in the treatment of established postoperative nausea and vomiting. The French Ondansetron Study Group.
    British journal of anaesthesia, 1997, Volume: 79, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia, General; Antiemetics; Double-Blind Method; F

1997
Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1997, Volume: 45, Issue:2

    Topics: Adult; Antiemetics; Dose-Response Relationship, Drug; Humans; Indoles; Male; Metoclopramide; Nausea;

1997
Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1997, Volume: 45, Issue:2

    Topics: Administration, Oral; Aerosols; Antiemetics; Carbon Dioxide; Disease-Free Survival; Dose Fractionati

1997
Comparison of ondansetron, metoclopramide, and placebo in the prevention of postoperative emesis in children undergoing ophthalmic surgery.
    CRNA : the clinical forum for nurse anesthetists, 1997, Volume: 8, Issue:4

    Topics: Adolescent; Antiemetics; Child; Child, Preschool; Eye Diseases; Humans; Infant; Metoclopramide; Onda

1997
Ondansetron dose response curve in high-risk pediatric patients.
    Journal of clinical anesthesia, 1997, Volume: 9, Issue:8

    Topics: Adenoidectomy; Antiemetics; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind

1997
Ondansetron is not superior to moderate dose metoclopramide in the prevention of post-operative nausea and vomiting after minor gynaecological surgery.
    European journal of anaesthesiology, 1997, Volume: 14, Issue:6

    Topics: Adult; Antiemetics; Dilatation and Curettage; Double-Blind Method; Female; Gynecologic Surgical Proc

1997
Prevention of nausea and vomiting in female patients undergoing breast surgery: a comparison with granisetron, droperidol, metoclopramide and placebo.
    Acta anaesthesiologica Scandinavica, 1998, Volume: 42, Issue:2

    Topics: Adult; Antiemetics; Breast Neoplasms; Double-Blind Method; Droperidol; Female; Granisetron; Humans;

1998
Prevention of PONV with granisetron, droperidol or metoclopramide in patients with postoperative emesis.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1998, Volume: 45, Issue:2

    Topics: Adult; Double-Blind Method; Droperidol; Female; Gastrointestinal Agents; Granisetron; Humans; Metocl

1998
International, multicentre, placebo-controlled study to evaluate the effectiveness of ondansetron vs. metoclopramide in the prevention of post-operative nausea and vomiting.
    European journal of anaesthesiology, 1998, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Anesthesia, General; Antiemetics; Double-Blind Method; Female; Gynecologic Surgic

1998
Prophylactic therapy with granisetron in the prevention of vomiting after paediatric surgery. A randomized, double-blind comparison with droperidol and metoclopramide.
    Paediatric anaesthesia, 1998, Volume: 8, Issue:2

    Topics: Antiemetics; Child; Child, Preschool; Double-Blind Method; Droperidol; Female; Granisetron; Humans;

1998
Anti-emetic efficacy of prophylactic granisetron, droperidol and metoclopramide in the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled trial.
    European journal of anaesthesiology, 1998, Volume: 15, Issue:2

    Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Droperidol; Female; Gr

1998
Prevention of postoperative nausea and vomiting in female patients during menstruation: comparison of droperidol, metoclopramide and granisetron.
    British journal of anaesthesia, 1998, Volume: 80, Issue:2

    Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Gynecologic Surgical Proce

1998
Prophylactic metoclopramide administered immediately after the induction of anesthesia has no effect on the incidence of postoperative emesis after strabismus surgery.
    Indian pediatrics, 1998, Volume: 35, Issue:3

    Topics: Anesthesia, General; Antiemetics; Chi-Square Distribution; Child; Child, Preschool; Double-Blind Met

1998
Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer.
    Cancer, 1998, Sep-15, Volume: 83, Issue:6

    Topics: Adult; Aged; Antiemetics; Chlorpromazine; Dexamethasone; Drug Therapy, Combination; Female; Humans;

1998
Prophylactic antiemetics for laparoscopic cholecystectomy: a comparison of perphenazine, droperidol plus ondansetron, and droperidol plus metoclopramide.
    Journal of clinical anesthesia, 1998, Volume: 10, Issue:6

    Topics: Adult; Aged; Antiemetics; Cholecystectomy, Laparoscopic; Double-Blind Method; Droperidol; Female; Hu

1998
Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.
    European journal of pediatrics, 1998, Volume: 157, Issue:10

    Topics: Antiemetics; Antineoplastic Agents; Child; Diphenhydramine; Drug Therapy, Combination; Female; Human

1998
Oral cisapride for the control of delayed vomiting following high-dose cisplatin.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:1

    Topics: Abdominal Pain; Administration, Oral; Aged; Antiemetics; Antineoplastic Agents; Cisapride; Cisplatin

1999
Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    American journal of clinical oncology, 1999, Volume: 22, Issue:2

    Topics: Acute Disease; Adult; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Co

1999
Granisetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting after thyroidectomy.
    The Laryngoscope, 1999, Volume: 109, Issue:4

    Topics: Adult; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Mi

1999
[Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron].
    Bulletin du cancer, 1999, Volume: 86, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Breast Neoplasms; Drug Therapy, Combination; Female;

1999
Sulpiride versus metoclopramide in nononcologic patients with vomiting or nausea.
    Journal of clinical gastroenterology, 1999, Volume: 29, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Dose-Response Relationship, Drug; Double-Bl

1999
[Postoperative nausea and vomiting after laparoscopic cholecystectomy].
    Annales francaises d'anesthesie et de reanimation, 1999, Volume: 18, Issue:6

    Topics: Adult; Antiemetics; Cholecystectomy, Laparoscopic; Humans; Metoclopramide; Middle Aged; Nausea; Post

1999
Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy.
    Journal of pain and symptom management, 1999, Volume: 18, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Female; Humans; Male; Methylprednisolone; Metoclopramide; Middle

1999
Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study Group.
    European journal of anaesthesiology, 1999, Volume: 16, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Double-Blind Method; Fe

1999
Granisetron, droperidol, and metoclopramide for the treatment of established postoperative nausea and vomiting in women undergoing gynecologic surgery.
    American journal of obstetrics and gynecology, 2000, Volume: 182, Issue:1 Pt 1

    Topics: Adult; Anesthesia, General; Antiemetics; Double-Blind Method; Droperidol; Female; Granisetron; Gynec

2000
Comparative evaluation of the clinical efficacy and safety of ondansetron and metoclopramide in the prophylaxis of emesis induced by cancer chemotherapy regimens including cisplatin.
    The Journal of the Association of Physicians of India, 1996, Volume: 44, Issue:2

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; C

1996
Prophylactic metoclopramide is unnecessary with intravenous analgesia in the ED.
    The American journal of emergency medicine, 2000, Volume: 18, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesia; Analgesics, Opioid; Antiemetics; Double-Blind

2000
High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer.
    Journal of chemotherapy (Florence, Italy), 2000, Volume: 12, Issue:5

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemoth

2000
Effects of i.v. metoclopramide, atropine and their combination on gastric insufflation in children anaesthetized with sevoflurane and nitrous oxide.
    Paediatric anaesthesia, 2001, Volume: 11, Issue:2

    Topics: Anesthesia, General; Anesthetics, Inhalation; Antiemetics; Atropine; Child; Double-Blind Method; Dru

2001
Gastric residual volume in children: a study comparing efficiency of erythromycin and metoclopramide as prokinetic agents.
    British journal of anaesthesia, 2001, Volume: 86, Issue:6

    Topics: Administration, Oral; Adolescent; Antiemetics; Child; Child, Preschool; Double-Blind Method; Erythro

2001
Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2001, Volume: 84, Issue:7

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Chi-Square Distribution; Cisplatin; Dexamethasone;

2001
A pilot study of the use of progressive muscle relaxation training in the management of post-chemotherapy nausea and vomiting.
    European journal of cancer care, 2000, Volume: 9, Issue:4

    Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cost

2000
Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting.
    Kidney & blood pressure research, 2002, Volume: 25, Issue:1

    Topics: Adult; Aged; Antiemetics; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Metoclopram

2002
A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2002, Volume: 10, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Double-Blind Method; Female; Humans

2002
Letter: Metoclopramide in parkinsonism.
    Lancet (London, England), 1975, May-31, Volume: 1, Issue:7918

    Topics: Clinical Trials as Topic; Humans; Levodopa; Metoclopramide; Nausea; Parkinson Disease; Promethazine;

1975
Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
    The Medical journal of Australia, 1979, Dec-15, Volume: 2, Issue:12

    Topics: Antiemetics; Antineoplastic Agents; Child; Clinical Trials as Topic; Double-Blind Method; Dronabinol

1979
Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.
    British journal of clinical pharmacology, 1978, Volume: 6, Issue:4

    Topics: Aged; Blood Pressure; Bromocriptine; Clinical Trials as Topic; Female; Growth Hormone; Humans; Male;

1978
Improvement of life quality in cancer patients undergoing chemotherapy.
    Clinical oncology, 1979, Volume: 5, Issue:1

    Topics: Alopecia; Antineoplastic Agents; Bone Marrow Diseases; Breast Neoplasms; Clinical Trials as Topic; C

1979
A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children.
    Postgraduate medical journal, 1979, Volume: 55 Suppl 1

    Topics: Antiemetics; Benzimidazoles; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method;

1979
Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide.
    Postgraduate medical journal, 1979, Volume: 55 Suppl 1

    Topics: Antiemetics; Benzimidazoles; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Dou

1979
Prevention of postoperative nausea and vomiting by domperidone: A double-blind randomized study using domperidone, metoclopramide and a placebo.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979, Nov-17, Volume: 56, Issue:21

    Topics: Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthesia, Obstetrical; Benzimidazoles; Cli

1979
Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting.
    British medical journal, 1979, Nov-10, Volume: 2, Issue:6199

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Benzimidazoles; Child; Child, Preschool; Female; Hum

1979
Metoclopramide: a review of its pharmacological properties and clinical use.
    Drugs, 1976, Volume: 12, Issue:2

    Topics: Animals; Basal Ganglia Diseases; Cardiovascular System; Central Nervous System; Clinical Trials as T

1976
Oral premedication: diazepam, metoclopramide and a drink.
    Anaesthesia, 1977, Volume: 32, Issue:4

    Topics: Administration, Oral; Adult; Atropine; Diazepam; Drinking; Female; Humans; Injections, Intramuscular

1977
The use of metoclopramide in acute pyloric obstruction. A clinical trial.
    The American journal of gastroenterology, 1975, Volume: 63, Issue:3

    Topics: Adolescent; Adult; Aged; Barium Sulfate; Clinical Trials as Topic; Duodenal Ulcer; Female; Follow-Up

1975
[Clinical experience with Paspertin in gastroenterology].
    Die Medizinische Welt, 1975, Oct-17, Volume: 26, Issue:42

    Topics: Biliary Dyskinesia; Clinical Trials as Topic; Gastrointestinal Diseases; Gastrointestinal Motility;

1975
Fractionated chemotherapy--granisetron or conventional antiemetics? The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A Suppl 1

    Topics: Adult; Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Administration Schedule; Drug Therapy

1992
A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 29A, Issue:1

    Topics: Antiemetics; Cisplatin; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Therapy, Combinati

1992
Effect of sumatriptan, a new selective 5HT1-like agonist, on liquid gastric emptying in man.
    Alimentary pharmacology & therapeutics, 1992, Volume: 6, Issue:6

    Topics: Adult; Double-Blind Method; Fats; Gamma Cameras; Gastric Emptying; Half-Life; Humans; Indoles; Infus

1992
Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet (London, England), 1992, Jul-11, Volume: 340, Issue:8811

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Clinical Protocols; De

1992
Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.
    Drugs, 1992, Volume: 43 Suppl 3

    Topics: Adult; Aged; Antiemetics; Cisplatin; Female; Humans; Indoles; Lorazepam; Male; Metoclopramide; Middl

1992
The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo.
    Seminars in oncology, 1992, Volume: 19, Issue:4 Suppl 10

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Double-Blind Method; Female; Humans; Imidazo

1992
Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide.
    Anesthesia and analgesia, 1992, Volume: 75, Issue:4

    Topics: Adult; Anesthesia, General; Anesthesia, Obstetrical; Antiemetics; Dilatation and Curettage; Double-B

1992
A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:11

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Cisplatin; Female; H

1992
Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy.
    Cancer, 1992, Nov-15, Volume: 70, Issue:10

    Topics: Adolescent; Adult; Cisplatin; Double-Blind Method; Humans; Injections, Intravenous; Male; Metoclopra

1992
Lignocaine vs bupivacaine in prominent ear correction: a controlled trial.
    British journal of plastic surgery, 1992, Volume: 45, Issue:7

    Topics: Acetaminophen; Adolescent; Adult; Anesthesia, General; Anesthesia, Local; Bupivacaine; Child; Child,

1992
Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial.
    Oncology, 1992, Volume: 49, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Dose-Response

1992
Economic evaluation of ondansetron: preliminary analysis using clinical trial data prior to price setting.
    The British journal of cancer. Supplement, 1992, Volume: 19

    Topics: Adult; Aged; Antineoplastic Agents; Costs and Cost Analysis; Double-Blind Method; Drug Industry; Fem

1992
Metoclopramide reduces the incidence of vomiting after tonsillectomy in children.
    Anesthesia and analgesia, 1992, Volume: 75, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Female; Huma

1992
Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9

    Topics: Adult; Aged; Antiemetics; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Therapy, Comb

1992
A double-blinded comparison of metoclopramide and droperidol for prevention of emesis following strabismus surgery.
    Anesthesiology, 1992, Volume: 76, Issue:3

    Topics: Adolescent; Ambulatory Surgical Procedures; Child; Child, Preschool; Double-Blind Method; Droperidol

1992
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients.
    American journal of clinical oncology, 1992, Volume: 15, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dexamethasone; Diphenhydramine; Double-

1992
Comparison of antiemetic effect among ephedrine, droperidol and metoclopramide in pediatric inguinal hernioplasty.
    Ma zui xue za zhi = Anaesthesiologica Sinica, 1992, Volume: 30, Issue:1

    Topics: Antiemetics; Child; Child, Preschool; Droperidol; Drug Evaluation; Ephedrine; Hernia, Inguinal; Huma

1992
[Droperidol versus metoclopramide. Prevention of emesis following strabismus surgery in children].
    Der Anaesthesist, 1992, Volume: 41, Issue:5

    Topics: Child; Child, Preschool; Double-Blind Method; Droperidol; Humans; Metoclopramide; Postoperative Comp

1992
Continuous infusion of high-dose metoclopramide: comparison of pharmacokinetically adjusted and standard doses for the control of cisplatin-induced acute emesis.
    European journal of clinical pharmacology, 1991, Volume: 40, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Resp

1991
Comparison of continuous and intermittent bolus infusions of metoclopramide during 5-day continuous intravenous infusion with cisplatin.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small

1991
Outpatient cholecystectomy simulated in an inpatient population.
    The American surgeon, 1991, Volume: 57, Issue:1

    Topics: Abdomen; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Surgical Procedures; Analgesics; An

1991
Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1990, Volume: 2, Issue:2

    Topics: Abdomen; Adolescent; Adult; Aged; Antiemetics; Double-Blind Method; Female; Humans; Imidazoles; Male

1990
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:9

    Topics: Adolescent; Adult; Antiemetics; Antineoplastic Agents; Diarrhea; Dose-Response Relationship, Drug; D

1991
Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis.
    Oncology, 1991, Volume: 48, Issue:5

    Topics: Antiemetics; Cisplatin; Dexamethasone; Humans; Lorazepam; Metoclopramide; Nausea; Prospective Studie

1991
Metoclopramide does not decrease the incidence of nausea and vomiting after alfentanil for outpatient anaesthesia.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1991, Volume: 38, Issue:8

    Topics: Adult; Alfentanil; Ambulatory Surgical Procedures; Anesthesia, Inhalation; Anesthesia, Intravenous;

1991
Nausea and vomiting after termination of pregnancy as day surgery cases: comparison of 3 different doses of droperidol and metoclopramide as anti-emetic prophylaxis.
    Singapore medical journal, 1991, Volume: 32, Issue:5

    Topics: Abortion, Induced; Adult; Ambulatory Surgical Procedures; Dose-Response Relationship, Drug; Droperid

1991
A comparison of controlled release metoclopramide and domperidone in the treatment of nausea and vomiting.
    The British journal of clinical practice, 1991,Winter, Volume: 45, Issue:4

    Topics: Delayed-Action Preparations; Domperidone; Double-Blind Method; Female; Humans; Male; Metoclopramide;

1991
A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Female; Humans; Imidazoles; Injections, Intr

1991
Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:2

    Topics: Cisplatin; Dexamethasone; Diphenhydramine; Double-Blind Method; Drug Administration Schedule; Drug T

1991
Anti-emetic control with ondansetron in the chemotherapy of breast cancer: a review.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27 Suppl 1

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Double-Blind Method;

1991
Progress in the control of acute and delayed emesis induced by cisplatin.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27 Suppl 1

    Topics: Akathisia, Drug-Induced; Cisplatin; Dystonia; Humans; Imidazoles; Metoclopramide; Ondansetron; Serot

1991
Effects of ondansetron on chemotherapy-induced acute and delayed emesis--a pilot study.
    Acta oncologica (Stockholm, Sweden), 1991, Volume: 30, Issue:5

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Biperiden; Cisplatin; Dexa

1991
The final assessment of a randomized double-blind comparative study of ondansetron vs. metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1991, Volume: 3, Issue:4

    Topics: Abdominal Neoplasms; Adult; Aged; Antiemetics; Double-Blind Method; Humans; Imidazoles; Metocloprami

1991
Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:9

    Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Double-Blind Method; Epirubicin; Female; Humans; Im

1991
Does propofol have an anti-emetic effect? A prospective study of the anti-emetic effect of propofol following laparoscopy.
    Anaesthesia and intensive care, 1991, Volume: 19, Issue:3

    Topics: Adult; Antiemetics; Blood Pressure; Female; Humans; Laparoscopy; Metoclopramide; Nausea; Postoperati

1991
Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:3

    Topics: Antiemetics; Cisplatin; Double-Blind Method; Drug Tolerance; Humans; Infusions, Intravenous; Metoclo

1991
Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
    Acta oncologica (Stockholm, Sweden), 1991, Volume: 30, Issue:5

    Topics: Antineoplastic Agents; Cisplatin; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Methyl

1991
Low dose, oral lorazepam: a safe and effective adjuvant to antiemetic therapy.
    Indian journal of cancer, 1991, Volume: 28, Issue:2

    Topics: Adjuvants, Pharmaceutic; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemothera

1991
Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin.
    Journal of pain and symptom management, 1991, Volume: 6, Issue:8

    Topics: Adult; Aged; Antiemetics; Cisplatin; Diphenhydramine; Drug Therapy, Combination; Female; Humans; Mal

1991
Cinnarizine for prevention of nausea and vomiting during platin chemotherapy.
    Acta oncologica (Stockholm, Sweden), 1991, Volume: 30, Issue:6

    Topics: Adult; Aged; Carboplatin; Cinnarizine; Cisplatin; Combined Modality Therapy; Female; Humans; Lorazep

1991
The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study.
    Oncology, 1991, Volume: 48, Issue:2

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Double-Blind Method; Drug Therapy, Comb

1991
Antiemetic efficacy of droperidol or metoclopramide combined with dexamethasone and diphenhydramine. Randomized open parallel study.
    Oncology, 1991, Volume: 48, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dexamethasone; Diphenhydramine; Droperidol; Drug The

1991
A double-blind randomized cross-over comparison of high-dose prochlorperazine with high-dose metoclopramide for cisplatin-induced emesis.
    Oncology, 1991, Volume: 48, Issue:3

    Topics: Adult; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mal

1991
Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study.
    American journal of clinical oncology, 1991, Volume: 14, Issue:3

    Topics: Cisplatin; Dexamethasone; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Sex Factors; Vo

1991
Antiemetic activity of high-dose methylprednisolone associated with continuous-infusion metoclopramide and oral alprazolam during multiple-day chemotherapy.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprazolam; Antineoplastic Combined Chemotherapy Protoco

1991
High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomiting.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:3

    Topics: Adult; Aged; Cisplatin; Double-Blind Method; Droperidol; Drug Therapy, Combination; Female; Humans;

1991
Betamethasone-dixyrazine versus betamethasone-metoclopramide as antiemetic treatment of cisplatin-doxorubicin-induced nausea in ovarian carcinoma patients.
    European journal of gynaecological oncology, 1991, Volume: 12, Issue:1

    Topics: Activities of Daily Living; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethaso

1991
[Antiemetic treatments associated with antineoplastic chemotherapy].
    Anales de medicina interna (Madrid, Spain : 1984), 1990, Volume: 7, Issue:5

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dox

1990
Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.
    The New England journal of medicine, 1990, Mar-22, Volume: 322, Issue:12

    Topics: Adult; Aged; Antiemetics; Cisplatin; Double-Blind Method; Drug Tolerance; Female; Humans; Imidazoles

1990
A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Brea

1990
A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blind study. International Emesis Study Group.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method;

1990
[Long-term results of the anti-emetic effectiveness of the 5-HT3 antagonist ondansetron].
    Onkologie, 1990, Volume: 13, Issue:4

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dou

1990
Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.
    Annals of internal medicine, 1990, Dec-01, Volume: 113, Issue:11

    Topics: Adult; Aged; Antiemetics; Cisplatin; Double-Blind Method; Female; Humans; Imidazoles; Male; Metoclop

1990
Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26 Suppl 1

    Topics: Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Headache; Humans; Indazole

1990
Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen.
    Journal of pain and symptom management, 1990, Volume: 5, Issue:2

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Diazepam; Diphenhydramine; Drug Therapy, Combination; Humans;

1990
A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
    Cancer, 1990, Aug-01, Volume: 66, Issue:3

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Evaluation; Female; Humans; Lorazep

1990
Ginger root--a new antiemetic. The effect of ginger root on postoperative nausea and vomiting after major gynaecological surgery.
    Anaesthesia, 1990, Volume: 45, Issue:8

    Topics: Adolescent; Adult; Aged; Analgesics; Antiemetics; Double-Blind Method; Female; Genital Diseases, Fem

1990
Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
    The Journal of reproductive medicine, 1990, Volume: 35, Issue:10

    Topics: Administration, Cutaneous; Cisplatin; Female; Genital Neoplasms, Female; Humans; Infusions, Intraven

1990
Randomized, double-blind cross-over study of acute cisplatin-induced nausea and vomiting, comparing a new schedule of the combination of metoclopramide and methylprednisolone versus metoclopramide alone.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:5

    Topics: Adult; Aged; Cisplatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methyl

1990
Comparison of antiemetic activity of chloropromazine and high doses of metoclopramide in cisplatin-based chemotherapy.
    Acta oncologica (Stockholm, Sweden), 1990, Volume: 29, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorpromazine; Cisplatin; Drug Adminis

1990
Metoclopramide reduces the incidence of vomiting following strabismus surgery in children.
    Anesthesiology, 1990, Volume: 72, Issue:2

    Topics: Adolescent; Ambulatory Surgical Procedures; Child; Child, Preschool; Double-Blind Method; Humans; Me

1990
Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo.
    American journal of clinical oncology, 1989, Volume: 12, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dex

1989
Effect of stimulation of the P6 antiemetic point on postoperative nausea and vomiting.
    British journal of anaesthesia, 1989, Volume: 63, Issue:5

    Topics: Acupuncture Points; Acupuncture Therapy; Adolescent; Adult; Anesthesia, General; Cyclizine; Electroa

1989
Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:1

    Topics: Adult; Aged; Antiemetics; Cisplatin; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; D

1989
Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study.
    Oncology, 1989, Volume: 46, Issue:3

    Topics: Adolescent; Adult; Aged; Antiemetics; Chlorpromazine; Cisplatin; Clinical Trials as Topic; Dexametha

1989
Dose-ranging antiemetic trial of high-dose oral metoclopramide.
    American journal of clinical oncology, 1989, Volume: 12, Issue:3

    Topics: Administration, Oral; Adult; Antineoplastic Agents; Clinical Trials as Topic; Diphenhydramine; Drug

1989
Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
    The Journal of pediatrics, 1989, Volume: 115, Issue:1

    Topics: Adolescent; Antineoplastic Agents; Benztropine; Child; Child, Preschool; Chlorpromazine; Clinical Tr

1989
Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model.
    Cancer, 1989, Sep-01, Volume: 64, Issue:5

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Dexamethasone; Doxorubicin; Drug Therapy, Combinat

1989
[A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin].
    Bulletin du cancer, 1989, Volume: 76, Issue:6

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Clorazepate Dipotassium; Cosyntropin; Dexamethason

1989
Metoclopramide versus droperidol for prevention of nausea and vomiting during epidural anesthesia for cesarean section.
    Southern medical journal, 1989, Volume: 82, Issue:10

    Topics: Adult; Akathisia, Drug-Induced; Anesthesia, Epidural; Anesthesia, Obstetrical; Cesarean Section; Dou

1989
The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
    British journal of cancer, 1989, Volume: 60, Issue:5

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Human

1989
Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:11

    Topics: Age Factors; Antiemetics; Cisplatin; Dexamethasone; Diphenhydramine; Drug Administration Schedule; D

1989
Methylprednisolone versus metoclopramide as antiemetic treatment in patients receiving adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) chemotherapy: a randomized crossover blind study.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; F

1989
Antiemetic activity of high-dose metoclopramide combined with methylprednisolone versus metoclopramide alone in dacarbazine-treated cancer patients. A randomized double-blind study of the Italian Oncology Group for Clinical Research.
    American journal of clinical oncology, 1989, Volume: 12, Issue:3

    Topics: Dacarbazine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolon

1989
Does parenteral magnesium sulfate have an antiemetic effect during chemotherapy with cis-platinum?
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:2

    Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Diazepam; Double-Blind Method; Drug Evaluation; Dru

1989
Effective control of moderate-dose cisplatin-induced emesis by a short-course regimen including metoclopramide, chlorpromazine and hydrocortisone: results of a randomized trial with metoclopramide alone.
    Oncology, 1989, Volume: 46, Issue:4

    Topics: Adolescent; Adult; Aged; Antiemetics; Chlorpromazine; Cisplatin; Drug Therapy, Combination; Female;

1989
[Comparative study on the tolerance and efficacy of high doses of metoclopramide and clebopride in vomiting induced by cisplatin].
    Medicina clinica, 1989, Jun-10, Volume: 93, Issue:2

    Topics: Adult; Aged; Antiemetics; Benzamides; Cisplatin; Drug Evaluation; Female; Humans; Male; Metocloprami

1989
Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1989, Volume: 15, Issue:2

    Topics: Antiemetics; Betamethasone; Cisplatin; Double-Blind Method; Doxorubicin; Female; Humans; Male; Metoc

1989
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Clinical Trials as Topic; Dexamethasone; Dronabinol

1988
[Dosage adjustment of metoclopramide for controlling vomiting induced by cisplatin: pharmacokinetic approach].
    Presse medicale (Paris, France : 1983), 1988, Jun-04, Volume: 17, Issue:22

    Topics: Adult; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasm

1988
Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
    Cancer, 1989, Feb-01, Volume: 63, Issue:3

    Topics: Adult; Aged; Amnesia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lor

1989
Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
    Japanese journal of clinical oncology, 1989, Volume: 19, Issue:1

    Topics: Adult; Aged; Antiemetics; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Infus

1989
Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery.
    British journal of anaesthesia, 1986, Volume: 58, Issue:8

    Topics: Abdomen; Adult; Antiemetics; Clinical Trials as Topic; Domperidone; Droperidol; Female; Humans; Hyst

1986
[Randomized controlled study of high-dose metoclopramide and dexamethasone in the prevention of CDDP-induced emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:5

    Topics: Adult; Aged; Anorexia; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Dexamethasone; Dr

1986
A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin.
    Cancer, 1988, Nov-15, Volume: 62, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dexameth

1988
Betamethasone-dixyrazine versus metoclopramide as antiemetic treatment in cancer chemotherapy.
    Acta oncologica (Stockholm, Sweden), 1988, Volume: 27, Issue:4

    Topics: Antiemetics; Antineoplastic Agents; Betamethasone; Clinical Trials as Topic; Double-Blind Method; Hu

1988
A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
    Cancer investigation, 1988, Volume: 6, Issue:5

    Topics: Adult; Aged; Antiemetics; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Female; Humans;

1988
[The effect of metoclopramide on postoperative nausea and vomiting].
    Ugeskrift for laeger, 1988, Jan-18, Volume: 150, Issue:3

    Topics: Abortion, Therapeutic; Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Hum

1988
Continuous infusion metoclopramide: clinical trials, pharmacokinetic considerations and cost-effectiveness.
    Progress in clinical and biological research, 1987, Volume: 248

    Topics: Cisplatin; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Infusions, Intravenous; Metoclop

1987
[Effect of medical vagotomy on the CDDP induced nausea and vomiting evaluated by the chemotherapy-vomiting time (CV time)].
    Nihon Sanka Fujinka Gakkai zasshi, 1988, Volume: 40, Issue:9

    Topics: Acetaminophen; Adult; Cisplatin; Female; Humans; Metoclopramide; Middle Aged; Nausea; Ovarian Neopla

1988
Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide and diphenhydramine.
    British journal of cancer, 1988, Volume: 57, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Dexamethasone; Diphenhydra

1988
A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
    American journal of clinical oncology, 1987, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Aged; Cisplatin; Clinical Trials as Topic; Costs and Cost Analysis; Female; Human

1987
High-dose oral and intravenous metoclopramide in doxorubicin/cyclophosphamide-induced emesis. A randomized double-blind study.
    American journal of clinical oncology, 1987, Volume: 10, Issue:3

    Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method;

1987
Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam.
    Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dexamethasone;

1987
A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin.
    Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:4

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Dexamethasone; Drug Therapy, Combination; Female;

1987
[Antiemetic effects of combinations of metoclopramide, droperidol and dexamethasone for the prevention of cisplatin-induced gastro-intestinal toxicity: a randomized crossover trial].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:7

    Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as

1987
High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis.
    Pharmacology & toxicology, 1987, Volume: 60, Issue:5

    Topics: Adult; Aged; Chlorpromazine; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Kinetic

1987
Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMF.
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:6

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as To

1987
[A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:10

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Dexamethasone; Drug Therapy, Combination; Female;

1987
Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
    Cancer, 1987, Dec-01, Volume: 60, Issue:11

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Dexamethasone; Diphenhydramine; Double-Blind Metho

1987
Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
    Cancer treatment reports, 1987, Volume: 71, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Com

1987
A randomised cross-over trial comparing low-dose metoclopramide and chlorpromazine with high-dose metoclopramide in Chinese patients with advanced cancer receiving cisplatinum and 5-fluorouracil.
    Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorpromazine; Cisplatin; Clinical Tri

1987
A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:12

    Topics: Administration, Cutaneous; Antiemetics; Antineoplastic Agents; Cisplatin; Clinical Trials as Topic;

1987
High-dose metoclopramide by infusion: a double-blind study of plasma concentration-effect relationships in patients receiving cancer chemotherapy.
    European journal of clinical pharmacology, 1987, Volume: 33, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Doub

1987
[The effect of metoclopramide, dexamethasone and antihistamine in the prevention of PAC chemotherapy-induced emesis].
    Nihon Sanka Fujinka Gakkai zasshi, 1988, Volume: 40, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; D

1988
High-dose versus low-dose metoclopramide in the prevention of cisplatin-induced emesis. A randomized crossover study in patients with ovarian carcinoma.
    Cancer, 1988, Jun-15, Volume: 61, Issue:12

    Topics: Adult; Aged; Cisplatin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Metoc

1988
High-dose dexamethasone and high-dose metoclopramide versus high-dose dexamethasone and sulpiride in the management of cisplatin-induced emesis.
    Oncology, 1988, Volume: 45, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dexamethasone;

1988
Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.
    Clinical pharmacy, 1988, Volume: 7, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Cisplatin; Female; Humans; Infusions, Intravenous; Injections, Intra

1988
Methylprednisolone versus metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide methotrexate 5-fluorouracil: a double-blind randomized study.
    Oncology, 1988, Volume: 45, Issue:5

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclopho

1988
Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto

1986
[Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
    Deutsche medizinische Wochenschrift (1946), 1986, Jan-24, Volume: 111, Issue:4

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cis

1986
Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation.
    Journal of clinical pharmacology, 1986, Volume: 26, Issue:2

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Electric Stimulation; Female;

1986
The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
    Clinical pharmacology and therapeutics, 1986, Volume: 39, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Do

1986
Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:3

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dexamethasone

1986
The antiemetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial.
    Cancer, 1986, Aug-15, Volume: 58, Issue:4

    Topics: Adult; Chlorpromazine; Cisplatin; Clinical Trials as Topic; Dexamethasone; Diphenhydramine; Drug Adm

1986
The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technology.
    Progress in clinical and biological research, 1986, Volume: 216

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dexamethasone;

1986
Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following gynaecological surgery in day cases.
    British journal of anaesthesia, 1986, Volume: 58, Issue:8

    Topics: Adolescent; Adult; Aged; Ambulatory Surgical Procedures; Antiemetics; Clinical Trials as Topic; Dila

1986
[Randomized crossover trial of the antiemetic effects obtained with metoclopramide and droperidol versus those obtained with metoclopramide, droperidol and methylprednisolone in patients receiving cis-platinum chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:8

    Topics: Aged; Cisplatin; Clinical Trials as Topic; Droperidol; Drug Therapy, Combination; Female; Humans; Lu

1986
[The treatment of vomiting caused by the administration of cytostatic agents].
    Nederlands tijdschrift voor geneeskunde, 1986, Aug-16, Volume: 130, Issue:33

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Humans; Loraz

1986
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1986, Volume: 9, Issue:4

    Topics: Antineoplastic Agents; Anxiety; Gastrointestinal Diseases; Humans; Methylprednisolone; Methylprednis

1986
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:1

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials

1987
High doses of metoclopramide or droperidol in the prevention of cisplatin-induced emesis.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:10

    Topics: Cisplatin; Clinical Trials as Topic; Droperidol; Head and Neck Neoplasms; Humans; Lung Neoplasms; Ma

1986
Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesis.
    Oncology, 1987, Volume: 44, Issue:2

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Doxorubicin; Dru

1987
Antiemetic therapy in patients treated with high-dose cytosine arabinoside.
    Oncology, 1987, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Cytarabine; Drug Therapy,

1987
Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:12

    Topics: Adult; Aged; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methylpred

1986
Metoclopramide as prophylaxis for nausea and vomiting induced by fluorescein.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1987, Volume: 105, Issue:5

    Topics: Female; Fluorescein Angiography; Humans; Male; Metoclopramide; Middle Aged; Nausea; Vomiting

1987
[Metoclopramide plus diphenhydramine compared with chlorpromazine in cisplatin-induced vomiting. Randomized, crossed and double-blind study].
    Medicina clinica, 1987, Oct-03, Volume: 89, Issue:10

    Topics: Adult; Aged; Chlorpromazine; Cisplatin; Diphenhydramine; Double-Blind Method; Drug Therapy, Combinat

1987
Examination of the correlation of serum metoclopramide levels with antiemetic efficacy in patients receiving cisplatin.
    Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; C

1987
[Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:7

    Topics: Adult; Aged; Cisplatin; Droperidol; Drug Administration Schedule; Female; Humans; Male; Methylpredni

1986
Antiemetic combination for cisplatin-induced emesis. Results from a controlled study.
    Bulletin du cancer, 1986, Volume: 73, Issue:3

    Topics: Adult; Aged; Cisplatin; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Hum

1986
Droperidol, alizapride and metoclopramide in the prevention and treatment of post-operative emetic sequelae.
    European journal of anaesthesiology, 1986, Volume: 3, Issue:1

    Topics: Adolescent; Adult; Droperidol; Drug Evaluation; Female; Humans; Intraoperative Care; Metoclopramide;

1986
Antiemetic effect and pharmacokinetics of high dose metoclopramide in cancer patients treated with cisplatin-containing chemotherapy regimens.
    European journal of clinical pharmacology, 1986, Volume: 31, Issue:1

    Topics: Adult; Cisplatin; Female; Half-Life; Humans; Kinetics; Male; Metoclopramide; Middle Aged; Neoplasms;

1986
Oral bioavailability of high-dose metoclopramide.
    European journal of clinical pharmacology, 1986, Volume: 31, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Biological Availability; Half-Life; Humans; Kinetics; Metoclopra

1986
Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
    British medical journal (Clinical research ed.), 1986, Nov-22, Volume: 293, Issue:6558

    Topics: Adult; Aged; Cisplatin; Female; Humans; Infusions, Parenteral; Male; Metoclopramide; Middle Aged; Na

1986
[Anti-emetic treatment with metoclopramide and other drugs during CDDP therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:1

    Topics: Aged; Cisplatin; Dexamethasone; Female; Humans; Lorazepam; Lung Neoplasms; Male; Metoclopramide; Mid

1987
Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis.
    Cancer investigation, 1986, Volume: 4, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Double-Blind Method

1986
The effect of administration rate on cisplatin-induced emesis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:4

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule;

1985
[Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:4

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Female; Humans; Infusions, Parenteral; Male; Metoc

1985
The evaluation of domperidone and metoclopramide as antiemetics in day care abortion patients.
    British journal of clinical pharmacology, 1985, Volume: 19, Issue:3

    Topics: Abortion, Therapeutic; Adolescent; Adult; Anesthesia, General; Anesthesia, Obstetrical; Clinical Tri

1985
Combination antiemetic therapy in cisplatin-induced nausea and vomiting.
    Cancer, 1985, Jun-01, Volume: 55, Issue:11

    Topics: Adult; Aged; Antiemetics; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Ge

1985
Comparative evaluation of two outpatient antiemetic regimens for cancer chemotherapy.
    Texas medicine, 1985, Volume: 81, Issue:7

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Dexamethasone; Humans; Metoclopramide; Nausea; Neop

1985
Clinical pharmacokinetics of high-dose metoclopramide in cancer patients receiving cisplatin therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:10

    Topics: Adult; Aged; Cisplatin; Clinical Trials as Topic; Dexamethasone; Drug Therapy, Combination; Female;

1985
[Metoclopramide in the prevention of nausea and vomiting caused by cytostatics].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1985, May-15, Volume: 38, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Humans; Mal

1985
Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
    Cancer treatment reports, 1985, Volume: 69, Issue:12

    Topics: Adult; Age Factors; Aged; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Female; Humans;

1985
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
    Cancer treatment reports, 1985, Volume: 69, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Cisplatin; Clinical Trials as

1985
Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs.
    British medical journal (Clinical research ed.), 1985, Feb-23, Volume: 290, Issue:6468

    Topics: Chlorpromazine; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Injections

1985
Comparison of the antiemetics metoclopramide and promethazine in labour.
    British medical journal (Clinical research ed.), 1985, Apr-20, Volume: 290, Issue:6476

    Topics: Clinical Trials as Topic; Consciousness; Double-Blind Method; Female; Humans; Meperidine; Metoclopra

1985
Pharmacokinetic studies of high-dose metoclopramide with and without forced diuresis.
    Klinische Wochenschrift, 1985, Jun-18, Volume: 63, Issue:12

    Topics: Adult; Aged; Cisplatin; Diuresis; Dose-Response Relationship, Drug; Female; Humans; Kinetics; Male;

1985
[Randomized controlled study of high-dose metoclopramide (2 mg/kg x 4:H) vs moderate-dose metoclopramide (1 mg/kg x 4:M) in the prevention of CDDP-induced emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:3 Pt 1

    Topics: Aged; Cisplatin; Drug Administration Schedule; Female; Humans; Metoclopramide; Middle Aged; Nausea;

1986
[Benefit and risk of high-dose metoclopramide in comparison to high-dose haloperidol or triflupromazine in cisplatin-induced vomiting].
    Klinische Wochenschrift, 1985, May-02, Volume: 63, Issue:9

    Topics: Cisplatin; Dose-Response Relationship, Drug; Haloperidol; Humans; Metoclopramide; Neoplasms; Risk; T

1985
The use of methylprednisolone and metoclopramide in control of emesis in patients receiving cis-platinum.
    Gynecologic oncology, 1985, Volume: 21, Issue:3

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Double-Blind Me

1985
Antiemetic efficacy of moderately high-dose metoclopramide in patients receiving varying doses of cisplatin. Controlled comparison with a combination of methylprednisolone and metoclopramide.
    Oncology, 1985, Volume: 42, Issue:6

    Topics: Adult; Cisplatin; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Humans; Male; Met

1985
Antiemetic activity of metoclopramide versus alizapride during cancer chemotherapy.
    Tumori, 1985, Dec-31, Volume: 71, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Metoclopramid

1985
Studies of drugs given before anaesthesia. XXII: Metoclopramide.
    British journal of anaesthesia, 1974, Volume: 46, Issue:7

    Topics: Adult; Blood Pressure; Consciousness; Diazepam; Gastrointestinal Motility; Humans; Hypnotics and Sed

1974
Flatulent dyspepsia.
    Postgraduate medical journal, 1973, Volume: 49 Suppl 4

    Topics: Clinical Trials as Topic; Dyspepsia; Female; Flatulence; Gastroesophageal Reflux; Heartburn; Humans;

1973
An evaluation of metoclopramide as an anti-emetic in seasickness.
    Postgraduate medical journal, 1973, Volume: 49 Suppl 4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Humans; Hypnotics a

1973
The effect of intra-muscular metoclopramide on gastric emptying during labour.
    Postgraduate medical journal, 1973, Volume: 49 Suppl 4

    Topics: Anesthesia, Obstetrical; Clinical Trials as Topic; Female; Gastrointestinal Motility; Humans; Inject

1973
The anti-emetic effect of metoclopramide with an account of some experiments to assess the effect of the drug on gastric emptying in early labour.
    Postgraduate medical journal, 1973, Volume: 49 Suppl 4

    Topics: Anesthesia, Obstetrical; Female; Gastrointestinal Motility; Humans; Inhalation; Labor, Obstetric; Me

1973

Other Studies

276 other studies available for metoclopramide and Emesis

ArticleYear
Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides.
    Journal of medicinal chemistry, 1992, Mar-06, Volume: 35, Issue:5

    Topics: Animals; Antiemetics; Benzamides; Benzofurans; Binding, Competitive; Bridged Bicyclo Compounds; Brid

1992
Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
    Journal of medicinal chemistry, 1992, Mar-06, Volume: 35, Issue:5

    Topics: Amides; Animals; Antiemetics; Benzamides; Benzofurans; Bridged Bicyclo Compounds; Bridged Bicyclo Co

1992
Extrapyramidal signs following a single intravenous dose of metoclopramide in an English Bulldog.
    Veterinary anaesthesia and analgesia, 2021, Volume: 48, Issue:6

    Topics: Administration, Intravenous; Animals; Antiemetics; Basal Ganglia Diseases; Dog Diseases; Dogs; Metoc

2021
GC-MS analysis of organic fractions of Chrozophora tinctoria (L.) A.Juss. and their prokinetic propensity in animal models.
    Brazilian journal of biology = Revista brasleira de biologia, 2022, Volume: 84

    Topics: Acetylcholinesterase; Animals; Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Dimenhydrinat

2022
Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case report.
    Neuropsychopharmacology reports, 2022, Volume: 42, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Antipsychotic Agents; Biperiden; Clonazepam; Dopamine; Humans; M

2022
Area postrema syndrome caused by medullary infarction.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2022, Volume: 31, Issue:9

    Topics: Area Postrema; Female; Humans; Infarction; Metoclopramide; Nausea; Ondansetron; Syndrome; Vomiting

2022
Metoclopramide-induced acute dystonic reaction: A pediatric case report.
    Medicine, 2023, Dec-01, Volume: 102, Issue:48

    Topics: Child; Dyskinesias; Humans; Male; Metoclopramide; Torticollis; Vomiting; Whooping Cough

2023
Comparison of metoclopramide and promethazine for the treatment of postoperative nausea and vomiting in the post-anesthesia care unit: A retrospective database analysis.
    Journal of clinical anesthesia, 2020, Volume: 60

    Topics: Anesthesia; Antiemetics; Double-Blind Method; Humans; Metoclopramide; Ondansetron; Postoperative Nau

2020
Reply to: Olanzapine: Sancho Panza for clinicians who care for patients with advanced cancer.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:4

    Topics: Antiemetics; Humans; Male; Metoclopramide; Nausea; Neoplasms; Olanzapine; Vomiting

2020
Olanzapine versus Metoclopramide for Treatment of Nausea and Vomiting in Advanced Cancer Patients with Incomplete Malignant Bowel Obstruction.
    Journal of palliative medicine, 2020, Volume: 23, Issue:7

    Topics: Antiemetics; Double-Blind Method; Humans; Metoclopramide; Nausea; Neoplasms; Olanzapine; Vomiting

2020
Ondansetron use in early pregnancy and the risk of miscarriage.
    Pharmacoepidemiology and drug safety, 2021, Volume: 30, Issue:2

    Topics: Abortion, Spontaneous; Antiemetics; Female; Humans; Metoclopramide; Ondansetron; Pregnancy; Vomiting

2021
Pregnancy outcome following in-utero exposure to ondansetron: A prospective comparative observational study.
    Reproductive toxicology (Elmsford, N.Y.), 2021, Volume: 99

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antiemetics; Child; Child, Preschool; Female; Heart

2021
Controversies in Gastroparesis: Discussing the Sticky Points.
    The American journal of gastroenterology, 2021, 08-01, Volume: 116, Issue:8

    Topics: Abdominal Pain; Antiemetics; Chronic Disease; Diabetes Complications; Diagnosis, Differential; Diagn

2021
The nature of nausea: prevalence, etiology, and treatment in patients with advanced cancer not receiving antineoplastic treatment.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019, Volume: 27, Issue:8

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Aged, 80 and over; Antiemetics; Female; Humans; M

2019
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019, Volume: 27, Issue:9

    Topics: Adrenal Cortex Hormones; Adult; Analgesics, Opioid; Antiemetics; Antipsychotic Agents; Cross-Section

2019
Intractable Vomiting in a 20-Month-Old Boy.
    Gastroenterology, 2019, Volume: 157, Issue:2

    Topics: Antiemetics; Drug Resistance; Failure to Thrive; Gastric Outlet Obstruction; Gastroscopy; Humans; In

2019
New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
    Journal of clinical epidemiology, 2019, Volume: 116

    Topics: Abnormalities, Drug-Induced; Adult; Antiemetics; Cohort Studies; Dicyclomine; Doxylamine; Drug Combi

2019
Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository.
    The Journal of pharmacy and pharmacology, 2013, Volume: 65, Issue:11

    Topics: Administration, Rectal; Animals; Antiemetics; Delayed-Action Preparations; Dopamine Antagonists; Dru

2013
Cost-effectiveness analysis of granisetron-based versus standard antiemetic regimens in low-emetogenic chemotherapy: a hospital-based perspective from Malaysia.
    Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:12

    Topics: Antiemetics; Antineoplastic Agents; Cost-Benefit Analysis; Dexamethasone; Drug Therapy, Combination;

2013
Long-lasting adverse effects after short-term low-dose treatment with metoclopramide for vomiting.
    International maritime health, 2014, Volume: 65, Issue:1

    Topics: Adult; Antiemetics; Diphenhydramine; Dyskinesias; Female; Gastroenteritis; Humans; Injections, Intra

2014
Confidence-interval construction for rate ratio in matched-pair studies with incomplete data.
    Journal of biopharmaceutical statistics, 2014, Volume: 24, Issue:3

    Topics: Antiemetics; Clinical Trials as Topic; Confidence Intervals; Humans; Likelihood Functions; Matched-P

2014
Managing reflux in infants: lifestyle modifications or medications?
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2014, Volume: 67, Issue:6

    Topics: Antiemetics; Child Development; Disease Management; Esophagitis, Peptic; Gastroesophageal Reflux; Hi

2014
Does Braun enteroenterostomy reduce delayed gastric emptying after pancreaticoduodenectomy?
    Medicine, 2014, Volume: 93, Issue:7

    Topics: Abdominal Abscess; Acupuncture; Anastomotic Leak; Antiemetics; Domperidone; Enterostomy; Erythromyci

2014
Drug treatment of adults with nausea and vomiting in primary care.
    BMJ (Clinical research ed.), 2014, Aug-07, Volume: 349

    Topics: Adult; Antiemetics; Domperidone; Droperidol; Female; Histamine Antagonists; Humans; Male; Metoclopra

2014
Neither ondansetron nor metoclopramide reduced nausea and vomiting in the emergency department.
    Annals of internal medicine, 2014, Dec-16, Volume: 161, Issue:12

    Topics: Antiemetics; Emergency Service, Hospital; Female; Humans; Male; Metoclopramide; Nausea; Ondansetron;

2014
Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.
    Journal of palliative medicine, 2015, Volume: 18, Issue:11

    Topics: Analgesics, Opioid; Antiemetics; Benzodiazepines; Chemoprevention; Domperidone; Health Care Surveys;

2015
[Phytotherapy for control of nausea and vomiting].
    MMW Fortschritte der Medizin, 2015, Dec-14, Volume: 157, Issue:21-22

    Topics: Drug Recalls; Drug Substitution; Humans; Metoclopramide; Nausea; Phytotherapy; Plant Extracts; Plant

2015
Preventing and alleviating patients' symptoms of nausea and vomiting while in the care of the ambulance service - a qualitative study.
    International emergency nursing, 2016, Volume: 28

    Topics: Ambulances; Antiemetics; Emergency Medical Services; Female; Humans; Male; Metoclopramide; Nausea; O

2016
Delayed nausea and vomiting from carboplatin doublet chemotherapy.
    Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:6

    Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Lora

2016
Oligoantiemesis or Inadequate Prescription of Antiemetics in the Emergency Department: A Local and National Perspective.
    The Journal of emergency medicine, 2016, Volume: 50, Issue:6

    Topics: Adult; Antiemetics; Emergency Service, Hospital; Female; Humans; Logistic Models; Male; Metocloprami

2016
Emergency department management of gastro-enteritis in Australia and New Zealand.
    Journal of paediatrics and child health, 2008, Volume: 44, Issue:10

    Topics: Acute Disease; Antiemetics; Australia; Data Collection; Dehydration; Diarrhea; Emergency Medicine; E

2008
Mechanism of the prostanoid TP receptor agonist U46619 for inducing emesis in the ferret.
    Naunyn-Schmiedeberg's archives of pharmacology, 2008, Volume: 378, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Antiemetics; Disease Mo

2008
Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
    Japanese journal of clinical oncology, 2009, Volume: 39, Issue:2

    Topics: Adult; Aged; Antiemetics; Benzimidazoles; Biliary Tract Neoplasms; Chemotherapy, Adjuvant; Female; F

2009
The safety of metoclopramide use in the first trimester of pregnancy.
    The New England journal of medicine, 2009, Jun-11, Volume: 360, Issue:24

    Topics: Abnormalities, Drug-Induced; Antiemetics; Cohort Studies; Female; Fetus; Humans; Infant, Low Birth W

2009
Circulatory collapse in a patient with gastrinoma after metoclopramide administration.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2009, Volume: 15, Issue:6

    Topics: Adolescent; Dopamine Antagonists; Gastrinoma; Humans; Male; Metoclopramide; Nausea; Pancreatic Neopl

2009
Nausea and vomiting in advanced cancer.
    The American journal of hospice & palliative care, 2010, Volume: 27, Issue:3

    Topics: Algorithms; Antiemetics; Causality; Decision Trees; Drug Therapy, Combination; Evidence-Based Medici

2010
Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:7

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Dopamine Antagonists; Health Care Surveys; Humans

2011
Effects of metoclopramide on emesis in cats sedated with xylazine hydrochloride.
    Journal of feline medicine and surgery, 2010, Volume: 12, Issue:12

    Topics: Animals; Antiemetics; Cat Diseases; Cats; Female; Hypnotics and Sedatives; Male; Metoclopramide; Sod

2010
Methylprednisolone reduces postoperative nausea in total knee and hip arthroplasty.
    Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Arthroplasty, Replacement, Hip; Arthroplasty, Replaceme

2010
Comparison the effects of metoclopramide and dropridol associated with dexamethasone on post operative nausea and vomiting.
    Pakistan journal of biological sciences : PJBS, 2010, Dec-15, Volume: 13, Issue:24

    Topics: Adolescent; Adult; Aged; Antiemetics; Dexamethasone; Droperidol; Female; Humans; Male; Metoclopramid

2010
Treatment and assessment of emergency department nausea and vomiting in Australasia: a survey of anti-emetic management.
    Emergency medicine Australasia : EMA, 2011, Volume: 23, Issue:2

    Topics: Antiemetics; Australia; Clinical Protocols; Cross-Sectional Studies; Dopamine Antagonists; Emergency

2011
Type I Brugada electrocardiogram pattern induced by metoclopramide.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:9

    Topics: Brugada Syndrome; Dizziness; Dopamine Antagonists; Flecainide; Humans; Male; Metoclopramide; Middle

2011
Treatment of severe nausea and vomiting of pregnancy with subcutaneous medications.
    American journal of perinatology, 2011, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Antiemetics; Female; Home Infusion Therapy; Humans; Infusions, Subcutaneous; Meto

2011
Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:10

    Topics: Antiemetics; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Casse

2011
Tolerance to enteral nutrition therapy in traumatic brain injury patients.
    Brain injury, 2012, Volume: 26, Issue:9

    Topics: Adult; Aged; Antiemetics; Brain Injuries; Cross-Sectional Studies; Domperidone; Enteral Nutrition; E

2012
Hypoglossal nerve palsy after extensive vomiting.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012, Volume: 19, Issue:5

    Topics: Adult; Antiemetics; Early Diagnosis; Female; Humans; Hypoglossal Nerve Diseases; Hypoglossal Nerve I

2012
Conservative management in a rare case of spontaneous bilateral cerebellar haemorrhage.
    BMJ case reports, 2012, Jun-14, Volume: 2012

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetazolamide; Adult; Antiemetics; Cerebellum; Diuretics, O

2012
Antiemetics for acute gastroenteritis-related vomiting in children and adolescents.
    American family physician, 2012, Jun-01, Volume: 85, Issue:11

    Topics: Acute Disease; Adolescent; Antiemetics; Child; Dimenhydrinate; Gastroenteritis; Humans; Metocloprami

2012
Impact of data by Fujii and colleagues on the meta-analysis of metoclopramide for antiemetic prophylaxis in women undergoing Caesarean delivery under neuraxial anaesthesia.
    British journal of anaesthesia, 2012, Volume: 109, Issue:5

    Topics: Anesthesia, Obstetrical; Anesthesia, Spinal; Antiemetics; Cesarean Section; Female; Humans; Intraope

2012
Is there an association between PONV and chemotherapy-induced nausea and vomiting?
    Acta anaesthesiologica Scandinavica, 2013, Volume: 57, Issue:6

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Breast Neoplasms;

2013
Metoclopramide-induced supersensitivity psychosis.
    The Annals of pharmacotherapy, 2002, Volume: 36, Issue:9

    Topics: Aged; Antiemetics; Antipsychotic Agents; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Hallucina

2002
Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study.
    American journal of perinatology, 2002, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Antiemetics; Brazil; Canada; Case-Control Studies; Congenital Abnormalities; Dopa

2002
Low incidence of nausea and vomiting with intravenous opiate analgesia in the ED.
    The American journal of emergency medicine, 2002, Volume: 20, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Double-Blind Method; Em

2002
[A new vomiting animal model--mink].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2003, Volume: 38, Issue:2

    Topics: Animals; Antiemetics; Apomorphine; Cisplatin; Copper Sulfate; Disease Models, Animal; Male; Metoclop

2003
[With evidence-based phytotherapy. Takes away gastric and intestinal irritation].
    MMW Fortschritte der Medizin, 2003, Mar-27, Volume: 145, Issue:13

    Topics: Antiemetics; Cisapride; Clinical Trials as Topic; Dopamine Antagonists; Evidence-Based Medicine; Gas

2003
Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew).
    European journal of pharmacology, 2005, Jan-31, Volume: 508, Issue:1-3

    Topics: Animals; Antiemetics; Butanols; Capsaicin; Cyclooxygenase Inhibitors; Dihydroergotamine; Diphenhydra

2005
Tolerability of the compound ABHR in hospice patients.
    Journal of palliative medicine, 2005, Volume: 8, Issue:6

    Topics: Aged; Antiemetics; Cohort Studies; Diphenhydramine; Drug Combinations; Female; Haloperidol; Hospice

2005
Value of mink vomit model in study of anti-emetic drugs.
    World journal of gastroenterology, 2006, Feb-28, Volume: 12, Issue:8

    Topics: Animals; Antiemetics; Apomorphine; Cisplatin; Copper Sulfate; Disease Models, Animal; Enterochromaff

2006
Anaphylaxis during treatment of nausea and vomiting: IgE-mediated metoclopramide allergy.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:10

    Topics: Adult; Anaphylaxis; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Immunoglobulin E

2006
A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosis.
    Southern medical journal, 2006, Volume: 99, Issue:11

    Topics: Adolescent; Antiemetics; Diphenhydramine; Dopamine Antagonists; Dystonia; Female; Fundoplication; Hi

2006
Please treat me with metoclopramide.
    Emergency medicine journal : EMJ, 2007, Volume: 24, Issue:10

    Topics: Adult; Antiemetics; Humans; Male; Metoclopramide; Patient Participation; Pyloric Stenosis; Treatment

2007
Metoclopramide: extrapyramidal symptoms in children.
    Prescrire international, 2007, Volume: 16, Issue:91

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Child; Humans; Metoclopramide; Nausea; Netherlands; Vo

2007
Antiemetics.
    British journal of hospital medicine, 1984, Volume: 32, Issue:2

    Topics: Age Factors; Aged; Antiemetics; Cisplatin; Dronabinol; Humans; Metoclopramide; Vomiting

1984
Can metoclopramide reveal Huntington's disease?
    Lancet (London, England), 1982, Nov-20, Volume: 2, Issue:8308

    Topics: Adolescent; Female; Humans; Huntington Disease; Male; Metoclopramide; Pedigree; Suppositories; Vomit

1982
Management of chemotherapy-induced nausea and emesis.
    American family physician, 1983, Volume: 27, Issue:1

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Butyrophenones; Cannabinoids; Histamine

1983
[Vomiting accompanying cytostatic treatment, and its control].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1984, Nov-19, Volume: 39, Issue:47

    Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Drug Evaluation; Histamine H1 Antagonists; Humans; M

1984
[Pharmacotherapy of emesis caused by cytostatic agents].
    Nederlands tijdschrift voor geneeskunde, 1982, May-01, Volume: 126, Issue:18

    Topics: Antiemetics; Antineoplastic Agents; Domperidone; Dronabinol; Humans; Metoclopramide; Phenothiazines;

1982
[Is there a proven methods for the prevention of cytostatic-induced vomiting?].
    Krankenpflege. Soins infirmiers, 1982, Issue:12

    Topics: Antiemetics; Appetite; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Humans; Metoclopramide

1982
An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting.
    Clinical radiology, 1984, Volume: 35, Issue:4

    Topics: Adult; Antiemetics; Dronabinol; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Radiother

1984
Antiemetics and cytotoxic drugs.
    British medical journal (Clinical research ed.), 1983, Feb-19, Volume: 286, Issue:6365

    Topics: Antineoplastic Agents; Drug Therapy, Combination; Humans; Metoclopramide; Premedication; Vomiting

1983
Antiemetics and cytotoxic drugs.
    British medical journal (Clinical research ed.), 1983, Mar-26, Volume: 286, Issue:6370

    Topics: Cisplatin; Humans; Metoclopramide; Vomiting

1983
Antiemetics and cytotoxic drugs.
    British medical journal (Clinical research ed.), 1983, Jul-30, Volume: 287, Issue:6388

    Topics: Adult; Antiemetics; Cisplatin; Humans; Metoclopramide; Vomiting

1983
Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy.
    Cancer chemotherapy and pharmacology, 1984, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Female; Huma

1984
Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:9

    Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Ad

1984
[A new solution for orthograde intestinal lavage].
    Minerva medica, 1984, Sep-22, Volume: 75, Issue:36

    Topics: Colonic Diseases; Humans; Intubation, Gastrointestinal; Metoclopramide; Nausea; Polyethylene Glycols

1984
Control of cancer chemotherapy-induced nausea and vomiting.
    Cancer, 1984, Dec-01, Volume: 54, Issue:11 Suppl

    Topics: Antineoplastic Agents; Butyrophenones; Cannabinoids; Drug Therapy, Combination; Glucocorticoids; Hum

1984
Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting.
    British journal of clinical pharmacology, 1984, Volume: 18, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Humans; Infusions, Parenteral; Kinetics; Metoclopramide; M

1984
Optimizing metoclopramide control of cisplatin-induced emesis.
    Annals of internal medicine, 1984, Volume: 100, Issue:3

    Topics: Adult; Aged; Body Weight; Chromatography, High Pressure Liquid; Cisplatin; Diarrhea; Drug Administra

1984
Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:4

    Topics: Administration, Oral; Adult; Cisplatin; Dose-Response Relationship, Drug; Drug Therapy, Combination;

1984
Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen.
    Cancer treatment reports, 1984, Volume: 68, Issue:12

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Diazepam; Dip

1984
[Metoclopramide plasma levels following oral administration of high doses for prophylaxis of emesis in cytostatic therapy].
    Arzneimittel-Forschung, 1984, Volume: 34, Issue:11

    Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Metoclopramide; Vomiting

1984
Metoclopramide: a brief review.
    Cancer nursing, 1983, Volume: 6, Issue:1

    Topics: Drug Interactions; Humans; Metoclopramide; Nausea; Vomiting

1983
Metoclopramide therapy for chemotherapy -- induced nausea and vomiting.
    Oncology nursing forum, 1983,Summer, Volume: 10, Issue:3

    Topics: Antineoplastic Agents; Humans; Metoclopramide; Nausea; Vomiting

1983
Pharmacist on call: I.V. metoclopramide--relief for cancer chemotherapy patients.
    Nursing, 1984, Volume: 14, Issue:4

    Topics: Antineoplastic Agents; Humans; Metoclopramide; Vomiting

1984
[Primperan].
    Soins; la revue de reference infirmiere, 1984, Issue:431

    Topics: Adult; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Metoclopramide; Vomiting

1984
Metoclopramide.
    Journal of the American Veterinary Medical Association, 1983, Dec-01, Volume: 183, Issue:11

    Topics: Animals; Atropine; Cat Diseases; Cats; Central Nervous System; Digestive System; Dog Diseases; Dogs;

1983
[Emesis due to cytostatic drugs. Update and review of our experiences].
    Medicina, 1983, Volume: 43, Issue:6 Pt 1

    Topics: Antineoplastic Agents; Dexamethasone; Haloperidol; Humans; Metoclopramide; Prochlorperazine; Vomitin

1983
Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy.
    The Journal of pediatrics, 1984, Volume: 104, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Child; Dystonia; Female; Humans; Male; Metoclopramide; Nau

1984
Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation.
    Cancer, 1984, Mar-15, Volume: 53, Issue:6

    Topics: Antineoplastic Agents; Diarrhea; Drug Administration Schedule; Drug Evaluation; Humans; Infusions, P

1984
Gastric emptying in patients with diabetes mellitus.
    Gastroenterology, 1984, Volume: 86, Issue:3

    Topics: Adult; Diabetes Mellitus, Type 1; Female; Food; Gastric Emptying; Humans; Male; Metoclopramide; Midd

1984
[New aspects in the antiemetic therapy of cytostatic drug-induced vomiting].
    Klinische Wochenschrift, 1984, May-15, Volume: 62, Issue:10

    Topics: Antiemetics; Antineoplastic Agents; Cannabinoids; Chemoreceptor Cells; Dose-Response Relationship, D

1984
Chronic intestinal pseudo-obstruction.
    Journal of clinical gastroenterology, 1981, Volume: 3, Issue:3

    Topics: Adult; Aged; Celiac Disease; Chronic Disease; Female; Humans; Intestinal Obstruction; Intestinal Pse

1981
High dose metoclopramide as an antiemetic for patients receiving chemotherapy with cis-platinum.
    Oncology nursing forum, 1982,Summer, Volume: 9, Issue:3

    Topics: Adult; Cisplatin; Drug Evaluation; Humans; Metoclopramide; Nausea; Neoplasms; Vomiting

1982
[Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1980, Feb-15, Volume: 105, Issue:7

    Topics: Budd-Chiari Syndrome; Dacarbazine; Humans; Male; Melanoma; Metoclopramide; Middle Aged; Mycobacteriu

1980
Enhanced gastroduodenal motility in children.
    American journal of diseases of children (1960), 1982, Volume: 136, Issue:4

    Topics: Adolescent; Child; Child, Preschool; Diabetic Neuropathies; Gastrointestinal Motility; Humans; Infan

1982
Metoclopramide (Reglan).
    The Medical letter on drugs and therapeutics, 1982, Jul-23, Volume: 24, Issue:614

    Topics: Antineoplastic Agents; Drug Interactions; Gastric Emptying; Humans; Metoclopramide; Vomiting

1982
Acute dystonic reaction to Maxolon (metoclopramide)
    The Medical journal of Australia, 1982, Sep-04, Volume: 2, Issue:5

    Topics: Child; Female; Humans; Metoclopramide; Muscle Cramp; Torticollis; Vomiting

1982
High-dose metoclopramide in cancer chemotherapy-induced nausea and vomiting.
    Cancer treatment reports, 1982, Volume: 66, Issue:12

    Topics: Antineoplastic Agents; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Vomiting

1982
High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial.
    Cancer treatment reports, 1982, Volume: 66, Issue:12

    Topics: Adult; Aged; Dacarbazine; Humans; Metoclopramide; Middle Aged; Vomiting

1982
[High dose metoclopramide during cancer chemotherapy. Phase II study in 80 consecutive patients].
    Bulletin du cancer, 1982, Volume: 69, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Drug Therapy, Combination; Female;

1982
Cisplatin-induced emesis in the Ferret: a new animal model.
    Cancer treatment reports, 1982, Volume: 66, Issue:1

    Topics: Animals; Carnivora; Castration; Cisplatin; Disease Models, Animal; Ferrets; Male; Metoclopramide; Vo

1982
A comparison of droperidol and metoclopramide in the treatment of nausea and vomiting during cis-platinum polichemotherapy in ovarian carcinoma.
    European journal of gynaecological oncology, 1981, Volume: 2, Issue:2

    Topics: Antineoplastic Agents; Cisplatin; Droperidol; Drug Therapy, Combination; Female; Humans; Metoclopram

1981
Experimental study on bromopride pharmacology in vivo. antiemetic activity, effects on intestinal transit, on bloating and on gastric ulcers; basal effects on CNS and interferences with the spontaneous motor activity.
    Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression, 1980, Volume: 21, Issue:1

    Topics: Animals; Antiemetics; Central Nervous System; Dogs; Female; Gastric Emptying; Male; Metoclopramide;

1980
High-dose metoclopramide for chemotherapy-induced nausea and vomiting.
    American journal of hospital pharmacy, 1981, Volume: 38, Issue:9

    Topics: Antineoplastic Agents; Humans; Metoclopramide; Nausea; Vomiting

1981
[Acetonemic vomiting. Treatment and prevention of recurrence].
    ZFA. Zeitschrift fur Allgemeinmedizin, 1980, Apr-10, Volume: 56, Issue:10

    Topics: Acetone; Child; Humans; Metoclopramide; Recurrence; Vomiting

1980
Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery.
    Journal of clinical anesthesia, 1995, Volume: 7, Issue:5

    Topics: Ambulatory Surgical Procedures; Antiemetics; Cost-Benefit Analysis; Costs and Cost Analysis; Droperi

1995
Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:9

    Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Child; Female; Humans;

1995
Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy: effects of antiemetics.
    Journal of clinical pharmacology, 1993, Volume: 33, Issue:8

    Topics: Adult; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Female; Humans; Hydroxyindoleacet

1993
Ondansetron or metoclopramide in children undergoing tonsillectomy.
    Anesthesiology, 1995, Volume: 82, Issue:5

    Topics: Child; Humans; Metoclopramide; Ondansetron; Tonsillectomy; Vomiting

1995
Emesis induced in domestic pigs: a new experimental tool for detection of antiemetic drugs and for evaluation of emetogenic potential of new anticancer agents.
    Journal of pharmacological and toxicological methods, 1994, Volume: 32, Issue:2

    Topics: Animals; Antiemetics; Antineoplastic Agents; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin;

1994
Re-examination of clinical aspects of pharmacoeconomic analysis.
    American journal of hospital pharmacy, 1994, Dec-01, Volume: 51, Issue:23

    Topics: Antineoplastic Agents; Economics, Pharmaceutical; Humans; Metoclopramide; Ondansetron; Pharmacology,

1994
On the relationship between nausea and vomiting in patients undergoing chemotherapy. Italian Group for Antiemetic Research.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1994, Volume: 2, Issue:3

    Topics: Antiemetics; Cisplatin; Confounding Factors, Epidemiologic; Dexamethasone; Diphenhydramine; Factor A

1994
Tropisetron (ICS 205-930) in pediatric oncology: first results in patients refractory to antiemetic metoclopramide-based treatments.
    The American journal of pediatric hematology/oncology, 1994, Volume: 16, Issue:3

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Humans; Indo

1994
Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
    Obstetrics and gynecology, 1994, Volume: 84, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Humans; Metocloprami

1994
Effective control of cisplatin induced emesis by combination drug regimen.
    Indian journal of cancer, 1994, Volume: 31, Issue:1

    Topics: Adult; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Combinations; Female; Follow-Up

1994
Pharmacoeconomic analyses: whose perspective counts and costs the most?
    American journal of hospital pharmacy, 1994, Jun-15, Volume: 51, Issue:12

    Topics: Adult; Cisplatin; Cost-Benefit Analysis; Decision Trees; Drug Evaluation; Humans; Metoclopramide; Na

1994
Cost-effectiveness, not cost containment.
    American journal of hospital pharmacy, 1994, Jun-15, Volume: 51, Issue:12

    Topics: Cisplatin; Cost Control; Cost-Benefit Analysis; Drug Evaluation; Humans; Metoclopramide; Nausea; Ond

1994
Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis.
    British journal of pharmacology, 1993, Volume: 108, Issue:1

    Topics: Animals; Atropine; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; C

1993
The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
    Japanese journal of pharmacology, 1993, Volume: 63, Issue:3

    Topics: Administration, Oral; Animals; Antiemetics; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, He

1993
Antiemetic-induced akathisia in cancer patients receiving chemotherapy.
    The American journal of psychiatry, 1994, Volume: 151, Issue:5

    Topics: Akathisia, Drug-Induced; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Male; Met

1994
[Prokinetic drugs in digestive disorders].
    La Clinica terapeutica, 1993, Volume: 143, Issue:3

    Topics: Antineoplastic Agents; Cisapride; Domperidone; Esophageal Motility Disorders; Gastroesophageal Reflu

1993
The effects of different antiemetic agents on morphine-induced emesis in ferrets.
    European journal of pharmacology, 1993, Sep-07, Volume: 241, Issue:1

    Topics: Anesthesia; Animals; Antiemetics; Droperidol; Ferrets; Granisetron; Injections, Intravenous; Isoflur

1993
Ondansetron versus metoclopramide and droperidol: an unfair comparison.
    Anesthesia and analgesia, 1993, Volume: 77, Issue:3

    Topics: Anesthesiology; Droperidol; Humans; Metoclopramide; Nausea; Ondansetron; Postoperative Complications

1993
Drugs for vomiting caused by cancer chemotherapy.
    The Medical letter on drugs and therapeutics, 1993, Dec-24, Volume: 35, Issue:912

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Humans; Metoclopramide; Ondansetron; Vomiting

1993
Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1993, Volume: 13 Suppl 2

    Topics: Cisapride; Diabetes Mellitus, Type 1; Erythromycin; Female; Gastric Emptying; Hospitalization; Human

1993
Adverse drug reaction to metoclopramide hydrochloride in a macaw with proventricular dilatation syndrome.
    Journal of the American Veterinary Medical Association, 1993, Aug-15, Volume: 203, Issue:4

    Topics: Animals; Bird Diseases; Dilatation, Pathologic; Diphenhydramine; Female; Metoclopramide; Nervous Sys

1993
Potential for combination therapy with the new antiserotonergic agents.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A Suppl 1

    Topics: Antiemetics; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination;

1993
Bionursing: the management of migraine and vomiting.
    Nursing standard (Royal College of Nursing (Great Britain) : 1987), 1996, Jan-31, Volume: 10, Issue:19

    Topics: Aged; Antiemetics; Female; Humans; Methysergide; Metoclopramide; Migraine Disorders; Occupational He

1996
Adverse reactions to metoclopramide (Reglan) presenting as depression in a bone marrow transplant patient.
    Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, 1995, Volume: 4, Issue:6

    Topics: Adult; Akathisia, Drug-Induced; Antiemetics; Antineoplastic Agents; Bone Marrow Transplantation; Dep

1995
Menstrual stage influences postoperative nausea and vomiting following epidural buprenorphine.
    Acta anaesthesiologica Scandinavica, 1996, Volume: 40, Issue:3

    Topics: Adult; Analgesia, Epidural; Analgesics, Opioid; Anesthesia, Epidural; Anesthetics, Local; Antiemetic

1996
Metoclopramide in trauma CT scanning: preventing emesis of oral radiographic contrast.
    The American journal of emergency medicine, 1996, Volume: 14, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Contrast Media; Glasg

1996
Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs.
    Japanese journal of pharmacology, 1996, Volume: 71, Issue:2

    Topics: Animals; Antiemetics; Apomorphine; Benzamides; Benzyl Compounds; Dogs; Domperidone; Dopamine Antagon

1996
Controlling the toxicity of palliative radiotherapy: the role of 5-HT3 antagonists.
    The Canadian journal of oncology, 1996, Volume: 6 Suppl 1

    Topics: Antiemetics; Clinical Trials as Topic; Dopamine Antagonists; Humans; Metoclopramide; Nausea; Neoplas

1996
Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
    Anti-cancer drugs, 1996, Volume: 7, Issue:7

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Epirubicin; Female; Hu

1996
Suspected herbicide toxicosis in a dog.
    Journal of the American Veterinary Medical Association, 1996, Dec-15, Volume: 209, Issue:12

    Topics: 2-Methyl-4-chlorophenoxyacetic Acid; Abdominal Pain; Animals; Anorexia; Antidotes; Antiemetics; Atax

1996
Can vomiting after squint surgery be prevented?
    Anaesthesia and intensive care, 1997, Volume: 25, Issue:1

    Topics: Adult; Antiemetics; Child, Preschool; Female; Humans; Male; Metoclopramide; Ondansetron; Postoperati

1997
Prophylactic antiemetics for laparoscopic cholecystectomy: ondansetron versus droperidol plus metoclopramide.
    Anesthesia and analgesia, 1997, Volume: 84, Issue:4

    Topics: Antiemetics; Cholecystectomy, Laparoscopic; Droperidol; Drug Therapy, Combination; Humans; Metoclopr

1997
Comparison of intravenous granisetron with metoclopramide plus dexamethasone in the prevention of nausea and vomiting associated with emetogenic cytotoxic chemotherapy.
    The Kaohsiung journal of medical sciences, 1997, Volume: 13, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Dexamethasone; Female; Granisetron; Humans; Injections, Intraven

1997
Biphasic emetic response of cyclophosphamide in the ferret.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 58, Issue:1

    Topics: Animals; Antiemetics; Antineoplastic Agents, Alkylating; Cyclophosphamide; Dose-Response Relationshi

1997
Correct choice of anti-emetic.
    Anaesthesia, 1997, Volume: 52, Issue:11

    Topics: Antiemetics; Humans; Metoclopramide; Nausea; Ondansetron; Postoperative Complications; Vomiting

1997
Ondansetron compared with metoclopramide in the treatment of PONV.
    British journal of anaesthesia, 1998, Volume: 80, Issue:3

    Topics: Antiemetics; Drug Therapy, Combination; Humans; Metoclopramide; Nausea; Ondansetron; Postoperative C

1998
Respiratory failure following oral administration of metoclopramide.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:10

    Topics: Administration, Oral; Adult; Antiemetics; Female; Humans; Metoclopramide; Nausea; Respiratory Insuff

1998
An audit of antiemetic use with CMF chemotherapy.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:5

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dex

1998
Cost and cost-effectiveness analysis of ondansetron versus metoclopramide regimens: a hospital perspective from Italy.
    PharmacoEconomics, 1994, Volume: 5, Issue:3

    Topics: Chemotherapy, Adjuvant; Cisplatin; Costs and Cost Analysis; Dexamethasone; Diphenhydramine; Dose-Res

1994
Metoclopramide and acute porphyria.
    Lancet (London, England), 1997, Oct-11, Volume: 350, Issue:9084

    Topics: Antiemetics; Humans; Metoclopramide; Porphyria, Acute Intermittent; Vomiting

1997
Gastroesophageal reflux and pulmonary complication in a neonate.
    Indian pediatrics, 1998, Volume: 35, Issue:7

    Topics: Antiemetics; Apnea; Cisapride; Follow-Up Studies; Gastroesophageal Reflux; Gastrointestinal Agents;

1998
Use of placebos in delayed-emesis studies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:5

    Topics: Antiemetics; Dexamethasone; Humans; Metoclopramide; Neurokinin-1 Receptor Antagonists; Vomiting

1999
Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy.
    International journal of radiation oncology, biology, physics, 1999, Jun-01, Volume: 44, Issue:3

    Topics: Adult; Antiemetics; Domperidone; Drug Administration Schedule; Female; Humans; Incidence; Indoles; M

1999
Prevention of cisplatin-induced emesis by a neurokinin-1-receptor antagonist.
    The New England journal of medicine, 1999, Jun-17, Volume: 340, Issue:24

    Topics: Acetals; Antiemetics; Aprepitant; Cisplatin; Dexamethasone; Humans; Metoclopramide; Morpholines; Neu

1999
Cost-effectiveness and quality of life evaluation of ondansetron and metoclopramide for moderately emetogenic chemotherapy regimens in breast cancer.
    Critical reviews in oncology/hematology, 1999, Volume: 32, Issue:2

    Topics: Antiemetics; Antineoplastic Agents; Breast Neoplasms; Canada; Cost-Benefit Analysis; Humans; Metoclo

1999
Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2000, Volume: 8, Issue:3

    Topics: Adult; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Huma

2000
Anthropometric and pharmacotherapeutic variables on acute emesis induced by cisplatin-containing chemotherapy.
    The Annals of pharmacotherapy, 2000, Volume: 34, Issue:5

    Topics: Acute Disease; Age Factors; Antiemetics; Antineoplastic Agents; Body Weights and Measures; Chlorprom

2000
Pre-emptive metoclopramide and ondansetron for nausea and vomiting associated with iloprost infusions.
    Pharmacy world & science : PWS, 2001, Volume: 23, Issue:3

    Topics: Aged; Antiemetics; Humans; Iloprost; Infusions, Intravenous; Male; Metoclopramide; Nausea; Ondansetr

2001
[Pheochromocytoma with severe paralytic ileus occurred from acute pulmonary edema caused by metoclopramide].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2001, Aug-10, Volume: 90, Issue:8

    Topics: Adrenal Gland Neoplasms; Adult; Antiemetics; Female; Humans; Intestinal Pseudo-Obstruction; Metoclop

2001
An analysis of the antiemetic protection of metoclopramide plus dexamethasone in Chinese patients receiving moderately high emetogenic chemotherapy.
    European journal of cancer care, 2002, Volume: 11, Issue:2

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; China; Cyclophosphamide; Dexamet

2002
Diseases of the alimentary system; Nausea and vomiting.
    British medical journal, 1976, Dec-18, Volume: 2, Issue:6050

    Topics: Antiemetics; Female; Histamine H1 Antagonists; Humans; Metoclopramide; Motion Sickness; Nausea; Phen

1976
Metoclopramide and renal failure.
    Lancet (London, England), 1979, Mar-10, Volume: 1, Issue:8115

    Topics: Dystonia Musculorum Deformans; Humans; Metoclopramide; Uremia; Vomiting

1979
Chlorpromazine, lithium, and metoclopramide: unrecognised synergistic and antagonistic effects.
    Lancet (London, England), 1979, Jul-14, Volume: 2, Issue:8133

    Topics: Adult; Antiemetics; Bipolar Disorder; Chlorpromazine; Drug Antagonism; Drug Synergism; Female; Human

1979
Antagonism of cisplatin induced emesis in the dog.
    Research communications in chemical pathology and pharmacology, 1979, Volume: 23, Issue:1

    Topics: Animals; Antiemetics; Chlorpromazine; Cisplatin; Dogs; Dronabinol; Female; Haloperidol; Indoles; Mal

1979
A single dose of metoclopramide in the control of vomiting from cis-dichlorodiammineplatinum(II) in man.
    Cancer treatment reports, 1978, Volume: 62, Issue:7

    Topics: Cisplatin; Humans; Metoclopramide; Vomiting

1978
Metoclopramide in young children.
    British medical journal, 1978, Dec-16, Volume: 2, Issue:6153

    Topics: Child, Preschool; Dystonia; Humans; Infant; Metoclopramide; Vomiting

1978
[Present status of Primperan in the surgical milieu].
    Semaine des hopitaux. Therapeutique, 1976, Volume: 52, Issue:10

    Topics: Digestion; Humans; Metoclopramide; Postoperative Complications; Preanesthetic Medication; Vomiting

1976
Pharmacological studies of caerulein. II. The possibility of mediation through the central nervous system.
    Japanese journal of pharmacology, 1975, Volume: 25, Issue:3

    Topics: Animals; Apomorphine; Atropine; Blood Pressure; Central Nervous System; Ceruletide; Chlorpromazine;

1975
Letter: Metoclopramide therapy following Ramstedt pyloromyotomy.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1975, Nov-08, Volume: 49, Issue:47

    Topics: Humans; Infant, Newborn; Male; Metoclopramide; Postoperative Care; Pyloric Stenosis; Pylorus; Vomiti

1975
Clinical studies with dopamine-receptor stimulants.
    Psychopharmacologia, 1975, Nov-21, Volume: 44, Issue:3

    Topics: Adult; Apomorphine; Blood Pressure; Dopamine; Female; Hallucinations; Humans; Male; Metoclopramide;

1975
[L-dopa-decarboxylase inhibitor combination preparation (Sinemet) in parkinsonism and syndromes imitating parkinsonism. 1 year's experience with 34 patients].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1976, Feb-10, Volume: 96, Issue:4

    Topics: Aged; Drug Combinations; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Nausea; Parkin

1976
Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in Parkinsonism.
    Psychopharmacologia, 1976, May-28, Volume: 47, Issue:2

    Topics: Adult; Apomorphine; Drug Therapy, Combination; Haloperidol; Humans; Male; Metoclopramide; Parkinson

1976
Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin.
    Journal of pain and symptom management, 1992, Volume: 7, Issue:8

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Female; Humans; M

1992
Control of cisplatin induced emesis--a multidisciplinary intervention strategy.
    Medical oncology and tumor pharmacotherapy, 1992, Volume: 9, Issue:2

    Topics: Adult; Aged; Biperiden; Cisplatin; Female; Humans; Lorazepam; Metoclopramide; Middle Aged; Nausea; O

1992
Prevention of cisplatin-induced emesis. The Italian Group for Antiemetic Research.
    Lancet (London, England), 1992, Oct-17, Volume: 340, Issue:8825

    Topics: Cisplatin; Humans; Metoclopramide; Vomiting

1992
Vagal afferent fibers and peripheral 5-HT3 receptors mediate cisplatin-induced emesis in dogs.
    Japanese journal of pharmacology, 1992, Volume: 59, Issue:2

    Topics: Afferent Pathways; Animals; Cisplatin; Dogs; Female; Indoles; Male; Metoclopramide; Receptors, Serot

1992
Tardive dyskinesia associated with use of metoclopramide in a child.
    The Journal of pediatrics, 1992, Volume: 121, Issue:6

    Topics: Child, Preschool; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Dyskinesia,

1992
Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis.
    European journal of pharmacology, 1992, Nov-10, Volume: 222, Issue:2-3

    Topics: Animals; Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic

1992
Postoperative nausea and vomiting in day-case surgery.
    British journal of anaesthesia, 1992, Volume: 69, Issue:7 Suppl 1

    Topics: Ambulatory Surgical Procedures; Child; Droperidol; Female; Humans; Male; Metoclopramide; Nausea; Pos

1992
Low dose ondansetron and dexamethasone: a cost effective alternative to high dose metoclopramide/dexamethasone/lorazepam in the prevention of acute cisplatin induced emesis.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1992, Volume: 4, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Cost-Benefit Analysis; Dexamethasone; Female

1992
Neuroleptic malignant syndrome associated with metoclopramide antiemetic therapy.
    Gynecologic oncology, 1992, Volume: 44, Issue:2

    Topics: Adenocarcinoma; Antiemetics; Female; Humans; Metoclopramide; Middle Aged; Nausea; Neuroleptic Malign

1992
Management of theophylline overdose patients in the intensive care unit.
    Anaesthesia and intensive care, 1992, Volume: 20, Issue:1

    Topics: Absorption; Adolescent; Adult; Arrhythmias, Cardiac; Charcoal; Critical Care; Drug Overdose; Female;

1992
[Control of cisplatin-induced delayed emesis].
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1991, Volume: 48, Issue:6

    Topics: Cisplatin; Dexamethasone; Female; Humans; Metoclopramide; Time Factors; Vomiting

1991
Acute and delayed emesis after cisplatin-based regimen: description and prevention.
    Oncology, 1991, Volume: 48, Issue:5

    Topics: Acute Disease; Antiemetics; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Humans; Lora

1991
Antiemetic efficacy of alprazolam in carboplatin-induced emesis.
    Chemotherapy, 1991, Volume: 37, Issue:5

    Topics: Administration, Oral; Aged; Alprazolam; Carboplatin; Drug Therapy, Combination; Female; Humans; Infu

1991
Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:6

    Topics: Animals; Antiemetics; Benzimidazoles; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocy

1991
[Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam].
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1991, Volume: 47, Issue:2

    Topics: Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lorazepam; Metoclopramide; Vomi

1991
Serotonin antagonists: a new class of antiemetic agents.
    Journal of the National Cancer Institute, 1991, May-01, Volume: 83, Issue:9

    Topics: Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Granise

1991
General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
    Arzneimittel-Forschung, 1991, Volume: 41, Issue:6

    Topics: Animals; Apomorphine; Bethanechol Compounds; Cisapride; Conditioning, Operant; Diarrhea; Dogs; Gastr

1991
Compounding nausea aid.
    American pharmacy, 1991, Volume: NS31, Issue:7

    Topics: Benztropine; Chemistry, Pharmaceutical; Dexamethasone; Diphenhydramine; Drug Combinations; Drug Comp

1991
Vomiting and chemotherapy.
    Lancet (London, England), 1990, Feb-03, Volume: 335, Issue:8684

    Topics: Adult; Age Factors; Antiemetics; Child; Cisplatin; Humans; Metoclopramide; Middle Aged; Vomiting

1990
The actions of fenfluramine and interaction with 5-HT3 receptor-antagonists to inhibit emesis in the ferret.
    The Journal of pharmacy and pharmacology, 1990, Volume: 42, Issue:2

    Topics: Animals; Antiemetics; Cisplatin; Fenclonine; Fenfluramine; Ferrets; Indoles; Male; Metoclopramide; R

1990
Familial dyskinesia following single dose metoclopramide.
    The Journal of the Association of Physicians of India, 1990, Volume: 38, Issue:10

    Topics: Adult; Diet, Vegetarian; Dyskinesia, Drug-Induced; Female; Humans; Male; Metoclopramide; Middle Aged

1990
[Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
    Gan no rinsho. Japan journal of cancer clinics, 1990, Volume: 36, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Therapy, Combination;

1990
Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:3

    Topics: Administration, Oral; Animals; Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo C

1990
[A combined anti-emesis therapy of oral prednisolone and alprazolam for cisplatin-induced delayed emesis].
    Gan no rinsho. Japan journal of cancer clinics, 1990, Volume: 36, Issue:8

    Topics: Administration, Oral; Adult; Aged; Alprazolam; Antineoplastic Combined Chemotherapy Protocols; Carci

1990
A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
    Oncology, 1990, Volume: 47, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Diphenhydramine; Drug Eval

1990
A nursing narrative.
    The Australian nurses' journal. Royal Australian Nursing Federation, 1990, Volume: 20, Issue:1

    Topics: Acute Disease; Adult; Humans; Male; Metoclopramide; Nausea; Pancreatitis; Seizures; Vomiting

1990
The neuroleptic malignant syndrome.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1990, Volume: 2, Issue:4

    Topics: Adult; Female; Haloperidol; Humans; Metoclopramide; Neuroleptic Malignant Syndrome; Postoperative Co

1990
Patient-controlled antiemesis for cancer chemotherapy-induced nausea and vomiting.
    Journal of pain and symptom management, 1990, Volume: 5, Issue:6

    Topics: Adolescent; Adult; Antiemetics; Antineoplastic Agents; Droperidol; Evaluation Studies as Topic; Huma

1990
[Trial with a new anti-nausea regime].
    Fag tidsskriftet sykepleien, 1990, Nov-15, Volume: 78, Issue:8

    Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Drug Therapy, Combination; Humans; Metoclopramide

1990
Combination metoclopramide and diphenhydramine short infusion for prevention of chemotherapy-induced emesis.
    American journal of clinical oncology, 1990, Volume: 13, Issue:2

    Topics: Diphenhydramine; Drug Therapy, Combination; Humans; Metoclopramide; Vomiting

1990
A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatin.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26, Issue:3

    Topics: Acupuncture Therapy; Adult; Aged; Cisplatin; Combined Modality Therapy; Dexamethasone; Diphenhydrami

1990
Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:3

    Topics: Animals; Antiemetics; Behavior, Animal; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compo

1990
Prevention of cisplatin-induced vomiting in patients with cancer. A pilot study with a multiagent protocol.
    Tumori, 1990, Jun-30, Volume: 76, Issue:3

    Topics: Cisplatin; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Neoplasms; Pilot Project

1990
[Evaluation of antiemetic effect of clonazepam, metoclopramide, dexamethasone and diphenhydramine for prevention of cisplatin-induced vomiting].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 1

    Topics: Adult; Antiemetics; Cisplatin; Clonazepam; Dexamethasone; Diphenhydramine; Female; Humans; Metoclopr

1990
[Intrapleural administration of CDDP against malignant pleural effusions in breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9

    Topics: Aged; Breast Neoplasms; Cisplatin; Female; Humans; Hydrocortisone; Infusions, Intravenous; Mastectom

1990
Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomiting.
    Arzneimittel-Forschung, 1989, Volume: 39, Issue:11

    Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Metoclopramide; Nausea; Neoplas

1989
[Antiemetic efficacy of betamethasone versus betamethasone combined with metoclopramide in cisplatin-treated cancer patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 1

    Topics: Adult; Aged; Antiemetics; Betamethasone; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Fema

1989
[Management of vomiting induced by polychemotherapy in Hodgkin's disease].
    Orvosi hetilap, 1989, Jun-25, Volume: 130, Issue:26

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Halop

1989
[The antiemetic effect and clinical evaluation of metoclopramide alone and combined with betamethasone in children with malignant tumor].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:11

    Topics: Adolescent; Adrenal Cortex; Antineoplastic Agents; Betamethasone; Child; Child, Preschool; Drug Eval

1989
Hormonal responses of metoclopramide-treated subjects experiencing nausea or emesis during parabolic flight.
    Aviation, space, and environmental medicine, 1987, Volume: 58, Issue:9 Pt 2

    Topics: Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Epinephrine; Humans; Metoclopramide; Motio

1987
Recurrent attacks of vomiting, hypertension and psychotic depression: a syndrome of periodic catecholamine and prostaglandin discharge.
    Acta endocrinologica, 1988, Volume: 117, Issue:2

    Topics: Adolescent; Adrenocorticotropic Hormone; Arginine Vasopressin; Child, Preschool; Clonidine; Dinopros

1988
Treatment of common minor ailments.
    British medical journal (Clinical research ed.), 1986, Dec-13, Volume: 293, Issue:6561

    Topics: Acetaminophen; Antacids; Antiemetics; Aspirin; Dyspepsia; Female; Heartburn; Histamine H1 Antagonist

1986
[Emesis induced by cisplatin and sulfato-1, sulfato-1,2-diaminocyclohexane platinum in dogs and their antiemetics].
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1986, Volume: 7, Issue:2

    Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Diphenhydramine; Dogs; Drug Therapy, Combina

1986
BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 244, Issue:3

    Topics: Animals; Antiemetics; Apomorphine; Cisplatin; Cyclophosphamide; Dogs; Doxorubicin; Female; Ferrets;

1988
The use of metoclopramide in treatment of cisplatin-induced emesis.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1986, Volume: 95, Issue:3 Pt 1

    Topics: Cisplatin; Humans; Metoclopramide; Vomiting

1986
The action of dazopride to enhance gastric emptying and block emesis.
    Neuropharmacology, 1987, Volume: 26, Issue:7A

    Topics: Animals; Benzamides; Callitrichinae; Dopamine Antagonists; Electric Stimulation; Ferrets; Gastric Em

1987
[Effect of metoclopramide in a subject at risk for Huntington's chorea].
    Journal de genetique humaine, 1985, Volume: 33, Issue:2

    Topics: Adolescent; Female; Humans; Huntington Disease; Metoclopramide; Pedigree; Risk; Vomiting

1985
[Metoclopramide].
    Krankenpflege Journal, 1988, Sep-01, Volume: 26, Issue:9

    Topics: Humans; Metoclopramide; Vomiting

1988
Domperidone: an alternative to metoclopramide.
    Drug and therapeutics bulletin, 1988, Jul-25, Volume: 26, Issue:15

    Topics: Acute Disease; Adolescent; Adult; Child; Domperidone; Humans; Metoclopramide; Nausea; Vomiting

1988
Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis.
    British journal of cancer, 1987, Volume: 56, Issue:2

    Topics: Animals; Antineoplastic Agents; Apomorphine; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Ci

1987
The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.
    Quarterly journal of experimental physiology (Cambridge, England), 1988, Volume: 73, Issue:1

    Topics: Animals; Antiemetics; Apomorphine; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Carnivora; C

1988
Managing chemotherapy-induced emesis.
    The American journal of nursing, 1988, Volume: 88, Issue:3

    Topics: Antineoplastic Agents; Humans; Infusions, Parenteral; Injections, Subcutaneous; Metoclopramide; Vomi

1988
Silent regurgitation in day case gynaecological patients.
    Anaesthesia, 1988, Volume: 43, Issue:4

    Topics: Adult; Ambulatory Surgical Procedures; Female; Gastroesophageal Reflux; Genital Diseases, Female; Hu

1988
Emesis and cancer chemotherapy.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Humans

1988
Oral metoclopramide with or without diphenhydramine: potential for prevention of late nausea and vomiting induced by cisplatin.
    Journal of the National Cancer Institute, 1988, Aug-03, Volume: 80, Issue:11

    Topics: Adolescent; Adult; Age Factors; Aged; Cisplatin; Diphenhydramine; Female; Humans; Male; Metocloprami

1988
Combination of glucagon and low-dose metoclopramide in management of cisplatin-induced nausea and vomiting.
    Journal of the National Cancer Institute, 1988, Aug-17, Volume: 80, Issue:12

    Topics: Cisplatin; Drug Therapy, Combination; Glucagon; Humans; Metoclopramide; Nausea; Vomiting

1988
[Antiemetic efficacy of high-dose metoclopramide, diphenhydramine, methylprednisolone and diazepam on chemotherapy-induced emesis in gynecological malignancy].
    Nihon Sanka Fujinka Gakkai zasshi, 1988, Volume: 40, Issue:7

    Topics: Adult; Aged; Cisplatin; Diazepam; Diphenhydramine; Drug Therapy, Combination; Female; Genital Neopla

1988
Effects of preoperative metoclopramide and droperidol on postoperative nausea and vomiting in ambulatory surgery patients.
    AANA journal, 1988, Volume: 56, Issue:4

    Topics: Adult; Ambulatory Surgical Procedures; Droperidol; Female; Humans; Metoclopramide; Nausea; Postopera

1988
[The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine].
    Nihon Sanka Fujinka Gakkai zasshi, 1987, Volume: 39, Issue:11

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dex

1987
[Metoclopramide, methylprednisolone and flunitrazepam in cytostatic-induced vomiting].
    Schweizerische medizinische Wochenschrift, 1987, Dec-26, Volume: 117, Issue:52

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Female; Flun

1987
Safety and antiemetic effects of metoclopramide in metrizamide myelography.
    Clinical pharmacy, 1987, Volume: 6, Issue:10

    Topics: Adult; Double-Blind Method; Female; Humans; Male; Metoclopramide; Metrizamide; Myelography; Nausea;

1987
Treatment of pseudopregnancy with bromocriptin, an ergot alkaloid.
    The Veterinary record, 1986, Aug-23, Volume: 119, Issue:8

    Topics: Animals; Bromocriptine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Lactation; Metoclopra

1986
A comparison of metoclopramide vs. droperidol/phenobarbital for emesis induced by chemotherapy.
    The American journal of the medical sciences, 1987, Volume: 293, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Droperido

1987
Administration of metoclopramide for prevention of nausea and vomiting during epidural anesthesia for elective cesarean section.
    Anesthesiology, 1987, Volume: 66, Issue:4

    Topics: Anesthesia, Epidural; Cesarean Section; Female; Fentanyl; Gestational Age; Humans; Metoclopramide; M

1987
Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:12

    Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Cisplatin; Dose-Response Relationship, Drug; Humans

1986
[Effectiveness of high-dose metoclopramide in the control of acute emesis induced by chemotherapy].
    Medicina clinica, 1987, Mar-14, Volume: 88, Issue:10

    Topics: Antineoplastic Agents; Humans; Metoclopramide; Vomiting

1987
Vomiting after ophthalmic surgery. Effects of intra-operative antiemetics and postoperative oral fluid restriction.
    Anaesthesia, 1987, Volume: 42, Issue:3

    Topics: Adult; Antiemetics; Drinking; Droperidol; Female; Humans; Male; Metoclopramide; Middle Aged; Ophthal

1987
Evaluation of ethanol as an antiemetic in patients receiving cisplatin.
    Clinical therapeutics, 1987, Volume: 9, Issue:4

    Topics: Cisplatin; Ethanol; Female; Humans; Infusions, Intravenous; Male; Metoclopramide; Nausea; Neoplasms;

1987
High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study.
    Oncology, 1987, Volume: 44, Issue:4

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplati

1987
Metoclopramide-induced neuroleptic malignant syndrome.
    Archives of internal medicine, 1987, Volume: 147, Issue:8

    Topics: Adult; Diabetes Mellitus, Type 1; Female; Humans; Metoclopramide; Nausea; Neuroleptic Malignant Synd

1987
Efficacy of continuous high-dose metoclopramide in patients receiving daily cisplatin infusions.
    Cancer treatment reports, 1987, Volume: 71, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethas

1987
Prochlorperazine and vomiting after eye surgery.
    Anaesthesia, 1987, Volume: 42, Issue:8

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Droperidol; Drug Therapy, Combination; Humans; Inf

1987
Antiemetic effects of metoclopramide (M) continuous infusion (CI): safety, efficacy, patient preference, and cost reduction.
    Progress in clinical and biological research, 1987, Volume: 248

    Topics: Cisplatin; Humans; Infusions, Intravenous; Metoclopramide; Nausea; Neoplasms; Vomiting

1987
Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility.
    Digestive diseases and sciences, 1986, Volume: 31, Issue:5

    Topics: Animals; Benzamides; Cisplatin; Dogs; Dose-Response Relationship, Drug; Female; Gastrointestinal Mot

1986
Effect of diphenhydramine on the antiemetic action of metoclopramide against cisplatin-induced emesis in dogs.
    Cancer treatment reports, 1986, Volume: 70, Issue:7

    Topics: Animals; Behavior, Animal; Central Nervous System Diseases; Cisplatin; Diphenhydramine; Dogs; Metocl

1986
[Antiemetic inefficacy of high intravenous doses of metoclopramide by short-term infusion in vomiting induced by antineoplastic chemotherapy].
    Medicina clinica, 1986, Jun-28, Volume: 87, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Infusions, Parenteral; Metoclop

1986
Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses.
    Oncology, 1986, Volume: 43, Issue:5

    Topics: Adult; Aged; Cisplatin; Dexamethasone; Drug Combinations; Female; Humans; Male; Metoclopramide; Midd

1986
Metoclopramide-induced parkinsonism in hemodialysis patients. Report of two cases.
    Archives of internal medicine, 1986, Volume: 146, Issue:10

    Topics: Adult; Aged; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Metoclopramide;

1986
5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis.
    Neuropharmacology, 1986, Volume: 25, Issue:8

    Topics: Animals; Antiemetics; Cisplatin; Ferrets; Indoles; Male; Metoclopramide; Receptors, Serotonin; Tropi

1986
Diabetes mellitus: gastrointestinal complications.
    Comprehensive therapy, 1986, Volume: 12, Issue:11

    Topics: Blood Glucose; Cholecystitis; Cholelithiasis; Diabetes Complications; Diabetic Neuropathies; Esophag

1986
[Evaluation of an antiemetic regimen with a high-dose metoclopramide, dexamethasone and diphenhydramine combination in chemotherapy regimens with cisplatin].
    Medicina clinica, 1986, Dec-06, Volume: 87, Issue:19

    Topics: Antiemetics; Cisplatin; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Humans; Metoclopr

1986
[Experimental study on the control of cisplatin-induced emesis in dogs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:3 Pt 1

    Topics: Analysis of Variance; Animals; Cisplatin; Dogs; Metoclopramide; Nausea; Vagotomy; Vomiting

1987
Metoclopramide versus chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs.
    British medical journal (Clinical research ed.), 1985, Apr-20, Volume: 290, Issue:6476

    Topics: Chlorpromazine; Humans; Metoclopramide; Nausea; Vomiting

1985
Metoclopramide as an antiemetic agent in pediatric oncology patients.
    Drug intelligence & clinical pharmacy, 1986, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Child; Female; Humans; Male; Metoclopramide; Neoplasms; Vo

1986
Antiemetic effect of high-dose metoclopramide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:3

    Topics: Antineoplastic Agents; Humans; Metoclopramide; Vomiting

1986
Continuous infusion of metoclopramide for prevention of chemotherapy-induced emesis.
    Clinical pharmacy, 1986, Volume: 5, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Dacarbazine; Female; Humans; Infusions, Parenteral; M

1986
Anaesthesia and emesis. Clinical usefulness of metoclopramide.
    Canadian Anaesthetists' Society journal, 1985, Volume: 32, Issue:2

    Topics: Adult; Anesthesia; Humans; Metoclopramide; Postoperative Complications; Vomiting

1985
[Primperan: recent pharmacological data on its gastromotor effect].
    Annales de gastroenterologie et d'hepatologie, 1985, May-28, Volume: 21, Issue:2 Pt 2

    Topics: Gastrointestinal Motility; Humans; Metoclopramide; Vomiting

1985
[Primperan during pregnancy].
    Annales de gastroenterologie et d'hepatologie, 1985, May-28, Volume: 21, Issue:2 Pt 2

    Topics: Female; Heartburn; Humans; Metoclopramide; Pneumonia, Aspiration; Pregnancy; Pregnancy Complications

1985
[Value of primperan in digestive studies].
    Annales de gastroenterologie et d'hepatologie, 1985, May-28, Volume: 21, Issue:2 Pt 2

    Topics: Biopsy; Digestive System; Endoscopy; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; I

1985
Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis.
    Clinical pharmacology and therapeutics, 1985, Volume: 37, Issue:1

    Topics: Adult; Cisplatin; Dose-Response Relationship, Drug; Humans; Infusions, Parenteral; Kinetics; Male; M

1985
[Cisplatin drug therapy. Antiemetic treatment. Experiences with the use of high-dose metoclopramide combined with chlopromazine and prochlorperazine].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1985, Jan-20, Volume: 105, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorpromazine; Cisplatin; Dose-Response Relat

1985
Parkinsonism following i.v. administration of high-dose metoclopramide used as an antiemetic agent during cancer chemotherapy.
    Cancer treatment reports, 1985, Volume: 69, Issue:3

    Topics: Abdominal Neoplasms; Adenocarcinoma; Aged; Cisplatin; Female; Humans; Metoclopramide; Nausea; Ovaria

1985
High-dose metoclopramide as an antiemetic in patients receiving cis-platinum-based combination chemotherapy.
    Gynecologic oncology, 1985, Volume: 21, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Female; Humans; Male; Metoclopr

1985
High-dose intravenous metoclopramide and intermittent intramuscular prochlorperazine and diazepam in the management of emesis induced by cis-dichlorodiammineplatinum.
    Cancer chemotherapy and pharmacology, 1985, Volume: 14, Issue:3

    Topics: Antiemetics; Cisplatin; Diazepam; Drug Therapy, Combination; Humans; Injections, Intramuscular; Meto

1985
Lack of antiemetic effect of high-dose metoclopramide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Humans;

1985
[Antiemetic combination of metoclopramide and methylprednisolone for cisplatin-induced vomiting].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:10

    Topics: Aged; Cisplatin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lung Neopl

1985
Review of the current status of prokinetic agents in gastroenterology.
    The American journal of gastroenterology, 1985, Volume: 80, Issue:12

    Topics: Benzamides; Chemical Phenomena; Chemistry; Cisapride; Dexamethasone; Digestive System; Domperidone;

1985
The relationship between steady state metoclopramide levels and control of emesis during treatment with cis-platinum.
    British journal of clinical pharmacology, 1985, Volume: 20, Issue:4

    Topics: Cisplatin; Humans; Kinetics; Metoclopramide; Nausea; Vomiting

1985
Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis.
    European journal of clinical pharmacology, 1985, Volume: 29, Issue:3

    Topics: Basal Ganglia Diseases; Cisplatin; Dose-Response Relationship, Drug; Hemodynamics; Humans; Metoclopr

1985
Sequential therapy with lithium in chemotherapy-induced vomiting.
    Tumori, 1985, Dec-31, Volume: 71, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Domperidone; Drug Evaluatio

1985
Metoclopramide in prevention of postanaesthetic vomiting.
    Journal of the Indian Medical Association, 1985, Volume: 83, Issue:8

    Topics: Adolescent; Adult; Aged; Anesthesia, Inhalation; Female; Humans; Male; Metoclopramide; Middle Aged;

1985
Triple tetracycline ('Deteclo') as a single dose oral treatment of uncomplicated gonorrhoea in the male.
    Current medical research and opinion, 1973, Volume: 1, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Chlortetracycline; Demeclocycline; Diarrhea; Drug Combinati

1973
Hyperthyroidism presenting with acute abdominal symptoms.
    The Practitioner, 1974, Volume: 212, Issue:1268

    Topics: Abdomen, Acute; Adult; Antacids; Body Weight; Carbimazole; Colic; Diarrhea; Female; Goiter; Hemateme

1974
Studies of drugs given before anaesthesia. XXIV: Metocloramide with morphine and pethidine.
    British journal of anaesthesia, 1974, Volume: 46, Issue:7

    Topics: Adult; Anxiety; Female; Humans; Infant, Newborn; Meperidine; Metoclopramide; Morphine; Nausea; Prean

1974
The premedicant and anti-emetic action of metoclopramide.
    Postgraduate medical journal, 1973, Volume: 49 Suppl 4

    Topics: Atropine; Diazepam; Female; Humans; Hypnotics and Sedatives; Meperidine; Metoclopramide; Nausea; Pre

1973
Metoclopramide--a new pharmacological approach?
    Postgraduate medical journal, 1973, Volume: 49 Suppl 4

    Topics: Animals; Antiemetics; Gastroesophageal Reflux; Gastrointestinal Motility; Humans; Metoclopramide; Vo

1973
The use of metoclopramide in the elderly.
    Postgraduate medical journal, 1973, Volume: 49 Suppl 4

    Topics: Aged; Digitalis; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Geriatrics; Hiccup; Humans;

1973
[Incorrect use of metoclopramide].
    Harefuah, 1974, Apr-15, Volume: 86, Issue:8

    Topics: Humans; Infant; Meningitis; Metoclopramide; Vomiting

1974